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Abstract	  	  
Fascin	   is	   an	   actin-­‐bundling	   protein	   whose	   upregulation	   is	   correlated	   with	   poor	  
prognosis	   in	   cancer.	   Previous	   studies	   have	   shown	   a	   role	   for	   fascin	   in	   regulating	  
assembly	   of	   actin	   bundles	   and	   stability	   of	   adhesion	   structures.	   Fascin	   has	   not	  
previously	   been	   localised	   at	   focal	   adhesions	   and	   the	   mechanisms	   by	   which	   it	  
contributes	   to	   adhesion	   dynamics	   and	   assembly	   is	   still	   unknown.	   The	   aim	   of	   this	  
thesis	   is	   to	   investigate	  whether	   fascin	   regulates	   focal	   adhesion	   (FA)	   dynamics	   and	  
tumour	   cell	   invasion	   through	   control	   of	   actin	   and	   microtubule	   (MT)	   crosstalk.	   To	  
analyse	   this,	   MT	   network	   integrity	   and	   focal	   adhesion	   area	   were	   quantified	   in	  
control,	   fascin	   knockdown	   (KD)	   and	   fascin	   mutant	   rescued	   breast	   carcinoma	   cells	  
treated	  with	  the	  MT-­‐depolymerising	  agent	  nocodazole	  or	  following	  washout	  of	  this	  
drug.	  Fascin	  KD	  cells	  showed	  a	  delay	  in	  the	  recovery	  of	  MT	  re-­‐growth,	  increased	  MT	  
stability	   and	   an	   increase	   in	   FA	   area	   following	   drug	  washout,	   compared	   to	   control	  
cells.	  Both	  events	  were	  rescued	  by	  the	  re-­‐expression	  of	  WT	  and	  S39A	  fascin	  (which	  
constitutively	  associates	  with	  F-­‐actin),	  but	  also	  by	  S39D	   fascin	   (is	  unable	   to	  bind	  F-­‐
actin).	   Interestingly,	  MT	   and	   FA	   assembly	  were	   increased	   compared	   to	   controls	   in	  
cells	   re-­‐expressing	   fascin	   that	   is	  mutated	  within	   a	   recently	   identified	   additional	   c-­‐
terminal	   actin-­‐binding	   domain	   (S274D).	   To	   investigate	   whether	   there	   is	   a	   direct	  
binding	   between	   MT	   and	   fascin	   that	   may	   explain	   these	   altered	   MT	   dynamics,	   I	  
performed	   in	   vitro	  MT	   polymerisation/binding	   assays,	   in	   absence	   and	   presence	   of	  
actin.	  WT	  and	  all	  fascin	  mutants	  showed	  association	  with	  tubulin	  in	  biochemical	  co-­‐
sedimentation	  assays.	  Interestingly,	  S274D	  fascin	  soluble	  fraction	  was	  not	  increased	  
in	   the	   presence	   of	   actin,	   suggesting	   mutations	   in	   this	   actin-­‐binding	   site	   are	  
preferentially	   involved	   in	   controlling	   association	   with	   MT.	   To	   elucidate	   the	  
mechanism	  regulating	  fascin	  binding	  to	  MT	  and	  its	  role	  in	  FA	  dynamics,	  I	  considered	  
the	  Focal	  Adhesion	  Kinase	  (FAK)	  as	  a	  possible	  downstream	  effector.	  I	  found	  fascin	  to	  
form	  a	  complex	  with	  FAK.	  In	  addition	  I	  showed	  fascin-­‐FAK	  complex	  formation	  to	  be	  
dependent	  on	  MT	   cytoskeleton	   integrity/stability	   and	   fascin-­‐binding	   to	   F-­‐actin	   and	  
MT.	   Thus,	   fascin	   regulates	   MT	   and	   adhesion	   dynamics	   coordinating	   the	   actin-­‐MT	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1.1.	  Overview	  of	  cell	  migration	  
	  
Cell	   migration	   is	   a	   complex	   process	   executed	   by	   all	   nucleated	   cell	   types	   and	   it	   is	  
central	   in	   tissue	   formation	   and	   development.	   Indeed,	   embryonic	   development,	  
wound	   healing	   and	   immune	   responses	   all	   require	   the	   orchestrated	   movement	   of	  
cells	  towards	  a	  specific	  direction	  to	  a	  precise	  site	  of	  the	  tissue/organism	  (Friedl	  et	  al.	  
2012).	   Disruptions	   in	   the	   maintenance	   of	   these	   processes	   results	   in	   different	  
pathological	   states	  such	  as	  vascular	  diseases,	  mental	   retardation,	  cancer	   formation	  
and	  metastasis.	  Thus,	  a	  better	  understanding	  of	   the	  molecular	  mechanisms	  driving	  
cell	   migration	   may	   provide	   therapeutic	   strategies	   to	   controlling	   some	   of	   these	  
diseases	  such	  as	  tumour	  progression.	  	  
Cells	  respond	  to	  a	  variety	  of	  external	  and	  internal	  signals	  to	  acquire	  the	  capability	  to	  
move.	  Chemical	  and	  mechanical	  signals	  coming	  from	  the	  environment	  together	  with	  
cell-­‐specific	  features	  contribute	  to	  the	  complexity	  of	  movement	  acquisition	  (Wolf	  et	  
al.	  2003).	  Moreover,	  different	  modes	  and	  mechanisms	  of	  motility	  have	  been	  studied	  
and	  describe	  the	  movement	  of	  a	  single	  cell	  or	  the	  collective	  motion	  of	  several	  cells	  as	  
a	   group	   (Van	   Zijl	   et	   al.	   2011).	   Although	   these	   molecular	   features	   are	   specific	   for	  
certain	  types	  of	  cells	  and	  tissue	  environment,	  they	  represent	  multiple	  variants	  of	  the	  
same	  cytoskeletal	  dynamics	  (Lämmermann	  &	  Sixt	  2009).	  
	  
1.1.1.	  Molecular	  models	  for	  cell	  migration	  
	  
Cells	   must	   dynamically	   modify	   their	   interactions	   with	   other	   cells	   and/or	   the	  
extracellular	   environment	   to	   acquire	   motile	   capabilities.	   A	   single	   cell	   modifies	   its	  
shape	   and	   stiffness	   to	   interact	   with	   the	   surrounding	   extracellular	   matrix	   (ECM)	  
(Geiger	   et	   al.	   2001).	   Live	   cell	   imaging	   experiments	   have	   shown	   a	   moving	   cell	  
undergoes	   several	   cell	   shape	   changes,	   but	   also	   generally	   displays	   a	   prominent	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edge	  of	  the	  cell	  provides	  a	  polarized	  protruding	  force	  to	  push	  the	  cell	  and	  enable	  it	  
to	  move	  forward	  (Insall	  &	  Machesky	  2009;	  Ridley	  2011).	  	  
	  
Two	  models	  have	  been	  proposed	  to	  explain	  how	  cells	  move:	  the	  cytoskeletal	  model	  
and	  the	  membrane	  flow	  model	  (Bretscher	  1996)(Figure	  1.1).	  The	  cytoskeletal	  model	  
proposes	   that	   cells	   become	   elongated	   and	   organise	   flat	   sheets	   of	   membrane	  
enriched	   in	   highly	   dynamic	   polymerised	   actin	   filaments	   at	   the	   front	   known	   as	  
lamellipodia	  (Small	  et	  al.	  2002)	  (Figure	  1.1a).	  These	  membrane	  protrusions	  increase	  
adhesion	   and	   promote	   increased	   mechanical	   tension	   within	   the	   cell	   that	   act	   to	  
stabilise	  adhesions	  and	  increase	  contraction	  of	  the	  cell	  rear	  (Small	  et	  al.	  2002).	  More	  
structured,	   parallel	   actin	   filaments	   known	  as	   filopodia	   and	   stress	   fibers	   also	   act	   to	  
drive	   the	   coupling	   of	   adhesions	   and	   the	   actin	   cytoskeleton	   at	   the	   leading	   edge	  
(Ridley	   et	   al.	   2003).	   ECM	   ligands	   are	   linked	   to	   the	   cell	  membrane	   via	   interactions	  
with	   the	   integrin	   family	   of	   heterodimeric	   transmembrane	   receptors.	   These	   ECM	  
receptors,	  together	  with	  multiple	  adhesion	  components	  (red	  circles	   in	  Figure	  1.1a),	  
form	  a	  strong	  bond	  between	   the	  cell	  and	   the	  ECM,	  which	  generate	   traction	   forces	  
and	  a	  molecular	  flow	  towards	  the	  leading	  edge	  (Insall	  and	  Machesky	  2009;	  Parsons	  
et	   al.	   2010).	   Surface	   proteases	   are	   then	   recruited	   to	   disrupt	   ECM	   contacts	   and	  
provide	  a	  focal	  degradation	  point	  for	  the	  cell	  to	  move	  into	  (Baldassarre	  et	  al.	  2006).	  
Finally,	   the	   disassembly	   of	   focal	   contacts	   at	   the	   rear	   results	   in	   directed	   cell	  
movement	   (Friedl	   &	   Wolf	   2003).	   In	   this	   model,	   actin	   polymerisation	   is	   critical	   in	  
driving	   formation	   of	   cellular	   protrusion	   and	   adhesion,	   force	   generation,	   cell	   body	  
movement	   and	   ECM	   degradation.	   Indeed,	   actin	   bundle	   (F-­‐actin)	   polymerisation	   at	  
the	   leading	   edge	   (blue	   filaments	   in	   Figure	   1.1a)	   pushes	   the	   cellular	   front	   to	  move	  
forward,	  while	  actin	  depolymerisation	  at	   the	   trailing	  edge	  generates	  actin	  subunits	  
(G-­‐actin,	   blue	   circles	   in	   Figure	   1.1a).	   Cell	   movement	   in	   fibroblasts	   and	   other	   cell	  
types	  relies	  on	  the	  coordinated	  actin	  polymerisation/depolymerisation	  cycle	  (yellow	  
arrows	   in	   Figure	   1.1a),	   membrane	   and	   adhesion	   systems	   (Schäfer	   et	   al.	   2010;	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The	   membrane	   flow	   model	   proposes	   the	   membrane	   to	   be	   site	   of	   a	   polarized	  
endocytic	   cycles	   (Fig	   1.1b).	   Endocytosis	   generates	   a	   vesicle	   flow	   in	   the	   plasma	  
membrane	   (Figure	   1.1),	   which	   decreases	   towards	   the	   cellular	   trailing	   edge.	  
Therefore,	  exocytosis/endocytosis	  cycles	  (green	  arrows	  in	  Figure	  1.1b)	  promote	  cell	  
polarization	   and	   drive	   cell	   movement.	   Although	   both	   models	   likely	   contribute	   to	  
migration	   in	   cells,	   in	   this	   thesis	   I	   will	   focus	   on	   elucidating	  mechanisms	   that	   drive	  
cytoskeleton	  remodeling	  rather	  than	  control	  of	  endocytic	  compartments.	  	  
	  
Figure	  1.1.	  Schematic	  for	  migration	  models	  
(a)	  Cytoskeletal	  model	  for	  cell	  migration.	  Cell	  is	  moving	  to	  the	  left.	  Yellow	  arrows	  in	  
Figure	   a	   show	   actin	   polymerisation/depolymerisation	   cycle,	   which	   is	   driven	   by	   F-­‐
actin	   filaments	   (blue	   filaments)	   assembly	   at	   the	   cellular	   leading	   edge	   and	   the	  
depolymerisation	   and	   G-­‐actin	   (blue	   circles)	   production	   at	   the	   trailing	   edge.	   (b)	  
Membrane	  flow	  model	  for	  cell	  migration.	  Cell	   is	  moving	  to	  the	   left.	  Figure	  b	  shows	  
endocytic-­‐coated	  pits	  formation,	  which	  decreased	  with	  the	  increased	  distance	  from	  
the	   leading	   edge,	   generating	   an	   exocytosis/endocytosis	   vesicle	   (in	   orange)	   flow	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1.1.2.	  Cell	  migration	  modes	  	  
	  
Different	  migration	  strategies	  have	  been	  studied	  to	  describe	  movement	  acquisition	  
by	  a	  single	  cell	  or	  collective	  motion	  of	  several	  cells	  (Friedl	  &	  Wolf	  2010).	  Actomyosin	  
contractility-­‐dependent	   cell	   shape	   changes	   and	   extracellular	   soluble	   and	   ECM-­‐
specific	   cues	   are	   all	   important	   in	   co-­‐ordination	   of	   efficient	   cell	   migration	   in	   both	  
single	  cells	  and	  groups	  (Ridley	  et	  al.	  2003;	  MacKay	  et	  al.	  2012).	  	  
	  
Single	   cell	   movement	   is	   usually	   classified	   in	   two	   different	   migration	   modes:	  
amoeboid	   and	   mesenchymal.	   Amoeboid	   migration	   describes	   the	   movement	   of	  
rounded	  cells	  with	  immature	  focal	  adhesions	  and	  a	  lack	  of	  stress	  fibers	  (Friedl	  2004;	  
Lämmermann	  &	  Sixt	  2009).	  The	  amoeboid	  migration	  mode	  can	  be	  divided	  into	  two	  
subtypes.	   The	   first	   is	   the	   ‘blebby’	   migration	   of	   cells,	   which	   do	   not	   adhere	   to	   the	  
substrate	   and	   they	   rather	  move	   in	   a	   propulsive	  manner	   (Sanz-­‐Moreno	  &	  Marshall	  
2009).	  The	  second	  occurs	   in	  more	  elongated	  amoeboid	  cells,	  which	   form	  actin-­‐rich	  
protrusions	  at	  the	  leading	  edge	  with	  a	  weak	  adhesion	  to	  the	  substrate	  (Friedl	  &	  Wolf	  
2010).	  Integrins	  are	  almost	  absent	  on	  the	  surface	  of	  these	  cells	  and	  their	  movement	  
is	   mainly	   dependent	   on	   cellular	   shape	   changes,	   driven	   by	   actin-­‐based	   cellular	  
contractility	  (Friedl	  2004).	  Hematopoietic	  stem	  cells,	  such	  as	  leukocytes,	  and	  certain	  
tumour	  cells	  move	  with	  amoeboid	  or	  pseudo-­‐amoeboid	  mode.	  These	  cellular	  types	  
use	  a	  ‘crawling’	  mechanism	  to	  migrate	  along	  the	  surface	  (Wolf	  et	  al.	  2003).	  Cells	  with	  
low	   contractility	   and	   strong	   adhesion	   to	   the	   substrate	   develop	   mesenchymal	  
migration	  mode	  (Friedl	  2004).	  Mesenchymal	  cells	  in	  vivo	  show	  elongated	  shape	  and	  
fibroblast-­‐morphology.	   Fibroblasts,	   myoblasts,	   single	   endothelial	   cells	   and	   tumour	  
cells	   show	   the	   characteristic	   spindle	   morphology	   and	   move	   in	   a	   mesenchymal	  
manner	   (Tamariz	   &	   Grinnell	   2002;	   van	   Zijl	   et	   al.	   2011).	   The	   elongated	   shape	   is	  
dependent	  on	   integrin	  activation	  and	  generation	  of	   traction	   forces	   throughout	   the	  
cell	  body.	  Both	  β1	  and	  β3	   integrin	   subtypes	  are	  known	  to	  be	   recruited	   to	   regulate	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Askari	   et	   al.	   2010).	   The	   mesenchymal	   migration	   mode	   shows	   typical	   molecular	  
features	  of	  the	  integrin-­‐dependent	  movement	  described	  in	  section	  1.1.1.	  (Wolf	  et	  al.	  
2003;	  Nagano	  et	  al.	  2012).	  Depending	  on	   levels	  of	  key	   signaling	  molecules	   such	  as	  
RhoA,	  Rac,	  Cdc42,	  matrix	  degradation	  and	  ECM	  architecture	  cells	  can	  establish	  one	  
of	   the	   two	  described	  migration	  modes.	   Indeed,	   amoeboid	  migratory	   style	   requires	  
high	   levels	   of	   RhoA/ROCK-­‐driven	   actomyosin	   contractility,	   whereas	   elongated	  
mesenchymal	  modes	   are	   primarily	   driven	   by	   Rac-­‐dependent	   F-­‐actin	   based	   leading	  
lamellipodia/filopodial	  formation	  in	  an	  integrin-­‐dependent	  manner	  (Sanz-­‐Moreno	  et	  
al.	  2011;	  Calvo	  et	  al.	  2011).	  	  	  
	  
Additionally,	   chemokine	   or	   morphogenic	   gradients	   and/or	   extracellular	   tissue	  
structures	   promote	   directed	   movement	   of	   cells	   moving	   together,	   in	   multicellular	  
streams	  or	   chains	   (Friedl	  et	  al.	   2012).	  The	   resulting	   collective	   cell	  migration	  occurs	  
when	  junctions	  between	  cells	  are	  retained	  over	  prolonged	  time	  periods	  so	  that	  cells	  
interact	   with	   their	   neighbours	   (Rørth	   2009).	   When	   cells	   move	   collectively,	   the	  
cytoskeleton	  of	  each	  cell	  acts	  independently	  to	  generate	  traction	  force	  on	  the	  matrix	  
(Kraning-­‐Rush	  et	  al.	  2010).	  Therefore,	  a	  complex	  synchronization	  of	  cell-­‐cell	  junction	  
structures	   with	   cytoskeletal	   components	   is	   necessary	   to	   complement	   different	  
adhesion	  types	  and	  drive	  collective	  migration	  (F.	  Huber	  et	  al.	  2013).	  Figure	  1.2	  gives	  
an	   overview	   of	   the	   described	   cell	   morphology	   changes	   and	   different	   migration	  
modes.	   Black	   arrows	   in	   Figure	   1.2	   show	   plasticity	   of	   different	   migration	   modes.	  
Indeed,	  each	  migration	  type,	  although	  driven	  by	  distinct	  mechanical	  and	  molecular	  
mechanisms,	   may	   undergo	   transition	   towards	   another	   migration	   type.	   These	  
transitions	   are	   central	   in	   processes	   such	   as	   macrophages	   and	   endothelial	   cell	  
differentiation	   (Friedl	   2004).	  Moreover,	   cancer	   cell	   progression	   and	   differentiation	  
provides	   useful	   insights	   to	   understand	   molecular	   mechanisms	   driving	   cellular	  
migration	  mode	  transitions.	  Epithelial-­‐mesenchymal	  transition	  (EMT)	   is	  a	  key	  event	  












Figure	  1.2.	  Cell	  morphology	  and	  migration	  modes	  (Friedl	  &	  Wolf	  2010)	  
Single	  cells	  movement	  is	  usually	  classified	  in	  amoeboid	  and	  mesenchymal	  migration	  
modes.	   Single	   cells	   migrating	   towards	   the	   same	   directions	   increase	   their	   cell-­‐cell	  
interaction,	  promoting	  multicellular	  streaming	  and	  collective	  migration.	  In	  Figure	  1.2	  
thin	  black	  arrows	  show	  how	  migration	  styles	  can	  be	  converted	  in	  others	  to	  highlight	  
plasticity	  of	  migration	  modes.	  Thick	  gray	  arrows	  show	  direction	  of	  movement.	  	  	  	  	  
	  	  
1.1.3.	  Pathological	  cell	  migration	  	  
	  
Single	   or	   collective	   cell	   movement	   is	   central	   in	   processes	   such	   as	   embryonic	  
development,	  wound	   healing	   and	   immune	   response	   (Friedl	   et	   al.	   2012).	   The	   actin	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global	   cell	   migration	   during	   tissue	   development	   and	   formation	   (Kurosaka	   and	  
Kashina	   2009).	   Furthermore,	   cytoskeletal	   proteins	   are	   implicated	   in	   many	   human	  
pathological	  conditions,	  including	  cancer,	  infection	  and	  cardiovascular,	  inflammatory	  
and	  neurodegenerative	   diseases	   (Rørth	   2009;	   Friedl	   et	   al.	   2012).	  Defects	   in	   neural	  
crest	   cell	  migration	   lead	   to	   cognitive	   and	  motor	  disabilities	   as	  well	   as	   neurological	  
disorders	   such	   as	   mental	   retardation	   (Perris	   &	   Perissinotto	   2000).	   Dysregulated	  
migration	  of	  endothelial	  cells	  directs	  abnormal	  angiogenesis	  causing	  processes	  such	  
inflammation	  and	  cardiovascular	  diseases	  (Reinhart-­‐King	  2008).	  	  
	  
One	  of	  the	  most	  described	  examples	  of	  cell	  migration	  in	  pathology	  is	  in	  the	  context	  
of	   cancer	   cell	  metastasis.	   Cancer	   cells	  must	   acquire	  motile	   capabilities	   to	   colonize	  
distant	   sites	   and	   give	   rise	   to	   metastases	   (Van	   Zijl	   et	   al.	   2011).	   Many	   molecules	  
involved	  in	  actin	  dynamics	  are	  dysregulated	  in	  invasive	  cancer	  cells	  (Parri	  &	  Chiarugi	  
2010;	   Nagano	   et	   al.	   2012).	   For	   instance,	   GAPs,	   GEFs	   and	   many	   GTPase	   effector	  
proteins	  have	  been	  shown	  to	  exhibit	  altered	  activation	  in	  cancer	  cells	  (Vega	  &	  Ridley	  
2008).	  Rho	  and	  Rac	  opportunistically	   regulate	  each	  other	   in	   cancer	   cells	   to	  modify	  
cell	   shape	  and	  promote	  metastatic	  dissemination	   (Parri	  &	  Chiarugi	  2010).	   Integrins	  
and	  main	   adhesion	   components	   such	   as	   Focal	   Adhesion	   Kinase	   (FAK)	   drive	   cancer	  
cell	   adhesion	   and	   invasion	   (Felding-­‐Habermann	   et	   al.	   2001;	   Provenzano	   and	   Keely	  
2009).	   Lastly,	   actin	   structures	   such	   as	   invadopodia	   are	   essential	   for	   tumour	   cell	  
matrix	  degradation	  (Buccione	  et	  al.	  2009).	  Cancer	  cells	  show	  high	  GTPase-­‐dependent	  
cell	   plasticity.	   Indeed,	   cancer	   cell	   invasion	   is	   tightly	   dependent	   on	   Rho-­‐	   and	   Rac-­‐
dependent	   determination	   of	   movement	   mode	   (Sanz-­‐Moreno	   et	   al.	   2008).	   In	  
particular,	   the	   switch	   from	   epithelial	   to	   mesenchymal	   migration	   mode	   (EMT)	   is	  
proposed	   to	   be	   used	   by	   cancer	   cells	   to	   escape	   from	   the	   primary	   tumour	   and	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1.2.	  The	  cellular	  cytoskeleton	  
	  	  	  	  
The	   cytoskeleton	   of	   eukaryotic	   cells	   is	   composed	   of	   three	   kinds	   of	   filaments:	  
microfilaments,	  intermediate	  filaments	  and	  microtubules.	  Together,	  these	  filaments	  
contribute	   to	  cellular	   shape,	   integrity	  and	  homeostasis	  as	  well	  as	  dynamic	  changes	  
during	  tissue	  remodelling	  or	  migration	  (Doherty	  &	  McMahon	  2008).	  	  Microfilaments	  
are	   composed	   of	   linear	   filaments	   of	   actin,	   intermediate	   filaments	   are	   formed	   of	  
different	  proteins,	  such	  as	  keratin	  and	  vimentin,	  whereas	  microtubules	  are	  polymers	  




Figure	  1.3.	  The	  cellular	  cytoskeleton	  components	  (adapted	  from	  (Huber	  et	  al.	  2013)	  
Three	   kinds	   of	   filaments	   form	   the	   cellular	   cytoskeleton:	   Microtubules,	  
Microfilaments	  (F-­‐actin	  filaments)	  and	  Intermediate	  filaments.	  
	  
1.2.1.	  Actin	  	  
	  
Actin	   is	   a	   42	   kDa-­‐	   globular	   protein	   and	   is	   highly	   conserved	   across	   species.	   Three	  
isoforms	  exist:	  α,	  β	  and	  γ.	  The	  α	  isoform	  is	  predominantly	  found	  in	  muscle	  whereas	  
the	  β	  and	  γ	  isoforms	  are	  ubiquitous	  and	  co-­‐exist	  in	  the	  cytoskeleton	  contributing	  to	  
diverse	   cellular	   structures	   (Khaitlina	   2001).	   The	   main	   function	   of	   actin	   is	   to	   form	  
filaments	   that	   comprise	   the	   actin	   cytoskeleton	   (microfilaments,	   also	   known	   as	  
filamentous	   or	   F-­‐actin,	   in	   Figure	   1.3).	   Actin	   filaments	   act	   as	   scaffolds	   for	   myosin	  
motors	  during	  cytoskeletal	  contraction	  as	  well	  as	  being	   important	   in	  driving	  vesicle	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conditions,	   monomeric	   G-­‐actin	   is	   transformed	   into	   the	   polymeric	   F-­‐actin	   by	   ATP-­‐
phosphorylation;	  the	  ATP	  on	  the	  F-­‐actin	  polymer	  is	  then	  hydrolysed	  to	  promote	  the	  
actin	  treadmilling.	  Nucleation	  factors	  are	  involved	  in	  F-­‐actin	  filament	  polymerization.	  
One	  example	   is	  the	  Arp2/3	  complex,	  which	  enhances	  actin	  filament	  polymerization	  
and	  promotes	  the	   initiation	  of	  new	  branches	   from	  existing	  ones	   (Egile	  et	  al.	  2005).	  
Figure	  1.3	  (middle	  panel)	  shows	  polarity	  of	  a	  growing	  actin	  filament,	  which	  is	  given	  
by	  continuous	  growth	  from	  the	  plus	  end	  (+)	  and	  G-­‐actin	  release	  from	  the	  minus	  end	  
(–).	   Filament	  nucleation	   and	  directional	   growth	  are	   fundamental	   to	   cell	   shape	  and	  
expansion,	  as	  well	  as	  to	  phagocytosis	  and	  internal	  vesicle	  motility	  (Bannigan	  &	  Baskin	  
2005).	  	  
	  
Several	   cross-­‐linking	   and	   bundling	   proteins	   bind	   actin	   to	   stabilize	   filaments	   and	  
regulate	   cell	   mechanics.	   Examples	   of	   these	   are	   α-­‐actinin	   and	   fascin,	   which	   are	  
involved	  in	  the	  assembly	  and	  maintenance	  of	  filopodia	  and	  stress	  fibres	  (Small	  et	  al.	  
2002).	  α-­‐actinin	  and	  fascin	  are	  both	  actin	  bundling	  proteins;	  the	  former	  binds	  actin	  
filaments	  in	  any	  orientation	  to	  provide	  crosslinking	  stability,	  whereas	  fascin	  is	  more	  
selective	  and	  only	  binds	  parallel-­‐oriented	  polymers	  (Courson	  and	  Rock	  2011).	  Fascin	  
is	  known	   to	   regulate	  cytoskeletal	   structures	   for	  maintenance	  of	   cell	  adhesions	  and	  
the	   promotion	   of	   invasive	   protrusions	   (Adams	   2004;	   Jayo	   and	   Parsons	   2010).	   The	  
loss	   of	   fascin	   or	   α-­‐actinin	   leads	   to	   a	   decrease	   in	   cell	   spreading,	   adhesion	   and	  
migration,	  underlining	  the	  importance	  of	  actin	  crosslinkers	  in	  these	  processes	  (Friedl	  
&	  Wolf	   2003).	   Rho	   family	   of	   small	   guanosine	   triphosphate	   (GTP)-­‐binding	   proteins	  
(GTPases)	  are	  key	  regulators	  of	  actin	  filament	  formation	  (Ridley	  et	  al.	  2003).	  GTPases	  
are	  bound	   to	  GTP	   in	   their	  active	   state	  and	   they	   then	   interact	  with	  a	  wide	  array	  of	  
molecular	  downstream	  effectors.	  GTPases	  are	  activated	  by	  guanine	  exchange	  factor	  
(GEFs)	  and	  inactivated	  by	  GTP-­‐activating	  proteins	  (GAPs).	  Rac	  and	  Cdc42	  are	  the	  best	  
characterized	   family	  members	  and	  are	  the	  GTPases	  mainly	   involved	   in	   lamellipodia	  
and	   filopodia	   formation.	   Their	   preferential	   targets	   are	   the	   Arp2/3	   complex	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(Zalevsky	  et	  al.	  2001;	  Stradal	  et	  al.	  2004).	   Similarly,	  WASP	  and	  WAVE	  bind	   to	  GEFs	  
and	  GAPs	  regulating	  Cdc42	  and	  Rac	  activity	  (Rohatgi	  et	  al.	  1999).	  Cdc42	  is	  one	  of	  the	  
master	  regulators	  of	  cell	  migration.	  It	  drives	  cell	  polarity	  through	  restricting	  the	  area	  
where	   the	   lamellipodia	   form	   (Itoh	  et	   al.	   2002).	   Cdc42	  also	  directs	   the	  microtubule	  
organizing	  centre	  (MTOC)	  and	  the	  Golgi	  apparatus	  towards	  movement	  direction	  (Cau	  
&	  Hall	  2005).	  Cdc42	  is	  in	  turn	  maintained	  at	  the	  leading	  edge	  by	  several	  signals,	  such	  
as	   its	   effector	   PAR6	   activation	   and	   integrin	   clustering	   at	   adhesion	   sites	   (Etienne-­‐
Manneville	  &	  	  Hall	  2001).	  	  
	  
Another	   important	   determinant	   of	   cell	   polarity	   is	   the	   activity	   of	   the	  
phosphoinositide(3,4,5)P3	  (PIP3)	  kinase	  (PI3K)	  and	  the	  PI3K	  phosphatase	  (PTEN).	  PI3K	  
produces	  and	  localises	  PIP3	  at	  the	  leading	  edge,	  while	  the	  phosphatase	  PTEN	  brings	  
its	  dephosphorylated	  form	  (PIP2)	  to	  the	  rear,	  contributing	  to	  chemo-­‐attractant	  agent	  
response	  (Kölsch	  et	  al.	  2009).	  Cdc42	  is	  known	  to	  be	  involved	  in	  removing	  PTEN	  from	  
the	  leading	  edge	  and	  PIP3	  appears	  to	  be	  involved	  in	  localising	  Cdc42	  at	  the	  cellular	  
front	   (Van	  Keymeulen	  et	   al.	   2006).	  Rac	   is	  one	  of	   the	   key	  molecules	   in	  maintaining	  
directional	   F-­‐actin	   protrusions.	   Rac	   activation	   induces	   integrin	   clustering	   and	  
activation,	   promoting	   new	   adhesion	   formation	   (Kiosses	   et	   al.	   2001).	  Mesenchymal	  
cell	   migration	   is	   dependent	   on	   Rac1-­‐mediated	   cell	   polarization	   and	   lamellipodia	  
formation	  and	  its	  reciprocal	  regulation	  with	  Rho	  GTPases	  drives	  cancer	  cell	  invasion	  
(Parri	  &	  Chiarugi	  2010).	  Furthermore,	  Rac	  recruits	  and	  activates	  PI3K	  at	  the	  plasma	  
membrane,	  promoting	  PIP3-­‐dependent	   cell	   polarity	   (Cho	  et	  al.	   2012).	  Rac	   can	  also	  
drive	   a	   positive	   feedback	   loop	   to	   control	   microtubule	   targeting	   and	   stability	  
(Rodriguez	  et	  al.	  2003).	  	  
1.2.2.	  Microtubules	  	  
	  
Microtubules	  (MTs)	  have	  a	  diameter	  of	  25	  nm	  and	  their	   length	  varies	  between	  200	  
nm	  and	  25	  µm.	  MTs	  are	  polymers	  made	  up	  of	  α	  and	  β	  tubulin	  (left	  panel	   in	  Figure	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exposing	  one	  minus	  end	  (-­‐)	  and	  one	  plus	  end	  (+).	  Parallel	  protofilaments	  bind	  each	  
other,	  forming	  MT	  bundles,	  creating	  a	  strong	  polarity	  between	  the	  +	  and	  -­‐	  ends.	  Ends	  
are	   named	   according	   to	   the	   direction	   of	   filament	   elongation	   and	   shrinking	   (Figure	  
1.4).	   The	   –	   end	   is	   capped	   and	   MTs	   assemble	   and	   disassemble	   at	   the	   +	   end,	  
promoting	  catastrophe	  and	  rescue	  of	  the	  bundles	  (Jiang	  and	  Akhmanova	  2011).	  MTs	  
are	  nucleated	  from	  the	  MTOCs	  (microtubules-­‐organizing	  centre)	  as	  basal	  bodies	  and	  
centrosomes.	   These	   structures	   contain	   γ	   tubulin	   subunits,	   which	   together	   form	   a	  
scaffold	  ring	  to	  the	  –	  end	  that	  grows	  in	  the	  +	  end	  direction	  (Heald	  &	  Nogales	  2002).	  
During	  polymerization,	  both	  α	  and	  β	  subunits	  of	  the	  tubulin	  are	  bound	  to	  GTP;	  the	  
binding	  at	  the	  –	  end	  is	  stable,	  while	  GTP	  at	  the	  +	  end	  may	  be	  hydrolyzed	  to	  GDP	  after	  
assembly	  leading	  to	  depolymerisation	  (Drechsel	  &	  Kirschner	  1994).	  
	  
	  
Figure	  1.4.	  MT	  structure	  and	  dynamic	  instability	  (Akhmanova	  &	  Steinmetz	  2008)	  
MT	  structure	   is	  highly	  dynamic.	   (1-­‐4)	  α	  and	  β	  subunits	  of	   the	  tubulin	  are	  bound	  to	  
GTP	   during	   MT	   growth.	   (3)	   GTP	   hydrolysis	   to	   GDP	   induces	   MT	   shrinking.	   (2)	   An	  
intermediate	   metastable	   form	   of	   MT	   exists	   due	   to	   a	   cycle	   of	   GTP	   binding	   and	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Assembly	  and	  disassembly	  of	  MTs	  are	  not	  only	  associated	  to	  GTP/GDP	  binding	  but	  
also	   capping	   proteins.	   Proteins	   known	   as	  microtubules-­‐associated	   proteins	   (MAPs)	  
directly	   bind	   tubulin,	   cross-­‐link	  MT	   bundles	   together	   or	  mediate	   interactions	  with	  
other	   proteins.	   Different	   proteins	   are	   involved	   in	  MAP-­‐MT	   binding	   and	   dynamics.	  
One	  class	  of	  these	  are	  known	  as	  the	  +TIPs	  (plus-­‐end	  tracking)	  proteins	  because	  they	  
are	   associated	  with	   the	   growth	  of	   the	   +	   end.	   Additionally,	  motor	   proteins	   such	   as	  
kinesin	  and	  dynein	  can	   ’walk’	  on	  MT	  bundles	  and	  drive	  vesicle	  movement	   through	  
interactions	  with	  tubulin.	  Most	  kinesins	  walk	  in	  the	  +	  end	  direction,	  while	  dynein	  is	  a	  
–	  end	  motor	  protein.	  They	  are	  vital	   for	  chromosome	  separation	  during	  mitosis	  and	  
meiosis,	   for	   intracellular	   trafficking	   and	   regulation	   of	   cell	   shape.	   They	   are	  
fundamental	   components	   of	   structures	   such	   as	   cilia	   and	   flagella	   (Walcott	   and	   Sun	  
2010)	  that	  generate	  forces	  from	  the	  cell	  surface	  to	  protect	  it	  from	  the	  environment.	  
Post-­‐translational	   modifications	   of	   tubulin	   such	   as	   acetylation,	   detyrosination,	  
polyglutamylation	  and	  polyglycylation	  modify	  the	  binding	  between	  +TIP	  proteins	  and	  
the	  MTs	   to	  permit	  specialized	   functions	  and	  enhanced	  stability	   (Ikegami	  and	  Setou	  
2010).	  	  
	  
+TIP	   proteins	   do	   not	   track	   microtubule	   tips	   processively,	   instead	   they	   exchange	  
rapidly	  by	  recognizing	  some	  specific	  structural	  features	  at	  the	  growing	  ends	  (Jiang	  &	  
Akhmanova	   2010).	   They	   are	   seen	   as	   rapidly	   moving,	   comet-­‐like	   dots	   that	   can	   be	  
visualized	  and	  used	  to	  quantify	  MT	  dynamics.	  +TIP	  proteins	  are	  separated	   into	  two	  
subclasses:	   those	  that	  directly	   interact	  with	  the	  microtubules	  +	  end	  and	  those	  that	  
interact	  with	  proteins	  belonging	  to	  this	  first	  group	  (Akhmanova	  &	  Steinmetz	  2008).	  
The	  prototypic	  +TIPs,	  are	  comprised	  of	  EB	  protein	  family	  (EB1,	  EB2	  and	  EB3)	  (Juwana	  
et	  al.	  1999),	  CLIP-­‐170	  and	  CLIP-­‐115	  (Perez	  et	  al.	  1999;	  Hoogenraad	  et	  al.	  2000).	  These	  
proteins	  have	  been	  used	  in	  studies	  as	  markers	  for	  monitoring	  MT	  dynamics	  (Matov	  
et	  al.	  2010).	  Motor	  proteins	  such	  as	  kinesin	  and	  dynein	  are	  considered	  in	  the	  second	  
subclass	   of	   TIPs	   with	   CLASP1,	   CLASP2	   (Akhmanova	   et	   al.	   2001),	   the	   Diaphanous-­‐
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and	   the	   adenomatous	   polyposis	   coli	   (APC)	   tumour	   suppressor	   protein	   (Mimori-­‐
Kiyosue	  et	  al.	  2000).	  
	  
The	  majority	  of	  the	  EB	  proteins	  contain	  highly	  conserved	  N-­‐	  and	  C	  terminal	  domains	  
that	   are	   separated	   by	   a	   less	   conserved	   linker	   sequence.	   The	  N-­‐terminal	   domain	   is	  
necessary	   and	   sufficient	   for	   MT	   binding	   (Lansbergen	   &	   Akhmanova	   2006).	   This	  
domain	  globular	  structure	  is	  characteristic	  of	  calponin	  homology	  domains,	  which	  are	  
formed	   by	   α-­‐helical	   repetitions	   and	   typically	   found	   in	   actin-­‐binding	   and	   signalling	  
proteins	  (Gimona	  et	  al.	  2002).	  Other	  +TIPs	  and	  MT	  motor	  proteins,	  such	  as	  some	  EB	  
family	  proteins	  and	  dynein	  share	  an	  α	  helical	  coiled	  coil	  domain,	  which	  mediates	  the	  
binding	  with	  MT	  (Akhmanova	  &	  Steinmetz	  2008;	  Redwine	  et	  al.	  2012).	  Several	  large	  
and	   complex	   multidomain	   +TIPs	   contain	   extensive	   sequence	   regions	   that	   are	  
enriched	  with	   basic	   and	   serine	   residues.	   These	   regions,	  which	   are	   predicted	   to	   be	  
flexible,	  often	  mediate	  the	   interaction	  with	  MT	  and	  other	  EB	  proteins.	  Examples	  of	  
serine-­‐rich	  MT	  binding	  proteins	  are	  APC	  and	  the	  microtubule-­‐actin	  crosslinking	  factor	  
ACF7	  (Jefferson	  et	  al.	  2004;	  Bamburg	  et	  al.	  1999).	  Other	  +TIP	  proteins	  such	  as	  CLIPs	  
contain	   cytoskeleton-­‐associated	   protein	   glycine-­‐rich	   domains	   at	   their	   N-­‐termini.	  
These	  domains	  mediate	  their	  interaction	  with	  MT	  and	  EB	  proteins	  (Perez	  et	  al.	  1999).	  
	  
The	  key	  role	  for	  MT	  in	  many	  cellular	  functions,	  including	  migration	  and	  mitosis,	  make	  
them	   potential	   targets	   for	   cancer	   treatment.	   Indeed,	   β	   tubulin	   isotypes	   are	  
differentially	  up-­‐regulated	  in	  many	  types	  of	  cancer	  and	  tubulin-­‐binding	  agents	  (TBAs)	  
are	   already	   used	   as	   anti-­‐cancer	   drugs	   (Wilson	   &	   Jordan	   2004).	   Interestingly,	   both	  
types	  of	  TBAs,	  whether	  destabilizing	  or	  stabilizing,	  have	  an	  effect	  on	  actin-­‐network.	  
For	   instance,	   it	   is	  known	  that	  nocodazole,	  an	  anti-­‐neoplastic	  drug	  that	   inhibits	  MTs	  
polymerization,	   induces	   stress	   fibres	   formation	   and	   cell	   contractile	   morphology	  
(Chang	  et	  al.	  2008).	  Conversely,	  changes	  in	  actin	  organization	  or	  in	  its	  regulators	  are	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1.2.3.	  Intermediate	  filaments	  
	  
Intermediate	   filaments	   (IF)	   are	   cytoskeletal	   components	   composed	   of	   a	   family	   of	  
related	  proteins	  with	  similar	  structure	  and	  sequence.	  They	  have	  been	  designated	  as	  
intermediate	   because	   their	   average	   diameter	   (10	   nm)	   is	   larger	   than	   actin	  
microfilaments,	  but	  narrower	  than	  myosin	  bundles,	  found	  in	  muscle	  cells	  (Herrmann	  
et	  al.	  2007).	  Most	  types	  of	  IF	  are	  cytoplasmic,	  except	  for	  lamins,	  which	  are	  nuclear.	  
All	   IF	   proteins	   have	   a	   central	   α-­‐helical	   rod	   domain	   composed	   with	   four	   α-­‐helical	  
segments	   (C.-­‐H.	   Lee	   et	   al.	   2012).	   The	   basal	   structure	   of	   an	   IF	   is	   a	   parallel	  
homo/hetero	  dimer,	  which	  is	  formed	  through	  the	  interaction	  of	  the	  rod	  domains	  to	  
form	  a	  coiled	  coil	   (right	  panel	   in	  Figure	  4.1).	  The	  C	  and	  N	  termini	  of	   IF	  proteins	  are	  
not	  α-­‐helical	  regions	  and	  the	  N	  terminus	  of	  nuclear	  IF	  proteins	  binds	  DNA	  (Wang	  et	  
al.	   2001).	   Vimentin	   heads	   are	   able	   to	   alter	   nuclear	   architecture	   and	   nuclear	  
distribution	   (Shoeman	  et	  al.	  2001).	  Cytoplasmic	   IF	  do	  not	   show	  a	  polar	  orientation	  
and	   unlike	   microfilament	   and	   microtubules,	   they	   do	   not	   play	   a	   key	   role	   in	   cell	  
motility	  and	  cellular	   transport	   (Kreplak	  &	  Fudge	  2007).	   In	  addition,	   IF	  do	  not	   show	  
any	  binding	  sites	  for	  nucleoside	  triphosphate.	  	  
	  
IF	  are	  classified	  in	  six	  types	  based	  on	  similarities	  in	  amino	  acid	  sequence	  and	  protein	  
structure.	  Type	  I	  and	  II	  are	  the	  most	  diverse	  IF	  proteins	  and	  the	  keratin	  family	  is	  the	  
most	  representative	  (C.-­‐H.	  Lee	  et	  al.	  2012).	  Vimentin	  belongs	  to	  the	  class	  III	  and	  it	  is	  
the	  most	  distributed	  IF	  proteins	  in	  cells	  (Qin	  et	  al.	  2009).	  IF	  proteins	  are	  deformable	  
and	  stretched,	  which	  contribute	  to	  cytoskeletal	  functions	  in	  cells.	  They	  interact	  with	  
cell-­‐cell	   adhesion	   structures	   such	   as	   desmosomes	   and	   cell-­‐matrix	   adhesion	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1.3.	  The	  role	  of	  actin	  and	  microtubule	  cytoskeletons	  in	  cell	  motility	  
	  
As	   principal	   components	   of	   the	   cellular	   cytoskeleton,	   actin	   and	   MT	   regulate	   cell	  
motility.	  The	  role	  of	  actin	  filament	  assembly/disassembly	  in	  regulating	  cytoskeleton	  
reorganization	  has	  been	  known	  for	  years.	  Moreover,	  recent	  studies	  have	  focused	  on	  
the	  contribution	  of	  MT	  to	  controlling	  adhesion	  dynamics	  and	  cell	  migration.	  	  
	  
1.3.1.	  The	  role	  of	  actin	  in	  adhesion	  and	  migration	  
	  
As	  mentioned	  in	  previous	  sections,	  cell	  migration	  requires	  a	  dynamic	  reorganization	  
of	   the	   actin	   cytoskeleton.	   Actin-­‐based	   protrusions	   formation	   is	   one	   of	   the	   main	  
events	   promoting	   cell	   polarity	   and	   migration.	   The	   main	   role	   for	   the	   actin	  
cytoskeleton	   is	   to	   provide	  mechanical	   stability	   to	   protrusions	   originating	   from	   the	  
plasma	   membrane	   (Ridley	   2011).	   There	   are	   different	   types	   of	   plasma	   membrane	  
protrusions,	   with	   diverse	   complexity	   and	   molecular	   activators.	   Their	   specific	  
activation	  allows	  cells	  to	  respond	  dynamically	  to	  the	  EC	  environment	  with	  the	  most	  
appropriate	  type	  of	  protrusion	  (Keren	  2011).	  
	  
1.3.1.1. Lamellipodia	  	  
	  
The	  elongation	  of	   flat	   sheets	  of	  membrane	  called	   lamellipodium	   is	  one	  example	  of	  
actin-­‐based	  protrusion	  (Small	  et	  al.	  2002).	  The	  lamellipodium	  is	  a	  large	  area	  forming	  
at	   the	   leading	   edge	   of	   motile	   cells	   and	   is	   formed	   by	   a	   dense	   network	   of	   F-­‐actin	  
filaments.	   The	   edge	   of	   the	   lamellipodium	   in	   fibroblasts	   and	   other	   cellular	   types	  
shows	   a	   ruffling	   appearance.	   This	   is	   due	   to	   the	   dynamic	   activity	   of	   the	   actin	  
filaments,	  which	  push	  the	  cell	  edge	  forward	  and	  quickly	  detach	  from	  the	  substrate.	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lamellipodia	   formation.	   Some	   of	   them	   are	   shown	   in	   the	   model	   for	   lamellipodia	  
(Figure	   1.5).	   Rho,	   Rac	   and	   Cdc42	   are	   critical	   in	   the	   formation	   of	   structures,	  
connecting	   the	   plasma	  membrane	  with	   the	  motility	  machinery	   (Ridley	   2011).	  New	  
actin	   filament	   nucleation	   is	   central	   in	   giving	   directionality	   to	   the	   lamellipodia.	   The	  
localisation	   of	   the	   Arp	   2/3	   complex	   and	   its	   activators	   at	   the	   plasma	   membrane	  
activate	   GTPases	   which	   in	   turn	   drive	   protrusion	   formation	   (Lai	   et	   al.	   2008).	  
Membrane	  receptor	  proteins	  are	  also	  critical	  in	  coupling	  the	  cellular	  cytoskeleton	  to	  
the	   EC	   environment.	   For	   instance,	   integrin	   activation	   stabilizes	   actin	   filaments	   in	  
early	  adhesion	  sites	  and	  promotes	  actin	  depolymerisation	  at	  the	  trailing	  edge	  (Ridley	  
et	  al.	  2003).	  	  
	  
Integrin-­‐dependent	  adhesion	  turnover	  requires	  the	  cooperation	  of	  many	  molecular	  
players,	  which	  will	   be	  described	   in	  more	  detail	   in	   the	  next	   section.	  Other	  proteins	  
have	   also	   been	   shown	   to	   contribute	   to	   actin	   filaments	   stabilization	   in	   the	  
lamellipodia.	   For	   instance,	   formin	   family	   proteins	   protect	   actin	   filaments	   from	  
capping	  (Goode	  &	  Eck	  2007).	  Molecules,	  such	  as	  VASP	  and	  cofilin,	  involved	  in	  F-­‐actin	  
bundle	  elongation	  and	  severing	  respectively,	  also	  contribute	  to	  lamellipodia	  function	  
(Van	   Rheenen	   et	   al.	   2009;	   Bear	  &	  Gertler	   2009).	  Moreover,	   cofilin	   and	   other	   ADF	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Figure	  1.5.	  Lamellipodia	  (Ridley	  2011)	  
Model	  for	  lamellipodia	  formation:	  (1)	  Free-­‐actin	  filaments	  barbed	  ends	  stabilized	  by	  
cofilin	   promote	   Arp2/3	   complex-­‐dependent	   new	   actin	   filaments	   nucleation.	   (2)	  
WAVE	   complex	   proteins	   and	   VASP	   contribute	   to	   actin	   nucleation	   and	   Rac/Cdc42-­‐
dependent	   protrusion	   formation.	   Actin	   monomers	   are	   originated	   by	   the	  
depolymerizing	   activity	   of	   cofilin	   and	   profilin.	   (3)	   Formins	   can	   also	   generate	  




Filopodia	  are	  long	  protrusions	  formed	  by	  parallel	  F-­‐actin	  bundles	  (Insall	  &	  Machesky	  
2009).	   Recent	   studies	   have	   shown	  mDia	   proteins	   of	   the	   formin	   family	   to	   promote	  
actin	   polymerisation	   in	   filopodia	   formation	   (Mellor	   2010).	   Several	   proteins	   have	  
been	  shown	  to	  promote	  filopodia	  formation	  and	  function	  (Figure	  1.6).	  For	  instance,	  
Ena/VASP	  proteins	   localise	  at	   the	  tips	  of	   filopodia,	  showing	  an	  anti-­‐capping	  activity	  
and	  promoting	  filopodia	  elongation	  (Mejillano	  et	  al.	  2004).	  Proteins	  containing	  I-­‐BAR	  
domains,	   such	   as	   IRSp53,	   have	   shown	   to	   induce	   filopodia	   formation	   in	   particular	  
conditions	   through	   induction	   of	   membrane	   curvature	   (Ahmed	   et	   al.	   2010).	  	  
Furthermore,	  Myosin	  X	   localises	  at	  the	  tips	  of	   filopodia	  and	   induces	  their	  assembly	  
(Sousa	   and	   Cheney	   2005).	   Cdc42	   activates	   N-­‐WASP,	   IRSp53	   and	  mDia2	   promoting	  
their	  localisation	  and	  elongating	  activity	  of	  filopodia	  (Figure	  1.6;	  (Ahmed	  et	  al.	  2010).	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assembly.	   For	   example,	   RhoF/Rif	   induces	   filopodia	   formation	   via	   mDia2	   in	   early	  
stages	   of	   dendritic	   spine	   formation	   in	   neurons	   (Mellor	   2010).	   Actin	   filaments	   are	  
held	  together	  to	  form	  filopodia	  by	  cross-­‐linking	  proteins.	  Fascin	  localises	  in	  filopodia	  
and	  promotes	  their	   formation	  and	  stability	   (Vignjevic	  et	  al.	  2006b).	  Fascin	  provides	  
invasive	   capabilities	   to	   filopodia	   contributing	   to	   its	   role	   in	   cancer	   metastasis	  




Figure	  1.6.	  Filopodia	  (Ridley	  2011)	  
Model	   for	   filopodia	   formation:	   (1)	   IRSp53	  bends	  the	  membrane	  and	   induces	  Cdc42	  
to	   recruit	   targets	   such	   as	   mDia2	   and	   VASP.	   These	   molecules	   induce	   actin	  
polymerisation.	  (2)	  Actin	  filaments	  can	  also	  be	  provided	  by	  Myosin	  X	  activity.	  (3)	  F-­‐
actin	   filaments	  grow	   towards	   the	  movement	  direction	  and	  proteins,	   such	  as	  VASP,	  
mDia2	  and	  Myosin	  X,	  localising	  at	  filopodia	  tips	  mediate	  their	  assembly	  and	  stability.	  
(4)	  mDia2	  and	  VASP	  deliver	  actin	  monomers	  to	  the	  growing	  ends	  of	  actin	  filaments,	  
while	  profiin	  contribute	  to	  the	  WASP/Arp2/3-­‐driven	  nucleation	  of	  new	  branches.	  	  
	  
1.3.1.3.	  Stress	  fibres	  
	  
Actomyosin	   contractility	   in	   non-­‐muscle	   cells	   is	   principally	   driven	   by	   myosin	   II-­‐
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F-­‐actin	  filaments	  with	  alternate	  polarity,	  held	  together	  by	  α-­‐actinin	  and	  other	  actin	  
binding	  proteins	  (Tojkander	  et	  al.	  2012).	  Stress	  fibres	  in	  non-­‐motile	  cells	  are	  usually	  
thick	   and	   stable,	   while	   highly	  motile	   cells	   show	   thiner,	  more	   dynamic	   actin	   stress	  
fibres	   (Pellegrin	  &	  Mellor	   2007).	   Stress	   fibre	   assembly	   is	   critical	   in	   connecting	   the	  
cytoskeleton	   to	   the	   ECM	   at	   adhesion	   sites	   called	   Focal	   Adhesions	   (FA).	   FA	   are	  
adhesion	   structures	   that	   act	   as	   platforms	   for	   recruitment	   of	   different	   molecular	  
players	   that	   ultimately	   contribute	   to	   the	   generation	   of	   mechanical	   stability	   and	  
forces	  required	  for	  cell	  movement	  (Hayakawa	  et	  al.	  2012;	  Schäfer	  et	  al.	  2010).	  Forces	  
created	   by	   stress	   fibres	   allow	   cells	   to	   ‘sense’	   the	   ECM	   and	   to	   develop	   different	  
protrusion	  or	  migration	  modes.	  ECM	  mechano-­‐sensing	   is	  also	  determinant	   in	  other	  
cellular	   processes	   such	   as	   cell	   fate	   and	   differentiation	   (Walcott	   &	   Sun	   2010).	   In	  
contrast	  to	  the	  well-­‐characterised	   lamellipodia	  and	  filopodia	  structures,	  stress	  fibre	  
assembly	   and	   formation	   mechanisms	   remain	   relatively	   poorly	   characterised.	  
However,	   three	   classes	   of	   stress	   fibres	   have	   been	   distinguished	   (Hotulainen	   &	  
Lappalainen	  2006).	  Ventral	  and	  dorsal	  stress	  fibres	  and	  transverse	  arcs	  are	  shown	  in	  
Figure	  1.7.	  Ventral	   stress	   fibres	  are	   contractile	   actin	   filaments	  and	  have	  both	  ends	  
associated	  with	  FA.	  They	  are	  found	  in	  the	  ventral	  part	  of	  the	  cell	  and	  they	  are	  central	  
to	   the	   co-­‐ordination	   of	   cell	   adhesion	   and	   contraction.	   Transverse	   arcs	   are	   not	  
directly	  associated	  with	  FA	  and	  elongate	  from	  the	  leading	  edge	  to	  the	  center	  of	  the	  
cell.	  Dorsal	  stress	  fibres	  are	  connected	  to	  FA	  at	  both	  ends	  and	  they	  follow	  the	  dorsal	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Figure	  1.7.	  Schematic	  of	  stress	  fibre	  types	  
Red	  lines	  represent	  ventral	  stress	  fibres,	  orange	  lines	  represent	  transverse	  arcs	  and	  
purple	  lines	  represent	  dorsal	  stress	  fibres.	  Green	  circles	  are	  FA	  localised	  at	  the	  ends	  
of	  ventral	  and	  dorsal	  stress	  fibres.	  Direction	  of	  movement	  is	  shown.	  
	  
Stress	  fibre	  assembly	   is	  regulated	  by	  signaling	  pathways	   involving	  the	  small	  GTPase	  
RhoA	   (Ridley	   et	   al.	   2003).	   Activated	   RhoA	   promotes	   Rho	   kinase	   (ROCK)-­‐mediated	  
contractility,	   which	   induces	   stress	   fibre	   formation	   by	   inhibiting	   actin	  
depolymerisation	   via	   LIMK-­‐dependent	   cofilin	   inactivation	   (Pritchard	   et	   al.	   2004)	   or	  
inducing	   myosin	   II	   phosphorylation	   (Kaneko-­‐Kawano	   et	   al.	   2012).	   Moreover	   RhoA	  





Integrins	   are	   heterodimeric	   transmembrane	   receptors	   consisting	   of	   an	   α-­‐	   and	   β-­‐	  
subunit.	  In	  mammals	  there	  are	  24	  different	  integrins	  formed	  by	  the	  combination	  of	  
18	   α-­‐subunits	   and	   8	   β-­‐subunits,	   the	   combination	   of	   which	   dictates	   ligand-­‐binding	  
specificity	   (Figure	  1.8).	   The	   amino-­‐terminal	   domain	   in	   the	  α-­‐	   and	  β-­‐	   subunit	   forms	  
the	   ligand-­‐binding	   site	   in	   the	  extracellular	  domain.	   Integrin	   subunits	  also	  contain	  a	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relatively	  high	  degree	  of	  conservation	  across	  α	  or	  β	  subunits	  (S.	  Shattil	  et	  al.	  2010).	  
Integrin	   affinity	   for	   their	   ECM	   ligands	   such	   as	   fibronectin,	   vitronectin,	   laminin	   and	  
collagen	   is	   regulated	   by	   ‘inside-­‐out’	   signalling	   or	   activation	   events.	   During	   this	  
process,	  intracellular	  effectors,	  such	  as	  talin	  or	  kindlin	  proteins	  bind	  to	  the	  β-­‐integrin	  
cytoplasmic	   tail,	   triggering	  conformational	   changes	  within	   the	  extracellular	  domain	  
and	   thus	   promote	   clustering	   of	   integrins	   (Harburger	   &	   Calderwood	   2009).	   This	  
results	   in	   an	   increased	   affinity	   for	   the	   extracellular	   ligands	   (integrin	   activation)	  
potentially	  through	  displacement	  of	  the	  integrin	  cytoplasmic	  tails.	  	  
	  
Talin	  is	  a	  well	  characterised	  integrin	  binding	  and	  activating	  protein,	  but	  how	  talin	  co-­‐
operates	   with	   kindlin	   family	   members	   to	   maximally	   activate	   integrins	   remains	  
unclear	   (Anthis	   et	   al.	   2009;	   Lai-­‐Cheong	   et	   al.	   2009).	   Inside-­‐out	   signalling	   controls	  
adhesion	   strength	   and	   ensures	   that	   there	   is	   sufficient	   force	   for	   cell	  migration	   and	  
ECM	   remodelling	   (E.	   Brown	   2002).	   An	   integrin	   ‘outside-­‐in’	   signalling	   also	   exists,	  
driven	   by	   the	   binding	   of	   integrins	   to	   extracellular	   ligands	   (Hynes	   2002).	  
Conformational	   changes	   in	   the	   extracellular	   domains	   of	   different	   α/β	   subunits	  
combinations	  determine	  a	  high	  specificity	  of	  each	  integrin	  dimer	  for	  its	  own	  ligand.	  
For	   example,	   active	   ανβ3	   integrins	   can	   bind	   either	   fibronectin	   or	   vitronectin	   with	  
different	  affinities	  (Harjanto	  and	  Zaman	  2010).	  Outside-­‐in	  signalling	  pathways	  can	  be	  
triggered	  in	  different	  integrin	  heterodimers	  by	  binding	  to	  ECM	  ligands.	  For	  example,	  
binding	   to	   fibronectin	   activates	   both	   β1	   and	   β3	   integrins,	   whereas	   adhesion	   to	  
collagen	  leads	  to	  α1β1	  or	  α2β1	  activation	  (Harjanto	  and	  Zaman	  2010).	  	  
	  
The	  main	  function	  of	  integrins	  is	  to	  assemble	  adhesion	  structures	  between	  cells	  and	  
the	   ECM	   regulating	   cell	   shape,	   polarity	   and	   migration	   (Askari	   et	   al.	   2010).	  
Intracellular	   adaptors	   and	   enzymes	   such	   as	   Rho	   family	   GTPases,	   tyrosine	   and	  
serine/threonine	  kinases	  and	  phosphatases	  are	  all	  activated	  by	  integrin	  engagement	  
(Brown	   2002;	   Zaidel-­‐Bar	   2009).	   Their	   activation	   and	   interaction	   with	   other	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decisions,	   survival	   or	   apoptosis,	   cell	   cycle	   phase	   progression	   or	   senescence	   and	  
tissue-­‐specific	  gene	  expression	  (Streuli	  &	  Akhtar	  2009).	  ECM	  signalling,	  together	  with	  
the	   action	   of	   growth	   factors	   (GFs),	   hormones	   and	   cytokines	   compose	   a	   complex	  
signalling	  network.	  Moreover,	  both	  β1	  and	  β3	   integrins	  have	  been	  associated	  with	  
increased	  cancer	   cell	   invasion	  and	  metastasis	   (Felding-­‐Habermann	  et	  al.	  2001)	  and	  
they	  have	  been	  proposed	  to	  be	  involved	  in	  different	  types	  of	  migration	  (Brockbank	  
et	  al.	  2005).	  
	  
	  
Figure	  1.8.	  The	  integrin	  receptor	  family	  (Hynes	  2002)	  
The	  combination	  of	  18	  α-­‐subunits	  and	  8	  β-­‐subunits	  dictates	  ligand-­‐binding	  specificity	  
of	  integrins.	  
	  
1.3.1.5.	  Extracellular	  matrix	  adhesion	  types	  
	  
Integrin	  clustering	  recruits	  many	  molecules	  to	  the	  membrane,	  which	  then	  form	  large	  
multi-­‐molecular	   adhesion	   complexes.	   Different	   types	   of	   adhesion	   structures	   have	  
been	   classified	   and	   divided	   in	   terms	   of	   function,	   size,	   temporal	   activation	   and	  
signalling.	  	  Classifications	  have	  divided	  these	  structures	  into	  the	  following	  categories:	  
nascent	  adhesions,	  focal	  complexes,	  focal	  adhesions,	  fibrillar	  adhesions,	  invadopodia	  







	   39	  
normal	  cell	  motility	  such	  as	  during	  development	  or	  tissue	  repair	  processes	  as	  well	  as	  
pathological	  settings	  (Worth	  and	  Parsons	  2010),	  whilst	  invadopodia/podosomes	  are	  
involved	  in	  mediating	  adhesion-­‐dependent	  invasion	  or	  ECM	  degradation	  (Gimona	  &	  
Buccione	  2006).	  	  
	  
Nascent	   adhesions	   form	   underneath	   the	   protruding	   lamellipodium	   at	   the	   leading	  
edge	   of	   the	   cell	   and	   undergo	   very	   rapid	   assembly	   and	   disassembly.	   Through	   an	  
unknown	  mechanism,	  a	  proportion	  of	  these	  adhesions	  can	  undergo	  stabilisation	  to	  
form	   focal	   complexes	   (FCs),	   which	   persist	   for	   tens	   of	   seconds	   and	   are	   thought	   to	  
‘sample’	  the	  local	  ECM	  environment	  (left	  panel	  in	  Figure	  1.9).	  FCs	  become	  elongated	  
and	   then	   give	   rise	   to	   larger,	   more	   classical	   adhesive	   structures	   known	   as	   focal	  
adhesions	  (T.	  Parsons	  et	  al.	  2010).	  FA	  are	  more	  stable	  and	  reside	  at	  the	  ends	  of	  actin	  
stress	   fibre	  bundles	   to	  provide	  mechanical	   stability	   and	   rigidity	  during	   cell	  motility	  
(centre	  panel	  in	  Figure	  1.9).	  A	  further	  subclass	  known	  as	  fibrillar	  adhesions	  (FBs)	  are	  
rich	  in	  α5β1	  integrin	  and	  are	  predominantly	  found	  in	  cells	  aligning	  along	  fibronectin	  
fibrils	   (right	   panel	   in	   Figure	   1.9).	   FAs	   and	   FBs	   are	   also	   involved	   in	   the	   ‘inside-­‐out’	  
signalling	  of	  integrins,	  transmitting	  signals	  linked	  for	  instance	  to	  matrix	  fibrillogenesis	  
and	  reorganization	  (Askari	  et	  al.	  2010).	  
	  
	  
Figure	  1.9.	  ECM	  adhesion	  types	  (adapted	  from	  Worth	  and	  Parsons	  2010)	  
Different	   types	   of	   classified	   adhesion	   structures.	   They	   are	   divided	   in	   terms	   of	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A	  further	  class	  of	   ‘invasive’	  adhesions	  known	  as	  podosomes	  and	   invadopodia	  show	  
some	  molecular	   similarities	   but	   also	   some	   differences	   between	   the	   adhesion	   sites	  
previously	  described.	   	  The	  main	  difference	   lies	   in	  the	  focal	  degradation	  of	  the	  ECM	  
by	  proteinases	  at	  these	  sites	  (Gimona	  et	  al.	  2008).	  Both	  podosomes	  and	  invadopodia	  
contain	  actin-­‐rich	  cores	  and	  are	  involved	  in	  protease	  secretion	  (such	  as	  membrane-­‐
type	   matrix	   metalloproteinases	   1	   and	   2).	   While	   the	   structure	   of	   podosomes	   has	  
recently	   been	   characterized	   at	   high	   resolution,	   the	   one	   of	   invadopodia	   is	   still	   not	  
completely	  understood	  (Caldieri	  et	  al.	  2009).	  Podosomes	  are	  highly	  dynamic,	  actin-­‐
rich	  cores	  surrounded	  by	  a	  ring	  of	  adhesion	  proteins.	  They	  form	  adhesion	  structures	  
of	  osteoclasts,	  macrophages,	  as	  well	  as	  epithelial,	  endothelial	  and	  vascular	  smooth	  
muscle	   cells	   (Evans	   &	   Matsudaira	   2006).	   They	   are	   involved	   in	   physiological	   cell	  
attachment	   to	   solid	   surfaces	   and	   govern	   tissue	   invasion	   and	   matrix	   remodelling	  
during	  development	  and	  immune	  responses.	  Similar	  functions	  have	  been	  attributed	  
to	   invadopodia	  that	  are	  predominantly	  found	   in	  transformed	  cells	  or	  those	  derived	  
from	   tumours.	   These	   are	   extended,	   specialized,	   proteolytically	   active	   plasma	  
membrane	  protrusions	  responsible	  for	  the	  focal	  degradation	  of	  the	  matrix	  in	  cancer	  
cells	  (Buccione	  et	  al.	  2009).	  
	  
Adhesions	  and	  invasive	  structures	  here	  described	  are	  all	  required	  for	  various	  steps	  to	  
control	  the	  dynamic	  processes	  leading	  to	  cell	  movement.	  This	  is	  achieved	  by	  striking	  
a	  dynamic	  balance	  between	  early	  FA	  maturation	  and	  the	  formation	  of	  new	  adhesive	  
structures	  (T.	  Parsons	  et	  al.	  2010).	  Two	  processes	  are	  fundamentally	  coupled	  in	  this	  
dynamic	   balance:	   actin	   polymerization	   and	   myosin-­‐II-­‐generated	   tension.	   The	  
assembly	   of	   the	   nascent	   adhesions	   in	   the	   lamellipodium	   is	   proportional	   to	   the	  
protrusion	   rate	   of	   the	   leading	   edge	   and	   requires	   Arp2/3-­‐complex-­‐mediated	   actin	  
polymerization	   (Small	   et	   al.	   2002).	   As	   adhesions	   mature	   and	   disassemble	   at	   the	  
leading	   edge,	   adhesions	   disassemble	   at	   the	   cell	   rear,	   leading	   it	   to	   move	   forward	  
(Webb	  et	  al.	  2002).	  A	  key	  regulator	  of	  the	  maturation	  is	  the	  myosin-­‐II-­‐activity,	  which	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(Kaneko-­‐Kawano	  et	  al.	  2012).	  Moreover,	  not	  all	   the	  adhesion	   sites	   share	   the	   same	  
amount	  and	  types	  of	  these	  proteins.	  They	  are	  highly	  specific	  for	  adhesion	  types	  and	  
their	   maturation	   timing	   (Harjanto	   and	   Zaman	   2010;	   Worth	   and	   Parsons	   2010).	  
Similar	  proteins	  are	  involved	  in	  FCs	  and	  in	  FAs	  formation,	  while	  a	  few	  proteins	  such	  
as	  tensin	  are	  involved	  in	  stabilising	  FBs.	  	  
	  
1.3.1.6.	  Focal	  adhesions	  	  
	  
Integrins	  drive	  the	  formation	  of	  focal	  adhesions	  (FA)	  at	  the	  ends	  of	  actin	  fibres.	  Over	  
150	  molecules	  are	  proposed	  to	  participate	  in	  integrin-­‐dependent	  adhesion	  formation	  
and	  signaling	  (Costa	  and	  Parsons	  2010;	  Webb	  et	  al.	  2002;	  Zaidel-­‐Bar	  2009).	  Each	  step	  
of	   the	   formation	   of	   adhesion	   structures	   is	   characterised	   by	   phosphorylation	   of	  
different	   effectors,	   and	   these	   dictate	   a	   range	  of	   diverse	   cellular	   processes	   such	   as	  
proliferation	  and	  differentiation,	  matrix	   remodeling,	  angiogenesis,	   tissue	   formation	  
and	  cell	  migration.	  It	  results	  in	  a	  dynamic	  network	  of	  cellular	  pathways	  regulated	  by	  
integrins	   and	   promoting	   FA	   assembly	   and	   maturation	   (Harburger	   &	   Calderwood	  
2009).	   Arp2/3	   complex	   and	   Rho	   family	   GTPase	   activation	   induce	   FA	   formation	   by	  
their	   actin	   nucleating	   and	   stabilising	   activities	   (Etienne-­‐Manneville	   &	   Hall	   2001;	  
Villalonga	  &	  Ridley	  2006).	  Furthermore,	  actin-­‐binding	  proteins	  such	  as	  cofilin	  and	  α-­‐
actinin	   can	   also	   contribute	   to	   different	   steps	   of	   the	   FA	   maturation	   process	  
(Hayakawa	  et	  al.	  2012).	  	  
	  
Not	  all	  of	  the	  FA	  components	  are	  able	  to	  bind	  integrins	  directly	  (Figure	  10).	  Proteins	  
such	  as	  talin	  and	  kindlins	  can	  bind	  integrins	  directly	  and	  they	  act	  as	  linkers	  between	  
the	   receptor	   and	   other	   adaptor	   proteins.	   During	   FA	   formation,	   the	   interaction	  
between	   talin	   and	   vinculin	   drives	   the	   binding	   of	   paxillin	   that	   triggers	   the	  
autophosphorylation	  of	  focal	  adhesion	  kinase	  (FAK).	  This	  phosphorylation	  provides	  a	  
docking	   site	   for	   the	   non-­‐receptor	   tyrosine	   kinase	   Src	   and	   other	   signal	   mediator	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transduction	  adaptors	  with	  a	   large	  number	  of	  protein-­‐protein	   interaction	  sites	  that	  
connect	   integrins	   with	   intracellular	   effectors	   (Turner	   2000).	   Paxillin	   is	  
phosphorylated	  by	   tyrosine	   kinases	   such	  as	   Src,	   PI3K	  and	   the	   FAK.	   Src	   is	   crucial	   to	  
invadopodia	   formation	   and	   the	   Src-­‐FAK	   complex	   is	   central	   in	   the	   regulation	   of	   FA	  
dynamics	   during	   cell	   migration	   (Balzer	   et	   al.	   2010;	   Webb	   et	   al.	   2004).	   FA	   are	  
dynamically	   regulated	   to	   drive	   normal	   cell	   migration,	   but	   their	   turnover	   is	   also	  
critical	   in	   disease	   progression	   such	   as	   cancer.	   Indeed,	   both	   ECM	   and	   mechanical	  
microenvironment	   contribute	   to	   cancer	   progression	   and	   metastasis	   (Seong	   et	   al.	  
2013).	   Moreover	   different	   FA	   components	   are	   disregulated	   in	   multiple	   human	  
tumours	  (Nagano	  et	  al.	  2012).	  	  
	  
	  
Figure	  1.10.	  Schematic	  of	  the	  main	  FA	  components	  
ECM	  binding	  recruits	  and	  activates	  integrins,	  which	  in	  turn	  promote	  FA	  components	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The	   Rho	   GTPase	   family	   acts	   as	   a	   regulatory	   downstream	   convergence	   node	   that	  
drives	  signals	  coming	  from	  Integrins	  (Etienne-­‐Manneville	  &	  Hall	  2002;	  Ridley	  2006).	  
Indeed,	  Rac,	  Cdc42	  and	  RhoA	  regulate	  FA	  assembly	  and	  disassembly	  together	  (Nobes	  
and	  	  Hall	  1995;	  T.	  Parsons	  et	  al.	  2010).	  Furthermore	  RhoB,	  another	  component	  of	  the	  
Rho	  GTPase	   family,	   has	   been	   recently	   shown	   to	   regulate	   directional	   cell	  migration	  
controlling	  β1	  integrin	  surface	  levels	  and	  activity	  (Vega	  et	  al.	  2012).	  Actin	  binding	  and	  
cross-­‐linking	   proteins	   such	   zyxin	   and	   α-­‐actinin	   link	   FA	   structures	   to	   the	   actin	  
cytoskeleton	   transmitting	   forces	   coming	   from	   the	   ECM	   and	   acting	   as	  
‘mechanosensors’	  (C.	  K.	  Choi	  et	  al.	  2008;	  Yoshigi	  et	  al.	  2005).	  Some	  of	  the	  described	  
molecules,	   such	   as	   talin,	   are	   able	   to	   translate	   mechanical	   cues	   and	   activate	  
intracellular	   chemical	   pathways	   (Hayakawa	   et	   al.	   2012).	   A	   nanoscale	  model	   of	   FA	  
architecture	  proposed	  a	  protein-­‐specific	  strata	  organisation	  of	  FA.	  In	  particular,	  talin	  
binding	  to	  integrin	  and	  its	  orientation	  towards	  actin	  filaments	  appeared	  to	  be	  critical	  
in	  straightening	  and	  stretching	  FA	  structures	  (Kanchanawong	  et	  al.	  2010).	  Moreover,	  
vinculin	  and	  FAK	  have	  been	  associated	  with	   increased	  strengthening	  FA	  (Dumbauld	  
et	   al.	   2011).	   Similarly,	   cell	   movement	   generates	   ECM	   components	   remodeling	  
(Kirmse	  et	  al.	  2011).	  Thus,	  FA	  turnover	  is	  a	  result	  of	  the	  complex	  coordinated	  activity	  
of	   F-­‐actin,	   myosin	   II	   and	   FA	   components	   (Gallant	   et	   al.	   2005).	   In	   addition,	  
microtubules	  are	  know	  to	  target	  FA	  and	  drive	  their	  dynamics	  modulating	  contraction	  
forces	   at	   the	   cell	   membrane	   (Stehbens	   &	   Wittmann	   2012;	   Small	   et	   al.	   2002).	  
Moreover,	   the	   asymmetry	   of	   the	   MT	   network	   coordinates	   the	   distribution	   of	   FA	  
disassembly	  in	  motile	  cells	  (Broussard	  et	  al.	  2008).	  	  
	  
1.3.1.7.	  Focal	  Adhesion	  Kinase	  (FAK)	  
	  
FAK	   is	   an	   intracellular	   non-­‐receptor	   tyrosine	   kinase	   identified	   as	   one	   of	   the	  most	  
relevant	   players	   in	   integrin-­‐dependent	   adhesion	   formation.	   FAK-­‐mediated	   FA-­‐actin	  
crosstalk	   generates	   traction	   forces	   promoting	   normal	   and	   cancer	   cell	   migration	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and	  thus	   initiation,	  progression	  and	  metastasis	  of	  many	  types	  of	  tumours	   including	  
breast	  carcinomas	  (Chan	  et	  al.	  2009;	  M.	  Luo	  and	  Guan	  2010).	  Indeed,	  FAK	  expression	  
and	   activity	   is	   up-­‐regulated	   in	   different	   cancer	   cell	   types	   (Provenzano	   and	   Keely	  
2010).	   Inhibition	  of	  FAK	  interaction	  with	  growth	  factor	  receptors	  such	  as	  cMET	  and	  
IGF-­‐R	  has	  been	  associated	  with	  decreased	  cancer	  cell	  growth	  in	  vitro	  and	  vivo	  (Ucar	  
et	   al.	   2012)	   and	   it	   has	   been	  proposed	   as	   a	   therapeutic	   target	   (Mitra	  &	   Schlaepfer	  
2006).	  Upon	  activation	  by	  integrins,	  FAK	  undergoes	  auto-­‐phosphorylation	  at	  tyrosine	  
397	  (Y397)	  to	  generate	  docking	  sites	  for	  SH2-­‐domain-­‐containing	  proteins	  such	  as	  Src	  
that	   in	   turn	  phosphorylate	  FAK.	  This	  promotes	  FAK	  kinase	  activity	  and	   interactions	  
with	   other	   proteins	   such	   as	   paxillin	   (Brown	   et	   al.	   2005).	   FAK	   triggers	   signalling	  
pathways,	  which	   regulate	   the	   remodelling	   of	   the	   actin	   cytoskeleton,	   including	   the	  
Arp2/3-­‐complex	   and	   facilitates	   the	   cyclic	   activation	   of	   GEFs	   and	   GAPs	   in	   the	  
regulation	  of	  the	  Rho	  subfamily	  of	  small	  GTPases	  (Tomar	  &	  Schlaepfer	  2009;	  Tomar	  
et	  al.	  2012).	  FAK	   interactions	  with	  actin-­‐related	  proteins	   includes	   its	  ability	   to	  bind	  
cortactin	  and	  thus	  regulate	  cortical	  F-­‐actin	  dynamics	  (Tomar	  et	  al.	  2012).	  The	  cartoon	  
shown	   in	   Figure	   1.11	   shows	   the	   three	   main	   domains	   of	   the	   FAK	   protein:	   the	   N-­‐
terminus	   FERM	  domain,	   a	   central	   kinase	   domain	   and	   a	   C-­‐terminal	   focal	   adhesion-­‐
targeting	  (FAT)	  region.	  The	  FERM	  domain	  at	  the	  N	  terminus	  of	  FAK	  is	  known	  to	  bind	  
integrins,	  growth	  factor	  receptors	  and	  scaffolding	  FA	  proteins	  that	   indirectly	   link	  to	  
the	  actin	  cytoskeleton	  such	  as	  ezrin	   (Frame	  et	  al.	  2010).	  The	  kinase	  domain,	  which	  
contains	  Y397,	  is	  essential	  for	  FAK	  phosphorylation	  activity	  (Schober	  et	  al.	  2007)	  and	  
the	  C	  terminus	  contains	  the	  Focal	  Adhesion	  Targeting	  (FAT)	  domain,	  which	  is	  critical	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Figure	  1.11.	  Main	  FAK	  domains	  and	  binding	  regions	  
Schematic	   representation	  of	   the	   three	   regulatory	  domains	  of	   FAK.	   The	  N-­‐terminus	  
FERM	  domain	  (in	  blue)	  binds	   integrin,	  growth	  factor	  receptors	  and	  FA	  components	  
such	  as	  ezrin.	  	  The	  kinase	  domain	  (in	  yellow)	  is	  essential	  for	  FAK	  kinase	  activity	  as	  it	  
contains	   Tyr	   397	   phosphorylated	   by	   Src.	   Lastly,	   the	   C-­‐terminus	   FAT	   domain	   (in	  
orange)	   recruits	   components	   such	   as	   talin	   and	   paxillin	   to	   FA.	   Moreover,	   the	   FAT	  
domain	   contains	   the	   phosphorylation	   site	   for	   RhoGEF.	   Moreover,	   FAK	   structure	  
contains	  three	  proline-­‐rich	  domains	  (in	  red).	  
	  
Src-­‐dependent	   FAK	   phosphorylation	   recruits	   proteins	   that	   drive	   FA	   assembly.	   I	  
previously	   mentioned	   FAK-­‐paxillin	   interaction	   (Brown	   et	   al.	   2005).	   Moreover,	   FAK	  
recruits	   talin	   at	   nascent	   adhesions	   promoting	   their	   maturation	   to	   more	   stable	  
adhesion	  structures	   (Lawson	  et	  al.	  2012).	  FAK-­‐Src	  activation	  regulates	  FA	  dynamics	  
also	   through	   direct	   binding	   to	   dynamin,	   whose	   Tyr-­‐phosphorylation	   activates	  
integrin	   endocytosis	   (Wang	   et	   al.	   2011).	   Although	   the	  mechanism	   is	   still	   not	   fully	  
understood,	  FAK-­‐dynamin	   interaction	  contributes	  to	  MT-­‐dependent	  FA	  disassembly	  
in	   the	   nocodazole	   treatment	   and	   washout	   assays	   (Ezratty	   et	   al.	   2005).	   Other	   FA	  
components,	   such	   as	   ZF21,	   have	   been	   shown	   to	   phosphorylate	   FAK	   at	   Y397	   and	  
collaborate	   in	  disassembling	  FA	  when	  MT	  have	  been	  depolymerised	  by	  nocodazole	  
treatment	   (Nagano	   et	   al.	   2010).	   Moreover,	   FAK-­‐Src	   interaction	   controls	   FA	  
disassembly	   driving	   a	   signaling	   pathway	   controlled	   by	   paxillin,	   the	   extracellular	  
signal-­‐regulated	   kinase	   (ERK)	   and	   myosin	   light-­‐chain	   kinase	   (MLCK)	   (Webb	   et	   al.	  
2004).	  Lastly,	  the	  integrin-­‐FAK	  signaling	  pathway	  facilitates	  Rho-­‐mDia	  MT	  stabilising	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molecules	   and	   signaling	   pathways	   driving	   MT-­‐FA	   crosstalk,	   especially	   during	   FA	  
disassembly,	  how	  MT	  triggers	  FAK	  activity	  and/or	  other	  FA	  components	  during	  their	  
regrowth	   is	   still	  under	   investigation.	  A	  Rac1	   independent	  signaling	  cascade	  may	  be	  





Fascin	  is	  a	  55kDa	  actin-­‐binding	  and	  bundling	  protein.	  The	  known	  role	  of	  fascin	  is	  to	  
regulate	  cytoskeletal	  structures	  for	  promotion	  of	  stable	  F-­‐actin	  bundles	  and	  invasive	  
protrusions	   (Adams	   2004;	   Jayo	   and	   Parsons	   2010).	   Therefore,	   fascin	   is	   critical	   in	  
processes	   such	   as	   embryogenesis	   and	   adult	   tissue	   formation	   (Zhang	   et	   al.	   2008).	  
Furthermore,	  both	  fascin	  mRNA	  and	  protein	  have	  been	  shown	  to	  be	  over-­‐expressed	  
in	   a	   range	   of	   different	   types	   of	   cancer	   and	   it	   has	   been	   suggested	   as	   a	   potential	  
prognostic	  biomarker	  of	  disease	  progression	  (Hashimoto	  et	  al.	  2005;	  Tan	  et	  al.	  2013).	  
	  
1.4.1.	  Fascin	  gene	  
	  
The	  human	  genome	  displays	  three	  fascin	  genes:	  FSCN1,	  FSCN2	  and	  FSCN3.	  FSCN1	  is	  
expressed	  in	  mesenchymal	  and	  nervous	  tissues,	  FSCN2	   in	  retinal	  cells	  and	  FSCN3	   in	  
testis.	  In	  humans,	  FSCN1	  and	  FSCN3	  genes	  reside	  on	  chromosome	  7,	  while	  FSCN2	  is	  
found	  on	  the	  chromosome	  17.	  Expression	  of	  the	  fascin	  gene	  is	  required	  during	  both	  
embryogenesis	   and	   adult	   tissue	   formation,	   in	   regions	   where	   cell	   migration	   is	  
required	   (Zanet	   et	   al.	   2009;	   De	   Arcangelis	   et	   al.	   2004).	   In	   particular,	   it	   has	   been	  
shown	  that	  fascin-­‐1	  expression	  during	  mouse	  embryonic	  development	   is	  principally	  
associated	  with	   neuronal	   development	   and	   formation,	  migration	   of	   dendritic	   cells	  
and	   differentiation	   of	   muscle	   somites.	   Fascin	   is	   not	   expressed	   in	   terminally	  
differentiated	   epithelial	   cells	   (Zhang	   et	   al.	   2008).	   Thus,	   fascin	   expression	   is	   time	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1.4.2.	  Fascin	  protein	  structure	  and	  actin-­‐binding	  
	  
Fascin	  belongs	  to	  the	  β-­‐trefoil	   fold	  domain	  family	  of	  proteins	  and	  has	  four	  β	  trefoil	  
domains	  (Ponting	  &	  Russell	  2000).	  Each	  β-­‐trefoil	  fold	  consists	  of	  six	  two-­‐stranded	  β-­‐
hairpins,	   three	  of	  which	   form	  a	  barrel	   structure,	  while	   the	   remaining	   three	   form	  a	  
triangular	   cap	   on	   the	   barrel.	   Another	   feature	   of	   this	   fold	   is	   that	   it	   is	   composed	  of	  
three	   structural	   repeats,	  which	   appear	   to	   be	   highly	   conserved.	   Fascin	  was	   initially	  
characterised	  as	  an	  actin-­‐bundling	  protein	  20	  years	  ago	  (Cant	  et	  al.	  1994).	  The	  four	  
β-­‐trefoil	   domains	   of	   fascin	   fold	   in	   a	   pseudo-­‐symmetric	   globular	   protein,	   which	  
account	  both	  for	  the	  actin-­‐bundling	  property	  of	  fascin	  and	  for	  the	  approximate	  1:4	  
stoichiometry	  of	   fascin:F-­‐actin	   bundles,	   assuming	   each	  domain	  possesses	   an	   actin-­‐
binding	  activity	  (Ponting	  &	  Russell	  2000).	  	  
	  
Several	  studies	  have	  shown	  both	  actin-­‐binding	  and	  bundling	  properties	  of	  fascin	  are	  
regulated	  by	  phosphorylation	  (Anilkumar	  et	  al.	  2003;	  Ono	  1996).	  In	  particular,	  it	  has	  
been	  shown	  that	   fascin	  associates	  both	   in	  vivo	   and	   in	  vitro	  with	  Protein	  Kinase	  Cα	  
(PKCα)	   and	   that	   this	   kinase	   can	   directly	   phosphorylate	   serine39	   in	   human	   fascin	  
(Anilkumar	   et	   al.	   2003).	   When	   the	   fascin-­‐PKCα	   interaction	   is	   inhibited,	   cellular	  
protrusion	   development	   and	   FA	   remodelling	   are	   increased.	   Although	   several	  
mutagenesis	   and	   phospho-­‐mapping	   experiments	   have	   been	   recently	   attempted	   to	  
identify	   actin	   binding	   and/or	   phosphorylated	   sites	   on	   fascin	   protein	   (Yang	   et	   al.	  
2012;	   Jansen	   et	   al.	   2011),	   only	   one	   actin-­‐binding	   site	   has	   been	   so	   far	   fully	  
characterised.	   Indeed,	   the	   best-­‐characterized	   actin-­‐binding	   site	   is	   located	   at	   the	  
amino	   terminus	   in	   the	   first	   beta-­‐trefoil	   domain	   (between	   aa29	   and	   aa47).	   This	  
domain	  also	  contains	  the	  phosphorylation	  site	  for	  PKCα.	  PKCα	  phosphorylates	  fascin	  
at	   serine	   39	   resulting	   in	   loss	   of	   actin	   binding,	   reduced	   formation	   of	   filopodia	   and	  
decreased	   cell	   migration	   (Anilkumar	   et	   al.	   2003;	   Adams	   2004).	   Recently,	   another	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between	  residues	  277	  and	  493	  within	  the	  C	  terminus	  of	  fascin.	  The	  C	  terminal	  actin-­‐
binding	  site	  has	  been	  identified	  in	  both	  Drosophila	  fascin	  (singed)	  as	  well	  as	  human	  
fascin.	  A	  phospho-­‐mimetic	  mutation	  on	  serine	  289	  in	  Drosophila	  fascin	  disrupted	  the	  
actin-­‐bundling	  capacity	  of	  fascin.	  Unexpectedly,	  the	  same	  mutation	  was	  able	  to	  fully	  
rescue	  filopodia	  formation	  in	  macrophages	  in	  fascin	  mutant	  flies	  (Zanet	  et	  al.	  2012).	  
Moreover,	   mutations	   in	   the	   corresponding	   conserved	   human	   site	   (S274)	   similarly	  
affected	   fascin-­‐actin	   bundling	   and	   altered	   filopodia	   formation.	   The	   mechanisms	  
regulating	   this	   second	  actin-­‐binding	   site	   in	   cells	   are	   still	   unclear.	  An	  actin-­‐bundling	  
independent	   activity	   has	   been	   suggested	   to	   explain	   filopodia	   formation	   in	  mutant	  
cells	   (Zanet	  et	  al.	  2012).	  This	  hypothesis	  was	  also	  supported	  by	  a	  recent	  study	  that	  
shows	   mutation	   on	   serine	   274	   and	   others	   to	   have	   a	   moderate	   effect	   on	   actin	  
bundling	  compared	  to	  S39D	  (Yang	  et	  al.	  2012).	  Therefore	  an	  alternative	  mechanism	  
regulating	  the	  other	  actin	  binding	  sites	  would	  explain	  an	  actin-­‐independent	  role	  for	  
fascin	  in	  filopodia	  formation.	  The	  regulation	  of	  phosphorylation	  at	  serine	  274	  is	  still	  
under	  investigation.	  Unpublished	  data	  and	  in	  silico	  analysis	  from	  our	  lab	  has	  shown	  
S274	   is	   phosphorylated	   in	   cells	   (through	   phospho	   mass	   spec	   analysis)	   and	   the	  
phosphorylation	  may	  be	  dependent	  on	  protein	  kinase	  A	  (PKA).	  Figure	  1.12	  shows	  a	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Figure	  1.12.	  Schematic	  of	  fascin	  actin	  binding	  sites	  and	  their	  regulators	  
The	  four	  β	  trefoil	  domains	  of	  fascin	  are	  shown.	  The	  best-­‐characterised	  actin-­‐binding	  
site	   lies	   on	   the	   Serine	   39	   in	   the	   first	  β	   trefoil	   domain	   (in	   red).	   PKCα	   regulates	   the	  
binding	  between	  fascin	  and	  actin	  filaments	  (yellow	  filaments).	  Fascin	  binding	  to	  actin	  
promotes	   protrusion	   formation.	   PKCα	   phosphorylation	   on	   the	   Serine	   39	   results	   in	  
loss	  of	   actin	  binding	   and	  decrease	   in	  protrusion	   formation.	  A	   second	  actin-­‐binding	  
site	  has	  been	   identified	  and	   in	  the	  third	  β	   trefoil	  domain	   (in	  blue).	  The	  mechanism	  
regulating	   this	  actin-­‐binding	  site	   is	  not	  clear	  yet,	  but	  serine	  274	  residue	  within	   this	  
region	   plays	   a	   key	   role.	   It	   is	   known	   that	   its	   binding	   to	   actin	   promotes	   protrusion	  
formation	   and	   a	   phospho-­‐dead	   mutation	   promotes	   the	   loss	   of	   the	   actin	   binding	  
without	  obvious	   change	   in	  protrusion	   formation.	   S274A	   fascin	  also	   localises	   to	   the	  
tips	  of	  filopodia,	  but	  does	  not	  colocalise	  with	  F-­‐actin	  in	  these	  regions.	  Therefore,	  an	  
actin-­‐independent	  activity	  for	  this	  mutant	   is	  suggested.	  Unpublished	  data	  proposes	  
PKA	   as	   a	   potential	   kinase	   promoting	   Serine	   274	   phosphorylation.	   Note	   the	  model	  
does	  not	  depict	  protein	  real	  sizes.	  
	  
1.4.3.	  Function	  of	  fascin	  	  
	  
Fascin	  plays	  a	  critical	  role	  in	  cell	  adhesion,	  motility	  and	  invasion	  through	  binding	  and	  
bundling	   actin	   filaments	   to	   stabilise	   them.	   Fascin,	   together	  with	   other	   actin	   cross-­‐
linking	   proteins,	   is	   involved	   in	   the	   assembly	   and	   maintenance	   of	   lamellipodia,	  
filopodia	  and	  stress	  fibres	  (Small	  et	  al.	  2002).	  Fascin	  binds	  actin	  filaments	  selectively,	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PKC-­‐dependent	  phosphorylation	  on	  fascin	  allows	  efficient	  and	  dynamic	  coordination	  
of	  filopodia	  elongation/invasiveness	  and	  bundling	  (Vignjevic	  et	  al.	  2006b).	  Fascin	  also	  
localizes	   in	   F-­‐actin	   containing	   structures	   such	   as	   podosomes	   and	   invadopodia,	  
promoting	   their	   stability	   (Li	   et	   al.	   2010;	  Quintavalle	  et	   al.	   2010).	   Fascin	  mRNA	  and	  
protein	   are	   both	   highly	   up-­‐regulated	   in	   many	   types	   of	   cancer	   and	   this	   acts	   to	  
promote	  invasiveness	  of	  cancer	  cells	  (Machesky	  &	  Li	  2010).	  Fascin	  role	  in	  promoting	  
cancer	   invasion	  and	  metastasis	   is	  also	  dependent	  on	  PKC-­‐phosphorylation	   (Li	  et	  al.	  
2010;	   Hashimoto	   et	   al.	   2007).	   Loss	   of	   fascin	   is	   associated	   with	   a	   decrease	   in	   cell	  
spreading,	   adhesion	   and	  migration	   (Adams	   2004).	   Fascin	   knockdown	  expression	   in	  
human	  carcinoma	  cell	  lines	  has	  previously	  been	  shown	  by	  our	  lab	  to	  decrease	  focal	  
adhesion	   dynamics,	   suggesting	   it	   may	   play	   a	   role	   in	   adhesion	   site	   stability	  
(Hashimoto	   et	   al.	   2007).	   However,	   fascin	   has	   not	   been	   found	   to	   localise	   in	   focal	  
adhesions	  and	  thus	  the	  way	  in	  which	  fascin	  may	  contribute	  to	  adhesion	  stability	  and	  
dynamics	  is	  still	  unknown.	  	  
	  
PKC-­‐binding	  and	  phosphorylation	  of	  fascin	  has	  previously	  been	  shown	  to	  depend	  in	  
part	  on	  the	  small	  GTPase	  Rac1	  and	  its	  downstream	  effector	  PAK1	  (Hashimoto	  et	  al.	  
2008).	   Fascin	   also	   cooperates	   with	   the	   Arp2/3	   complex	   and	   formins	   to	   assemble	  
filopodia	   and	   invadopodia,	   but	   this	   is	   not	   thought	   to	   be	   via	   direct	   associations	  
between	   these	   proteins	   and	   fascin	   (Baldassarre	   et	   al.	   2006;	   Lizárraga	   et	   al.	   2009).	  
More	  recently,	  RhoA	  has	  been	  suggested	  as	  another	  regulator	  of	   fascin	   function	   in	  
the	   assembly	   of	   F-­‐actin	   structures	   (Jayo	   et	   al.	   2012).	   In	   particular,	   fascin-­‐F-­‐actin	  
binding	   is	  regulated	  by	  Rho	  kinase	  (ROCK)	  activity,	  but	   independent	  of	  myosin	   II	  or	  
fascin/PKC	  complex	  formation.	  RhoA	  activation	  promotes	  fascin	  complex	  formation	  
with	  LIM	  kinase	   (LIMK),	  which	   regulates	   filopodia	   stability.	   Furthermore,	   cofilin,	  an	  
actin-­‐depolymerising	   molecule,	   has	   been	   shown	   to	   cooperate	   with	   fascin	   in	  
disassembling	   filopodia	   filaments	   (Breitsprecher	   et	   al.	   2011).	   Figure	   1.13	   shows	   a	  












Figure	  1.13.	  Regulation	  and	  functions	  of	  fascin	  (Jayo	  and	  Parsons	  2010)	  
Fascin	   role	   in	   regulating	   stress	   fiber	   and	   FA	   formation	   together	  with	   filopodia	   and	  
invading	  protrusion	  assembly	  is	  downstream	  of	  RhoA-­‐driven	  ROCK	  activity	  and	  Rac1-­‐





1.5.	  Microtubule-­‐actin	  crosstalk	  in	  cell	  adhesion	  and	  motility	  
	  
Many	  studies	  have	  shown	  MT	  to	  play	  a	  positive	  role	  in	  migration	  by	  regulating	  actin	  
polymerisation,	  transport	  membrane	  vesicles	  to	  the	  leading	  edge	  and	  facilitating	  the	  
turnover	  of	   adhesion	   sites	   (Small	   et	   al.	   2002;	  Ridley	  2011).	   The	   first	   studies	  of	   the	  
role	   of	   MT	   role	   in	   migration	   showed	   cells	   treated	   with	   MT-­‐depolymerising	   drugs	  
results	  in	  increased	  cell	  migration	  speed	  (Ueda	  et	  al.	  1997).	  Recently,	  mutations	  in	  β	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MT-­‐targeting	  drugs	  have	  shown	  to	   increase	  actin	  protrusions	  formation	  and	  induce	  
FA	   assembly.	   For	   instance,	   treatment	   of	   cells	   with	   nocodazole,	   a	   drug	   which	   de-­‐
polymerises	   MT,	   results	   in	   increased	   stress	   fibre	   formation	   and	   cell	   contractility	  
(Chang	  et	  al.	  2008).	  On	  the	  other	  hand,	  the	  MT-­‐stabilising	  agent	  Taxol	  prevents	  the	  
strengthening	  effect	  on	  FA	  promoted	  by	  nocodazole	  (Ganguly	  et	  al.	  2012).	  It	  has	  also	  
been	   shown	   that	   both	   increased	   cell	   contractility	   and	   FA	   assembly	   are	   rescued	   to	  
normal	  levels	  by	  MT	  repolymerisation	  (Ezratty	  et	  al.	  2005).	  Moreover,	  MT	  assembly	  
exerts	  a	  pushing	  force	  that	  can	  act	  to	  counterbalance	  the	  contractile	  forces	  exerted	  
by	   the	   actin	   fibres.	   Although	   the	   molecular	   details	   of	   how	   actin-­‐MT	   crosstalk	  
regulates	   cell	   adhesion	   and	   migration	   are	   still	   not	   fully	   understood,	   the	   current	  
concept	   is	   that	   protrusion	   initiation	   signals	   may	   be	   driven	   by	   the	   actin	   network,	  
whereas	  adhesion	  turnover	  and	  protrusion	  elongation	  may	  be	  due	  to	  crosstalk	  and	  
co-­‐operation	  between	  actin	  and	  microtubules	  (Schoumacher	  et	  al.	  2011;	  Small	  et	  al.	  
2002).	   Two	   zones	   within	   cells	   have	   been	   distinguished:	   an	   actin-­‐rich	   region	   with	  
lamellipodia	  and	  filopodia	  and	  a	  MT-­‐rich	  region	  where	  actin	  polymerisation	  is	  limited	  
(Etienne-­‐Manneville	  2004)	  (Figure	  1.14).	  The	  relative	  extension	  of	  the	  actin/MT	  rich	  
regions	  depends	  on	  cell	   and	  protrusion	   types.	   Indeed,	   lamellipodia	   formation	  does	  
not	   require	  dynamic	  MT,	  but	   these	  are	  essential	   for	   cell	   body	  movement	  and	   rear	  
retraction	   (Webb	   et	   al.	   2002).	   MT	   co-­‐operate	   with	   stress	   fibres	   promoting	  
maturation	   and	   turnover	   of	   FA	   at	   both	   the	   leading	   and	   trailing	   edge	   (Stehbens	  &	  
Wittmann	  2012).	  In	  some	  cell	  types,	  MT	  have	  also	  been	  shown	  to	  mediate	  filopodia	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Figure	  1.14.	  Actin	  and	  MT	  rich-­‐regions	  in	  the	  regulation	  of	  stress	  fibre	  and	  FA	  
dynamics	  	  
Two	  regions	  can	  be	  distinguished	  in	  the	  cellular	  leading	  edge:	  an	  actin-­‐rich	  region	  (in	  
red)	  and	  a	  MT-­‐rich	   region	   (in	  blue).	   The	   first	  one	   comprises	  actin-­‐based	   structures	  
such	   as	   lamellipodia	   and	   filopodia,	  while	   the	   second	   shows	  MT	   (in	   blue)	   radiating	  
from	  the	  MTOC	   (in	  black)	  and	  growing	  with	   their	  +ends	   towards	   the	   leading	  edge.	  
MT	  target	  and	  stabilise	  FA	  (green	  circles).	  Actin	  structures	  in	  the	  MT-­‐rich	  region	  are	  
limited	  to	  stress	  fibres	  (red	  lines)	  co-­‐operating	  with	  MT	  in	  FA	  assembly.	  Stress	  fibres	  
and	  MT	  are	  also	  critical	   in	  regulating	  FA	  and	  trail	   retraction	  at	  the	  back	  of	  the	  cell.	  
Direction	  of	  the	  movement	  is	  shown.	  
	  
The	   role	   of	   MT	   in	   cell	   motility	   became	   more	   complex	   when	   studies	   observed	  
different	   effects	   on	   cell	   migration	   depending	   on	   the	   concentration	   of	   MT-­‐
depolymerising	   drugs	   used	   (Ganguly	   &	   Cabral	   2011).	   Low	   concentrations	   of	  
nocodazole	   induces	   loss	   of	   MT	   dynamics	   and	   thus	   decreased	   fibroblast	   motility,	  
without	  evident	   changes	   in	  MT	  assembly/polymerisation	   (Liao	  et	   al.	   1995).	  On	   the	  
other	  hand,	  high	  concentrations	  of	  the	  drug	  promote	  cell	  contractility	  and	  migration,	  
affecting	  MT	  polymerisation	  (Ganguly	  &	  Cabral	  2011).	  Therefore,	  MT	  polymerisation	  
and/or	  dynamic	  integrity	  have	  different	  effects	  on	  cell	  motility.	  Additionally,	  tubulin	  
post-­‐translation	  modifications	  have	  been	  associated	  with	  changes	  in	  F-­‐actin	  stability	  
and	   cell	  motility.	   For	   instance,	   increased	   levels	   of	   tubulin	   acetylation	   after	   histone	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Furthermore	  the	  mechanism	  may	  involve	  the	  HDAC6	  acetylation	  of	  cortactin,	  which	  
alters	  the	  ability	  of	  cortactin	  to	  bind	  and	  stabilise	  F-­‐actin	  (Zhang	  et	  al.	  2007).	  
	  
The	   actin-­‐MT	   crosstalk	   can	   be	   classified	   as	   either	   ‘regulatory’	   or	   ‘structural’	  
(Rodriguez	  et	  al.	  2003).	  The	  structural	  interactions	  are	  the	  ones	  where	  actin	  and	  MT	  
are	  physically	  linked.	  Some	  molecules	  regulating	  the	  assembly	  and/or	  stability	  of	  the	  
two	  major	   cytoskeleton	   components	   have	   been	   demonstrated	   to	   directly	   interact	  
with	   each	   other	   (Rodriguez	   et	   al.	   2003).	   For	   instance,	   MT	   +TIP	   proteins	   can	   co-­‐
operate	  with	  actin-­‐dependent	  adhesion	  structures	  to	  drive	  protrusion	  formation	  and	  
generate	  forces	  to	  push	  the	  leading	  edge	  forward	  (Lansbergen	  &	  Akhmanova	  2006;	  
Morrison	  2007).	  EB1	  has	  been	  shown	  to	  interact	  with	  PKC	  in	  maintaining	  cell	  polarity	  
(Schober	   et	   al.	   2012).	   Additionally,	   EB3	   has	   been	   shown	   to	   directly	   bind	   to	   the	   F-­‐
actin-­‐associated	   protein	   drebrin	   and	   both	   proteins	   co-­‐localize	   in	   the	   filopodia	  
protrusions	  during	  neuritogenesis	  (Geraldo	  et	  al.	  2008).	  Formins,	  such	  as	  INF2,	  mDia	  
1	   and	   mDia2,	   have	   been	   shown	   to	   have	   different	   interaction	   with	   MT	   and	   thus	  
different	  effects	  on	  either	  MT	  growth	  or	  catastrophe	  rate	  (Gaillard	  et	  al.	  2011).	  The	  
MAP	  CLIP-­‐170	  has	  been	  shown	  to	  interact	  with	  the	  actin-­‐binding	  protein	  IQGAP1	  in	  
regulating	  dendrite	  morphology	  (Swiech	  et	  al.	  2011).	  	  
	  
Additionally,	  proteins	   that	  directly	   link	  actin	  and	  MT	   together	  have	  been	   reported.	  
For	  instance,	  ACF7	  is	  both	  a	  MT	  +TIP	  and	  actin-­‐binding	  protein	  and	  has	  been	  shown	  
to	  regulate	  both	  cytoskeletons	  through	  different	  mechanisms	  (Jefferson	  et	  al.	  2004;	  
Wu	   et	   al.	   2011).	   The	  MAP	   doublecortin	   promotes	   lamellipodia	   formation	   in	   brain	  
development	  inducing	  F-­‐actin	  reorganisation	  and	  decreasing	  MT	  bundling	  (Toriyama	  
et	  al.	  2012).	  LIM	  kinase	  1	  promotes	  actin	  polymerisation	  both	  inhibiting	  cofilin	  actin	  
depolymerising	  activity	  but	  also	  promoting	  MT	  destabilisation	  via	  complex	  formation	  
with	   tubulin	   (Gorovoy	   at	   al	   2006).	   Lastly,	   proteins	   which	   activate	   the	   Arp2/3	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microtubules),	   have	   been	   shown	   to	   alter	   membrane	   dynamics	   modifying	   the	  
interplay	  between	  actin	  and	  MT	  (Campellone	  et	  al.	  2008).	  	  
	  
The	  regulatory	  cooperation	  is	  the	  one	  in	  which	  actin	  and	  MT	  indirectly	  crosstalk,	  via	  
activation	   of	   common	   signalling	   cascades.	   The	   Rho	   family	   GTPases	   regulation	   of	  
actomyosin	  contractility	  together	  with	  MT	  stability	  is	  one	  of	  the	  best	  cited	  examples	  
(Wittmann	  &	  Waterman-­‐Storer	  2001).	  MT	  can	  alter	  actomyosin	  contractility	  via	  the	  
small	   GTPase	   RhoA,	   by	   locally	   modulating	   its	   activation	   (Stehbens	   &	   Wittmann	  
2012).	   Nocodazole	   treatment	   induces	   the	   MT-­‐associated	   guanine	   nucleotide	  
exchange	  factor	  GEF-­‐H1	  to	  be	  released	  from	  binding	  to	  MT	  and	  thus	  RhoA	  activation	  
(Chang	   et	   al.	   2008).	   RhoA	   activation	   results	   in	   increased	   FA	   assembly	   and	   cell	  
contractility	  observed	  after	  nocodazole	  treatment	  and	  inhibition	  of	  Rac1-­‐dependent	  
effects	   on	   cell	   contractility	   (Etienne-­‐Manneville	   2004).	   In	   contrast,	   MT	   re-­‐growth	  
following	  nocodazole	  washout	  results	  in	  rapid	  FA	  disassembly	  in	  a	  signaling	  cascade	  
pathway	   involving	   the	   endocytic	   GTPase	   dynamin	   and	   FAK	   (Ezratty	   et	   al.	   2005).	  
Although	  MT-­‐dependent	   FA	   disassembly	   has	   been	   shown	   to	   be	   driven	   by	   the	  GEF	  
STEF-­‐dependent	   Rac1	   activation	   (Rooney	   et	   al.	   2010),	   Rac1	   inhibition	   does	   not	  
disrupt	  MT-­‐dependent	   FA	   disassembly	   (Ezratty	   et	   al.	   2005).	   Therefore,	   the	   precise	  
MT-­‐dependent	  FA	  disassembly	  mechanisms	  are	  not	  known.	  However	  it	  is	  clear	  that	  
MT	   together	  with	  GTPases	  act	   coordinately	   to	  promote	  FA	  dynamics	   (Wittmann	  &	  
Waterman-­‐Storer	  2001)	  (Figure	  15).	  	  
	  
Interactions	   between	   +TIPs	   and	   Rho	   family	   GTPases	   and	   other	   actin	   regulatory	  
proteins	  has	  been	  shown	  to	  occur	  in	  a	  number	  of	  different	  contexts	  (Lansbergen	  &	  
Akhmanova	  2006).	  The	  depletion	  of	  a	  +TIP	  protein	  known	  as	  GTSE1	  has	  been	  shown	  
to	   inhibit	   FA	   disassembly	   following	   nocodazole	   washout	   (Scolz	   et	   al.	   2012).	   APC	  
regulate	  cell	  polarization	  connecting	  EB1	  to	  Rho	  family	  GTPases	  (Etienne-­‐Manneville	  
2004).	  CLIP-­‐170	  is	  captured	  by	  both	  Rac1	  and	  Cdc42	  to	  stabilize	  MTs	  at	  the	  cellular	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protein,	   has	   been	   found	   to	   stabilize	   microtubules	   and	   promote	   cell	   migration	   by	  
interacting	  with	  EB1	  and	  APC	  (Wen	  et	  al.	  2004).	  Moreover,	  the	  MT-­‐stabilising	  protein	  
Calpain-­‐6	   has	   been	   shown	   to	   mediate	   the	   Rac1-­‐dependent	   increased	   cell	  
contractility	  via	  interaction	  with	  GEF-­‐H1	  (Tonami	  et	  al.	  2011).	  	  
	  
	  
Figure	  1.15.	  Signalling	  cascades	  regulating	  FA	  assembly	  and	  disassembly	  
MT	  depolymerisation	  after	  nocodazole	   treatment	   induces	  GEF-­‐H1	  release	   from	  MT	  
and	   RhoA	   activation.	   RhoA	   activity	   promotes	   increased	   FA	   assembly,	   stress	   fibre	  
formation	   and	   cell	   contractility	   in	   a	   Rac1-­‐independent	   way.	   Conversely,	   MT	   re-­‐
growth	   following	  nocodazole	  washout	  re-­‐captures	  GEF-­‐H1	  and	  somehow	  promotes	  
FA	   disassembly	   and	   decreased	   stress	   fibre	   formation	   and	   cell	   contractility.	   MT-­‐
dependent	   FA	   disassembly	   is	   known	   to	   be	   driven	   by	   dynamin	   and	   FAK.	   However,	  
how	  MT	  trigger	  this	  signaling	  cascade	  is	  still	  unknown.	  
	  
Actin-­‐MT	   crosstalk	   involves	   a	   feedback	   control	   of	  microtubules	   dynamics	   by	   actin-­‐
based	  structures.	  For	  instance,	  stress	  fibres	  emanating	  from	  FAs	  can	  act	  to	  stabilize	  
the	  MT	  network	  (Small	  et	  al.	  2002;	  Palazzo	  et	  al.	  2004)	  and	  FA	  components	  such	  as	  
paxillin	   regulate	   MT	   growing/shortening	   in	   adhesion	   sites	   (Andrey	   Efimov	   et	   al.	  
2008).	   MT	   stability	   is	   also	   regulated	   by	   actin-­‐capping	   protein	   such	   as	   the	   formin	  
mDia	   (Bartolini	   et	   al.	   2012).	  Moreover,	   the	   Cdc42-­‐MRCK	   regulation	   of	   actomyosin	  
contractility	  establishes	  MTOC	  polarisation	  during	  nuclear	  movement	  (Gomes	  et	  al.	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MTs	  may	   interfere	   with	   the	   affinity	   of	   integrins	   to	   ECM-­‐components	   and	   thereby	  
regulate	   cell	   polarity	   and	  migration	   (Small	   et	   al.	   1999).	   In	   turn,	  MTs	   stability	   and	  
dynamics	  are	  modified	  by	   integrin	  activation	  and	  ECM	  compliance	   (Lei	  et	  al.	  2012;	  
Myers	   et	   al.	   2011).	   	   The	  mutual	   regulation	   of	   actin	   and	  microtubules	   is	   central	   in	  
processes	   such	   as	   neuronal	   cone	   development	   (Zhou	   et	   al.	   2002)	   and	   metastasis	  
dissemination	   in	   cancer	   progression	   (Hall	   2009).	   Although	   the	   identification	   of	  
shared	  pathways	  between	  actin	  and	  MT	  have	  been	  the	  focus	  of	  much	  interest	  in	  the	  
field,	  mechanisms	  driving	  their	  interactions	  are	  still	  poorly	  defined;	  particularly	  in	  the	  




The	  hypothesis	   leading	   to	   this	   thesis	   is	   that	   fascin	   controls	   cell	   adhesion	  dynamics	  
through	   association	   with	   microtubules,	   and	   acts	   to	   co-­‐ordinate	   actin	   and	  












The	  work	  conducted	  in	  this	  thesis	  is	  designed	  to	  address	  the	  following	  aims:	  
	  
	  
-­‐ Determine	   the	   role	   of	   fascin-­‐actin	   binding	   in	   controlling	   focal	   adhesion	  
assembly	  and	  size	  in	  human	  cancer	  cells.	  
-­‐ Investigate	  whether	   fascin-­‐actin	  binding	  contributes	   to	  microtubule-­‐induced	  
focal	  adhesion	  dynamics	  or	  vice	  versa.	  
-­‐ Determine	   whether	   fascin	   associates	   directly	   or	   indirectly	   with	   the	  
microtubule	  network.	  
-­‐ Examine	   the	   role	   of	   fascin-­‐actin	   binding	   in	   possible	   crosstalk	   with	   the	  
microtubule	  cytoskeleton.	  
-­‐ Investigate	  whether	   fascin	   forms	  a	  complex	  with	   focal	  adhesions-­‐associated	  











	  	  	  	  	  
2 MATERIAL	  AND	  METHODS.	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2.1.	  Reagents	  	  	  
	  
Table	  2.1.	  Cell	  culture	  reagents	  
	  
Reagent	  	   Source	  	  
Bovine	  Collagen,	  Type	  I	   BD	  Biosciences	  
Calyculin	  A	  (10	  µM	  final)	   Calbiochem	  
Dimethyl	  sulphoxide	  (DMSO)	   Sigma	  
Foetal	  Bovine	  Serum	   Sera	  Laboratories	  International	  Ltd.	  
High	   Glucose	   Dulbecco’s	   modified	   Eagle’s	  
media	  (DMEM)	  
Sigma	  Aldrich	  




Lipofectamine	   Invitrogen	  









Phosphate	  Buffered	  Saline	  (PBS)	   Lonza	  
Polybrene	  (hexadimethrine	  bromide)	   Sigma	  Aldrich	  
Protease	   inhibitor	   (PI)	   cocktail	   set	   1	   (stock	  
100X,	  dilute	  to	  1X)	  
Containing:	  
AEBSF,	  Hydrochloride	  -­‐	  500	  µM	  
Aprotinin,	  Bovine	  lung,	  crystalline	  –	  150	  nM	  
E-­‐64	  Protease	  Inhibitor	  -­‐	  1	  µM	  
EDTA	  Disodium	  –	  0.5	  mM	  
Leupeptin,	  Hemisulphate	  –	  1	  µM	  	  	  
Calbiochem	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Table	  2.2.	  Molecular	  biology	  reagents	  
	  
Reagent	  	   Source	  	  
Agarose	  	   Sigma	  Aldrich	  
Ampicillin	  	   Sigma	  Aldrich	  	  
BL21	  (DE3)	  competent	  cells	   Agilent	  Technologies	  
Bovine	  serum	  albumin	  (BSA)	   New	  England	  Biolabs	  
Deoxynucleosides	  (DNTPs)	   Bioline	  
Hyperladder	  I	   Biolabs	  





Linear	  Polyethylenimine	  (PEI)	  
Luria	  Bertani	  (LB)	  agar	  and	  broth	  
Polysciences,	  Inc	  
Sigma	  Aldrich	  
Midiprep	  kit	   Qiagen	  	  
Miniprep	  kit	   Qiagen	  
NEbuffers	  	   New	  England	  Biolabs	  
One	  Shot	  TOP10	  chemically	  competent	  E.Coli	   Invitrogen	  
Phusion	  Hot	  Start	  DNA	  polymerase	   Finnzymes	  
Phusion	  buffer	  (10X)	   New	  England	  Biolabs	  
Phusion	  polymerase	   New	  England	  Biolabs	  
QIAquick	  gel	  extraction	  kit	   Qiagen	  
Quickchange	  Site-­‐directed	  mutagenesis	  kit	  	   Stratagene	  
Restriction	  enzymes	   New	  England	  Biolabs	  
Safeview	  	   NBS	  Biologicals	  	  
T4	  DNA	  Ligase	  and	  Buffer	  	   New	  England	  Biolabs	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Table	  2.3.	  Biochemical	  assay	  reagents	  	  
	  
Reagent	  	   Source	  	  





30%	  Acrylamide/Bis	  solution	   Biorad	  
A/G	  agarose	  affinity	  matrix	   Alpha	  Diagnostic	  International	  
Adenosine-­‐5’-­‐triphosphate	  (ATP)	  
Ammonium	  persulphate	  (APS)	  
Sigma	  Aldrich	  
Sigma	  Aldrich	  
Bovine	  Brain	  Tubulin	  Protein	  
Bovine	  Serum	  Albumin	  
Cytoskeleton	  
PAA	  the	  cell	  culture	  company	  
Bromophenol	  blue	   Sigma	  Aldrich	  
Calcium	  Chloride	  
















Glutathione	  Sepharose	  4	  Fast	  Flow	  beads	  
Sigma	  Aldrich	  
Amersham	  
Glycine	   Sigma	  Aldrich	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Glycerol	   VWR	  International	  
Guanosine	  5’-­‐Triphosphate	  Sodium	  Salt	  
Hydrate	  (GTP)	  
Hybond	  ECL	  Nitrocellulose	  membrane	  	  
Sigma	  Aldrich	  
	  
Amersham	  Biosciences	  	  
Immersol	  510	  Immersion	  oil	   Zeiss	  
Isopropyl	  β-­‐D-­‐1-­‐thiogalactopyranoside	  (IPTG)	   Sigma	  Aldrich	  
Magnesium	  Chloride	  




Ni-­‐NTA	  Agarose	  Beads	  
MERCK	  
Qiagen	  
Paraformaldehyde	  (PFA)	   Sigma	  Aldrich	  
PeqGOLD	  protein	  marker	  V	   PeqLab	  
Pierce	  BCA	  protein	  assay	  kit	   Thermo	  Scientific	  
PBS	  tablets	  	   Oxoid	  
Pierce	  ECL	  western	  blotting	  substrate	   Thermo	  Scientific	  
Ponceau	  S	  solution	   Sigma	  Aldrich	  
Porcine	  Brain	  Tubulin	  Protein	  (Rhodamine)	  
Potassium	  Chloride	  






Tetramethylethylenediamine	  (TEMED)	   Sigma	  Aldrich	  
Tissue-­‐Tek	  OCT	  compound	   VWR	  international	  
Tris-­‐Base	  	   Sigma	  Aldrich	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Table	  2.4.	  Solutions	  for	  biochemical	  assays	  
	  
Buffers/Solutions	   Composition	  
5%	  stacking	  acrylamide	  gel	   5%	   30%-­‐acrylamide	   mix,	   125mM	  
Tris-­‐HCl	   (pH6.8),	   0.1%	   Sodium	  
dodecyl	   sulphate	   (SDS),	   0.1%	  
ammonium	   persulphate	   (APS),	   1%	  
TEMED	  
8%	  resolving	  acrylamide	  gel	   8%	   30%-­‐acrylamide	   mix,	   400	   mM	  
Tris	   (pH	   8.8),	   0.1%	   SDS,	   0.1%	   APS,	  
0.05%	  TEMED	  
10%	  resolving	  acrylamide	  gel	   10%	   30%-­‐acrylamide	   mix,	   400	   mM	  
Tris	   (pH	   8.8),	   0.1%	   SDS,	   0.1%	   APS,	  
0.05%	  TEMED	  
Coomassie	  staining	  solution	   0.025%	   Coomassie	   brilliant	   blue	  
R250,	  40%methanol,	  7%	  acetic	  acid	  
Destaining	  solution	   50%	  methanol,	  10%	  acetic	  acid	  
F-­‐Actin	  Polymerisation	  Buffer	  
	  
	  
G-­‐Actin	  Resuspension	  Buffer	  (KME	  10x)	  
	  




His6	  tagged	  Protein	  Purification	  Lysis	  Buffer	  	  
	  
	  
His6	  tagged	  Protein	  Wash	  Buffer	  1	  
	  
50	  mM	  Potassium	  Chloride,	  2	  mM	  
Magnesium	  Chloride,	  1	  mM	  ATP	  	  
500	  mM	  Potassium	  Chloride,	  10	  
mM	  Magnesium	  Chloride,	  10	  mM	  
EGTA,	  100	  mM	  imidazole	  (pH	  7)	  
50	  mM	  PIPES	  (pH	  6.8),	  1	  mM	  EGTA,	  
1	  mM	  Magnesium	  Chloride	  
50	  mM	  Sodium	  Phosphate,	  10	  mM	  
imidazole,	  300	  mM	  Sodium	  Chloride	  
(pH	  8)	  
50	  mM	  Sodium	  Phosphate,	  20	  mM	  
imidazole,	  300	  mM	  Sodium	  Chloride	  
	  





	   66	  
	  
His6	  tagged	  Protein	  Wash	  Buffer	  2	  
	  
	  
His6	  tagged	  Protein	  Elution	  Buffer	  	  
	  
	  




50	  mM	  Sodium	  Phosphate,	  50	  mM	  
imidazole,	  300	  mM	  Sodium	  Chloride	  
(pH	  8)	  
50	  mM	  Sodium	  Phosphate,	  250	  mM	  
imidazole,	  300	  mM	  Sodium	  Chloride	  
(pH	  8)	  
PBS	  1x,	  10	  mM	  imidazole,	  10%	  
Glycerol	  (pH	  8)	  
50	  mM	  Tris	  (pH7.2),	  500	  mM	  NaCl,	  	  
10mM	  MgCl,	  0.5%	  sodium	  
deoxycholate,	  1%	  Triton	  X-­‐100,	  PI	  
cocktail,	  Phosphatase	  inhibitors:	  50	  
mM	  Sodium	  Fluoride	  and	  1	  µM	  
Calyculin	  A	  
PBS-­‐Tween	  (1x)	   10	   tablets	   of	   Phosphate	   buffered	  
saline,	  0.1%	  Tween-­‐20	  
PlusOne	  Silver	  Staining	  Kit	  
Running	  Buffer	  (10x)	  
GE	  Healthcare	  
0.25	  M	  Tris	  base,	  1.92	  M	  glycine,	  1%	  
SDS	  
SDS	  Sample	  Loading	  Buffer	  (2x)	   60mM	   Tris-­‐HCl	   (pH	   6.8),	   25%	  
Glycerol,	   2.5%	   SDS,	   0.02%	  
Bromophenol	  blue	  
TBS-­‐Tween	  (10x)	   20	  mM	  Tris-­‐base	   (pH	  7.5),	  150	  mM	  
NaCl,	  0.1%	  Tween-­‐20	  




Tubulin	  Pelleting	  Buffer	  (TB2)	  	  	  
General	   Tubulin	   Buffer,	   10%	  
Glycerol,	   5	   mM	   Magnesium	  
Chloride,	  1	  mM	  GTP	  	  
General	   Tubulin	   Buffer,	   50%	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Tubulin	  Resuspension	  Buffer	  (TB3)	  
	  
Transfer	  buffer	  (10x)	  
Glycerol,	  1mM	  GTP,	  80	  uM	  Taxol	  
General	   Tubulin	  Buffer,	  1	  mM	  GTP,	  
80	  uM	  Taxol	  












Table	  2.5.	  Antibodies	  	  	  
Target	   Dilution	  	   Species	   Source	  
α/β	  Tubulin	  	  
	  
	  
















































































Anti-­‐Rabbit	  HRP	   1/1000	  (WB)	   Goat	   DAKO	  
Anti-­‐Mouse	  Alexa	  488	   1/400	  (IF)	   Goat	   Molecular	  
Probes	  































































2.3.1.	  Molecular	  biology	  and	  cloning	  
	  
2.3.1.1.	  Generation	  of	  lentiviral	  vector	  to	  target	  fascin	  expression	  	  	  
Human	   lentiviral	   short	   hairpin	   RNA	   (shRNA)	   targeting	   fascin	   was	   cloned	   into	   the	  
pLentiLox	  3.7	  (LL3.7),	  kindly	  donated	  by	  Dr	  Monypenny	  (King’s	  College	  London).	  The	  
vector	  map	  is	  shown	  in	  Figure	  2.1.	  	  
	  
	  
Figure	  2.1.	  Map	  of	  the	  pLentiLox	  (LL3.7)	  lentiviral	  vector	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The	  sequence	  of	   the	  shRNA	   (gift	   from	  Dr	  Adams,	  University	  of	  Bristol,	  UK)	  used	   to	  
knock	  down	  fascin	  was	  5’-­‐GCCTGAAGAAGAAGCAGAT-­‐3’	  directed	  to	  the	  first	  exon	  of	  
the	   human	   fascin	   gene,	   isoform	   1	   (FSCN1)	   (Figure	   2.2).	   Additionally,	   a	   scrambled	  
sequence	  of	  the	  shRNA	  was	  cloned	  into	  the	  LL3.7	  vector	  and	  used	  as	  a	  control.	  	  	  
	  
Figure	  2.2.	  The	  target	  sequence	  of	  the	  shRNA	  is	  located	  in	  the	  first	  exon	  of	  human	  
fascin	  gene	  	  	  
ShRNA-­‐resistant	  hFascin	  cDNA	  in	  which	  the	  shRNA	  target	  sequence	  was	  changed	  to	  
5’-­‐GCCTGAAAAAAAAACAGAT-­‐3’	   (bold	   letter	   indicate	   changes)	   by	   site	   directed	  
mutagenesis	  and	  its	  wild	  type	  and	  mutant	  forms	  were	  generated	  and	  tagged	  in	  the	  N	  
terminal	  site	  with	  EGFP	  (pEGFP	  vector,	  Takara	  Bio	  Inc).	  
	  
The	  four	  Fascin	  mutant	  forms	  studied	  in	  this	  thesis	  were	  Ser39	  and	  274	  mutated	  to	  
either	   a	   non-­‐phosphorylatable	   Alanine	   (A)	   or	   a	   phosphorylatable	   Aspartic	   Acid	   (D)	  
and	   were	   generated	   as	   described	   in	   (Zanet	   et	   al.	   2012).	   For	   recombinant	   fascin	  
purification,	  the	  cDNA	  encoding	  hfascin	  wild	  type	  and	  mutants	  were	  cloned	  between	  
Notl	   and	  Xhol	   restriction	   sites	   in	   the	   p-­‐ET30a(+)	   vector	   (Novagen).	   Scrambled	   and	  
fascin	   targeting	   shRNA	   sequences	   were	   also	   cloned	   into	   a	   pLKO	   lentiviral	   vector	  
(RNAi	   Consortium)	   between	   the	   AgeI	   and	   EcoRI	   sites	   (Dr	   Jayo,	   King’s	   College	  
London).	   Antiparallel	   oligonucleotides	   containing	   the	   shRNA	   target	   sequence	   and	  
flanking	  AgeI	  and	  EcoRI	  restriction	  sites	  used	  were:	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Sense:	  5’-­‐CCG	  GGC	  CTG	  AAG	  AAG	  AAG	  CAG	  ATC	  TCT	  CGA	  GAG	  ATC	  TGC	  TTC	  TTC	  TTC	  
AGG	  CTT	  TTT	  G-­‐3’	  
Antisense:	  5’-­‐AAT	  TCA	  AAA	  AGC	  CTG	  AAG	  AAG	  AAG	  CAG	  ATC	  TCT	  CGA	  GAG	  ATC	  TGC	  
TTC	  TTC	  TTC	  AGG	  C-­‐3’	  
	  
	  
The	   human	  α-­‐tubulin	   cDNA	  was	   cloned	   in	  m-­‐Cherry	   tagged	   lentiviral	   vector	   pLVX	  
(gift	   from	   Dr	   Monypenny,	   KCL)	   between	   XhoI	   and	   BamHI-­‐HF	   sites.	   The	   following	  
primers	  were	  used	  for	  PCR:	  
	  
Sense:	  5’-­‐CTC	  GAG	  GGA	  GGT	  GGA	  ATG	  CGT	  GAG	  TGC	  ATC	  TCC	  AT-­‐3’	   
Antisense:	  5’-­‐GGA	  TCC	  TTA	  GTA	  TTC	  CTC	  TCC	  TCT	  T-­‐3’	  
	  
The	  cDNAs	  encoding	   the	  GST	   tagged	  FERM	  domain,	  Kinase	  domain	  and	  C	   terminal	  




2.3.1.2.	  Transformation	  of	  pGEX	  GST	  vectors	  
	  
2	  µl	  of	  DNA	  was	  added	  into	  25	  µl	  of	  BL21	  competent	  cells,	  left	  on	  ice	  for	  30	  min	  and	  
heat	  shocked	  at	  42°C	  in	  a	  waterbath	  for	  45	  seconds	  and	  then	  left	  in	  ice	  for	  2	  min.	  250	  
µl	  SOC	  media	  was	  added	  and	  placed	  in	  a	  37	  C	  shaking	  incubator	  for	  1	  h.	  Finally	  the	  
solution	   was	   streaked	   on	   an	   agar	   plate	   with	   the	   appropriate	   selection	   antibiotic	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2.3.1.3.	  Bacterial	  Transformation	  
	  
Transformations	   were	   performed	   according	   to	   protocols	   provided	   by	   Invitrogen.	  
Briefly,	  One	  Shot	  Top10	  E.coli	  were	   thawed	  on	   ice,	   then	  1-­‐5	  μl	  DNA	  was	  added	   to	  
each	  vial	  (50	  μl)	  of	  competent	  cells	  and	  were	  incubated	  for	  30	  min	  on	  ice.	  This	  was	  
followed	  by	  incubation	  at	  42	  °C	  for	  45	  seconds	  and	  then	  immediate	  incubation	  on	  ice	  
for	  2	  min.	  250	  μl	  S.O.C.	  media	  was	  then	  added	  and	  incubated	  for	  1-­‐2	  h	  shaking	  at	  37	  
°C.	   LB	   agar	   plates	   containing	   Kanamycin	   (50	   µg/mL)	   were	   then	   spread	   with	   the	  
solution.	  Plates	  were	  inverted	  and	  incubated	  at	  37°C	  overnight.	  
	  
2.3.1.4.	  Restriction	  digests	  
	  
Restriction	  digests	  were	  performed	  according	  to	  protocols	  provided	  by	  New	  England	  
BioLabs.	  Briefly,	  the	  restriction	  digest	  was	  made	  up	  of	  2-­‐3	  μg	  DNA,	  the	  appropriate	  
NEbuffer	   (1X)	   (New	   England	   BioLabs),	   BSA	   (1X)	   (New	   England	   BioLabs),	   0.5	   μl	  
restriction	  enzyme	  (New	  England	  BioLabs)	  per	  1	  μg	  DNA	  and	  made	  up	  to	  50	  μl	  with	  
deionised	  water.	  For	  double	  digest	  both	  enzymes	  were	  added	  at	  the	  same	  time,	  or	  if	  
sequential	   the	   second	   restriction	   enzyme	   was	   added	   after	   digest	   with	   the	   first	  
restriction	  enzyme.	  Loading	  buffer	  was	  added	  to	  each	  digest	  and	  they	  were	  run	  on	  a	  
1%	  agarose	  gel	  containing	  1:50	  (1%	  stock,	  0.02%	  final)	  ethidium	  bromide.	  
	  
2.3.1.5.	  Gel	  extraction	  
	  
DNA	  was	  extracted	  using	   the	  QIAquick	   gel	   extraction	   kit	   according	   to	   the	  protocol	  
provided	  by	  QIAGEN.	  Briefly,	  the	  DNA	  fragment	  was	  removed	  from	  the	  agarose	  gel	  
and	  3	  volumes	  of	  Buffer	  QG	  were	  added	  to	  1	  volume	  of	  gel.	  The	  sample	  was	  placed	  
in	  a	  QIAquick	  spin	  column	  and	  was	  centrifuged	   for	  1	  min.	  The	  sample	  was	  washed	  
with	  500	  μl	  of	  Buffer	  QG	  and	  centrifuged	  for	  a	  further	  1	  min,	  and	  also	  washed	  with	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750	  μl	  of	  Buffer	  PE	  and	  centrifuged	  for	  a	  further	  1	  min.	  The	  column	  was	  centrifuged	  
for	  a	  further	  1	  min	  and	  placed	  in	  a	  clean	  1.5	  ml	  microcentrifuge	  tube,	  30	  μl	  elution	  
buffer	  was	  added	  to	  the	  column	  and	   left	   to	  stand	  for	  1	  min.	  Then	  the	  column	  was	  
centrifuged	   for	   1	  min	   to	   elute	   the	  DNA.	   A	  Nanodrop	   Spectrophotometer	   (Labtech	  




1	   ml	   of	   bacterial	   overnight	   culture	   with	   the	   appropriate	   selection	   antibiotic	   was	  
centrifuged	   at	   13,000	   rpm	   for	   5	   min.	   The	   supernatant	   was	   discarded	   and	   the	  
pelleted	  bacterial	  cells	  were	  resuspended	  in	  250	  μl	  of	  Buffer	  P1.	  Before	  using	  Buffer	  
P1,	  LyseBlue	  reagent	  was	  added	  to	  Buffer	  P1	  at	  a	  ratio	  of	  1	  to	  1000,	  RNase	  was	  also	  
added	  and	  mixed	   in.	  250	  μl	  of	  Buffer	  P2	  was	  then	  added	  and	  mixed	  thoroughly	  by	  
inverting	   the	   tube	  4–6	   times	  until	   the	   solution	  became	  clear.	   	   The	   solution	   turned	  
blue	   due	   to	   the	   addition	   of	   LyseBlue	   reagent.	   350	  μl	   of	   Buffer	  N3	  was	   added	   and	  
mixed	   immediately	   and	   thoroughly	   by	   inverting	   the	   tube	   4–6	   times	   or	   until	   the	  
solution	  became	  colourless.	  The	  solution	  was	  centrifuged	  for	  10	  min	  at	  13,000	  rpm	  
(~17,900	  x	  g)	   in	  a	  table-­‐top	  microcentrifuge	  at	  room	  temperature.	  The	  supernatant	  
was	  transferred	  to	  the	  QIAprep	  spin	  column	  and	  centrifuged	  for	  1	  min	  and	  the	  flow-­‐
through	  was	   discarded.	   To	  wash	   the	  QIAprep	   spin	   column,	   0.75	  ml	   Buffer	   PE	  was	  
added	  and	  centrifuged	  for	  1	  min	  and	  the	  flow-­‐through	  was	  discarded.	  The	  QIAprep	  
spin	   column	   was	   centrifuged	   again	   for	   1	   min	   to	   remove	   residual	   wash	   buffer.	   To	  
elute	  DNA,	  50	  μl	   of	   deionised	  water	  was	   added	   to	   the	   centre	  of	   the	  QIAprep	   spin	  
column,	  and	  allowed	  to	  stand	  for	  1	  min	  at	  room	  temperature	  and	  finally	  centrifuge	  
for	   1	   min.	   The	   flow-­‐through	   contained	   the	   DNA	   which	   was	   measured	   using	   a	  
Nanodrop	  Spectrophotometer.	  	  
	  
	  









25-­‐50	  ml	  of	  bacterial	  culture	  was	  grown	  up	  overnight	  with	  the	  appropriate	  antibiotic	  
and	  pelleted	  by	  centrifugation	  at	  13000	  rpm	  for	  15	  min.	  The	  pellet	  was	  resuspended	  
by	  pipetting	  in	  2	  ml	  of	  Buffer	  P1.	  2	  ml	  of	  Buffer	  P2	  was	  added	  and	  gently	  mixed	  by	  
inverting	  and	  incubated	  at	  room	  temperature	  for	  3	  min.	  LyseBlue	  reagent	  was	  added	  
to	  Buffer	  P2	  and	   the	  cell	   suspension	   turned	  blue	  as	  a	  control	  of	  cell	   lysis	  and	  DNA	  
denaturation.	  Then	  a	   further	  2	  ml	  of	  Buffer	  S3	  was	  added	   to	   the	   lysate	  and	  mixed	  
immediately	   by	   inverting	   4–6	   times.	   Addition	   of	   Buffer	   S3	   caused	   rapid	   pH	  
neutralisation	   and	   a	   fluffy	   white	   precipitate	   to	   form	   containing	   genomic	   DNA,	  
proteins,	  cell	  debris,	  and	  SDS.	  The	  suspension	  was	  mixed	  until	  all	  trace	  of	  blue	  was	  
gone	   and	   the	   suspension	   was	   colourless.	   The	   mixture	   was	   transferred	   into	   the	  
QIAfilter	   cartridge	   and	   incubated	   at	   room	   temperature	   for	   10	  min.	   A	   plunger	  was	  
inserted	   into	   the	  QIAfilter	   cartridge	  and	   the	   cell	   lysate	  was	   filtered	   the	   into	  a	  new	  
tube,	  to	  which	  2	  ml	  of	  Buffer	  BB	  was	  added	  and	  mixed	  by	  inverting	  4–6	  times.	  The	  
lysate	  was	  then	  transferred	  to	  a	  QIAGEN	  Plasmid	  Plus	  Midi	  spin	  column	  with	  a	  tube	  
extender	   attached	   on	   the	   QIAvac	   24	   Plus.	   Using	   vacuum,	   the	   solution	  was	   drawn	  
through	  the	  column.	  DNA	  bound	  to	  the	  column	  was	  washed	  with	  0.75	  ml	  of	  Buffer	  
and	  again	  washed	  with	  0.7	  ml	  of	  Buffer	  PE.	  To	  completely	  remove	  the	  residual	  wash	  
buffer,	  the	  column	  was	  centrifuged	  for	  1	  min	  at	  10,000	  x	  g	  in	  a	  microcentrifuge.	  The	  
column	  was	   then	  placed	   into	  a	  clean	  1.5	  ml	  microcentrifuge	   tube	  and	   to	  elute	   the	  
DNA,	  200	  μl	  of	  deionised	  water	  was	  added	  to	  the	  centre	  of	  the	  column,	  with	  1	  min	  
incubation	   at	   room	   temperature,	   and	   then	   finally	   centrifuged	   for	   1	  min.	   The	  DNA	  













2.3.2.	  Cell	  culture	  	  
	  
2.3.2.1.	  Cell	  lines	  	  
MDA-­‐MB-­‐231	   human	   breast	   carcinoma,	   293T	   and	   HeLa	   cervical	   cancer	   cells	   were	  
maintained	  at	  37	  °C	  in	  Dulbecco’s	  Modified	  Eagle’s	  Medium	  (DMEM)	  with	  4500	  mg/L	  
glucose	   supplemented	   with	   10%	   fetal	   bovine	   serum	   (FBS),	   1%	   L-­‐Glutamine,	   1:100	  
dilution	   of	   10000	   penicillin	   units	   and	   10	  mg/ml	   of	   streptomycin.	   To	   passage,	   cells	  
were	  washed	  once	  with	  PBS	   (without	  Ca	  and	  Mg,	  PAA)	   and	   trypsinised	   (Trypsin	   in	  
EDTA	  at	  0.05%	  concentration).	  After	  detachment	  the	  cells	  were	  centrifuged	  for	  3	  min	  
at	  1200	  rpm	  and	  resuspended	  in	  6	  ml	  of	  media,	  which	  were	  divided	  in	  T75cm2	  flasks.	  
To	  freeze	  the	  cells	  down,	  they	  were	  resuspended	  in	  3	  ml	  of	  media	  with	  10%	  DMSO	  
and	  divided	  in	  three	  vials.	  Stocks	  of	  all	  cell	  lines	  were	  retained	  in	  liquid	  nitrogen.	  
	  
2.3.2.2.	  Producing	  lentiviral	  particles	  and	  infecting	  cells	  
	  
To	   generate	   stable	   cell	   lines	   of	  MDA-­‐MB-­‐231	   cells	   expressing	   the	   shRNA	   targeting	  
fascin,	   this	   was	   cloned	   into	   the	   pLentiLox	   3.7	   (LL3.7)	   or	   pLKO	   lentiviral	   vector.	   A	  
scrambled	  sequence	  of	  the	  shRNA	  was	  also	  cloned	  and	  used	  as	  a	  control.	  For	  each	  
plasmid	   to	   be	   transfected,	   a	   flask	   of	   T25	   cm2	   of	   HEK293T	   was	   plated.	   The	  
transfection	  mix	  was	  prepared	  with	  a	  total	  of	  11.4	  µg	  of	  DNA	  (5.7	  µg	  target	  plasmid	  
i.e.	  LL3.7	  transfer	  vector	  containing	  the	  scrambled	  or	  the	  shRNA	  sequence,	  4.3	  µg	  of	  
packaging	  plasmid	  Δ8.91	  and	  1.4	  µg	  of	  envelope	  plasmid	  pMD2.G)	  in	  600	  µl	  of	  OPTI-­‐
MEM.	   A	  mastermix	   of	   PEI	   transfection	   reagent	   in	   serum-­‐free	   OPTI-­‐MEM	  was	   also	  
created.	   This	   consisted	  of	   5	   µl	   of	   PEI	   (30	  µM,	  diluted	   from	  an	  original	   stock	   of	   10	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mM)	  in	  600	  µl	  of	  OPTI-­‐MEM	  for	  every	  reaction.	  These	  were	  left	  to	  incubate	  for	  5	  min	  
at	   room	  temperature.	  The	  PEI	  mastermix	  was	   then	  added	   to	   the	  DNA	   transfection	  
mix	  and	  incubated	  for	  a	  further	  20	  min	  at	  room	  temperature.	  The	  DNA:PEI	  mix	  was	  
added	   to	   the	  HEK293T	   cells,	   the	  media	   in	   these	   cells	  were	   changed	   to	  OPTI-­‐MEM	  
beforehand	  to	  remove	  the	  presence	  of	  antibiotics.	  The	  cells	  were	  incubated	  for	  4-­‐5	  
hours	  at	  37	  °C.	  The	  media	  was	  then	  changed	  to	  remove	  the	  transfection	  reagent	  and	  
replaced	   with	   DMEM	   plus	   10%	   FBS	   and	   penicillin/streptomycin	   and	   again	   left	   to	  
incubate	   for	   24	   h	   at	   37	   °C.	   At	   this	   point	   the	   virus	  was	   harvested	   by	   removing	   the	  
media,	  which	  contained	  the	  virus	  particles	  and	  centrifuging	  at	  1200	  rpm	  for	  3	  min	  as	  
well	  as	  filtering	  through	  a	  0.45	  µm	  filter	  to	  remove	  cells.	  The	  cells	  were	  replaced	  with	  
fresh	   media	   and	   the	   virus	   was	   collected	   again	   after	   24	   h.	   The	   virus	   was	   used	  
immediately	  for	  infecting	  cells	  or	  was	  stored	  at	  -­‐80	  °C.	  	  
	  
For	   infection	  of	   the	   target	   cells,	  MDA-­‐MB-­‐231	  or	  HeLa	   cells	  were	  plated	  on	  6	  well	  
plates	  and	  grown	  to	  70%	  confluency.	  The	  media	  was	  replaced	  but	  with	  the	  addition	  
of	  polybrene	  at	  a	  concentration	  of	  8	  µg/ml	  to	  increase	  efficiency	  of	  viral	  infection.	  1	  
ml	  of	  lentiviral	  particle	  solution	  was	  added	  to	  the	  cells	  and	  left	  to	  incubate	  at	  37	  °C.	  
The	  media	  was	   changed	  after	   24	  h	   to	   remove	   the	   virus	   and	   cells	  were	   grown	  and	  
passaged.	   Cells	   infected	   with	   the	   LL3.7	   lentiviral	   vector	   were	   put	   through	  
fluorescence	   activated	   cell	   sorting	   (FACS)	   and	   selected	   for	   GFP	   expression.	   The	  
divided	   cell	   populations	   were	   trypsinised	   and	   centrifuged	   at	   1200	   rpm	   for	   3	  min.	  
They	  were	  then	  resuspended	  in	  5	  ml	  of	  10%	  DMEM	  media,	  plated	  on	  T25	  cm2	  flasks	  
and	  used	  for	  further	  experiments.	  Cells	  infected	  with	  the	  pLKO	  vector	  were	  selected	  
with	   Puromycin	   0.5	   µg/mL.	   Expression	   levels	   of	   GFP-­‐fascin/fascin	   were	   regularly	  
checked	  by	  immunofluorescence	  and	  western	  blotting.	  	  
	  
For	   transient	   re-­‐expression	   of	   GFP-­‐tagged	   wild	   type	   and	   mutant	   forms,	   shRNA-­‐
resistant	  hFascin	  cDNA	  wild	   type	  and	  mutant	   fascin	  were	   tagged	   in	   the	  N	   terminal	  
site	  with	  EGFP	  (pEGFP	  vector,	  Takara	  Bio	  Inc).	  To	  generate	  MDA-­‐MB-­‐231	  fasKD	  cells	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transiently	   expressing	   the	   shRNA-­‐resistant	   fascin	   (rescued	   or	   res	   cells),	   cells	   were	  
grown	  to	  50%	  confluence	  the	  day	  before	  transfection.	  Each	  DNA	  mix	  was	  prepared	  
with	  1	  µg	  of	  DNA	  in	  50	  µl	  of	  OPTI-­‐MEM.	  2	  µl	  of	  lipofectamine	  in	  50	  µl	  of	  OPTI-­‐MEM	  
was	  also	  prepared	  for	  every	  reaction.	  These	  were	  left	  to	  incubate	  for	  5	  min	  at	  room	  
temperature.	  The	  lipofectamine	  mixture	  was	  then	  added	  to	  the	  DNA	  and	  incubated	  
for	  a	  further	  20	  min	  at	  room	  temperature.	  The	  DNA:lipofectamine	  mix	  was	  added	  to	  
the	  MDA-­‐MB-­‐231	  fasKD	  cells,	   the	  media	   in	   these	  cells	  were	  changed	  to	  OPTI-­‐MEM	  
beforehand	  to	  remove	  the	  presence	  of	  antibiotics.	  The	  cells	  were	  incubated	  for	  4-­‐5	  
hours	  at	  37	  °C.	  The	  media	  was	  then	  changed	  to	  remove	  the	  transfection	  reagent	  and	  
replaced	   with	   DMEM	   plus	   10%	   FBS	   and	   penicillin/streptomycin	   and	   again	   left	   to	  
incubate	   for	   24	   h	   at	   37	   °C	   to	   allow	   cells	   to	   recover	   and	   express	   the	   GFP	   tagged	  
proteins.	   An	   epifluorescence	  microscope	   was	   used	   to	   check	   the	   efficiency	   of	   GFP	  
tagged	  wild	  type	  and	  mutant	  fascin	  epression.	  Note	  that	  GFP	  expression	  in	  rescued	  
cells	  was	  much	  stronger	  than	  in	  fasKD	  stable	  cells	  (example	  images	  are	  shown	  in	  the	  
Result	  sections).	  
	  
2.3.2.3.	  Nocodazole	  treatment	  and	  washout	  assay	  	  
	  
For	   the	   nocodazole	   treatment	   and	  washout	   assay,	  MDA-­‐MB-­‐231	   and	  HeLa	   control	  
and	   fascin	  knockdown	  or	   rescued	  cells	  were	   seeded	  on	  24	  well	  plates	  on	  different	  
ECM	  proteins.	  The	  day	  after,	  the	  cells	  were	  treated	  with	  nocodazole	  (Sigma)	  used	  at	  
10	   µM	   diluted	   in	   10%	   FBS	   DMEM	   media	   for	   15	   min	   to	   completely	   inhibit	   MT	  
polymerisation.	   Dimethyl	   sulfoxide	   (DMSO)	   was	   diluted	   in	   10%	   DMEM	  media	   and	  
used	   as	   control.	   After	   the	   treatment,	   the	   cells	   were	   either	   fixed	   with	   4%	   para-­‐
formaldehyde	   (PFA)	   in	  PBS	  and	  stained	   for	   immunofluorescence	  or	   the	  nocodazole	  
was	  washed	  out	  and	  replaced	  with	  fresh	  10%	  FBS	  DMEM	  media	  for	  30	  or	  60	  min	  to	  
allow	   MT	   re-­‐growth	   followed	   by	   fixation	   with	   PFA.	   The	   cells	   were	   stained	   with	  
antibodies	   for	   total	   tubulin	   or	   phospho-­‐tyrosine	   and	   imaged	   with	   confocal	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microscopy.	  Imaged	  cells	  were	  scored	  for	  microtubule	  assembly	  or	  adhesion	  size	  and	  
number	  (see	  Image	  Analysis	  section).	  
	  
2.3.2.4.	  Cell	  binding	  assay	  
	  
For	  the	  adhesion	  assay,	  MDA-­‐MB-­‐231	  control,	  fascin	  knockdown	  or	  WT	  and	  mutant	  
fascin	  rescued	  cells	  were	  plated	  in	  a	  24-­‐well	  plate	  onto	  coverslips,	  previously	  coated	  
with	   fibronectin	   (see	  Microscopy	  section).	  The	  cells	  were	   left	  overnight	   in	  10%	  FBS	  
DMEM.	   The	   day	   after,	   the	   media	   was	   changed	   and	   the	   cells	   adhering	   to	   the	  
substrate	  were	  counted.	  Multiple	   fields	  of	  view	  were	  analysed	   in	  each	  experiment,	  
which	  was	  repeated	  at	  least	  three	  times.	  
	  
	  
2.3.3.	  Protein	  production,	  purification	  and	  MT/actin	  polymerisation/co-­‐
sedimentation	  analysis	  
	  
2.3.3.1.	  His6	  tagged	  WT	  and	  mutant	  fascin	  purification	  
	  
BL21	  cells	  containing	  DNA	  of	   interest	  were	  grown	  overnight	  at	  37°C	  overnight.	  The	  
culture	  was	   diluted	   (1:100)	   with	   fresh	   broth	   and	   cells	   grown	   at	   37°C	   in	   a	   shaking	  
incubator	   for	   3-­‐4	   h.	   Protein	   production	   was	   induced	   with	   Isopropyl	   β-­‐D-­‐1-­‐
thiogalactopyranoside	  (IPTG,	  0.2	  mM)	  and	  incubated	  for	  a	  further	  5	  h	  at	  37°C.	  	  The	  
bacterial	  culture	  was	  pelleted	  by	  centrifuging	  at	  3900	  rpm	  for	  15	  min,	  4°C.	  The	  pellet	  
was	   then	   resuspended	   in	   50	   µl	   ice	   cold	   PBS	   per	   ml	   of	   original	   culture	   volume,	  
containing	   protease	   inhibitors	   (Calbiochem)	   and	   disrupted	   by	   sonication	   for	   2	  
minutes,	  using	  10	  second	  pulses	  at	  10	  A	  on	  ice.	  The	  solution	  was	  centrifuged	  at	  3900	  
rpm	  for	  30	  min	  at	  4°C	  and	  the	  supernatant	  collected.	  Ni-­‐NTA	  agarose	  beads	  (Qiagen)	  
were	  equilibrated	  with	  Lysis	  Buffer	  and	  subsequently	  added	  to	  the	  supernatant	  to	  5	  
µl	   beads/1	   ml	   original	   culture	   and	   left	   to	   mix	   overnight	   at	   4°C.	   The	   beads	   were	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centrifuged	   and	   washed	   with	   buffers	   containing	   increasing	   concentration	   of	  
imidazole.	   A	   high	   concentration	   of	   imidazole	   (250	   mM)	   was	   used	   to	   elute	   the	  
proteins.	   The	  eluted	  was	  dialysed	  against	   Storage	  Buffer	   three	   times	   for	   at	   least	  2	  
hours	  at	  4	  °C.	  Proteins	  were	  recovered	  and	  used	  for	  further	  experiments.	  Stocks	  of	  
protein	  were	  kept	  at	  -­‐80	  °C	  and	  SDS-­‐PAGE	  was	  run	  to	  check	  protein	  purification.	  	  
	  
	  
2.3.3.2.	  GST	  Focal	  Adhesion	  Kinase	  domain	  purification	  
	  
The	  cDNAs	  encoding	   the	  GST	   tagged	  FERM	  domain,	  Kinase	  domain	  and	  C	   terminal	  
domain	   of	   Focal	   Adhesion	   Kinase	   were	   kindly	   donated	   by	   Dr	   Margaret	   Frame	  
(University	  of	  Edinburgh,	  UK).	  5	  ml	  of	  LB	  broth	  and	  ampicillin	  (1:1000)	  were	  seeded	  
with	  BL21	  cells	   containing	  DNA	  of	   interest	  and	  grown	  overnight	  at	  37°C	  overnight.	  
The	  culture	  was	  diluted	  (1:100)	  with	  fresh	  broth	  and	  cells	  grown	  at	  37°C	  in	  a	  shaking	  
incubator	   for	   3-­‐4	   h.	   Protein	   production	   was	   induced	   with	   Isopropyl	   β-­‐D-­‐1-­‐
thiogalactopyranoside	  (IPTG,	  0.2	  mM)	  and	  incubated	  for	  a	  further	  5	  h	  at	  37°C.	  	  The	  
bacterial	  culture	  was	  pelleted	  by	  centrifuging	  at	  3900	  rpm	  for	  15	  min,	  4°C.	  The	  pellet	  
was	   then	   resuspended	   in	   50	   µl	   ice	   cold	   PBS	   per	   ml	   of	   original	   culture	   volume,	  
containing	   protease	   inhibitors	   (Calbiochem)	   and	   disrupted	   by	   sonication	   for	   2	  
minutes,	  using	  10	  second	  pulses	  at	  10	  A	  on	  ice.	  The	  solution	  was	  centrifuged	  at	  3900	  
rpm	   for	   10	   min	   at	   4°C	   and	   the	   supernatant	   collected.	   Pre-­‐washed	   glutathione	  
Sepharose	  4B	  beads	  (GE	  Healthcare)	  were	  added	  to	  the	  supernatant	  to	  1	  µl	  beads/1	  
ml	   original	   culture	   and	   left	   to	   mix	   overnight	   at	   4°C.	   The	   beads	   were	   spin	   down,	  
washed	  and	  resuspended	  in	  1	  ml	  buffer	  with	  protease	  inhibitor.	  SDS-­‐PAGE	  was	  run	  
to	   check	   protein	   purification.	   Regardless	   different	   purification	   experiments,	   it	   was	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2.3.3.3.	  Microtubule	  polymerisation	  and	  co-­‐sedimentation	  assays	  
	  
The	   microtubule	   polymerisation	   and	   co-­‐sedimentation	   assays	   were	   performed	   as	  
previously	   described	   (Beraud-­‐Dufour	   et	   al	   2007).	   Briefly,	   bovine	   brain	   tubulin	  
powder	   (Cytoskeleton)	   was	   diluted	   in	   General	   Tubulin	   Buffer	   (GTB)	   in	   a	   final	  
concentration	   of	   10	   µg/µl.	   Tubulin	   stocks	   were	   kept	   at	   -­‐80	   °C	   for	   further	  
experiments.	  5	  µg	  of	  purified	  tubulin	  were	  polymerised	  for	  15	  min	  at	  37	  °C	  in	  Tubulin	  
Polymerisation	   Buffer	   (TB1).	   Increasing	   concentrations	   of	   paclitaxel	   (taxol)	   were	  
added	  every	  10	  min.	  The	  turbidity	  of	  the	  reaction	  was	  measured	  as	  index	  of	  tubulin	  
polymerisation	   and	  microtubule	   structure	  was	   analysed	   using	   electron	  microscopy	  
(EM	  facility,	  Guy’s	  campus,	  King’s	  College	  London)	  (see	  Section	  5.2	  in	  Result	  Chapter	  
3).	   The	   mixture	   (approximately	   90	   µl)	   was	   then	   layered	   onto	   60	   µl	   of	   Tubulin	  
Pelleting	  Buffer	   (TB2)	  and	  centrifuged	  at	  13,000	   rpm	   for	  20	  min	  at	  25	   °C.	  TB2	  was	  
prepared	  in	  50%	  glycerol,	  which	  allows	  polymerised	  tubulin	  (MT)	  sedimentation.	  The	  
MT	  pellet	  was	  resuspended	   in	  60	  µl	  of	  Tubulin	  resuspension	  buffer	   (TB3)	  and	  used	  
for	   5-­‐6	   co-­‐sedimentation	   reactions.	   Polymerised	   tubulin	   corresponding	   to	  
approximately	   5	   µg	   (1	  µmol)	  was	   incubated	  with	  His6	  tagged	  WT	  or	  mutant	   fascin	  
protein	  (1:1	  ratio)	  in	  GTB	  for	  30	  min	  at	  25	  °C.	  Each	  reaction	  mixture	  (approximately	  
30	  µl)	  was	  then	  layered	  onto	  20	  µl	  of	  GTB	  (2	  µM	  taxol	  and	  30%	  glycerol	  were	  added	  
to	  GTB	  to	  preserve	  tubulin	  polymerisation	  and	  protein	  co-­‐sedimentation).	  Reactions	  
were	  finally	  centrifuged	  at	  13,000	  rpm	  for	  30	  min	  at	  25	  °C.	  As	  a	  control,	  MT,	  WT	  and	  
mutant	   fascin	   proteins	   were	   subjected	   to	   centrifugation	   alone	   in	   every	   co-­‐
sedimentation	  experiment.	  5x	  Loading	  Buffer	  was	  added	  to	  supernatants	  (unbound	  
fraction),	   while	   each	   pellet	   was	   resuspended	   in	   40	   µl	   of	   GTB	   (15%	   Glycerol	   was	  
added	  to	  GTB)	  and	  2x	  Loading	  Buffer	  was	  added.	  The	  supernatant	  (s)	  and	  pellet	  (p)	  
fractions	  were	  recovered	  by	  SDS-­‐PAGE	  and	  stained	  by	  silver	  staining.	  Protein	  bands	  
were	  quantified	  by	  densitometry.	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2.3.3.4.	  Actin	  polymerisation	  and	  co-­‐sedimentation	  assays	  
	  
The	  actin	  polymerisation	  and	  co-­‐sedimentation	  assays	  were	  repeated	  as	  in	  (J.	  Zanet	  
et	  al.	  2012).	  Briefly,	  G-­‐actin	  powder	  (Sigma	  Aldrich)	  was	  resuspended	  in	  KME	  buffer	  
1x	   in	   a	   final	   concentration	   of	   1.35	   µg/µl.	   G-­‐actin	   stocks	   were	   kept	   at	   -­‐80	   °C	   for	  
further	  experiments.	  67.5	  µg	  of	  G-­‐actin	  were	  polymerised	   in	  F-­‐actin	  Polymerisation	  
Buffer	   for	   1	   hour	   at	   25	   °C.	   Fresh	   buffer	   was	   prepared	   for	   every	   experiment.	   The	  
mixture	  reaction	  was	  centrifuged	  at	  80,000	  rpm	  (Beckman	  TLA	  100	  rotor)	  for	  1	  hour	  
at	  25	  °C.	  The	  pellet	  was	  resuspended	  in	  50	  µl	  of	  KME	  buffer	  1x.	  2	  µl	  of	  this	  reaction	  
correspond	   approximately	   to	   3	   µg	   of	   F-­‐actin	   was	   added	   to	   fascin	   proteins	   or	  
polymerised	  MT	  or	  to	  the	  two	  together	  after	  their	  co-­‐sedimentation	  for	  15	  min	  at	  25	  
°C.	  Reactions	  were	  finally	  centrifuged	  at	  13,000	  rpm	  for	  30	  min	  at	  25	  °C.	  As	  a	  control,	  
F-­‐actin	  was	  subjected	  to	  centrifugation	  alone	  in	  every	  co-­‐sedimentation	  experiment.	  
5x	  Loading	  Buffer	  was	  added	  to	  supernatants	  (unbound	  fraction),	  while	  each	  pellet	  
was	  resuspended	  in	  40	  µl	  of	  either	  KME	  1x	  buffer	  (if	   incubated	  with	  fascin)	  or	  15%	  
glycerol	   GTB	   (if	   incubated	   with	   MT)	   and	   then	   2x	   Loading	   Buffer	   was	   added.	   The	  
supernatant	   (s)	   and	   pellet	   (p)	   fractions	   were	   recovered	   by	   SDS-­‐PAGE	   and	   stained	  
with	  silver	  staining.	  Protein	  bands	  were	  quantified	  by	  densitometry.	  
	  
2.3.3.5.	  GST	  pulldowns	  
	  
Control	  or	   fascin	   knockdown	  MDA-­‐MB-­‐231	   cells	   rescued	   for	  GFP	   tagged	  WT	   fascin	  
were	  washed	   twice	  with	   ice-­‐cold	  PBS.	  The	  cells	  were	   scraped	   into	   cold	   lysis	  buffer	  
(50	  mM	  Tris	   (pH7.2),	   500	  mM	  NaCl,	   10	  mM	  MgCl,	   0.5%	   sodium	  deoxycholate,	   1%	  
Triton	  X-­‐100),	  containing	  protease	  inhibitor	  cocktail	  (see	  Table	  2.1)	  and	  phosphatase	  
inhibitors	   (50	  mM	  sodium	   fluoride	  and	  1	  µM	  calyculin	  A.	  500	  µl	  of	   the	   lysis	  buffer	  
were	  used	  for	  ~80%	  confluent	  T75	  cm2	  flask.	  Cells	  were	  then	  transferred	  into	  1.5	  ml	  
tubes.	  These	  were	  left	  on	  a	  rotator	  at	  4	  °C	  for	  30	  min	  to	  ensure	  complete	  lysis	  and	  
then	  centrifuged	  at	  13,000	  rpm	  for	  1	  min	  at	  4	  °C	  to	  pellet	  insoluble	  material.	  20	  µl	  of	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the	   sample	   of	   cell	   lysate	   was	   removed	   before	   adding	   lysate	   to	   beads	   to	   allow	  
analysis	   of	   total	   protein	   on	   the	   same	   gel	   as	   the	   pulldown	   samples.	   The	   cleared	  
lysates	  were	   transferred	   into	   tubes	  with	  50	  µl	  GST-­‐tagged	  protein	  and	  placed	  on	  a	  
rotator	  at	  4	  °C	  for	  60	  min.	  The	  beads	  were	  washed	  4	  times	  with	  ice-­‐cold	  lysis	  buffer.	  
After	   the	   final	   wash,	   the	   wash	   buffer	   was	   removed	   and	   SDS	   sample	   buffer	   was	  
added.	   The	   sample	   was	   boiled	   for	   10	  min	   and	   run	   on	   a	   10%	   acrylamide	   gel.	   The	  
western	  blotting	  protocol	  was	  then	  followed.	  Each	  pulldown	  was	  performed	  at	  least	  
3	  times.	  
	  
2.3.3.6.	  Immunoprecipitation	  (IP)	  
	  
Control	   or	   fascin	   knockdown	   MDA-­‐MB-­‐231	   cells	   rescued	   for	   GFP	   tagged	   WT	   or	  
mutant	  fascin	  expression	  were	  cultured	  until	  80%	  confluent	  in	  6-­‐well	  plate	  and	  lysed	  
in	  250	  μl	   lysis	   buffer	  on	   ice.	  A/G	  agarose	  affinity	  matrix	   suspension	  was	  washed	  3	  
times	   with	   PBS	   prior	   to	   use.	   Lysates	   were	   pre-­‐cleared	   with	   100	   μl	   washed	   A/G	  
agarose	  affinity	  matrix	  suspension	  rotating	  at	  4	  °C	  for	  30	  min,	  and	  50	  μl	   lysate	  was	  
kept	  (1:1	  IP	  buffer:	  sample	  buffer)	  prior	  to	  pre-­‐clearing	  at	  -­‐20	  °C	  for	  an	  input	  sample.	  
Pre-­‐cleared	   lysates	  were	   centrifuged	  and	   the	   supernatants	  were	   collected.	   Each	   IP	  
experiment	  had	  a	  duplicate	  of	  primary	  antibody	  and	  control	  IgG.	  Antibody	  or	  control	  
IgG	  was	  incubated	  with	  200	  μl	  pre-­‐cleared	  lysate	  tumbling	  at	  4	  °C	  overnight.	  Then	  50	  
μl	   of	   washed	   A/G	   agarose	   affinity	   matrix	   suspension	   was	   added	   to	   the	   antibody	  
lysate	  mix	   for	  2	  h	   tumbling	  at	  4	   °C.	  Alternatively,	  antibody	  was	  pre-­‐incubated	  with	  
beads	  overnight	  tumbling	  at	  4	  °C.	  Then,	  excess	  antibody	  was	  removed	  by	  washing	  3	  
times	   with	   PBS,	   and	   pre-­‐cleared	   lysate	   was	   added	   to	   each	   antibody	   A/G	   agarose	  
affinity	  matrix	  suspension	  mix	  for	  2	  h	  tumbling	  at	  4	  °C.	  After	  antibody,	  lysate	  and	  A/G	  
agarose	  affinity	  matrix	  suspension	  incubation,	  the	  mixtures	  were	  centrifuged	  and	  25	  
μl	   supernatant	   (1:1	   supernatant:	   sample	   buffer)	  was	   kept	   for	   an	   unbound	   sample	  
and	  was	   stored	   at	   -­‐20	   °C.	   The	   rest	   of	   the	   supernatant	  was	   removed	   and	   the	   A/G	  
agarose	  affinity	  matrix	  suspension	  was	  washed	  three	  times	  for	  10	  min	   in	   IP	  buffer.	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Samples	  were	  either	  used	  immediately	  or	  stored	  at	  -­‐20°C.	  Lysates	  were	  boiled	  at	  95	  
°C	  and	  centrifuged	  to	  clear	  cell	  debris	  before	  use.	  40	  μl	  of	  each	  sample	  was	  loaded	  in	  
each	  well	  of	  8	  or	  10%	  SDS-­‐PAGE	  gels	  in	  1.5	  mm	  cassettes	  and	  subjected	  to	  SDS-­‐PAGE,	  




2.3.3.7.	  SDS	  PAGE	  analysis	  
	  
Sodium	   dodecyl	   sulphate-­‐polyacrylamide	   gel	   electrophoresis	   (SDS-­‐PAGE)	   separates	  
protein	   based	   on	   molecular	   weights.	   SDS	   loading	   buffer,	   containing	   β-­‐
mercaptoethanol,	  was	  added	  to	  the	  samples,	  which	  denatured	  the	  protein	  from	  its	  
tertiary	  structure	  to	  the	  basic	  amino	  acid	  primary	  structure.	  The	  SDS	  also	  induced	  a	  
negative	   charge	   to	   proteins	   so	   that	   when	   an	   electrical	   charge	   was	   applied	   the	  
protein	  would	  migrate	  towards	  the	  cathode	  pole.	  Gels	  of	  8%	  or	  10	  %	  were	  made	  in	  
1.5	  mm	  cassettes	  with	  stacking	  gel	  on	  top	  and	  resolving	  gel	  beneath.	  Along	  with	  the	  
samples,	   a	   marker	   was	   run	   which	   includes	   molecular	   weight	   standards	   of	   known	  
sizes.	  The	  gel	  was	  run	  for	  1.5	  h	  at	  100	  V.	  	  
	  
2.3.3.8.	  Silver	  staining	  
	  
The	   silver	   staining	   was	   used	   to	   detect	   binding	   in	   MT/actin	   co-­‐sedimentation	  
experiments.	   The	   polyacrylamide	   gels	   were	   silver-­‐stained	   using	   the	   Plusone	   silver	  
staining	   kit	   (GE	   Healthcare)	   to	   provide	   higher	   sensitivity	   for	   band	   detection.	   After	  
SDS	  PAGE,	  the	  gel	  was	  first	   left	   in	   fixing	  solution	  for	  30	  min	  (40%	  ethanol	  and	  10%	  
glacial	  acetic	  acid	  in	  deionised	  water)	  and	  then	  left	  in	  sensitising	  solution	  for	  30	  min	  
(30%	   ethanol,	   25%	   sodium	   thiosulphate	   (5%	  w/v)	   and	   0.07	   g/ml	   sodium	   acetate).	  
The	  gel	  was	  washed	  with	  deionised	  water	  3	  times	  for	  5	  min	  and	  silver	  solution	  was	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added	  (10%	  silver	  nitrate	  solution	  (2.5	  %	  w/v)	  in	  deionised	  water).	  After	  20	  min,	  the	  
gel	  was	  washed	  2	   times	   for	  1	  min	  and	   then	  developing	   solution	  was	  added	   (0.025	  
g/ml	  sodium	  carbonate	  and	  0.08%	  formaldehyde	  (37	  %	  w/v)	  in	  deionised	  water),	  the	  
gel	  was	   transferred	   to	  stopping	  solution	  when	  bands	   reached	  the	  desired	   intensity	  
(0.015	  g/ml	  EDTA-­‐Na2·∙2H2O	  in	  deionised	  water).	  After	  washing	  for	  a	  further	  3	  times	  
for	  5	  min	   the	  gel	  was	   left	   in	  preserving	   solution	   (30%	  ethanol	   and	  22%	  glycerol	   in	  
deionised	  water)	  for	  30	  min,	  twice.	  
	  
2.3.3.9.	  Western	  Blotting	  
	  
Western	   blotting	  was	   used	   for	   specific	   protein	   detection	   following	   SDS-­‐PAGE.	   The	  
proteins	  were	   transferred	   onto	   nitrocellulose	  membranes	   (Amersham	  Biosciences)	  
for	  1	  h	  at	  100	  V	  using	  a	  transfer	  kit	   (Biorad)	   in	  Transfer	  Buffer	   (see	  Table	  2.4).	  The	  
membranes	  were	  blocked	  using	  3%	  Milk/TBS	  Tween-­‐20	  (TBST,	  0.1%	  Tween	  in	  TBS)	  or	  
3%	  BSA/TBST	  for	  1	  h	  at	  room	  temperature.	  The	  membranes	  were	  then	  probed	  with	  
the	   primary	   antibody	   overnight	   at	   4	   °C	   or	   for	   3	   h	   at	   room	   temperature.	   The	  
membranes	  were	  then	  washed	  3	  times	  for	  10	  min	  each	  with	  TBST	  prior	  to	  incubation	  
with	   horseradish	   peroxidase-­‐conjugated	   secondary	   antibodies	   for	   1	   h	   at	   room	  
temperature.	  Membranes	  were	   then	  washed	   a	   further	   3	   times	   and	   proteins	  were	  
detected	   by	   ECL	   chemiluminescence	   kit	   (Thermo	   Scientific)	   and	   either	   exposed	   on	  
Medical	   X-­‐ray	   film	   (Fuji)	   and	   developed	   using	   a	   Xograph	   compact	   X4	   developer	  
(Imaging	  Systems)	  or	  directly	   imaged	  using	  the	  BioRad	   imager.	  For	  reprobing,	  blots	  
were	  stripped	  with	  Re-­‐blot	  strong	   (10X)	   (Chemicon)	  diluted	  to	  1X	   in	  distilled	  water	  
for	  10	  min	  at	  room	  temperature,	  and	  then	  treated	  as	  before.	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2.3.4.	  Microscopy	  
	  
2.3.4.1.	  Immunofluorescence	  	  
	  
The	  cells	  were	  plated	  onto	  24-­‐well	  plates	  containing	  acid	  washed	  circular	  coverslips	  
(diameter	  =	  13	  mm,	  VWR).	  Briefly,	   coverslips	  were	   incubated	   in	  1M	  HCl	  overnight,	  
washed	  2-­‐3	  times	  with	  distilled	  water	  and	  then	  in	  70%	  ethanol	  one	  time.	  Coverslips	  
were	   dried	   in	   a	   laminar-­‐flow	   hood	   overnight.	   Before	   plating	   cells,	   coverslips	  were	  
coated	  with	  extracellular	  matrix	   (ECM)	  proteins:	  human	  plasma	   fibronectin	   (FN,	  10	  
µg/ml)	   (Millipore),	   bovine	   collagen	   type	   I	   (COL,	   50	  µg/ml)	   (BD	   Biosciences)	   or	   rat	  
plasma	   vitronectin	   (VN,	   10	   µg/ml)	   (Sigma	   Aldrich).	   Fibronectin	   and	   vitronectin	  
matrices	  were	  diluted	  in	  PBS	  1x	  for	  a	  minimum	  of	  30	  min,	  while	  collagen	  I	  in	  acetic	  
acid	  (0.02	  N).	  Coated	  coverslips	  were	  then	  washed	  3	  times	  with	  PBS.	  The	  cells	  were	  
plated	  in	  media	  and	  left	  overnight	  at	  37	  °C.	  At	  this	  point,	  cells	  were	  fixed	  using	  4%	  
para-­‐formaldehyde	   (PFA/PBS)	   for	   10	   min,	   washed	   twice	   with	   PBS	   and	   then	  
permeabilised	  with	  0.2%	  Triton-­‐X/PBS	  for	  10	  min.	  Coverslips	  were	  again	  washed	  with	  
PBS	  and	  blocked	  with	  3%	  BSA/PBS	  for	  20	  min.	  The	  selected	  primary	  and	  secondary	  
antibodies	  were	  diluted	   in	  3%	  BSA/PBS	   for	  3	  h	  and	   then	  2	  h	  at	   room	  temperature	  
successively.	   Coverslips	  were	  washed	   three	   times	  with	  PBS	   and	  once	  with	  distilled	  
water	   and	   finally	   mounted	   on	   slides	   using	   mounting	   media	   (FluorSave	   reagent,	  
Calbiochem).	  Images	  of	  fixed	  cells	  were	  acquired	  on	  a	  confocal	  microscope	  with	  a	  40	  
or	  60x	  oil	  immersion	  objective.	  	  
	  
2.3.4.2.	  Fluorescence	  assay	  for	  analysis	  of	  F-­‐actin	  and	  MT	  	  
	  
The	   fluorescence	   assay	   for	   F-­‐actin-­‐MT	   cross-­‐linking	   was	   performed	   as	   previously	  
published	  (Miller	  2004).	  Rhodamine-­‐labelled	  tubulin	  (Cytoskeleton)	  was	  polymerised	  
and	   stabilised	   by	   Paclitaxel	   as	   described	   in	   section	   2.3.3.3.	   Rhodamine-­‐labelled	  
polymerised	   MT	   were	   mixed	   with	   WT	   or	   mutant	   fascin	   for	   30	   min	   at	   25	   °C,	   as	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previously	  described.	  Similarly,	  G-­‐actin	  was	  also	  polymerised	  as	  described	  in	  section	  
2.3.3.4	   and	   then	   incubated	  with	  Alexa	   488-­‐phallodin	   (1:10)	   for	   15	  min	   at	   25	   °C	   to	  
stabilise	   and	   label	   F-­‐actin.	   After	   MT	   binding	   reaction	   with	   fascin	   proteins,	   488-­‐
labelled	   F-­‐actin	   was	   added	   to	   the	  mixture	   for	   an	   additional	   15	  min	   at	   25	   °C.	   The	  
mixture	  was	  then	  diluted	  fivefold,	  dropped	  onto	  a	  microscope	  slide,	  covered	  with	  a	  
coverslip	   and	   visualised	   by	   fluorescence	   microscopy	   with	   a	   100x	   oil	   immersion	  
objective.	  
	  
2.3.4.3.	  Confocal	  microscopy	  
	  
Images	   of	   fixed	   cells	  were	   acquired	   on	   a	  Nikon	   A1R	   inverted	   confocal	  microscope	  
(Nikon	  Instruments	  UK)	  equipped	  with	  an	  environmental	  chamber	  heated	  to	  37	  °C.	  
Excitation	  wavelengths	   of	   488	   nm	   (Argon	   laser),	   568	   nm	   (Diode	   laser),	   or	   633	   nm	  
(diode	   laser)	   were	   used.	   Images	   were	   taken	   using	   a	   63x	   oil	   Plan	   Fluor	   immersion	  
objective	   (numerical	   aperture	   1.4)	   or	   100x	   oil	   objective	   (NA1.49).	   Images	   were	  
exported	   in	   .nd2	   file	   format	   and	   analysed	   in	   NIS-­‐Elements	   Imaging	   software	   and	  
saved	  into	  TIFF	  files	  for	  further	  analysis.	  For	  live	  imaging	  of	  HeLa	  control	  and	  fascin	  
knockdown	  cells	  expressing	  mCherry-­‐α-­‐tubulin,	   the	  cells	  were	  plated	  with	  10%	  FBS	  
DMEM	  medium	  in	  a	  15	  µm-­‐slide-­‐8-­‐well	  chamber	  (Ibidi),	  pre-­‐coated	  with	  fibronectin	  
(10μg/ml).	   The	   cells	   were	   imaged	   using	   the	   Nikon	   A1R	   confocal	   microscope	   (as	  
above).	   One	   image	   was	   acquired	   every	   three	   seconds	   for	   5	   minutes.	   For	   the	  
Interference	  Reflection	  Microscopy	  (IRM)	  experiments,	  MDA-­‐MB-­‐231	  control,	  fascin	  
knockdown	  and	  rescued	  cells	  were	  plated	  in	  the	  same	  chamber	  as	  above	  and	  imaged	  
with	   488nm	   Argon-­‐Ion	   laser	   (reflection	   signal	   recovered	   at	   457-­‐514	   nm	   and	   GFP	  
fluorescence	   emitted	   at	   520-­‐560	   nm).	   The	   cells	   were	   imaged	   throughout	   the	  
nocodazole	  assay	  acquiring	  one	  image	  every	  30	  seconds.	  All	  files	  were	  saved	  as	  AVI	  
for	  export	  into	  ImageJ.	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2.3.4.4.	  Image	  analysis	  	  
	  
The	  Microtubule	   score	   (MT	   score)	  was	   calculated	   from	   images	   of	   cells	   stained	   for	  
total	   tubulin	   and	   acquired	   on	   confocal	  microscope	   as	   the	   percentage	   of	   cells	  with	  
normal	  MT	  network.	  Polymerised	  MT	  bundles,	  distributed	  throughout	  the	  cell	  body	  
with	   a	   visible	  MT	  organising	   centre	   (MTOC)	  were	   scored	  with	   a	   high	  MT	   score	   (≈ 
100%),	   while	   cells	   exhibiting	   small	   rounded	   area	   and	   depolymerised	   MT	   network	  
with	  some	  residual	  MT	  present	  were	  given	  score	  close	  to	  zero	  (≈ 5%).	  Re-­‐spreading	  
cells	  exhibiting	  an	  incomplete	  development	  of	  MT	  network	  or	  lacking	  a	  clear	  MTOC	  
were	   scored	  ≈	   50%).	   Figure	  2.3	   shows	  example	   images	  of	   cells	   for	  each	  MT	   score	  
given.	  Left	  panel	  shows	  untreated	  cell	  stained	  for	  total	  tubulin	  and	  scored	  with	  high	  
MT	  score,	  centre	  panel	  shows	  tubulin	  staining	  in	  nocodazole	  treated	  cell	  scored	  with	  
low	  score	  and	   right	  panel	   shows	  60	  minute	  washed	  cell	  with	  delayed	  MT	  recovery	  
and	  scored	  with	  MT	  score	  ≈	  50%.	  	  	  	  
 
	  
Figure	  2.3.	  Example	  images	  of	  assignment	  of	  MT	  score	  	  
Quantification	  of	  cell	  size	  and	  focal	  adhesion	  (FA)	  size	  and	  number	  was	  performed	  by	  
manual	   threshold	   of	   phospho-­‐tyrosine	   stained	   images	   in	   ImageJ	   software.	   The	  
Analyze	  Particle	  plug-­‐in	  was	  used	  to	  measure	  adhesion	  sites	  between	  1	  and	  3	  µm	  in	  
size.	  The	  threshold	  included	  adhesion	  sites	  sized	  between	  1	  and	  3	  µm.	  FA	  size	  data	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were	   corrected	  per	   cell	   area	  and	   calculated	  as	  %	  of	   cell	   occupied	  by	   FA.	   In	   all	   the	  
analysis,	  at	  least	  20	  cells	  were	  evaluated	  in	  three	  different	  experiments.	  
	  
2.3.4.5.	  Statistical	  analysis	  
	  
All	  statistical	  tests	  were	  performed	  using	  Student	  T-­‐tests	  (Excel)	  and	  confirmed	  using	  
Prism	   software.	   Data	   are	   expressed	   as	   means	   ±	   s.e.m.	   Significance	   was	   taken	   as	  
p<0.001,	   0.005	   and	   0.05	   and	   significance	   values	   were	   assigned	   in	   specific	  






	  	  	  	  
3 Fascin-­‐dependent	  control	  of	  
microtubule	  and	  adhesion	  dynamics.	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INTRODUCTION	  
	  
Previous	  studies	  have	  shown	  a	  role	  for	  fascin	  in	  promoting	  cancer	  cell	  migration	  and	  
invasion	  by	  regulating	  assembly	  of	  actin	  bundles	  and	  stability	  of	  adhesion	  structures	  
(Adams	  2004).	  Fascin	  has	  not	  been	  found	  to	  localise	  in	  focal	  adhesions	  (FA)	  and	  the	  
mechanisms	  by	  which	  fascin	  contributes	  to	  adhesion	  dynamics	  and	  assembly	  remain	  
unknown.	  Moreover,	  it	  remains	  unclear	  whether	  fascin-­‐actin	  binding	  is	  required	  for	  
fascin-­‐dependent	  control	  of	  FA	  assembly.	  Both	  actin	  and	  microtubule	  cytoskeletons	  
are	  known	  to	  be	  essential	   for	  normal	  FA	  formation,	  and	  a	  number	  of	  proteins	  that	  
stabilize	   actin	   filaments	   have	   been	   shown	   to	   co-­‐ordinately	   control	   MT	   stability	   (	  
Etienne-­‐Manneville	   2004;	   Palazzo	   et	   al.	   2004;	   Gaillard	   et	   al.	   2011).	   I	   hypothesised	  
that	   fascin	  may	  play	   a	  dual	   role	   in	   co-­‐ordination	  of	   actin	   and	  MT	   cytoskeletons	   to	  
regulate	  FA	  assembly/disassembly	  and	  cell	  invasion.	  
	  
The	   aim	   of	   the	   experiments	   in	   this	   chapter	   is	   to	   analyse	   the	   role	   of	   fascin	   in	  
regulating	   MT	   and	   FA	   assembly	   using	   previously	   described	   nocodazole	   treatment	  
and	  washout	  assays.	  Nocodazole	   (NOC)	   is	  a	  MT-­‐depolymerising	  drug	  that	  has	  been	  
used	  previously	   to	   study	  MT-­‐dependent	  FA	   regulation.	   It	  has	  been	   shown	   that	  MT	  
depolymerisation	   following	   NOC	   treatment	   results	   in	   increased	   FA	   assembly,	   and	  
that	   subsequent	   drug	   washout	   leads	   to	   FA	   disassembly	   (Stehbens	   &	   Wittmann	  
2012).	  Previous	  studies	   in	   fibroblasts	  have	  shown	  that	   this	  mechanism	  depends	  on	  
dynamin	   and	   FAK	   (Ezratty	   et	   al.	   2005),	   but	   the	   role	   of	   cytoskeletal	   associated	  
proteins	  in	  this	  process	  has	  not	  been	  tested.	  This	  assay	  therefore	  provides	  a	  robust	  
model	   system	   in	   which	   to	   test	   the	   involvement	   of	   fascin	   in	   both	   FA	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3.1.	   Characterisation	   of	   fascin	   knockdown	   in	   human	   MDA-­‐MB-­‐231	   breast	  
carcinoma	  and	  HeLa	  cells	  
	  
Fascin	  is	  known	  to	  be	  upregulated	  in	  many	  different	  types	  of	  human	  cancers	  and	  its	  
overexpression	   is	  associated	  with	  poor	  prognosis	  (Hashimoto	  et	  al.	  2005;	  Tan	  et	  al.	  
2013).	  Therefore,	   I	   chose	   to	  analyse	   the	   role	  of	   fascin	   in	  adhesion	   formation	  using	  
two	  different	  human	  cancer	  cell	  lines:	  MDA-­‐MB-­‐231	  breast	  carcinoma	  cells	  and	  HeLa	  
cervical	  cancer	  cells.	  	  
Both	  MDA-­‐MB-­‐231	  and	  HeLa	   cell	   lines	  were	   infected	  with	  a	   lentivirus	   containing	  a	  
shRNA	   sequence	   to	   specifically	   knockdown	   fascin.	   A	   lentivirus	   carrying	   a	   shRNA	  
scrambled	  sequence	  was	  used	  to	  infect	  the	  same	  cells	  as	  a	  control.	  The	  efficiency	  of	  
the	  fascin	  knockdown	  was	  assessed	  by	  western	  blotting	  (Figure	  3.1a).	  Western	  blots	  
demonstrated	   >90%	   reduction	   in	   fascin	   protein	   levels	   in	   both	   fascin	   knockdown	  
MDA-­‐MB-­‐231	  and	  HeLa	  cells	  (fasKD)	  compared	  to	  the	  respective	  control	  cells	  (ctrl).	  
The	   reduction	   in	   fascin	   levels	   in	   both	   knockdown	   cell	   lines	   was	   quantified	   by	  
densitometry	   analysis	   of	   multiple	   western	   blots	   (p=<	   0.001,	   Figure	   3.1b).	   Fascin	  
knockdown	   was	   stably	   maintained	   in	   cells	   throughout	   passaging	   and	   monitored	  
regularly.	  
	  
Fascin	   localisation	   and	   knockdown	   was	   also	   assessed	   by	   immunofluorescence	  
(Figure	  3.1c).	  The	  top	  panel	  in	  Fig	  3.1c	  shows	  MDA-­‐MB-­‐231	  control	  cells	  stained	  for	  
fascin.	   Endogenous	   fascin	   localisation	   in	  MDA-­‐MB-­‐231	   control	   cells	   was	   cytosolic	  
and	   also	   localised	   in	   actin-­‐based	   structures	   such	   as	   filopodia	   and	   stress	   fibres	  
(shown	   in	   top	   left	   panel	   in	   Figure	   3.1c).	   Staining	   for	   fascin	   in	   HeLa	   control	   cells	  
(shown	  in	  bottom	  left	  panel	  in	  Figure	  3.1c)	  also	  showed	  partial	  cytosolic	  localisation	  
and	   a	   population	   of	   fascin	   localised	   in	   filopodia	   and	   stress	   fibres.	   The	   significant	  
reduction	   of	   fascin	   protein	   levels	   in	   both	   knockdown	   cell	   lines	  was	   confirmed	   by	  
immunofluorescence	  analysis	  (centre	  panels	  in	  Figure	  3.1c).	  MDA-­‐MB-­‐231	  and	  HeLa	  
fasKD	  cells	  were	  transiently	  transfected	  with	  a	  plasmid	  encoding	  a	  shRNA	  resistant	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WT	   fascin-­‐GFP	   to	   rescue	   fascin	   expression	   levels	   (resWT).	   The	   efficiency	   of	  
expression	   was	   assessed	   in	   immunofluorescence	   (right	   panels	   in	   Figure	   3.1c).	  
Around	   90%	   of	   both	   rescue	   cell	   lines	   showed	   efficient	   expression	   of	   GFP-­‐fascin	  
level.	  WT	  fascin-­‐GFP	  in	  MDA-­‐MB-­‐231	  cells	  (top	  right	  panel	  in	  3.1c)	  was	  localised	  at	  
the	  cell	  periphery,	  and	  was	  clearly	  localised	  in	  filopodia	  and	  stress	  fibers	  in	  Hela	  cells	  
(bottom	  right	  panel).	  
These	  results	  demonstrate	  that	  MDA-­‐MB-­‐231	  and	  HeLa	  control,	  fasKD	  and	  resWT	  
cells	  are	  suitable	  tools	  to	  study	  the	  role	  of	  fascin	  in	  adhesion	  formation.	  	  
	  
	  










Figure	  3.1.	  Characterisation	  of	  fascin	  knockdown	  in	  human	  breast	  carcinoma	  
MDA-­‐MB-­‐231	  and	  HeLa	  cells	  
(a)	   Western	   blots	   of	   lysates	   from	   MDA-­‐MB-­‐231	   or	   HeLa	   cells	   expressing	   control	  
shRNA	  or	   shRNA	   specifically	   targeting	   fascin.	   (b)	   Statistical	   analysis	   of	   fascin	   levels	  
was	  performed	  by	  densitometry	  analysis	  of	  at	   least	  three	  western	  blots.	  P-­‐value	  =<	  
0.001	   (***)	   was	   considered	   as	   significant.	   Data	   are	   expressed	   as	  mean±	   sem	   and	  
corrected	   on	   GAPDH	   loading	   as	   control.	   (c)	   Confocal	   microscope	   images	   of	   cells	  
stained	  for	  fascin	  in	  both	  MDA-­‐MB-­‐231	  (top	  panels)	  and	  HeLa	  (bottom	  panels).	  Left	  
panels	  show	  control	  cells,	  centre	  panels	  show	  fasKD	  cells	  and	  right	  panels	  show	  cells	  
expressing	  fascin	  shRNA	  re-­‐expressing	  shRNA	  resistant	  WT	  fascin-­‐GFP.	  Scale	  bar=	  10	  
um. 
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3.2.	  Silencing	  fascin	  expression	  results	  in	  increased	  focal	  adhesion	  assembly	  
	  
Fascin	   is	   known	   to	   play	   a	   role	   in	   regulating	   cell	   adhesion	   (Adams	   2004)	   but	   the	  
mechanisms	   are	   unknown.	   Fascin	   associates	   with	   the	   actin	   cytoskeleton	   and	   is	  
known	  to	  regulate	  actin	  stability	  in	  filopodia.	  	  However,	  microtubule	  (MT)	  assembly	  
and	  dynamics	  are	  known	  to	  be	  more	  directly	  involved	  in	  focal	  adhesion	  (FA)	  turnover	  
(Wehrle-­‐Haller	  &	  Imhof	  2003).	  It	  was	  therefore	  important	  to	  analyse	  the	  MT	  network	  
integrity	   in	   conjunction	   with	   FA	   number	   and	   size	   under	   basal	   conditions	   in	   fascin	  
knockdown	  (fasKD)	  cells.	  
	  
MDA-­‐MB-­‐231	  control	   (ctrl),	   fascin	  knockdown	  (fasKD)	  and	  fasKD	  cells	   re-­‐expressing	  
WT	   fascin-­‐GFP	   (resWT)	   were	   plated	   on	   coverslips,	   fixed	   and	   stained	   with	   tubulin	  
antibodies	   to	   define	   the	  MT	   network	   and	   imaged	   by	   confocal	   microscopy.	   Figure	  
3.2a	  shows	  example	  images	  of	  total	  tubulin	  staining	  in	  control	  (left),	   fasKD	  (centre)	  
and	  resWT	  cells	   (right).	  Fascin	  knockdown	  cells	   showed	  no	  clear	  difference	   in	   total	  
tubulin	  staining	  compared	  to	  control	  or	  resWT	  cells.	  MT	  in	  control,	  fasKD	  and	  resWT	  
cells	  were	  polymerised	  and	  distributed	  throughout	  the	  cell	  body.	  The	  MT	  organising	  
centre	  (MTOC)	  was	  visible	  and	  clear	   in	  all	  cells	  adjacent	  to	  the	  nucleus	  (stained	  for	  
total	  tubulin).	  These	  data	  suggest	  that	  depleting	  fascin	  does	  not	  grossly	  disrupt	  the	  
MT	  cytoskeleton	  under	  basal	  conditions.	  	  
	  
As	   fascin	   depletion	   results	   in	   decreased	   FA	   turnover	   (Hashimoto	   et	   al.	   2007),	   I	  
analysed	   whether	   FA	   assembly	   was	   altered	   in	   control,	   fasKD	   and	   fasKD	   cells	   re-­‐
expressing	  WT	  fascin	  (resWT).	  MDA-­‐MB-­‐231	  control,	  fasKD	  and	  resWT	  were	  stained	  
for	  phospho-­‐tyrosine	  (p-­‐Tyr)	  as	  a	  marker	  of	  focal	  adhesions	  (Maher	  et	  al.	  1985)	  and	  
imaged	   by	   confocal	   microscopy	   to	   observe	   and	   quantify	   changes	   in	   %	   of	   cell	  
occupied	  by	  FA	  (FA	  size)	  and	  FA	  number.	  Figures	  in	  3.2b	  show	  example	  images	  of	  p-­‐
Tyr	  staining	  in	  control	  (left),	  fasKD	  (centre)	  and	  resWT	  cells	  (right).	  P-­‐Tyr	  staining	  in	  
control	   cells	   showed	  peripheral	  FA	  with	  some	  smaller	  punctate	  FA	  underneath	   the	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nucleus/cell	  body.	  FasKD	  cells	  showed	  a	  similar	  FA	  distribution	  but	  with	  more	  FA	  at	  
the	  periphery	  compared	  to	  control	  cells.	  Rescuing	  WT	  fascin	  expression	  in	  fasKD	  cells	  
(right	   panel	   in	   3.2b),	   FA	   distribution	   was	   restored	   to	   levels	   seen	   in	   control	   cells.	  
Analysis	   of	   p-­‐Tyr	   staining	   in	   control,	   fasKD	   and	   resWT	   cells	   from	   three	   different	  
experiments	  was	  performed	   in	   ImageJ	  and	  corrected	   for	  cell	  area	   (at	   least	  20	  cells	  
were	  analysed	  in	  each	  experiment).	  Quantification	  of	  %	  of	  cell	  occupied	  by	  FAs	  (FA	  
size)	  and	  FA	  number	  per	   cell	   in	   control	   (black	  bars),	   fasKD	   (white	  bars)	  and	   resWT	  
(red	  bars)	  is	  shown	  in	  Figure	  3.2c,d.	  Data	  showed	  a	  significant	  increase	  in	  both	  %	  of	  
cell	  occupied	  by	  FAs	  and	  FA	  number	  in	  fasKD	  cells	  compared	  to	  controls.	  	  
	  
To	   confirm	   that	   fascin	   depletion	   does	   not	   grossly	   affect	   normal	   MT	   growth,	   I	  
performed	   live	   imaging	   experiments	   in	   control	   and	   fasKD	   Hela	   cells	   expressing	  
mCherry-­‐α-­‐tubulin	   (Movie	  1	  and	  2).	  Figure	  3.2e	   left	  panel	  shows	  a	  still	   image	  from	  
Movie	   1	   (mCherry-­‐α-­‐tubulin	   control	   Hela	   cell)	   and	   right	   panel	   shows	   a	   still	   image	  
from	  Movie	   2	   (mCherry-­‐α-­‐tubulin	   fasKD	  Hela	   cell).	   Control	   and	   fasKD	   cells	   did	  not	  
show	   any	   major	   difference	   in	   total	   tubulin	   arrangement	   and	   distribution	   in	   basal	  
conditions.	  
	  
Taken	  together,	  these	  results	  show	  that	  fascin	  depletion	  in	  MDA-­‐MB-­‐231	  cells	  does	  
not	  have	  an	  obvious	  effect	  on	  the	  basal	  MT	  network	  integrity	  but	  results	  in	  increased	  
FA	  assembly.	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Figure	  3.2.	  Silencing	  fascin	  expression	  results	  in	  increased	  focal	  adhesion	  assembly	  
Confocal	  microscope	   images	   of	  MDA-­‐MB-­‐231	   cells	   stained	   for	   total	   tubulin	   (a)	   and	  
phospho-­‐tyrosine	   (p-­‐Tyr)	   (b).	   Left	   panels	   show	   MDA-­‐MB-­‐231	   control	   cells,	   centre	  
panels	   show	   MDA-­‐MB-­‐231	   fascin	   knockdown	   cells	   and	   right	   panels	   show	   fascin	  
knockdown	  cells	  re-­‐expressing	  WT	  fascin-­‐GFP.	  Scale	  bar=	  10	  um.	  (c,	  d)	  Quantification	  
of	  %	  of	  cell	  occupied	  by	  FAs	  (c)	  and	  FA	  number	  per	  cell	  (d)	  in	  control	  cells	  (in	  black),	  
fasKD	  cells	  (in	  white)	  and	  fasKD	  cells	  re-­‐expressing	  WT	  fascin-­‐GFP	  (in	  red).	  Statistical	  
analysis	  of	  p-­‐Tyr	  staining	  was	  performed	  in	  ImageJ.	  At	  least	  20	  cells	  were	  evaluated	  in	  
three	  different	  experiments.	  P-­‐value	  =<	  0.05	   (*)	  was	  considered	  as	  significant.	  Data	  
are	  expressed	  as	  mean±	  sem	  and	  corrected	  on	  cell	  area.	  (e)	  Still	  images	  from	  Movies	  
1	  and	  2.	  Scale	  bar	  =	  20	  um. 	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3.3.	  Endogenous	  and	  GFP-­‐fascin	  localises	  with	  microtubules	  at	  the	  cell-­‐periphery	  in	  
MDA-­‐MB-­‐231	  cells	  
	  
As	   data	   in	   Figure	   3.2	   demonstrated	   a	   role	   for	   fascin	   in	   regulating	   FA	   size,	   it	   was	  
important	   to	  determine	  whether	   fascin	   localised	  to	  or	  near	  sites	  of	  FA	  assembly	   in	  
these	   cells.	   As	   MTs	   are	   known	   to	   target	   FA	   and	   be	   involved	   in	   regulating	   FA	  
dynamics,	  I	  hypothesised	  a	  possible	  co-­‐ordination	  between	  fascin	  and	  MTs	  at	  sites	  of	  
adhesion	  formation	  to	  regulate	  FA	  dynamics.	  	  
	  
To	  test	  this	  hypothesis,	  MDA-­‐MB-­‐231	  control	  (ctrl)	  cells	  were	  stained	  for	  fascin	  and	  
total	   tubulin	   and	   imaged	   by	   confocal	   microscopy.	   Top	   panels	   in	   Figure	   3.3	   show	  
example	  images	  of	  fascin	  and	  total	  tubulin	  staining	  in	  cells.	  Fascin	  localised	  at	  the	  cell	  
periphery	   co-­‐localising	  with	   the	   distal	   ends	   of	  MTs,	   suggesting	   fascin-­‐MT	   interplay	  
may	  occur	   at	   the	   cell	   edge.	   To	   confirm	   this,	   total	   tubulin	   staining	  was	   repeated	   in	  
resWT-­‐GFP	  cells	  and	  observed	  by	  confocal	  microscopy	  together	  with	  GFP-­‐WT	  fascin.	  
Bottom	  panels	  in	  Figure	  3.3	  show	  example	  images	  of	  total	  tubulin	  staining	  in	  resWT-­‐
GFP	  cells.	  WT	  fascin-­‐GFP	  also	  localised	  at	  the	  cell	  periphery	  similar	  to	  that	  seen	  with	  
endogenous	   fascin,	   showing	  co-­‐localisation	  with	  MTs.	  GFP	  alone	  did	  not	   localise	  at	  
the	  cell	  periphery	  (data	  not	  shown).	  
These	  data	  together	  suggest	  that	  fascin	  and	  MT	  may	  co-­‐operate	  at	  the	  cell	  periphery	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Figure	  3.3.	  Endogenous	  and	  rescue	  GFP-­‐fascin	  localisation	  with	  microtubules	  at	  the	  
cell	  periphery	  in	  MDA-­‐MB-­‐231	  cells	  
Confocal	  microscope	   images	   of	   cell	   co-­‐stained	   for	   fascin	   and	   total	   tubulin	   in	  MDA-­‐
MB-­‐231	  control	  cells	  (top	  panels)	  and	  fasKD	  cells	  re-­‐expressing	  WT	  fascin-­‐GFP	  stained	  
for	  total	   tubulin	   (bottom	  panel).	  Left	  panel	  top	  row	  shows	  co-­‐staining	  of	   fascin	  and	  
total	  tubulin	  in	  control	  cells,	  whereas	  centre	  and	  right	  panels	  show	  single	  staining	  of	  
fascin	  and	  total	  tubulin,	  respectively.	  Left	  panel	  bottom	  row	  shows	  staining	  of	  total	  
tubulin	   in	   fasKD	  cells	   re-­‐expressing	  WT	  fascin-­‐GFP,	  whereas	  centre	  and	  right	  panels	  
show	  GFP-­‐fascin	  and	  staining	  of	  total	  tubulin,	  respectively.	  Scale	  bar=	  10	  um.	   
Zoom	  of	  the	  highlighted	  area	  is	  shown	  to	  show	  fascin	  co-­‐localisation	  with	  end	  of	  MTs	  
at	  the	  cell	  periphery.	  Scale	  bar=	  3	  um. 
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3.4.	  Fascin	  depletion	  leads	  to	  higher	  levels	  of	  acetylated	  tubulin	  
	  
Data	  in	  Fig	  3.3	  showed	  fascin	  co-­‐localising	  with	  the	  ends	  of	  MTs	  at	  the	  cell	  periphery,	  
suggesting	   a	   co-­‐operation	   and	   potential	   involvement	   in	   regulating	   FA	   dynamics.	  
However,	   Figure	   3.2	   showed	   that	   fascin	   depletion	   had	   no	   obvious	   effect	   on	   MT	  
network	   assembly	   in	   cells	   under	   basal	   conditions.	   Therefore,	   it	   was	   important	   to	  
investigate	  whether	  fascin	  knockdown	  affects	  any	  other	  aspect	  of	  MT	  integrity.	  MT	  
stability	   has	   been	   previously	   shown	   to	   correlate	   directly	   with	   post-­‐translational	  
acetylation	   of	   α-­‐tubulin	   and	   to	   be	   important	   in	   regulating	   cell	   function	   and	   MT	  
targeting	  (Ikegami	  &	  Setou,	  2010).	  In	  addition,	  it	  has	  been	  reported	  that	  an	  increased	  
MT	  stability	  leads	  to	  a	  decrease	  in	  cell	  spreading	  and	  motility	  (Tran	  et	  al.	  2007).	  	  
To	   investigate	   a	   possible	   role	   for	   fascin	   in	   regulating	   MT	   stability,	   total	   and	  
acetylated	  tubulin	  levels	  were	  analysed	  by	  western	  blotting	  in	  MDA-­‐MB-­‐231	  control	  
(ctrl)	  and	  fascin	  knockdown	  (fasKD)	  cells	  (Figure	  3.4a).	  Western	  blots	  demonstrated	  a	  
2-­‐fold	   increase	   in	  acetylated	  tubulin	   levels	   in	   fasKD	  cells	  compared	  to	  control	  cells,	  
whereas	  total	  tubulin	  levels	  remained	  unchanged.	  Total	  and	  acetylated	  tubulin	  levels	  
in	   control	   and	   fasKD	   cells	   were	   quantified	   by	   densitometry	   analysis	   of	   multiple	  
western	  blots	  (p=	  <	  0.001,	  Figure	  3.4b).	  
	  
To	  confirm	  increased	  levels	  of	  acetylated	  tubulin	  in	  fasKD	  cells	  compared	  to	  controls	  
were	   dependent	   upon	   fascin,	   WT	   fascin-­‐GFP	   was	   expressed	   in	   fasKD	   cells	   and	  
acetylated	  tubulin	  levels	  analysed	  in	  fasKD	  and	  resWT	  cells	  on	  the	  same	  coverslip	  by	  
confocal	   microscopy.	   As	   explained	   in	   the	   Material	   and	   Method	   section,	   the	   GFP	  
expression	  in	  rescued	  cells	  was	  much	  stronger	  than	  in	  fasKD	  stable	  cells.	  Figure	  3.4c	  
shows	  example	   images	  of	   acetylated	   tubulin	   staining	   in	   fasKD	  cells	   (really	   low	  GFP	  
levels)	   together	  with	   resWT	   fascin	   cells	   (green	   cells).	  Merge	   channel	   of	  GFP-­‐fascin	  
and	  acetylated	  tubulin	  and	  respective	  channels	  alone	  are	  shown.	  Figure	  3.4c	  shows	  a	  
strong	  increase	  in	  tubulin	  acetylation	  in	  fasKD	  cells	  compared	  to	  cells	  expressing	  WT	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Figure	  3.4.	  Fascin	  depletion	  leads	  to	  higher	  levels	  of	  acetylated	  tubulin	  
(a)	  Western	  blots	  of	  lysates	  from	  MDA-­‐MB-­‐231	  control	  and	  fasKD	  cells.	  (b)	  Statistical	  
analysis	  of	   total	  and	  acetylated	   levels	  was	  performed	  by	  densitometry	  analysis	  of	  at	  
least	  three	  western	  blots.	  P-­‐value	  =<	  0.001	  (***)	  was	  considered	  as	  significant.	  Data	  
are	  expressed	  as	  mean±	  sem	  and	  corrected	  on	  actin	   loading	  as	  control.	   (c)	  Confocal	  
microscope	   images	  of	   fasKD	  cells	  re-­‐expressing	  GFP-­‐WT	  fascin	  stained	  for	  acetylated	  
tubulin.	   Left	   panel	   shows	   staining	   of	   acetylated	   tubulin	   in	   cells	   re-­‐expressing	   WT	  
fascin-­‐GFP,	  whereas	   centre	  panel	   shows	   cells	   re-­‐expressing	  WT	   fascin-­‐GFP	  and	   right	  
panel	   shows	   staining	   of	   acetylated	   tubulin	   in	   either	   a	   fasKD	   cell	   or	   a	   fasKD	   cell	   re-­‐
expressing	  WT	  fascin-­‐GFP.	  Scale	  bar=	  20	  um. 
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3.5.	  Fascin	  knockdown	  does	  not	  alter	  total	  levels	  of	  focal	  adhesion	  proteins	  
	  
Having	  demonstrated	  fascin	  translocation	  to	  the	  cell	  periphery	  and	  shown	  a	  role	  for	  
fascin	   in	   regulating	   FA	   assembly,	   it	   was	   important	   to	   clarify	   whether	   levels	   of	   FA	  
components	  were	   affected	   by	   fascin	   knockdown.	   FA	   proteins	   such	   as	   vinculin	   and	  
Focal	  Adhesion	  Kinase	   (FAK)	  are	  key	  components	   in	   the	  regulation	  of	  cell	  adhesion	  
and	  FA	  turnover	  (Carisey	  &	  Ballestrem,	  2010;	  Hamadi	  et	  al.,	  2005).	  Therefore,	  levels	  
of	  these	  proteins	  were	  analysed	  in	  control	  and	  fascin	  depleted	  cells.	  
	  
Vinculin	   staining	   was	   performed	   in	   MDA-­‐MB-­‐231	   control	   (ctrl),	   fascin	   knockdown	  
(fasKD)	  and	  fasKD	  cells	  re-­‐expressing	  WT	  fascin	  (resWT).	  Figure	  3.5a	  shows	  examples	  
of	   confocal	   images	   of	   vinculin	   staining	   in	   ctrl	   cells	   (left	   panel),	   fasKD	   cells	   (centre	  
panel)	  and	   resWT	  cells	   (right	  panel).	  Vinculin	  was	  present	   in	   large	  peripheral	  FA	   in	  
control	  cells	  and	  in	  the	  larger	  more	  densely	  packed	  FA	  previously	  seen	  in	  fasKD	  cells.	  
ResWT	   cells	   did	   not	   show	  differences	   in	   FA	   size	   and	   number	   compared	   to	   control	  
cells.	  
	  
To	  further	  determine	  whether	  vinculin	   levels	  were	  altered	  in	  the	  absence	  of	  fascin,	  
FA	  protein	  levels	  were	  analysed	  by	  western	  blotting.	  Figure	  3.5b	  shows	  total	  FAK	  and	  
vinculin	   levels	   in	   control	   (ctrl),	   fascin	   knockdown	   (fasKD)	   and	   fasKD	   cells	   re-­‐
expressing	  WT	  fascin-­‐GFP	  (resWT)	  MDA-­‐MB-­‐231.	  Endogenous	  and	  GFP-­‐fascin	   levels	  
were	   also	   assessed	   in	   the	   same	   samples.	   Total	   tubulin	   and	   GAPDH	   were	   used	   as	  
loading	  controls.	  FAK	  and	  vinculin	  levels	  were	  quantified	  by	  densitometry	  analysis	  of	  
multiple	   western	   blots	   (Figure	   3.5c)	   together	   with	   endogenous	   or	   GFP-­‐fascin	   and	  
total	  tubulin	  levels	  in	  control,	  fasKD	  and	  resWT	  cells.	  Data	  confirmed	  the	  efficiency	  of	  
both	   fascin	   knockdown	   and	   re-­‐expression	   in	   cells	   and	   similar	   total	   tubulin	   levels	  
between	   control	   and	   fasKD	   cells.	   No	   differences	   in	   total	   levels	   of	   FAK	   or	   vinculin	  
were	  detected	  between	   the	  different	  conditions.	  Thus,	   fascin	  knockdown	  does	  not	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result	   in	  change	  of	  total	   level	  of	  FA	  proteins.	  This	  data	  suggest	  that	  fascin	  does	  not	  
regulate	  FA	  size	  through	  control	  of	  total	  FA	  protein	  levels.	  
	  
To	   further	   investigate	   the	   role	  of	   fascin	   in	   FA	  dynamics,	   cell	   adhesion	  assays	  were	  
performed	  on	  fibronectin-­‐coated	  coverslips.	  Control	  (ctrl),	  fascin	  knockdown	  (fasKD)	  
and	   fasKD	   re-­‐expressing	  WT	   fascin-­‐GFP	   (resWT)	  MDA-­‐MB-­‐231	  cells	  were	  plated	  on	  
fibronectin	   and	   the	   number	   of	   adhered	   cells	   were	   counted.	   Figure	   3.5d	   shows	  
quantification	  of	  the	  number	  of	  control,	  fasKD	  and	  resWT	  cells.	  FasKD	  cells	  showed	  
higher	  adhesion	  to	  fibronectin	  compared	  to	  control	  and	  resWT	  cells,	  correlating	  with	  
the	  previous	  observation	  of	  increase	  FA	  size	  in	  fasKD	  cells.	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Figure	   3.5.	   Fascin	   knockdown	   does	   not	   alter	   total	   levels	   of	   focal	   adhesion	   proteins	  
(a)	  Confocal	  images	  of	  cells	  stained	  for	  vinculin	  in	  MDA-­‐MB-­‐231	  control	  cells	  (left	  panel),	  
fasKD	   cells	   (centre	   panel)	   and	   fasKD	   cells	   re-­‐expressing	  WT	   fascin-­‐GFP	   (resWT).	   Scale	  
bar=	   10	   um.	   (b)	  Western	   blots	   of	   lysates	   from	  MDA-­‐MB-­‐231	   control	   cells,	   fasKD	   and	  
resWT	   cells.	   (c)	   Statistical	   analysis	   of	   fascin,	   total	   tubulin,	   total	   Focal	   Adhesion	  Kinase	  
(FAK)	   and	   vinculin	   levels	   was	   performed	   by	   densitometry	   analysis	   of	   at	   least	   three	  
western	  blots.	  P-­‐value	  =<	  0.001	  (***)	  was	  considered	  as	  significant.	  Data	  are	  expressed	  
as	  mean±	  sem	  and	  corrected	  on	  GAPDH	  loading	  as	  control.	  (d)	  Count	  of	  control,	  fasKD	  
and	   resWT	  adhering	  on	   fibronectin.	  Statistical	  analysis	  was	  performed	  using	  T-­‐Test.	  P-­‐
value	  =<	  0.001	  (***)	  was	  considered	  as	  significant.	  Data	  are	  expressed	  as	  mean±	  sem.	  At	  
least	  20	  cells	  were	  evaluated	  in	  three	  separate	  experiments.	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3.6.	   β1	   integrin	   ligation	   is	   required	   for	   MT	   re-­‐growth	   following	   nocodazole	  
washout	  
	  
Having	   identified	   a	   potential	   role	   for	   fascin	   in	   regulating	   MT	   stability	   and	   FA	  
assembly,	  it	  was	  therefore	  important	  to	  study	  whether	  fascin	  plays	  a	  role	  in	  the	  MT-­‐
dependent	   regulation	   of	   FA	   dynamics.	   It	   has	   been	   shown	   that	   treatment	  with	   the	  
MT-­‐depolymerising	  drug	  nocodazole	   leads	   to	   increased	   FA	   assembly	   in	   fibroblasts.	  
Conversely,	  MT	  re-­‐growth	  after	  nocodazole	  washout	  drives	  FA	  disassembly	  (Ezratty	  
et	  al.	  2005).	  	  To	  characterise	  the	  relationship	  between	  MT	  and	  FA,	  nocodazole	  (NOC)	  
treatment	   and	   washout	   assays	   were	   performed	   on	   both	   MDA-­‐MB-­‐231	   and	   HeLa	  
cells.	   Control	   cells	   were	   either	   left	   untreated,	   treated	   with	   NOC	   for	   15	   minutes,	  
followed	   by	  washout	   of	   the	   drug	   for	   30	   or	   60	  minutes.	   Cells	  were	   then	   fixed	   and	  
stained	   for	   total	   tubulin	   and	   phospho-­‐tyrosine	   (p-­‐Tyr)	   and	   imaged	   by	   confocal	  
microscopy.	  
	  
Firstly,	  the	  adhesion	  receptor	  requirements	  for	  FA	  disassembly	  during	  MT	  re-­‐growth	  
were	   characterised.	   To	   analyse	   this,	   control	   MDA-­‐MB-­‐231	   cells	   were	   plated	   on	  
different	   extracellular	   matrix	   (ECM)	   proteins	   and	   subjected	   to	   treatment	   with	  
nocodazole	   followed	   by	  washout	   of	   the	   drug.	   Cells	  were	   stained	   for	   total	   tubulin,	  
imaged	  by	  confocal	  microscopy	  (Figure	  3.6a)	  and	  scored	  for	  percentage	  of	  cells	  with	  
normal	  MT	  network	  (MT	  score	  in	  Figure	  3.6b).	  Polymerised	  MT	  bundles,	  distributed	  
throughout	   the	   cell	   body	  with	   a	   visible	  MT	  organising	   centre	   (MTOC)	  were	   scored	  
with	   a	   high	   MT	   score	   (≈ 100%),	   while	   cells	   exhibiting	   small	   rounded	   area	   and	  
depolymerised	  MT	  network	  were	  given	  score	  close	  to	  zero	  (≈ 5%).	  I	  decided	  to	  give	  
5%	   score	   rather	   than	   0%	   because	   I	   did	   not	   use	   a	   direct	   measurement	   of	   MT	  
depolymerisation.	  Lastly,	  re-­‐spreading	  cells	  exhibiting	  an	  incomplete	  development	  of	  
MT	  network	  or	  without	  a	  clear	  MTOC	  were	  given	  score	  ≈	  50%).	  Example	  images	  of	  
cells	  scored	  for	  MT	  are	  shown	  in	  Matherial	  and	  Method	  section	  (Figure	  2.3).	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Cells	  were	  plated	  on	  three	  different	  ECM	  proteins:	  fibronectin	  (FN),	  collagen	  I	  (COL)	  
or	  vitronectin	  (VN).	  These	  ECM	  proteins	  are	  ligands	  for	  different	  types	  of	  β	  integrins.	  
Fibronectin	  binds	   to	  both	  β1	  and	  β3	   integrins,	  collagen	   I	  binds	  only	   to	  β1	  whereas	  
vitronectin	   binds	  only	   to	  β3.	   Thus	   this	   choice	  of	   ligands	  would	   enable	   any	   specific	  
requirements	  for	  integrin	  subunits	  to	  be	  defined.	  
	  
Figure	   3.6a	   shows	   examples	   of	   confocal	   images	   of	   total	   tubulin	   staining	   in	   control	  
cells	  plated	  on	  FN	  (first	  row),	  COL	  (second	  row)	  or	  VN	  (third	  row).	  The	  first	  column	  
shows	  untreated	  cells	  (UT),	  second	  shows	  nocodazole	  treated	  cells	  (NOC)	  and	  third	  
and	   fourth	   show	   cells	   30	   and	   60	   minutes	   post-­‐NOC	   washout	   respectively.	   MT	  
bundles	   in	   untreated	   cells	   plated	   on	   all	   the	   ECM	   proteins	   appeared	   normal.	   The	  
MTOC	  was	  visible	  in	  all	  cells	  (stained	  for	  total	  tubulin)	  and	  was	  particularly	  evident	  in	  
cells	  plated	  on	  FN	  (first	  panel,	  first	  row	  in	  3.6a)	  and	  COL	  (first	  panel,	  second	  row	  in	  
3.6a)	   compared	   to	   that	   seen	   in	   cells	   on	   VN	   (first	   panel,	   third	   row	   in	   3.6a).	  
Nocodazole	   treatment	   led	   to	   some	   cell	   rounding	   and	   MT	   organisation	   and	  
polymerisation	   were	   completely	   lost	   in	   NOC	   treated	   cells	   on	   all	   ECM	   proteins	  
(second	  column	  panels	  in	  3.6a).	  30	  minutes	  after	  NOC	  washout	  (30’W,	  third	  column	  
in	  3.6a),	  only	  control	  cells	  plated	  on	  FN	  (third	  panel,	  first	  row	  in	  3.6a)	  and	  COL	  (third	  
panel,	  second	  row	  in	  3.6a)	  recovered	  the	  MT	  network	  back	  to	  that	  seen	  in	  untreated	  
cells,	  while	  no	  MT	  recovery	  was	  seen	  in	  cells	  plated	  on	  VN	  (third	  panel,	  third	  row	  in	  
3.6a).	   30	   minutes	   post-­‐washout,	   cells	   on	   VN	   appeared	   rounded	   with	   no	   MT	  
polymerisation,	   suggesting	   that	   β1	   integrin	   ligation	   is	   essential	   in	   allowing	   MT	  
recovery	  after	  nocodazole	  washout.	  Additionally,	  MT	  recovery	  after	  30	  minutes	  NOC	  
washout	  was	  more	  efficient	  in	  cells	  plated	  on	  COL	  than	  on	  FN,	  further	  suggesting	  a	  
preferential	   role	   for	   β1	   in	   the	   MT	   re-­‐growth.	   MTs	   in	   cells	   plated	   on	   VN	   did	   not	  
recover,	  even	  following	  washout	  periods	  of	  up	  to	  6	  hours	  (data	  not	  shown).	  
	  
The	   graph	   shown	   in	   Figure	   3.6b	   demonstrates	   quantification	   of	   the	   percentage	   of	  
control	   cells	   plated	   on	   FN	   (green	   bars),	   COL	   (blue	   bars)	   and	   VN	   (red	   bars)	   with	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normal	  MT	  networks	  during	  the	  time	  course	  of	  the	  nocodazole	  washout	  assay.	  Data	  
confirms	   that	   NOC	   leads	   to	   total	  MT	   disassembly	   in	   cells	   on	   all	   ECM	   proteins.	   30	  
minutes	  after	  NOC	  washout,	  a	  normal	  MT	  score	  was	  seen	  in	  ~50%	  of	  cells	  plated	  on	  
FN	  and	   in	  ~70%	  of	   cells	  plated	  on	  COL,	  whereas	  no	   cells	  with	  normal	  MT	  network	  
were	  found	  on	  VN.	  Moreover,	  quantification	  confirmed	  a	  more	  efficient	  MT	  recovery	  
in	   cells	   on	   COL	   than	   on	   FN	   at	   30	   minutes	   post-­‐NOC	   washout.	   60	   minutes	   post-­‐
washout,	  cells	  on	  FN	  showed	  a	  significant	  2-­‐fold	  increase	  in	  MT	  recovery,	  similar	  to	  
levels	  achieve	  in	  cells	  on	  COL.	  The	  MT	  score	  in	  60	  minute	  washed	  cells	  plated	  on	  VN	  
was	  still	  negligible	  (p-­‐value	  in	  60	  minute	  washout	  on	  VN	  compared	  to	  control	  cells	  =<	  
0.001).	  	  
This	  data	  demonstrates	  that	  MT	  recovery	  is	  dependent	  on	  β1	  integrins.	   	  Moreover,	  
data	   show	   that	  MT	   re-­‐growth	  occurs	   faster	  on	  COL	   than	  on	  FN,	   further	   suggesting	  
the	  preferential	  role	  of	  β1	  integrin	  engagement	  and	  activation	  in	  MT	  re-­‐growth	  after	  
NOC	  washout.	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Figure	  3.6.	  β1	  integrin	  ligation	  is	  required	  for	  MT	  re-­‐growth	  following	  nocodazole	  
washout	  
(a)	   Confocal	   microscope	   images	   of	   cells	   stained	   for	   total	   tubulin	   in	   MDA-­‐MB-­‐231	  
control	   cells	  untreated	   (UT,	   first	   column),	  nocodazole	   treated	   (NOC,	   second	  column),	  
30	  minute	  washed	  (30’W,	  third	  column)	  and	  60	  minute	  washed	  (60’W,	  fourth	  column)	  
plated	  on	   fibronectin	   (FN,	   first	   row),	  collagen	   (COL,	   second	  row)	  and	  vitronectin	   (VN,	  
third	   row).	   Scale	   bar=	   20	   um.	   (b)	   Statistical	   analysis	   of	   %	   of	   cells	   with	   normal	   MT	  
network	  (MT	  score)	  in	  the	  same	  conditions	  as	  above.	  P-­‐value	  =<	  0.001	  (***),	  =<	  0.005	  
(**)	  and	  =<	  0.05	  (*)	  were	  considered	  as	  significant.	  Data	  are	  expressed	  as	  mean±	  sem.	  
At	  least	  20	  cells	  were	  evaluated	  in	  three	  separate	  experiments.	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3.7.	   Fascin	   knockdown	   cells	   show	   delayed	   microtubule	   re-­‐growth	   following	  
nocodazole	  washout	  
	  
Having	   tested	   MDA-­‐MB-­‐231	   control	   cells	   and	   identified	   specific	   adhesion	  
requirements	  in	  the	  nocodazole	  assay,	  the	  next	  step	  was	  to	  analyse	  whether	  fascin	  
was	  involved	  in	  MT	  and	  FA	  dynamics	  as	  measured	  in	  the	  assay.	  To	  do	  so,	  nocodazole	  
treatment	  and	  washout	  assays	  were	  performed	  in	  control,	  fascin	  knockdown	  (fasKD)	  
or	   fasKD	   cells	   re-­‐expressing	  WT	   fascin	   (resWT)	   plated	   on	   fibronectin	   (FN).	   FN	  was	  
chosen	   as	   a	   suitable	   ligand	   because	   this	   enabled	   the	   study	   of	   both	   β1	   and	   β	   3	  
integrin	  engagement	  and	  because	  the	  slower	  MT	  recovery	  speed	  observed	  in	  cells	  on	  
FN	   allowed	   more	   careful	   analysis	   of	   any	   potential	   temporal	   differences	   in	   MT	  
recovery	  between	  cell	  types.	  
	  
Figure	  3.7a	  shows	  example	  confocal	  images	  of	  total	  tubulin	  staining	  in	  MDA-­‐MB-­‐231	  
control	  (first	  row),	  fasKD	  (second	  row)	  and	  resWT	  cells	  (third	  row)	  during	  Nocodazole	  
treatment	   and	   washout	   assay.	   First	   column	   shows	   untreated	   cells	   (UT),	   second	  
column	   shows	   nocodazole	   treated	   cells	   (NOC),	   third	   column	   shows	   30	   minute	  
washed	   cells	   (30’W)	   and	   fourth	   column	   shows	   60	  minute	  washed	   cells	   (60’W).	   As	  
previously	   observed,	   there	   were	   no	   differences	   in	   basal	   MT	   network	   formation	  
between	  control,	   fasKD	  and	  resWT	  cells	   (figure	  3.7a).	  Nocodazole	   treatment	   led	  to	  
rounding	  in	  all	  cells	  and	  a	  complete	  loss	  of	  the	  MT	  network	  (second	  column	  panels	  in	  
3.7a).	  30	  minutes	  after	  NOC	  washout,	   the	  majority	  of	   control	   cells	   recovered	   their	  
MT	   network	   (third	   panel,	   first	   row	   in	   Figure	   3.7a),	   whereas	   fasKD	   cells	   showed	  
delayed	  MT	  re-­‐growth	  (third	  panel,	  second	  row	  in	  Figure	  3.7a).	  Indeed,	  after	  the	  30	  
minute	  NOC	  washout,	  fasKD	  cells	  did	  not	  show	  a	  clear	  MT	  network,	  despite	  showing	  
an	   increase	   in	   spread	   area.	   Fascin	   re-­‐expression	   in	   fasKD	   cells	   resulted	   in	   MT	  
polymerization	   and	   recovery	   as	   seen	   in	   control	   cells,	   with	   visible	   MTOC	   in	   the	  
majority	  of	  cells	  (third	  panel,	  third	  row	  in	  3.7a).	  After	  the	  60	  minute	  NOC	  washout,	  
control	  cells	  re-­‐spread	  and	  fully	  restored	  the	  MT	  network	  (fourth	  panel,	  first	  row	  in	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3.7a),	  whereas	  only	   few	   fasKD	  cells	   showed	   recovered	  MT	  networks	   (fourth	  panel,	  
second	   row	   in	   3.7a).	   A	   complete	  MT	   recovery	  was	   seen	   after	   the	   60	  minute	  NOC	  
washout	  in	  fasKD	  cell	  re-­‐expressing	  WT	  fascin-­‐GFP	  (fourth	  panel,	  third	  row	  in	  3.7a).	  
	  
Cells	  were	  scored	  for	  MT	  recovery	  (Figure	  3.7b)	  to	  quantify	  the	  percentage	  of	  cells	  
with	  normal	  MT	  network	  at	  all	  time	  points.	  Control	  (black	  bars),	   fasKD	  (white	  bars)	  
and	   resWT	   (grey	  bars)	   cells	   all	   showed	  complete	  MT	  disassembly	  after	  nocodazole	  
treatment.	   30	   minutes	   following	   NOC	   washout,	   50%	   of	   control	   and	   resWT	   cells	  
recovered	   their	   MT	   network,	   while	   fasKD	   cells	   showed	   a	   significant	   delay	   in	   the	  
recovery.	  60	  minutes	  post-­‐NOC	  washout,	  both	  control	  and	  resWT	  cells	  showed	  ~80	  
%	  of	  cells	  with	  normal	  MT	  network,	  confirming	  the	  observed	  gradual	  MT	  recovery	  on	  
FN	  seen	  previously	  (Fig	  3.6.).	  However,	  fasKD	  cells	  were	  delayed	  in	  MT	  recovery	  after	  
60	  minute	  NOC	  washout,	  showing	  ~40%	  of	  cells	  with	  normal	  MTs.	  
This	   data	   demonstrates	   that	   fascin	   is	   required	   for	   efficient	   MT	   recovery	   after	  
nocodazole	  washout.	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Figure	  3.7.	  Fascin	  knockdown	  cells	  show	  delayed	  microtubule	  re-­‐growth	  following	  
nocodazole	  washout	  
(a)	   Confocal	   microscope	   images	   of	   cells	   stained	   for	   total	   tubulin	   in	   MDA-­‐MB-­‐231	  
control	   cells	   (first	   row),	   fasKD	   cells	   (second	   row)	   and	   fasKD	   cells	   re-­‐expressing	   WT	  
fascin-­‐GFP	   (third	   row).	   First	   column	   shows	   untreated	   cells	   (UT),	   second	   shows	  
nocodazole	  treated	  cells	  (NOC),	  third	  shows	  30	  minute	  washed	  cells	  (30’W)	  and	  fourth	  
shows	  60	  minute	  washed	  cells	  (60’W).	  Scale	  bar=	  20	  um.	  (b)	  Statistical	  analysis	  of	  %	  of	  
cells	  with	  normal	  MT	  network	  (MT	  score)	  in	  the	  same	  conditions	  as	  above.	  P-­‐values	  =<	  
0.001	  (***)	  and	  =<0.05	  (*)	  were	  considered	  as	  significant.	  Data	  are	  expressed	  as	  mean±	  
sem.	  At	  least	  20	  cells	  were	  evaluated	  in	  three	  separate	  experiments.	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3.8.	  Characterisation	  of	  nocodazole	  treatment	  and	  washout	  assay	  in	  HeLa	  cells	  
	  
After	  studying	  MT	  and	  FA	  dynamics	  in	  MDA-­‐MB-­‐231	  cells,	  we	  wanted	  to	  characterise	  
the	  relationship	  between	  MT	  and	  FA	  in	  HeLa	  cells.	  I	  included	  this	  cell	  line	  in	  our	  study	  
because	  it	  is	  a	  suitable	  model	  to	  study	  cell	  spreading	  and	  cytoskeletal	  dynamics.	  The	  
nocodazole	   treatment	   and	   washout	   assay	   was	   therefore	   repeated	   in	   HeLa	   cells	  
plated	  on	  fibronectin.	  Cells	  were	  then	  stained	  for	  total	  tubulin	  and	  phospho-­‐Tyrosine	  
(p-­‐Tyr)	  and	  imaged	  by	  confocal	  microscopy.	  
	  
Figure	   3.8	   shows	   example	   images	   of	  merge	   and	   total	   tubulin	   and	   p-­‐Tyr	   respective	  
staining	   in	  HeLa	   cells.	  Untreated	   cells	   (Figure	  3.8,	   first	   row)	  were	  well	   spread	  with	  
polymerised	  MTs	  and	  peripheral	  regular	  FAs.	  As	  previously	  reported,	  NOC	  treatment	  
lead	  to	  MT	  depolymerisation	  (second	  row,	  centre	  panel)	  and	  an	   increase	   in	  FA	  size	  
(second	  row,	  right	  panel).	  MTs	  were	  still	  depolymerised	  following	  the	  30	  minute	  NOC	  
washout	   (third	   row,	   centre	   panel)	   and	   therefore	   FA	   remained	   larger	   than	   in	  
untreated	   cells	   at	   this	   time	   point	   (third	   row,	   right	   panel).	   60	   minutes	   post-­‐	   NOC	  
washout	   led	   to	  MT	  re-­‐growth	   (fourth	   row,	  centre	  panel)	  and	  FA	  appeared	  smaller,	  
similar	  to	  untreated	  cells	  (fourth	  row,	  right	  panel).	  	  
	  
These	  data	  show	  that	  MT	  regulate	  FA	  turnover	  after	  NOC	  washout	  in	  HeLa	  cells.	  This	  
characterization	  is	  important	  for	  future	  experiments	  to	  analyse	  fascin	  dependent	  FA	  
and	  MT	  assembly	  in	  these	  cells.	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Figure	  3.8.	  Characterisation	  of	  Nocodazole	  treatment	  and	  washout	  assay	  in	  HeLa	  
cells	  
Confocal	  microscope	  image	  of	  cells	  stained	  for	  total	  tubulin	  and	  phospho-­‐tyrosine	  (p-­‐
Tyr)	  in	  Hela	  cells	  untreated	  (UT,	  first	  row),	  nocodazole	  treated	  (NOC,	  second	  row),	  30	  
minute	   washed	   (30’W,	   third	   row)	   and	   60	   minute	   washed	   (60’W)	   plated	   on	  
fibronectin.	   First	   column	   shows	   total	   tubulin	   and	   p-­‐Tyr	   staining	   together,	   whereas	  
second	  and	   third	   columns	   show	   total	   tubulin	  and	  p-­‐Tyr	   staining,	   respectively.	   Scale	  
bar=	  10	  um. 
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3.9.	   Fascin	   knockdown	   cells	   do	   not	   disassemble	   focal	   adhesions	   following	  
nocodazole	  washout	  
	  
Having	  identified	  a	  role	  for	  fascin	  in	  MT	  recovery	  after	  NOC	  washout,	  the	  next	  step	  
was	  to	  investigate	  whether	  fascin	  also	  plays	  a	  role	  in	  MT-­‐dependent	  FA	  disassembly	  
in	  the	  NOC	  assay.	  To	  assess	  this,	  the	  nocodazole	  treatment	  and	  washout	  assay	  was	  
repeated	  in	  MDA-­‐MB-­‐231	  control,	  fascin	  knockdown	  (fasKD)	  and	  fasKD	  re-­‐expressing	  
WT	  fascin	  (resWT)	  cells	  and	  cells	  were	  stained	  for	  phospho-­‐Tyr	  (p-­‐Tyr)	  to	  analyse	  FA.	  	  
	  
Figure	   3.9a	   shows	   example	   images	   of	   p-­‐Tyr	   staining	   in	   control	   (first	   row),	   fasKD	  
(second	   row)	   and	   resWT	   cells	   (third	   row)	   during	   nocodazole	   assay.	   First	   column	  
shows	   untreated	   cells	   (UT),	   second	   column	   shows	   nocodazole	   treated	   cells	   (NOC)	  
and	  third	  column	  shows	  60	  minute	  post-­‐NOC	  washout	  cells	  (60’W).	  Only	  60	  minute	  
washout	  cells	  were	  analysed	  as	  the	  delayed	  MT	  recovery	  observed	  in	  fasKD	  cells	  was	  
greater	  at	  this	  time	  point	  rather	  than	  at	  30	  minutes.	  As	  shown	  previously	   in	  Figure	  
3.2,	   fasKD	   cells	   had	   a	   higher	   FA	   coverage	   per	   cell	   compared	   to	   either	   control	   or	  
resWT	   cells	   in	   untreated	   conditions	   (first	   column	   in	   3.9a).	   Nocodazole	   treatment	  
resulted	   in	   increased	   FA	   area	   per	   cell	   in	   control,	   fasKD	   and	   resWT	   cells	   (second	  
column	   in	   3.9a).	   Control	   cells	   showed	   fewer	   and	   smaller	   FA	   60	  minutes	   post-­‐NOC	  
washout	   (third	  panel,	   first	   row	   in	  3.9a),	  confirming	  FA	  disassembly	  occurred	  as	  has	  
been	   previously	   reported	   in	   other	   cell	   types.	   Conversely,	   fasKD	   cells	   did	   not	  
disassemble	   FA	   after	   nocodazole	   washout,	   showing	   strong	   p-­‐Tyr	   localisation	   after	  
drug	  washout	  (third	  panel,	  second	  row	  in	  3.9a).	  This	  data	  suggests	  a	  role	  for	  fascin	  in	  
MT-­‐dependent	  FA	  disassembly.	  In	  addition,	  FAs	  did	  disassemble	  after	  NOC	  washout	  
by	  rescuing	  WT	  fascin	  expression	  in	  fasKD	  cells	  (third	  panel,	  third	  row	  in	  3.9a).	  
	  
Quantification	  of	  p-­‐Tyr	  staining	   in	  control,	   fasKD	  and	  resWT	  cells	  was	  performed	  in	  
ImageJ.	  The	  percentage	  of	   cell	  occupied	  by	  FA	   (FA	   size)	  and	  FA	  number	  per	   cell	   in	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control	   (black	  bars),	   fasKD	   (white	  bars)	  and	  resWT	  (red	  bars)	  was	  calculated	  and	   is	  
shown	   in	   Figure	   3.9b,	   c.	   All	   data	   was	   normalised	   against	   cell	   area.	   Quantification	  
(figure	  3.9b)	  confirmed	  the	  increased	  FA	  assembly	  in	  untreated	  fasKD	  cells	  compared	  
to	  both	  control	  or	  resWT	  cells.	  Data	  showed	  a	  significant	   increase	   in	  percentage	  of	  
cell	  occupied	  by	  FAs	  in	  all	  NOC	  treated	  cells	  (Figure	  3.9b,	  p-­‐value	  between	  untreated	  
and	  treated	  fasKD	  or	  resWT	  cells	  =<	  0.001).	  Statistical	  analysis	  confirmed	  a	  decrease	  
in	   FA	   size	   to	   untreated	   levels	   in	   control	   and	   resWT	   cells,	   while	   fasKD	   showed	   no	  
recovery	   in	  FA	   size	   following	  NOC	  washout.	   Figure	  3.9c	   shows	  quantification	  of	   FA	  
number	  per	  cell	  during	  the	  nocodazole	  treatment	  and	  washout	  assay.	  Both	  control	  
and	  resWT	  cells	  showed	  increased	  FA	  number	  after	  NOC	  treatment,	  while	  fasKD	  cells	  
showed	  a	  decrease	   in	  FA	  number.	   In	  addition,	  60	  minute	  NOC	  washout	  results	   in	  a	  
decrease	  of	  FA	  number	  per	  cell	  in	  control	  and	  resWT	  cells,	  while	  fasKD	  cells	  did	  not	  
show	   a	   regulation	   of	   FA	   number	   after	   NOC	   washout.	   Taken	   together,	   these	   data	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Figure	  3.9.	  Fascin	  knockdown	  cells	  do	  not	  disassemble	  focal	  adhesions	  following	  
nocodazole	  washout	  
(a)	  Confocal	  microscope	   images	  of	  MDA-­‐MB-­‐231	   cells	   stained	   for	  phospho-­‐tyrosine	   (p-­‐
Tyr)	  in	  control	  cells	  (first	  row),	  fasKD	  cells	  (second	  row)	  and	  fasKD	  cells	  re-­‐expressing	  WT	  
fascin-­‐GFP	   (third	   row).	   Left	   column	   shows	   untreated	   cells	   (UT),	   centre	   column	   shows	  
nocodazole	  treated	  cells	  (NOC)	  and	  right	  column	  shows	  60	  minute	  washed	  cells	  (60’W).	  
Scale	  bar=	  5	  um.	  (b,	  c)	  Quantification	  of	  %	  of	  cell	  occupied	  by	  FAs	  (b)	  and	  FA	  number	  per	  
cell	  (c)	   in	  control	  cells	  (in	  black),	  fasKD	  cells	  (in	  white)	  and	  fasKD	  cells	  re-­‐expressing	  WT	  
fascin-­‐GFP	  (in	  red).	  Statistical	  analysis	  of	  p-­‐Tyr	  staining	  was	  performed	  in	  ImageJ.	  At	  least	  
20	  cells	  were	  evaluated	  in	  three	  different	  experiments.	  P-­‐value	  =<	  0.001	  (***),	  =<	  0.005	  
(**)	  and	  =<	  0.05	   (*)	  were	   considered	  as	   significant.	  Data	  are	  expressed	  as	  mean±	   sem	  
and	  corrected	  on	  cell	  area. 
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3.10.	  Fascin	  is	  required	  for	  control	  of	  FA	  dynamics	  following	  MT	  re-­‐growth	  in	  IRM	  
live	  imaging	  experiments	  
	  
Data	   showed	   in	   section	  3.9	   showed	   fascin	   to	  play	   a	   role	   in	  driving	   FA	  disassembly	  
following	   MT	   re-­‐growth.	   To	   confirm	   this	   further,	   I	   performed	   live	   imaging	  
experiments	   in	  MDA-­‐MB-­‐231	   control,	   fasKD	   and	   fasKD	   rescued	   for	   GFP-­‐WT	   fascin	  
expression	   during	   nocodazole	   treatment	   and	   washout	   assay.	   Cells	   were	   plated	   in	  
chambers	   pre-­‐coated	   with	   fibronectin	   and	   imaged	   by	   Interference	   Reflection	  
Microscopy	   (IRM)	   throughout	   the	  nocodazole	  assay.	  Note	   that	   IRM	  shows	   in	  black	  
the	  area	  of	  the	  cell	  in	  contact	  with	  the	  ECM.	  	  
	  
Figure	  3.10	  shows	  still	  images	  taken	  from	  IRM	  Movies	  3,4	  and	  5.	  As	  expected,	  control	  
cells	  showed	  increased	  FA	  assembly	  after	  NOC	  treatment	  and	  subsequent	  decrease	  
following	  drug	  washout	  (top	  row).	  On	  the	  other	  hand,	  fasKD	  cells	  after	  NOC	  washout	  
were	  delayed	  in	  disassembling	  FA,	  whose	  assembly	  was	  induced	  by	  NOC	  treatment	  
(centre	  row).	  FA	  dynamics	  observed	  in	  control	  cells	  during	  the	  NOC	  assay	  were	  also	  
observed	   in	   fasKD	   cells	   rescued	   for	   GFP-­‐WT	   fascin	   expression	   (bottom	   row).	   This	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Figure	  3.10.	  Fascin	  is	  required	  for	  control	  of	  FA	  dynamics	  following	  MT	  re-­‐growth	  in	  IRM	  
live	  imaging	  experiments	  
Still	   images	  from	  IRM	  movies	  3,4,5	  of	  MDA-­‐MB-­‐231	  control	  (top	  row),	  fasKD	  (centre	  row)	  
and	   fasKD	  rescued	   for	  GFP-­‐WT	  fascin	   (resWT,	  bottom	  row)	  during	  nocodazole	   treatment	  
and	   washout	   assay.	   First	   column	   shows	   untreated	   cells	   (UT),	   second	   column	   shows	  
nocodazole	   treated	   cells	   (NOC)	   and	   third	   column	   shows	  60	  minute	  washed	   cells	   (60’W).	  
Scale	  bar=	  20	  um. 
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3.11.	  Fascin	  localises	  to	  the	  cell	  periphery	  following	  Nocodazole	  washout	  
	  
As	  shown	   in	  Figure	  3.3,	   fascin	   is	   recruited	   to	   the	  cell	  periphery	  where	   it	   shows	  co-­‐
localisation	  with	  the	  tips	  of	  MTs.	  After	  identifying	  a	  role	  for	  fascin	  in	  regulating	  both	  
MT	   and	   FA	   dynamics,	   it	  was	   important	   to	  more	   carefully	   define	   fascin	   localisation	  
during	  the	  Nocodazole	  treatment	  and	  washout	  assay	  in	  control	  and	  resWT	  MDA-­‐MB-­‐
231	  cells.	  
	  
Figure	  3.11	  shows	  example	  images	  of	  fascin	  staining	  in	  untreated	  control	  cells	  (UT),	  
Nocodazole	   treated	   cells	   (NOC),	   30	   minute	   washed	   cells	   (30’W)	   and	   60	   minute	  
washed	  cells	  (60’W).	  Endogenous	  fascin	  and	  rescued	  WTfascin-­‐GFP	  in	  fasKD	  cells	  was	  
seen	  at	  the	  cell	  periphery	  in	  untreated	  cells	  (first	  panels).	  	  Nocodazole	  treatment	  led	  
to	  decreased	   levels	  of	   fascin	  at	  the	  cell	  periphery	   in	  both	  endogenous	  and	  rescued	  
fasWT	   cells	   (second	   panels,	   Figure	   3.11).	   Interestingly,	   30	   minutes	   after	   NOC	  
washout	   (third	  panel,	   top	  row	   in	  3.11)	   fascin	  was	  clearly	   recruited	   to	   the	  cell	  edge	  
within	  dot-­‐like	  structures	  and	  this	  was	  also	  evident	  at	  60	  minutes	  washout	   in	  both	  
cell	   types.	   These	   data	   suggest	   that	   fascin	   translocation	   to	   the	   cell	   periphery	   could	  
provide	  a	  mechanism	  for	  fascin	  to	  regulate	  MT	  stability	  and	  FA	  dynamics.	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Figure	  3.11.	  Fascin	  localises	  to	  the	  cell	  periphery	  following	  nocodazole	  washout	  
Confocal	  microscope	   image	   of	   cells	   stained	   for	   endogenous	   fascin	   in	   control	   cells	   (above)	  
and	  WT	  fascin-­‐GFP	  rescue	  in	  MDA-­‐MB-­‐231	  fasKD	  cells	  re-­‐expressing	  WT	  fascin-­‐GFP	  (below).	  
First	   column	   shows	   untreated	   cells	   (UT),	   second	   column	   shows	   nocodazole	   treated	   cells	  
(NOC),	   third	   column	   shows	   30	   minute	   washed	   cells	   (30’W)	   and	   fourth	   column	   shows	   60	  
minute	  washed	  cells	  (60’W).	  Scale	  bar=	  10	  um. 
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DISCUSSION	  	  	  
	  
Data	  presented	   in	  this	  chapter	  demonstrates	  a	  role	   for	   fascin	   in	  regulating	  MT	  and	  
FA	   dynamics	   after	   Nocodazole	   washout.	   This	   could	   potentially	   happen	   through	  
transient	   localization	   of	   fascin	   to	   the	   periphery	   of	   the	   cell,	   adjacent	   to	   FA,	   during	  
dynamic	  membrane	  MT	  targeting.	  It	  has	  been	  previously	  demonstrated	  that	  MT	  play	  
a	  role	  in	  the	  regulation	  of	  FA	  stability	  (Ballestrem	  et	  al.	  2000;	  Wehrle-­‐Haller	  &	  Imhof	  
2003)	  and	  studies	  using	  Nocodazole	  (NOC)	  have	  shown	  MT	  depolymerisation	  drives	  
adhesion	   growth,	   and	   MT	   recovery	   induces	   FA	   disassembly	   (Ezratty	   et	   al.	   2005).	  
Although	   molecular	   mediators	   of	   the	   MT-­‐FA	   crosstalk	   have	   been	   proposed,	   the	  
details	   of	   how	   MT	   regulate	   adhesion	   dynamics	   remain	   unclear	   (Rodriguez	   et	   al.	  
2003).	   In	   addition,	   role	   for	   fascin	   in	   stabilising	   F-­‐actin	   structures	   has	   been	   well	  
documented	  by	  our	   lab	   and	  others	   (Anilkumar	   et	   al.	   2003;	  Hashimoto	  et	   al.	   2007;	  
Parsons	   &	   Adams	   2008).	   However,	   the	   role	   of	   fascin	   in	   controlling	   adhesion	  
dynamics	  has	  not	  been	  yet	  addressed.	  Here	  I	  show	  fascin	  regulation	  of	  MT	  re-­‐growth	  
and	   FA	   disassembly	   after	   NOC	   washout,	   suggesting	   fascin	   regulates	   adhesions	  
dynamics	  potentially	  through	  control	  of	  MT.	  	  
	  
Data	  shown	  in	  this	  chapter	  demonstrates	  that	  fascin	  has	  a	  role	  in	  regulating	  MT	  re-­‐
growth	  after	  NOC	  washout	  on	  fibronectin	  (FN,	   ligand	  for	  both	  β1	  and	  β3	   integrins)	  
and	  collagen	  I	  (COL,	  ligand	  for	  β1	  integrin	  only).	  The	  complete	  lack	  of	  MT	  recovery	  in	  
cells	  plated	  on	  vitronectin	  (ligand	  for	  β3	  integrin	  only)	  suggests	  that	  the	  engagement	  
of	  β1	   integrin	   is	  an	  essential	   requirement	   for	  MT	  re-­‐growth	   in	  cells.	  Moreover,	   the	  
delayed	  MT	  assembly	  following	  NOC	  washout	  on	  FN	  compared	  to	  that	  seen	  on	  COL	  
suggests	  that	  the	  activation	  of	  β3	  integrin	  may	  act	  as	  a	  negative	  modulator	  of	  MT	  re-­‐
growth.	  Accordingly,	  the	  faster	  MT	  recovery	  in	  cells	  plated	  on	  COL	  compared	  to	  FN	  
confirms	  a	  major	  role	  for	  β1	  integrin	  in	  fascin	  regulation	  of	  MT	  dynamics.	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Both	  β1	  and	  β3	   integrins	  have	  been	  associated	  with	   increased	  cancer	   cell	   invasion	  
and	  metastasis	  (Felding-­‐Habermann	  et	  al.	  2001)	  and	  they	  have	  been	  proposed	  to	  be	  
involved	  in	  different	  types	  of	  migration	  (Brockbank	  et	  al.	  2005).	  β1	  integrin	  has	  been	  
shown	  to	  be	  required	  for	  the	  invasive	  behavior	  of	  squamous	  carcinoma	  cells,	  while	  
β3	   integrin	   up-­‐regulation	   drives	   cell	   proliferation.	   It	   is	   therefore	   possible	   a	  
preferential	   requirement	   of	   β1	   integrin	   in	   the	   regulation	   of	   cancer	   cell	   adhesion.	  
Furthermore,	   β3	   integrin	   has	   been	   already	   proposed	   as	   a	   negative	   modulator	   of	  
adhesion	  dynamics	  and	  migration	  (Worth	  &	  Parsons	  2010).	   Interestingly,	  molecules	  
such	  as	   the	  MT	  plus-­‐end	   tracking	  protein	   (+TIP)	  EB3	  has	  been	  demonstrated	   to	  be	  
recruted	   specifically	   in	   β1,	   but	   not	   β3	   integrin-­‐adhesion	   complexes	   in	   mass	  
spectrometry	  analysis	  (Byron	  et	  al.	  2012).	  
	  
Fascin	   knockdown	   expression	   in	   human	   carcinoma	   cell	   lines	   has	   been	   previously	  
shown	  by	  our	  lab	  to	  decrease	  FA	  dynamics,	  suggesting	  it	  may	  play	  a	  role	  in	  adhesion	  
site	   stability	   (Hashimoto	   et	   al.	   2007).	   Fascin	   localises	   in	   structures	   such	   as	  
podosomes	   and	   invadopodia,	   promoting	   their	   stability	   and	   regulating	   PKC-­‐
dependent	   invasiveness	   of	   the	   filopodia	   (Quintavalle	   et	   al.	   2003;	   Li	   et	   al.	   2010;	  
Vignjevic	  et	  al.	  2006).	  However,	  previous	  studies	  had	  not	  found	  fascin	  to	  be	  localised	  
in	  FA.	  Data	  presented	  here	  proposes	  fascin	  localisation	  at	  the	  cell	  periphery	  through	  
co-­‐operation	  with	  MT	  as	  a	  mechanism	  regulating	  FA	  dynamics.	  Therefore,	  peripheral	  
localisation	  enables	  fascin	  to	  regulate	  basal	  MT	  and	  FA	  stability	  and	  turnover.	  Fascin	  
localisation	  in	  FA	  is	  not	  as	  stable	  and	  clear	  in	  these	  membrane	  punctate	  structures	  as	  
in	  filopodia	  structures.	  Peripheral	  fascin	  may	  be	  transiently	  localised	  in	  regions	  near	  
or	  within	  FA	  contributing	  to	  their	  turnover.	  In	  addition,	  the	  role	  of	  fascin	  at	  adhesion	  
sites	  might	   be	   dynamically	   regulated	   by	   other	   FA	   components	   and	   by	   fascin-­‐actin	  
binding.	  These	  issues	  will	  be	  addressed	  experimentally	  in	  the	  following	  chapters.	  
	  
Fascin	  depleted	  cells	  showed	  increased	  MT	  stability,	  without	  any	  major	  effect	  on	  MT	  
polymerisation.	  Peripheral	  fascin	  co-­‐localises	  with	  ends	  of	  MT,	  potentially	  promoting	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the	  dynamic	  instability	  of	  MT	  as	  they	  target	  the	  membrane.	  Fascin	  depletion	  (Jayo	  &	  
Parsons,	  2010)	  and	  decreased	  MT	  dynamics	  due	  to	  higher	  acetylated	  tubulin	   levels	  
(Ikegami	   &	   Setou,	   2010;	   Perdiz	   et	   al.	   2010)	   have	   been	   shown	   to	   decrease	   cell	  
migration.	   In	   addition,	   the	   data	   presented	   in	   this	   chapter	   shows	   increased	   tubulin	  
acetylation	   in	   fasKD	   cells	   and	   delayed	  MT	   recovery	   after	  NOC	  washout	   suggesting	  
that	  fascin	  control	  of	  MT	  dynamics	  may	  be	  required	  for	  MT	  re-­‐growth	  and	  network	  
assembly.	  MT	   dynamics	   and	   stability	   are	   controlled	   by	  MT	   +TIP	   proteins.	   Proteins	  
such	  as	  EB1	  and	  EB3	  are	  master	  regulators	  of	  the	  MT	  +	  end	  network,	  mediating	  the	  
interaction	   between	   MT	   and	   other	   proteins	   (Matov	   et	   al.,	   2010).	   Other	   capping	  
proteins	  are	  involved	  in	  the	  regulation	  of	  MT	  stability.	  Molecules	  involved	  in	  tubulin	  
acetylation,	  such	  as	  histone	  deacetylase	  6	  (HDAC6),	  have	  been	  shown	  to	  play	  a	  role	  
in	   regulating	   tubulin	   post-­‐translational	   modifications	   and	   cell	   motility	   (Tran	   et	   al.	  
2007).	  Therefore,	  I	  speculated	  about	  a	  possible	  role	  for	  peripheral	  fascin	  in	  displacing	  
MT	   +TIP	   proteins	   or	   in	   controlling	   enzymes	   regulating	   tubulin	   acetylation.	  
Experiments	   in	   following	   chapters	   will	   address	   how	   fascin	   binding	   to	   actin	   may	  
contribute	   to	   this,	   and	   whether	   fascin	   may	   associate	   directly	   with	   the	   MT	  
cytoskeleton.	  
	  
Fascin	  regulation	  of	  MT	  may	  also	  promote	  a	  feedback	  loop	  control	  of	  MT	  on	  fascin	  
localisation	  at	  the	  cell	  edge.	  MT	  are	  known	  to	  target	  FA	  and	  this	  is	  thought	  to	  deliver	  
FA	  components	  at	  adhesion	  sites	  (Morrison	  2007;	  Stehbens	  &	  Wittmann	  2012).	  Our	  
hypothesis	  is	  that	  highly	  dynamic	  MT	  may	  transiently	  interact	  with	  fascin,	  promoting	  
its	   localisation	   at	   the	   periphery	   near	   FA	   and	   therefore	   enabling	   fascin-­‐dependent	  
control	   of	   FA	   turnover.	   Fascin	   depleted	   cells	   also	   showed	   increased	   FA	   assembly	  
under	  basal	  conditions.	  This	  might	  be	  due	  to	  the	  more	  stable	  MT	  observed	  in	  fasKD	  
cells,	  which	   in	   turn	  slows	  down	  FA	   turnover,	  causing	  accumulation	  of	  molecules	  at	  
adhesion	  sites.	  Data	  presented	  in	  this	  chapter	  demonstrates	  that	  levels	  of	  total	  FAK	  
or	   vinculin	   (characterized	   classical	   components	   of	   FA)	   are	   not	   affected	   by	   fascin	  
depletion.	  Therefore,	  fascin	  likely	  controls	  dynamics	  of	  FA	  proteins	  rather	  than	  levels	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through	  transcriptional	  mechanisms.	  This	  would	  also	  agree	  with	  a	  role	   for	   fascin	   in	  
control	  of	  MT	  stability.	  
	  
Given	  the	  observed	  role	  for	  fascin	  in	  both	  MT	  and	  FA	  dynamics	   in	  this	  chapter,	  the	  
next	  important	  step	  therefore	  was	  to	  study	  the	  mechanism	  explaining	  this	  new	  role	  








4 The	  role	  of	  fascin-­‐actin	  binding	  in	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INTRODUCTION	  	  
	  
Fascin	  is	  most	  well-­‐known	  for	  its	  ability	  to	  cross-­‐link	  parallel	  actin	  filaments	  and	  form	  
finger-­‐like	   structures	   called	   filopodia	   (Vignjevic	   et	   al.	   2006).	   Fascin	   actin	   bundling	  
activity	   is	   directed	   by	   the	   two	  major	   actin	   binding	   sites,	   situated	   at	   the	  N-­‐	   and	   C-­‐
terminal	   β-­‐trefoil	   domain,	   respectively	   (Ono	   1996).	   The	   best-­‐characterised	   actin-­‐
binding	  site	  resides	  on	  the	  N-­‐terminus	  at	  Serine	  39	  (Ser39)	  within	  the	  first	  β-­‐trefoil	  
domain.	   PKC-­‐dependent	   phosphorylation	   of	   Ser39	   results	   in	   the	   loss	   of	   the	   actin	  
binding	   and	   greatly	   reduced	   filopodia	   formation	   (Anilkumar	   et	   al.	   2003;	   J.	   Adams	  
2004).	   In	  addition,	  a	  second	  actin-­‐binding	  site	  at	   the	  C	  terminus	  of	   the	  protein	  has	  
been	  recently	  characterised	  (Zanet	  et	  al.	  2012).	  The	  molecular	  mechanism	  regulating	  
this	   novel	   actin-­‐binding	   site	   is	   not	   yet	   understood,	   but	   evidence	   suggests	   that	   it	  
involves	  phosphorylation	  changes	  on	  serine	  274	  (Ser274).	  Mutations	  of	  Ser274	  to	  a	  
non-­‐phosphorylatable	   residue	   (alanine,	  A)	   or	   to	   a	   phospho-­‐mimic	   aspartic	   acid	   (D)	  
result	  in	  the	  disruption	  of	  fascin	  actin	  binding	  activity.	  In	  cells,	  it	  has	  been	  shown	  that	  
S274A	  fascin	  expression	  can	  still	  promote	  filopodia	  formation	  even	  in	  the	  absence	  of	  
normal	  actin	  binding	  activity,	  whereas	  S274D	  fascin	  cannot.	  This	  serine	  is	  known	  to	  
reside	  in	  a	  non-­‐exposed	  fold	  between	  the	  second	  and	  the	  third	  β-­‐trefoil	  domains	  of	  
fascin,	  which	  does	  not	  allow	  an	  efficient	  binding	  to	  actin.	   Its	  binding	  mechanism	  is,	  
therefore,	   under	   investigation	   (Jansen	   et	   al.,	   2011).	   Since	   both	   mutations	   that	  
change	   S274	   phosphorylation	   status	   (A/D)	   affect	   fascin-­‐actin	   binding	   and	   show	  
different	  effects	  on	  filopodia	  formation,	  an	  actin-­‐independent	  mechanism	  or	  role	  for	  
fascin	  has	  been	  suggested.	  	  
	  
Experiments	   in	   this	   chapter	   aim	   to	   analyse	   the	   potential	   co-­‐operation	   between	  
fascin,	  actin	  binding	  and	  MT	  dynamics	  in	  controlling	  FA	  assembly.	  This	  will	  make	  use	  
of	   these	  previously	  published	  mutants	  of	   fascin	  within	   S39	  and	  S274	   to	  determine	  
whether	  uncoupling	  of	  fascin-­‐actin	  binding	  can	  lead	  to	  changes	  in	  MT	  dynamics.	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4.1.	  Fascin-­‐actin	  binding	  is	  required	  for	  Focal	  Adhesion	  stability	  
	  
Data	   in	   the	   previous	   chapter	   demonstrated	   a	   role	   for	   fascin	   in	   controlling	   MT	  
stability	  and	  focal	  adhesion	  assembly.	  To	  determine	  whether	  this	  novel	  role	  of	  fascin	  
depended	   upon	   fascin	   binding	   to	   actin,	   fascin	   expression	   was	   rescued	   in	   fascin	  
knockdown	  MDA-­‐MB-­‐231	   cells	   (fasKD)	   by	   re-­‐expression	  of	  GFP	   tagged	   sh-­‐resistant	  
fascin	   constructs.	   Cells	   were	   transfected	   with	   either	   GFP-­‐tagged	  WT	   fascin,	   fascin	  
S39A	  (known	  to	  bind	  and	  bundle	  actin),	  fascin	  S39D	  (does	  not	  bundle	  actin),	  S274A	  
or	   S274D	   (neither	   bundle	   actin,	   but	   are	   not	  well	   characterized	   in	   other	   functions)	  
(Zanet	  et	  al.	  2012).	  
	  
Cells	  were	  plated	  on	  fibronectin	  and	  stained	  for	  phospho-­‐tyrosine	  (p-­‐Tyr)	  levels	  as	  a	  
marker	   of	   FA.	   Cells	   were	   imaged	   by	   confocal	  microscopy	   to	   observe	   and	   quantify	  
changes	   in	  percentage	  of	  cell	  occupied	  by	  FA	   (FA	  size)	  and	  FA	  number.	  Figure	  4.1a	  
shows	   example	   images	   of	   p-­‐Tyr	   staining	   in	   fasKD	   cells	   rescued	   with	  WT	   fascin	   or	  
mutant	  fascin-­‐GFP.	  As	  previously	  described	  in	  section	  3.2	  (Results	  Chapter	  1),	  p-­‐Tyr	  
staining	   in	   fasKD	   cells	   rescued	   for	   WT	   fascin	   (resWT)	   showed	   peripheral	   FA	   with	  
some	   smaller	   punctate	   FA	   beneath	   the	   cell	   body.	   S39A	   fascin	   expression	   in	   fasKD	  
cells	   resulted	   in	   increased	   FA	   number	   and	  more	   peripherally	   localized	   FA	   (left	   top	  
panel	   in	   Figure	   4.1a).	   P-­‐Tyr	   staining	   in	   resS39A	   fascin	   cells	   showed	   larger	   FA	  
compared	   to	   those	   seen	   in	   resWT	   cells,	   suggesting	   that	   fascin-­‐actin	   binding	   can	  
promote	  FA	  stability.	  Conversely,	  S39D	  fascin	  rescue	  cells	   (right	  top	  panel	   in	  Figure	  
4.1a)	   showed	   significantly	   fewer	   and	   smaller	   FA	   compared	   to	   resS39A	   expressing	  
cells,	  with	   localisation	   of	   small	   FA	   underneath	   the	   cell	   body.	   This	   further	   supports	  
the	  concept	  of	  fascin-­‐actin	  binding	  being	  required	  for	  regulation	  of	  FA	  stability.	  Cells	  
expressing	  S274A	  fascin	  (left	  bottom	  panel	  in	  Figure	  4.1a)	  had	  numerous	  membrane	  
spikes	  with	  FA	  localised	  at	  the	  ends	  of	  these	  spikes.	  P-­‐Tyr	  staining	  in	  cells	  expressing	  	  
S274D	  fascin	  (right	  bottom	  panel	  in	  Figure	  4.1a)	  showed	  large	  and	  densely	  packed	  FA	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decorating	  the	  cell	  edge,	  similar	  to	  p-­‐Tyr	  staining	  observed	  in	  S39A	  fascin	  expressing	  
cells.	  
	  
P-­‐Tyr	  staining	  was	  quantified	  in	  fasKD	  cells	  re-­‐expressing	  WT	  and	  mutant	  fascin	  from	  
three	  different	  experiments.	  FA	  size	  and	  number	  quantification	  was	  performed	  using	  
in	  ImageJ	  and	  data	  was	  corrected	  for	  cell	  area	  (at	  least	  20	  cells	  were	  analysed	  in	  each	  
experiment).	  Quantification	  of	  the	  percentage	  of	  cell	  occupied	  by	  FAs	  (FA	  size)	  and	  
FA	  number	  per	  cell	  in	  fasKD	  cells	  rescue	  for	  WT	  (black	  bars),	  S39A	  (green	  bars),	  S39D	  
(orange	  bars),	  S274A	  (blue	  bars)	  and	  S274D	  (purple	  bars)	   is	  shown	  in	  Figure	  4.1b,c.	  
Quantification	  showed	  an	  increase	  in	  both	  %	  of	  cell	  occupied	  by	  FAs	  and	  FA	  number	  
in	   cells	   expressing	   S39A	   fascin	   compared	   to	   resWT	   cells.	   A	   significant	   decrease	   in	  
both	  FA	  occupied	  cell	  area	  and	  FA	  number	  was	  observed	  in	  cells	  re-­‐expressing	  S39D	  
fascin,	   confirming	   the	   smaller	   FA	   observed	   in	   these	   images.	   Furthermore,	   a	  
significant	   increase	   in	   FA	   size	   and	   FA	  number	   in	   cells	   expressing	   S274A	   fascin	  was	  
observed.	   Indeed,	  FA	   in	  S274A	  fascin	  cells	  were	   larger	  and	  more	  numerous	  than	   in	  
S39A	  fascin	  cells	  (p-­‐value	  S274A	  compared	  to	  S39A	  cells:	  p=<	  0.05).	  S274A	  fascin	  re-­‐
expression	  had	  a	  greater	  effect	  on	  FA	  size	  than	  FA	  number.	  FA	  in	  S274D	  fascin	  cells	  
were	  larger	  and	  more	  numerous	  compared	  to	  WT.	  Interestingly,	  similar	  FA	  size	  and	  
number	  was	  observed	  between	  S274D	  fascin	  rescue	  cells	  (purple	  bars)	  and	  cells	  re-­‐
expressing	   S39A	   fascin	   (green	  bars),	   implying	   two	  different	  mechanisms	   regulating	  
fascin	  role	  in	  FA	  stability,	  one	  actin-­‐binding	  dependent	  and	  one	  independent.	  Taken	  
together,	   this	   data	   shows	   that	   fascin-­‐actin	   binding	   is	   required	   for	   FA	   stability	   and	  
also	   proposes	   that	   a	   second	   actin-­‐binding	   independent	   mechanism	   may	   exist	   for	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* 	   	  	   * 
Figure	  4.1.	  Fascin-­‐actin	  binding	  is	  required	  for	  focal	  adhesion	  stability	  	  
(a)	   Confocal	   microscope	   images	   of	   phospho-­‐tyrosine	   (p-­‐Tyr)	   staining	   in	   MDA-­‐MB-­‐231	  
fasKD	  cells	  expressing	  fascin	  shRNA	  re-­‐expressing	  shRNA	  resistant	  WT	  or	  mutant	  fascin-­‐
GFP.	   Scale	   bar=	   10	   um.	   (b,	   c)	   Quantification	   of	   %	   of	   cell	   occupied	   by	   FAs	   (b)	   and	   FA	  
number	  per	  cell	  (c)	  in	  fasKD	  cells	  re-­‐expressing	  WT	  and	  mutant	  fascin.	  Statistical	  analysis	  
of	   p-­‐Tyr	   staining	   was	   performed	   in	   ImageJ.	   At	   least	   20	   cells	   were	   evaluated	   in	   three	  
different	   experiments.	   P-­‐value	   =<	   0.05	   (*)	   was	   considered	   as	   significant.	   Data	   are	  
expressed	  as	  mean±	  sem	  and	  corrected	  on	  cell	  area. 
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4.2.	   Expression	   of	   fascin	   mutants	   does	   not	   alter	   total	   levels	   of	   focal	   adhesion	  
proteins	  
	  
Having	   identified	  changes	   in	  FA	  size	  and	  number	   in	  cells	  expressing	   fascin	  mutants	  
with	   different	   actin	   bundling	   capabilities,	   it	   was	   next	   important	   to	   determine	  
whether	   these	   changes	   were	   due	   to	   altered	   total	   levels	   of	   FA	   components.	  
Therefore,	   levels	  of	  FAK	  and	  vinculin	  were	  analysed	   in	  fascin	  knockdown	  MDA-­‐MB-­‐
231	   (fasKD)	   cells	   rescued	   with	   WT	   and	   mutant	   fascin	   by	   western	   blotting	   as	  
previously	  also	  performed	  in	  Results	  Chapter	  1(3.5).	  
	  
Figure	   4.2a	   shows	   western	   blots	   for	   total	   FAK	   and	   vinculin	   levels	   in	   lysates	   from	  
fasKD	   cells	   re-­‐expressing	   GFP-­‐tagged	   WT	   (resWT),	   S39A,	   S39D,	   S274A,	   or	   S274D	  
fascin.	  GFP-­‐fascin	  levels	  are	  also	  shown	  and	  GAPDH	  was	  used	  as	  loading	  control.	  FAK	  
and	   vinculin	   levels	   were	   quantified	   by	   densitometry	   analysis	   of	   multiple	   western	  
blots,	  together	  with	  GFP-­‐fascin	  levels	  in	  fasKD	  cells	  rescue	  for	  WT	  and	  mutant	  fascin	  
(Figure	  4.2b).	  Data	  showed	  similar	  efficiency	  of	  fascin	  re-­‐expression	  in	  all	  cases.	  No	  
differences	   in	   total	   levels	  of	  FAK	  or	  vinculin	  were	  detected	  between	  mutant	   fascin	  
expressing	  cells.	  Thus,	  expression	  of	  fascin	  mutants	  does	  not	  result	  in	  change	  of	  total	  
level	  of	  these	  FA	  proteins.	  	  
	  
To	   investigate	   whether	   the	   observed	   dependence	   of	   fascin-­‐actin	   bundling	   on	   FA	  
dynamics	   played	   a	   functional	   role	   in	   cell	   adhesion,	   cell-­‐binding	   assays	   were	  
performed	  on	  fibronectin-­‐coated	  coverslips.	  FasKD	  cells	  re-­‐expressing	  WT	  or	  mutant	  
fascin-­‐GFP	  were	  plated	  on	  fibronectin	  and	  cells	  were	  counted	  after	  24	  hours.	  Figure	  
4.2c	   shows	  quantification	  of	   the	  number	  of	   adhered	   cells	   re-­‐expressing	  WT,	   S39A,	  
S39D,	  S274A	  or	  S274D	  fascin.	  S39A	  fascin	  expressing	  cells	  showed	  significantly	  higher	  
adhesion	   to	   fibronectin	   compared	   to	   resWT	   cells	   (p-­‐value	   S39A	   rescue	   cells	  
compared	   to	  WT	   =<	   0.001),	   whereas	   S39D	   fascin	   cells	   showed	   lower	   adhesion	   to	  
fibronectin	   (p-­‐value	   S39D	   rescue	   cells	   compared	   to	   WT	   =<	   0.001).	   Adhesion	   to	  
	  





	   135	  
fibronectin	  in	  S274A	  rescue	  cells	  was	  as	  efficient	  as	  that	  seen	  in	  resWT	  cells	  (p-­‐value	  
S274A	   rescue	   cells	   compared	   to	   WT	   =<	   0.001).	   Conversely,	   S274D	   fascin	   re-­‐
expressing	  cells	  showed	  lower	  adhesion	  compared	  to	  WT	  fascin	  rescue	  cells	  (p-­‐value	  
S274D	   rescue	   cells	   compared	   to	   WT	   =<	   0.001).	   Interestingly,	   S274D	   rescue	   cells	  
showed	  similarly	  sized	  FA	  to	  those	  seen	  in	  S39A	  fascin	  rescue	  cells	  (Figure	  4.1),	  but	  















Figure	  4.2.	  Expression	  of	  fascin	  mutants	  does	  not	  alter	  total	  levels	  of	  focal	  adhesion	  
proteins	  
(a)	  Western	  blots	  of	   lysates	  from	  MDA-­‐MB-­‐231	  fasKD	  cells	  re-­‐expressing	  WT	  or	  mutant	  
fascin-­‐GFP.	   (b)	   Statistical	   analysis	   of	   GFP-­‐fascin	  WT	   and	  mutants,	   total	   Focal	   Adhesion	  
Kinase	  (FAK)	  and	  vinculin	  levels	  was	  performed	  by	  densitometry	  analysis	  of	  at	  least	  three	  
western	   blots.	   Data	   are	   expressed	   as	  mean±	   sem	   and	   corrected	   on	  GAPDH	   loading	   as	  
control.	   (c)	   Count	   of	   cells	   re-­‐expressing	   WT	   or	   mutant	   fascin-­‐GFP	   adhering	   on	  
fibronectin.	  Statistical	  analysis	  was	  performed	  using	  T-­‐Test.	  P-­‐value	  =<	  0.001	   (***)	  was	  
considered	   as	   significant.	   Data	   are	   expressed	   as	   mean±	   sem.	   At	   least	   20	   cells	   were	  
evaluated	  in	  three	  separate	  experiments. 
	  





	   137	  
4.3.	  Fascin-­‐actin	  binding	  promotes	  increased	  cell	  spreading	  
	  
Data	  shown	  in	  Chapter	  1	  showed	  WT	  fascin	  localisation	  at	  the	  cell	  periphery	  in	  small	  
punctate	  structures,	   that	  potentially	   represent	   transient	  sites	   for	   fascin	   to	   regulate	  
MT	   and	   FA	   dynamics.	   As	   data	   in	   Figure	   4.2	   also	   showed	   fascin-­‐actin	   binding	   to	  
regulate	   FA	   stability,	   it	   was	   important	   to	   also	   determine	   localization	   of	   mutant	  
fascin-­‐GFP	  expressed	  in	  fasKD	  cells.	  	  
	  
To	  test	  this,	  WT	  and	  mutant	  fascin-­‐GFP	  constructs	  were	  expressed	  in	  MDA-­‐MB-­‐231	  
fasKD	  cells	  and	  localisation	  analysed	  by	  confocal	  microscopy.	  Example	  representative	  
images	  are	  shown	  in	  Figure	  4.3a.	  Zoom	  of	  cell	  periphery	  area	  is	  shown	  in	  each	  panel	  
to	  show	  fascin	  localisation.	  WT	  fascin-­‐GFP	  (first	  panel)	  localised	  at	  the	  cell	  periphery	  
in	  the	  same	  way	  as	  endogenous	  fascin	  (see	  Figure	  3.3	  in	  Results	  chapter	  1).	  Zoomed	  
area	  in	  resWT	  fascin	  panel	  shows	  fascin	  localisation	  to	  filopodia	  and	  larger	  peripheral	  
structures.	   As	   previously	   reported,	   S39A	   fascin	   (left	   top	   panel	   in	   Figure	   4.3a)	  
localised	   to	   actin-­‐based	   structures	   such	   as	   filopodia	   and	   stress	   fibres,	   without	  
showing	   localisation	   in	   punctuate	   FA	   (zoomed	   area	   in	   left	   top	   panel).	   S39D	   fascin	  
(right	  top	  panel	  in	  Figure	  4.3a)	  was	  localized	  diffusely	  in	  the	  cytoplasm	  and	  not	  seen	  
in	  any	  peripheral	  actin-­‐based	  structures	  (zoomed	  area	  in	  the	  right	  top	  panel).	  S274A	  
fascin	  (left	  bottom	  panel	  in	  Figure	  4.3a)	  localised	  at	  the	  cell	  periphery,	  particularly	  at	  
the	   end	   of	   the	   spikes	   formed	   in	   these	   cells	   (Figure	   4.1	   and	   zoomed	   area	   in	   left	  
bottom	  panel).	  S274D	  fascin	  (right	  bottom	  panel	  in	  Figure	  4.3a)	  also	  localised	  to	  the	  
cell	  periphery	  and	  also	  within	  intracellular	  punctate	  or	  striped	  structures	  (Figures	  4.1	  
and	  4.2c	  and	  zoomed	  area	  in	  right	  bottom	  panel	  in	  4.3a).	  Dynamic	  turnover	  of	  focal	  
adhesions	  is	  required	  to	  drive	  changes	  in	  cell	  spreading.	  Therefore,	  the	  spread	  area	  
was	   analysed	   in	   cells	   expressing	   WT	   or	   mutant	   fascin	   to	   compare	   with	   the	   FA	  
characterization	   data.	   Cells	   were	   stained	   for	   phospho-­‐Tyr	   (p-­‐Tyr)	   as	   before,	   and	  
images	  were	  quantified	  using	  ImageJ	  in	  three	  different	  experiments	  (at	  least	  20	  cells	  
were	  evaluated	  in	  each	  experiment).	  P-­‐Tyr	  was	  used	  as	  a	  marker	  of	  cell	  area	  as	  this	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faithfully	   reported	  on	   cell	   area	   changes	   induced	  by	   nocodazole	   treatment	   (Figures	  
3.7	  and	  3.8,	  Results	  Chapter	  1).	  Figure	  4.3b	  shows	  analysis	  of	  cell	  area	  in	  fasKD	  MDA-­‐
MB-­‐231	  cells	  re-­‐expressing	  GFP-­‐fascinWT	  (black	  bar),	  S39A	  (green	  bar),	  S39D	  (orange	  
bar),	  S274A	  (blue	  bar)	  or	  S274D	  (violet	  bar)	  fascin.	  Cells	  expressing	  S39A	  fascin	  were	  
significantly	  more	  spread	  than	  WT	  fascin	  rescue	  cells	  (p-­‐value	  S39A	  expressing	  cells	  
compared	  to	  WT	  =<	  0.001),	  correlating	  with	  large	  FA	  observed	  in	  these	  cells	  (Figure	  
4.1).	  S39D	  expressing	  cells	  showed	  smaller	  cell	  area	  than	  WT	  fascin	  rescue	  cells.	  Cells	  
expressing	  S274A	  and	  S39D	  fascin	  rescue	  cells	  showed	  a	  similar	  significant	  reduction	  
in	  cell	  area	  when	  compared	  to	  WT	  fascin.	  Conversely,	  S274D	  fascin	  expressing	  cells	  
had	  a	  larger	  cell	  area	  than	  WT	  fascin	  rescue	  cells	  (p-­‐value	  in	  S274D	  expressing	  cells	  
compared	   to	   WT	   =<	   0.001),	   but	   smaller	   than	   S39A	   fascin	   rescue	   cells.	   This	   data	  
suggests	  that	  fascin-­‐actin	  binding	  can	  control	  both	  FA	  size/number	  and	  location	  and	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Figure	  4.3.	  Fascin-­‐actin	  binding	  promotes	  increased	  cell	  spreading	  
(a)	  Confocal	  microscope	   images	  of	  WT	  and	  mutant	   fascin-­‐GFP	   in	  MDA-­‐MB-­‐231	   fascin	  
knockdown	  cells	   re-­‐expressing	  WT	  or	  mutant	   fascin-­‐GFP.	   Scale	  bar=	  10	  um.	   Zoom	  of	  
the	   highlighted	   area	   is	   shown	   in	   each	   panel	   to	   show	   WT	   or	   mutant	   fascin-­‐GFP	  
localisation.	  Scale	  bar	  =	  3	  um.	  (b)	  Quantification	  of	  cell	  size	  in	  fasKD	  cells	  re-­‐expressing	  
WT	  and	  mutant	  fascin.	  Statistical	  analysis	  of	  p-­‐Tyr	  staining	  was	  performed	  in	  ImageJ.	  At	  
least	   20	   cells	   were	   evaluated	   in	   three	   different	   experiments.	   P-­‐value	   =<	   0.001	   (***)	  
was	  considered	  as	  significant.	  Data	  are	  expressed	  as	  mean±	  sem.	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4.4.	  Rescue	  of	   fascin	  knockdown	  cells	  with	  S274D	   fascin	   restores	  microtubule	   re-­‐
growth	  following	  nocodazole	  washout	  
	  
Data	  shown	  in	  Figures	  3.7	  and	  3.8	  in	  Results	  Chapter	  1	  showed	  fascin	  plays	  a	  role	  in	  
control	   of	   MT-­‐dependent	   regulation	   of	   FA	   disassembly.	   After	   characterising	   FA	   in	  
cells	   expressing	   mutant	   fascin	   and	   observing	   S274D	   fascin	   localisation	   at	   the	   cell	  
periphery,	  the	  next	  step	  was	  to	  investigate	  whether	  fascin-­‐actin	  binding	  also	  affected	  
basal	  MT	  integrity	  and	  MT	  recovery	  in	  nocodazole	  treatment	  and	  washout	  assays.	  
	  
To	  test	  this,	   fascin	  knockdown	  MDA-­‐MB-­‐231	  (fasKD)	  cells	  expressing	  WT	  or	  mutant	  
fascin-­‐GFP	   were	   left	   untreated	   or	   treated	   with	   nocodazole	   for	   15	   minutes	   or	  
following	  washout	  of	  the	  drug	  for	  60	  minutes.	  Total	  tubulin	  staining	  was	  performed	  
and	  cells	  were	  scored	  for	  percentage	  of	  normal	  MT	  network	  (MT	  score)	  as	  in	  Results	  
Chapter	  1.	  Figure	  4.4a	  shows	  example	   images	  of	   tubulin	  staining	   in	  untreated	  cells	  
(UT,	   first	   row),	  nocodazole	   treated	  cells	   (NOC,	  second	  row)	  and	  60	  minute	  washed	  
cells	  (60’W,	  third	  row).	  First	  column	  in	  Figure	  4.4a	  shows	  staining	  of	  the	  MT	  network	  
during	   the	   NOC	   assay	   in	   fasKD	   cells	   expressing	   WT	   fascin,	   S39A	   fascin	   (second	  
column),	   S39D	   (third	   column),	   S274A	   fascin	   (fourth	   column)	   or	   S274D	   fascin	   (fifth	  
column).	   No	   obvious	   effects	   were	   seen	   on	   basal	   MT	   polymerization	   or	   network	  
formation	   in	   any	   of	   the	   cells	   expressing	   WT	   or	   mutant	   forms	   of	   fascin.	   All	   cells	  
showed	   polymerised	   MT	   bundles	   with	   clear	   MT	   organising	   centre	   (MTOC).	   As	  
reported	   in	   Chapter	   1,	   NOC	   treatment	   led	   to	   rounded	   cells	   with	   complete	   MT	  
depolymerisation	   in	   all	   the	   cell	   lines	   (second	   row	   in	   Figure	   4.4a).	   As	   observed	   in	  
Figure	  3.7	  in	  Result	  Chapter	  1,	  WT	  fascin	  expressing	  cells	  showed	  a	  fully	  restored	  MT	  
network	   after	   60	   minute	   NOC	   washout,	   showing	   clear	   MT	   bundles	   and	   MTOC	  
localisation	  adjacent	  to	  the	  nucleus	  (first	  panel,	  third	  row	  in	  Figure	  4.4a).	  Conversely,	  
S39A	   and	   S39D	   expressing	   cells	   were	   delayed	   in	   MT	   recovery	   following	   NOC	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washout,	  showing	  depolymerised	  MT	  and	  no	  clear	  MTOC	  (third	  row	  in	  Figure	  4.4a).	  
S274A	  expressing	  cells	  showed	  more	  organized	  MT	  than	  S39	  mutant	  expressing	  cells	  
following	  NOC	  washout,	  but	  not	   to	   levels	   seen	   in	  WT	   fascin	   cells.	  However,	   S274D	  
fascin	   expressing	   cells	   demonstrated	   a	   complete	   MT	   recovery	   post-­‐NOC	   washout	  
with	  normal	  MT	  bundles	  and	  visible	  MTOC	  next	  to	  the	  nucleus,	  similar	  to	  that	  seen	  in	  
WT	  fascin	  cells.	  	  
	  
Cells	   were	   scored	   for	   MT	   recovery	   (as	   in	   Results	   Chapter	   1)	   to	   quantify	   the	  
percentage	   of	   cells	   with	   normal	  MT	   network	   in	   the	   nocodazole	   assay	   time	   points	  
(Figure	  4.4b).	  FasKD	  cells	  were	  rescued	  for	  WT	  fascin	  (black	  bars),	  S39A	  (green	  bars),	  
S39D	   (orange	   bars),	   S274A	   (blue	   bars)	   and	   S274D	   (purple	   bars).	   Over	   80%	   of	  
untreated	   cells	   in	   all	   conditions	   showed	   normal	   MT	   network	   while	   <5%	   had	  
polymerised	  MT	   bundles	   after	   NOC	   treatment.	  WT	   fascin	   expressing	   cells	   showed	  
efficient	  MT	   recovery	  post-­‐NOC	  washout	   to	  ~80%	  of	   that	   seen	   in	  pre-­‐NOC	   treated	  
cells.	   Statistical	   analysis	   on	   both	   S39	   mutants	   confirmed	   a	   delay	   in	   MT	   recovery	  
following	   NOC	   washout	   (MT	   score	   ≈	   50-­‐60%),	   whereas	   both	   S274	   fascin	   mutant	  
rescue	   cells	   showed	  more	   efficient	  MT	   recovery	   after	   drug	  washout	   (Figure	   4.4b).	  
Around	   70%	   of	   S274A	   fascin	   expressing	   cells	   showed	   a	   normal	   MT	   network,	   but	  
more	  than	  80%	  of	  S274D	  fascin	  rescue	  cells	  restored	  their	  MT	  network	  completely.	  
S274D	  fascin	  expressing	  cells	  showed	  an	  efficient	  MT	  recovery	  as	  seen	  in	  WT	  fascin	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Figure	  4.4.	  Rescue	  of	  fascin	  knockdown	  cells	  with	  S274D	  fascin	  restores	  microtubule	  
re-­‐growth	  following	  nocodazole	  washout	  
(a)	  Confocal	  microscope	  images	  of	  cells	  stained	  for	  total	  tubulin	  in	  MDA-­‐MB-­‐231	  fasKD	  
cells	  re-­‐expressing	  WT	  fascin-­‐GFP	  (first	  column),	  S39A-­‐GFP	  (second	  column),	  S39D-­‐GFP	  
(third	   column),	   S274A-­‐GFP	   (fourth	   column)	   and	   S274D-­‐GFP	   (fifth	   column).	   First	   row	  
shows	  untreated	  cells	   (UT),	  centre	  shows	  nocodazole	  treated	  cells	   (NOC)	  and	  bottom	  
shows	  60	  minute	  washed	  cells	  (60’W).	  Scale	  bar=	  20	  um.	  (b)	  Statistical	  analysis	  of	  %	  of	  
cells	   with	   normal	  MT	   network	   (MT	   score)	   in	   same	   conditions	   as	   above.	   P-­‐values	   =<	  
0.001	  (***)	  was	  considered	  as	  significant.	  Data	  are	  expressed	  as	  mean±	  sem.	  At	   least	  
20	  cells	  were	  evaluated	  in	  three	  separate	  experiments.	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4.5.	   Cells	   expressing	   fascin	   S39	   and	   S274	   mutants	   exhibit	   distinct	   responses	   to	  
nocodazole	  
	  
Data	  in	  Figure	  4.4	  demonstrated	  that	  S274D	  was	  the	  only	  mutant	  form	  of	  fascin	  able	  
to	  full	  restore	  the	  MT	  network	  to	  levels	  seen	  in	  WT	  cells	  following	  NOC	  washout.	  In	  
Chapter	   1,	   data	   demonstrated	   that	   fascin	   was	   required	   for	   MT-­‐dependent	   FA	  
disassembly	   following	   NOC	   washout.	   The	   next	   question	   was	   therefore	   whether	  
mutant	   fascin	   also	   regulated	   FA	   size	   or	   number	   following	   NOC	   treatment	   or	  
washout.	  	  
	  
To	  test	  this,	  MDA-­‐MB-­‐231	  fascin	  knockdown	  (fasKD)	  cells	  expressing	  WT	  or	  the	  four	  
mutant	   fascin	  were	   subjected	   to	   the	   nocodazole	   treatment	   and	  washout	   assay	   as	  
described	  in	  paragraph	  4.4.	  Cells	  were	  stained	  for	  phospho-­‐Tyrosine	  (p-­‐Tyr)	  at	  each	  
time	   point.	   Figure	   4.5a	   shows	   example	   images	   of	   p-­‐Tyr	   staining	   in	   untreated	   cells	  
(UT,	   first	   row),	  nocodazole	   treated	  cells	   (NOC,	  second	  row)	  and	  60	  minute	  washed	  
cells	   (60’W,	   third	   row).	   Columns	   1-­‐5	   in	   Figure	   4.5a	   shows	   FA	   during	  NOC	   assay	   in	  
fasKD	   cells	   re-­‐expressing	   WT	   fascin,	   S39A	   fascin,	   S39D	   fascin,	   S274A	   fascin	   and	  
S274D	   fascin	   respectively.	   Basal	   changes	   in	   FA	   assembly	   previously	   reported	   in	  
paragraph	  4.1	  were	  observed	  also	  in	  these	  experiments.	  Figure	  4.4	  showed	  the	  MT	  
network	  was	   completely	   disrupted	   by	   nocodazole	   treatment	   in	   cells	   expressing	   all	  
fascin	  constructs.	  Conversely,	  FA	  responses	  to	  nocodazole	  were	  different	  depending	  
on	  the	  fascin	  mutant	  expressed.	  WT	  fascin	  expressing	  cells	  showed	  an	  increase	  in	  FA	  
assembly	  following	  NOC	  treatment	  (first	  column,	  first	  two	  images	  in	  Figure	  4.5a)	  and	  
a	   similar	   response	  was	   observed	   in	   S39A	   and	   S39D	   fascin	   expressing	   cells	   (second	  
and	  third	  column,	  respectively,	  first	  two	  images	  in	  Figure	  4.5a).	  Interestingly,	  S274A	  
expressing	   cells	   showed	   no	   change	   in	   FA	   size	   compared	   to	   untreated	   cells	   (fourth	  
column,	   first	   two	   images	   in	   Figure	   5.4a).	   Conversely,	   S274D	   fascin	   rescue	   cells	  
showed	   reduced	   FA	   size	   compared	   with	   untreated	   cells	   (fifth	   column,	   first	   two	  
images	  in	  Figure	  4.5a).	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As	   shown	   in	   Figure	   3.8	   in	   Results	   Chapter	   1,	   WT	   fascin	   expression	   promoted	   FA	  
disassembly	  following	  NOC	  washout	  (first	  column	  in	  Figure	  4.5a).	  Similar	  levels	  of	  FA	  
disassembly	  were	  observed	  in	  S39A	  and	  S39D	  fascin	  expressing	  cells	  60	  minute	  after	  
NOC	  washout	   (second	  and	   third	  column,	   respectively,	   in	  Figure	  4.5a).	  S274A	   fascin	  
expressing	   cells	   did	   not	   show	   any	   response	   to	   NOC	   treatment	   in	   terms	   of	   FA	  
assembly,	  but	  these	  cells	  showed	  decreased	  FA	  assembly	  after	  NOC	  washout	  (fourth	  
column	   in	   Figure	   4.5a).	   Conversely,	   the	   S274D	   expressing	   cells	   had	   significantly	  
smaller	  FA	  after	  NOC	  treatment	  and	  instead	  showed	  a	  significant	  increase	  in	  FA	  size	  
after	  NOC	  washout.	  	  	  
	  
Quantification	  of	  p-­‐Tyr	  staining	  in	  fasKD	  cells	  rescued	  for	  WT	  and	  mutant	  fascin	  was	  
performed	   in	   ImageJ.	   The	  percentage	  of	   cell	   area	  occupied	  by	   FA	   (FA	   size)	   and	  FA	  
number	  per	  cell	  in	  fasKD	  expressing	  WT	  fascin	  (black	  bars),	  S39A	  fascin	  (green	  bars),	  
S39D	   (orange	   bars),	   S274A	   fascin	   (blue	   bars)	   and	   S274D	   fascin	   (purple	   bars)	   was	  
calculated	  and	  data	  is	  shown	  in	  Figure	  4.5b,	  c.	  All	  data	  was	  normalised	  to	  control	  for	  
differences	   in	   cell	   area.	   Quantification	   confirmed	   basal	   differences	   in	   FA	   size	   and	  
number	  previously	  shown	  in	  cells	  expressing	  WT	  or	  mutant	  fascin.	  Figure	  4.5b	  shows	  
the	   FA	   assembly/disassembly	   in	   response	   to	   both	   nocodazole	   treatment	   and	   60	  
minute	  washout	  was	  similar	  in	  cells	  expressing	  WT,	  S39A	  and	  S39D	  fascin.	  S39A	  and	  
S39D	   rescue	   NOC	   treated	   cells	   significantly	   increased	   FA	   size	   and	   decreased	   the	  
percentage	  of	  cell	  area	  occupied	  by	  FA	   following	  NOC	  washout.	  This	  data	  confirms	  
that	  the	  phosphorylation	  state	  of	  the	  well-­‐characterised	  fascin-­‐actin	  S39	  binding	  site	  
is	  not	  principally	  involved	  in	  regulating	  FA	  dynamics	  following	  NOC	  washout.	  Analysis	  
of	  percentage	  of	  cell	  occupied	  by	  FA	  confirmed	  S274A	  rescue	  cells	  did	  not	  respond	  to	  
NOC	   treatment	   in	   terms	   of	   FA	   growth.	   274D	   fascin	   expressing	   cells	   demonstrated	  
opposite	   responses	   to	   both	   NOC	   treatment	   and	   washout	   compared	   to	   other	  
mutants.	   Indeed,	   274D	   fascin	   expressing	   cells	   showed	   a	   significant	   decrease	   in	   FA	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size	  compared	  to	  WT	  and	  S39	  mutants	  when	  treated	  with	  NOC	  and	  an	  increased	  FA	  
size	  following	  NOC	  washout.	  
Figure	   4.5c	   shows	   FA	   number	   quantification	   in	   the	   same	   conditions	   as	   described	  
above.	  WT,	  S39A	  and	  S39D	  fascin	  rescue	  cells	  showed	  more	  FA	  than	  untreated	  cells	  
after	  NOC	  treatment,	  although	  the	  effect	  in	  S39A	  rescue	  cells	  was	  not	  as	  dramatic	  as	  
in	   WT	   fascin	   rescue	   cells.	   Moreover,	   WT,	   S39A	   and	   S274A	   fascin	   expressing	   cells	  
showed	  a	  decrease	   in	  FA	  number	  post-­‐NOC	  washout,	   similar	   to	   the	  data	   shown	   in	  
Figure	  4.5b.	  However,	  S39D	  expressing	  cells	  showed	  a	  small	   increase	   in	  FA	  number	  
after	   NOC	   washout,	   and	   S274D	   fascin	   cells	   showed	   a	   significant	   decrease	   in	   FA	  
number	   following	  NOC	  treatment	  and,	  conversely,	   increased	  FA	  number	  after	  drug	  
washout	   again	   confirming	   opposing	   responses	   to	   NOC	   in	   cells	   expressing	   this	  
mutant.	   Taken	   together	   this	   data	   demonstrates	   that	   the	   S274D	   non-­‐actin	   binding	  
fascin	  mutant	  can	  fully	  restore	  the	  MT	  re-­‐growth	  defects	  in	  fasKD	  cells	  following	  NOC	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Figure	  4.5.	  Cells	  expressing	  fascin	  S39	  and	  S274	  mutants	  exhibit	  distinct	  responses	  to	  
nocodazole	  
(a)	   Confocal	   microscope	   images	   of	   phospho-­‐tyrosine	   (p-­‐Tyr)	   staining	   in	   MDA-­‐MB-­‐231	  
fasKD	   cells	   re-­‐expressing	   WT	   or	   mutant	   fascin-­‐GFP.	   Scale	   bar=	   10	   um.	   (b,	   c)	  
Quantification	  of	  %	  of	  cell	  occupied	  by	  FAs	  (b)	  and	  FA	  number	  per	  cell	  (c)	  in	  fasKD	  cells	  
re-­‐expressing	  WT	  and	  mutant	  fascin.	  Statistical	  analysis	  of	  p-­‐Tyr	  staining	  was	  performed	  
in	   ImageJ.	   At	   least	   20	   cells	   were	   evaluated	   in	   three	   different	   experiments.	   P-­‐value	   =<	  
0.05	  (*)	  was	  considered	  as	  significant.	  Data	  are	  expressed	  as	  mean±	  sem	  and	  corrected	  
on	  cell	  area. 
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4.6.	   S274D	   fascin	   is	   localised	   to	   the	   cell	   periphery	   and	   colocalises	   with	   MT	  
following	  nocodazole	  washout	  
	  
Data	  in	  Figure	  4.3	  demonstrated	  that	  WT	  and	  S274D	  fascin	  could	  translocate	  to	  the	  
cell	   periphery	   and	   that	   this	   correlated	   with	   increased	   FA	   disassembly.	   In	   Results	  
Chapter	   1,	   both	   endogenous	   and	  WT	   fascin-­‐GFP	   expressed	   in	   fasKD	   cells	   showed	  
partial	  colocalisation	  with	  MT	  at	  the	  cell	  periphery	  and	  this	  co-­‐localisation	  increased	  
after	   nocodazole	   washout.	   It	   was,	   therefore,	   important	   to	   study	   mutant	   fascin	  
localisation	  with	  respect	  to	  MT	  and	  the	  response	  to	  NOC	  washout	  to	  define	  whether	  
these	  observations	  were	  dependent	  upon	  fascin-­‐actin	  binding.	  
	  
To	  test	  this,	  MDA-­‐MB-­‐231	  fascin	  knockdown	  (fasKD)	  cells	  expressing	  WT	  or	  mutant	  
fascin-­‐GFP	  were	   subjected	   to	   the	   nocodazole	   (NOC)	   treatment	   and	  washout	   assay	  
and	  fascin	  localisation	  with	  MT	  was	  analysed	  before	  and	  after	  NOC	  washout.	  Figure	  
4.6	  first	  row	  shows	  example	  images	  of	  total	  tubulin	  staining	  together	  with	  GFP	  fascin	  
in	  untreated	  WT	  and	  mutant	  fascin	  rescued	  cells.	  As	  observed	  in	  Figure	  4.3,	  WT	  and	  
S274D	   fascin	   localised	   in	   peripheral	   punctuate	   adhesion-­‐like	   structures	   in	   basal	  
conditions.	  Total	  tubulin	  co-­‐staining	  confirmed	  partial	  WT	  fascin	  co-­‐localisation	  with	  
MT	   at	   the	   cell	   periphery	   as	   also	   observed	   in	   Figure	   3.3	   in	   Result	   Chapter	   1	   (first	  
panel,	   first	   row	   in	  Figure	  4.6).	  S39A	  fascin	   localised	   in	   filopodia	   (second	  panel,	   first	  
row	   in	   Figure	   4.6),	   while	   S39D	   fascin	   did	   not	   translocate	   to	   the	   cell	   periphery,	  
remaining	  mainly	  cytosolic	  (third	  panel,	  first	  row	  in	  Figure	  4.6).	  In	  addition,	  neither	  of	  
the	  S39	  mutants	  showed	  colocalisation	  with	  MT	  at	  the	  cell	  periphery.	  S274A	  fascin	  
did	  not	  localise	  in	  FA	  or	  show	  any	  overlap	  with	  MT	  (fourth	  panel,	  first	  row	  in	  Figure	  
4.6).	  Interestingly,	  S274D	  fascin,	  which	  localised	  at	  the	  cell	  periphery	  also	  showed	  co-­‐
localisation	  with	  MT	  bundles	  (fifth	  panel,	  first	  row	  in	  Figure	  4.6).	  	  
	  
Images	  in	  Figure	  4.6	  second	  row	  show	  total	  tubulin	  staining	  in	  fasKD	  cells	  expressing	  
WT	  or	  mutant	  fascin-­‐GFP	  after	  NOC	  treatment	  and	  60	  minute	  washout.	  The	  zoomed	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panel	   of	   the	   highlighted	   area	   is	   shown	   to	   more	   clearly	   demonstrate	   fascin	   co-­‐
localisation	  with	   the	  ends	  of	  MT	  after	  nocodazole	  washout.	  As	  described	   in	   Figure	  
3.9	  in	  Results	  Chapter	  1,	  WT	  fascin	  translocation	  to	  the	  cell	  periphery	  increased	  after	  
NOC	  washout	  (first	  panel,	  second	  row	  in	  Figure	  4.6),	  increasing	  its	  colocalisation	  with	  
the	  ends	  of	  MT	  (zoomed	  area	   in	   the	   first	  panel).	  S39A	  and	  S39D	  fascin	   localisation	  
post-­‐NOC	  was	   less	  peripheral	  than	  WT	  fascin	  (second	  and	  third	  panel,	  respectively,	  
second	  row	  in	  Figure	  4.6)	  and	  these	  mutants	  did	  not	  show	  a	  clear	  colocalisation	  with	  
MT	  (zoomed	  area	   in	  second	  and	  third	  panel).	  S274A	  fascin	  translocation	  to	  the	  cell	  
periphery	  following	  NOC	  washout	  was	  more	  prominent	  than	  in	  S39	  mutant	  rescued	  
cells	   (fourth	  panel,	  second	  row	  in	  Figure	  4.6)	  and	  showed	  some	  colocalisation	  with	  
MT	   ends	   (zoomed	   area	   in	   fourth	   panel).	   However,	   fascin	   translocation	   induced	   by	  
NOC	  washout	  effect	  in	  S274A	  rescue	  cells	  was	  not	  as	  notable	  as	  in	  WT	  fascin	  rescued	  
cells.	   S274D	   fascin	   showed	   strong	   translocation	   to	   the	   cell	   periphery	   after	   NOC	  
washout	  (fifth	  panel,	  second	  row	  in	  Figure	  4.6)	  and	  clear	  colocalisation	  with	  the	  ends	  
of	  MT	   (zoomed	   area	   in	   fifth	   panel).	   Indeed,	   S274D	   fascin	  was	   localised	   at	   the	   cell	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Figure	  4.6.	  S274D	  fascin	  is	  localised	  to	  the	  cell	  periphery	  and	  colocalises	  with	  MT	  
following	  nocodazole	  washout	  
Confocal	  microscope	   images	  of	   fascin	  WT	  and	  mutant-­‐GFP	   in	  MDA-­‐MB-­‐231	   fasKD	  cells	  
re-­‐expressing	   WT	   or	   mutant	   fascin-­‐GFP	   stained	   for	   total	   tubulin.	   First	   line	   shows	  
untreated	   cells	   (UT),	   whereas	   second	   line	   shows	   60	   minute-­‐nocodazole	   washed	   cells	  
(60’W).	   Scale	   bar=	   10	   um.	   Zoom	   of	   the	   highlighted	   area	   is	   shown	   to	   show	   fascin	   co-­‐
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4.7.	  S274D	  fascin	  colocalises	  with	  acetylated	  tubulin	  at	  the	  cell	  periphery	  
	  
In	   Figure	   3.4	   in	   Result	   Chapter	   1,	   data	   demonstrated	   that	   fascin	   knockdown	   cells	  
showed	   higher	   acetylated	   tubulin	   levels	   compared	   to	   fascin	   expressing	   cells.	   This	  
suggests	   a	   fascin-­‐dependent	   regulation	   of	   MT	   stability.	   I	   therefore	   analysed	  
acetylated	   tubulin	   staining	   in	   WT	   and	   mutant	   fascin	   rescue	   cells	   to	   determine	  
whether	   MT	   stability	   correlates	   with	   the	   different	   roles	   of	   fascin	   mutants	   in	  
regulating	  FA	  dynamics.	  
	  
Figure	   4.7	   show	   example	   images	   of	   acetylated	   tubulin	   staining	   in	   MDA-­‐MB-­‐231	  
fascin	   knockdown	   (fasKD)	   cells	   rescued	   for	  WT	   and	  mutant	   fascin-­‐GFP	   expression.	  
First	  column	  in	  Figure	  4.7	  shows	  merge	  images	  of	  cells	  re-­‐expressing	  WT	  and	  mutant	  
fascin-­‐GFP	  (green)	  stained	  for	  acetylated	  tubulin	  (red),	  respectively,	  whereas	  second	  
column	  show	  acetylated	  tubulin	  staining	  alone.	  	  
Figure	  4.7	  shows	  acetylated	  tubulin	  staining	  in	  fasKD	  cells	  rescue	  for	  WT	  and	  mutant	  
fascin-­‐GFP.	   S39A	   fascin	   expressing	   cells	   (second	   row	   images	   in	   Figure	   4.7)	   showed	  
similar	  acetylated	  tubulin	  levels	  as	  in	  WT	  fascin	  expressing	  cells	  (first	  row	  images	  in	  
Figure	   4.7).	   Cells	   showed	   a	   clear	   MT	   organising	   centre	   (MTOC)	   with	   stable	   MT	  
bundles.	  However,	   S39D	   fascin	   and	   S274A	   fascin	   expressing	   cells	   (third	   and	   fourth	  
row	  respectively	  in	  Figure	  4.7)	  showed	  lower	  acetylated	  tubulin	  levels	  compared	  to	  
WT.	  Interestingly,	  S274D	  fascin	  expressing	  cells	  (fifth	  row	  Figure	  4.7)	  showed	  similar	  
acetylated	   tubulin	   staining	   to	   that	   seen	   in	   WT	   and	   S39A	   cells,	   with	   clear	   MTOC	  
localisation	  and	  acetylated	  MT	  bundles.	   S274D	   fascin,	   but	  not	   S39A	   fascin	   showed	  
partial	  colocalisation	  with	  acetylated	  MT	  bundles.	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Figure	  4.7.	  S274D	  fascin	  colocalises	  with	  acetylated	  tubulin	  at	  the	  cell	  periphery	  
Confocal	   microscope	   images	   of	   acetylated	   tubulin	   staining	   in	   MDA-­‐MB-­‐231	   fasKD	   re-­‐
expressing	  WT	   and	  mutant	   fascin-­‐GFP.	   First	   column	   shows	   cells	   re-­‐expressing	  WT	   and	  
mutant	   fascin-­‐GFP	   stained	   for	   acetylated	   tubulin,	   whereas	   second	   column	   shows	  
acetylated	  tubulin	  staining	  alone.	  Scale	  bar=	  10	  um.	  
	  





	   154	  
DISCUSSION	  
	  
Data	  presented	  in	  this	  chapter	  suggested	  a	  potential	  mechanism	  by	  which	  fascin	  co-­‐
operate	  with	  MT	  to	  regulate	  FA	  disassembly.	  The	  molecular	  mechanisms	  driving	  FA	  
assembly	   have	   been	   well	   characterised	   and	   they	   are	   known	   to	   be	   dependent	   on	  
integrin	  engagement	  and	  Rho	  family	  GTPases	  (Small	  et	  al.	  2002).	  On	  the	  other	  hand,	  
mechanisms	  regulating	  FA	  disassembly	  are	  still	  poorly	  understood.	  However,	   it	  has	  
been	   reported	   that	   FA	   disassembly	   is	   not	   simply	   a	   passive	   response	   to	   losing	   FA	  
maturation	   or	   stability	   signals	   (Ezratty	   et	   al.	   2005).	   Rather	   data	   has	   demonstrated	  
that	   FA	  disassembly	   is	   an	   active	  process	   involving	   crosstalk	   between	  MT,	   dynamin	  
and	   Focal	   Adhesion	   Kinase	   (FAK).	   The	   suggested	   mechanism	   proposes	   FAK-­‐
dependent	   recruitment	   of	   dynamin	   at	   FA	   and	   this	   in	   turn	   promotes	   dynamin	   co-­‐
operation	  with	  MT	  in	  inducing	  FA	  disassembly	  (Ezratty	  et	  al.	  2005).	  FAK	  accumulation	  
at	   FA	   has	   been	   previously	   suggested	   to	   be	   involved	   in	   the	   release	   or	   delivery	   of	  
‘relaxing	  factors’	  which	  may	  drive	  FA	  disassembly	  (Tomar	  &	  Schlaepfer	  2009).	  
	  
The	  regulation	  and	  function	  of	  the	  actin-­‐binding	  site	  within	  the	  C	  terminus	  of	  fascin	  
is	  not	  fully	  understood,	  although	  mutation	  of	  residues	  within	  this	  domain	  has	  been	  
suggested	   to	   reveal	   functions	   for	   fascin	   that	   are	   independent	   of	   actin	   binding	  
(Jansen	  et	  al.,	  2011;	  Zanet	  et	  al.,	  2012).	  Data	  shown	  here	  demonstrates	  that	  S274A	  
fascin	  expressing	  cells	  assemble	  peripheral	  actin	  spikes	  with	  large	  FA	  situated	  at	  the	  
base	  of	  these	  protrusions.	  The	  phenotype	  observed	  in	  these	  cells	  was	  specific	  to	  this	  
mutant	  and	  offers	  a	  potential	  explanation	   for	   the	   larger	  FA	  size	  and	  the	  decreased	  
cell	  area	  observed	   in	   these	  cells	   (Figures	  4.1	  and	  4.3).	  Unexpectedly,	  S274A	  rescue	  
cells	  showed	  normal	  adhesion	  to	  fibronectin	  without	  fascin	  localisation	  to	  punctate	  
adhesion-­‐like	   structures	   at	   the	   cell	   periphery.	   We	   have	   previously	   shown	   S274A	  
fascin	  localises	  in	  the	  distal	  end	  of	  actin-­‐rich	  filopodia,	  promoting	  their	  stability.	  This	  
suggests	   this	   mutant	   may	   play	   a	   non-­‐actin	   binding	   dependent	   role	   or	   associating	  
with	   filopodial	   tip	   complex	   proteins	   via	   an	   yet	   unknown	  mechanism	   (Zanet	   et	   al.	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2012).	  This	  might	  also	  go	  some	  way	  to	  explaining	  the	  changes	  to	  FA	  size	  and	  number	  
seen	  in	  these	  cells.	  	  
	  
S274D	  fascin	  expressing	  cells	  showed	  the	  same	  size	  and	  number	  of	  FA	  as	  S39A	  fascin	  
cells.	  Surprisingly,	  despite	  not	  being	  able	  to	  efficiently	  bundle	  actin,	  274D	  fascin	  was	  
also	   found	   to	   localise	   at	   the	   cell	   periphery	   as	   seen	   for	  WT	   fascin,	   suggesting	   this	  
localization	  may	  contribute	  to	  the	  decreased	  FA	  disassembly	  seen	  in	  cells	  expressing	  
this	  mutant.	  In	  addition,	  S274D	  expressing	  cells	  showed	  lower	  adhesion	  and	  smaller	  
cell	   area	   compared	   to	   S39A	   expressing	   cells.	   These	   observations	   suggest	   that	   the	  
large	   FA	   in	   S274D	   fascin	   expressing	   cells	  may	   potentially	   support	   faster	   spreading	  
through	   control	   of	   cell	   membrane	   contact	   area	   with	   the	   substrate.	   Moreover,	   It	  
suggests	   that	   peripherally	   localized	   S274D	   fascin	  may	   have	   a	   role	   in	   regulating	   FA	  
disassembly,	  in	  an	  actin-­‐binding	  independent	  manner.	  
	  
MT	   are	   known	   to	   regulate	   FA	   disassembly	   in	   the	   nocodazole	   washout	   assay	  
employed	  here	  (Ezratty	  et	  al.	  2005)	  and	  in	  Chapter	  1,	  data	  showed	  that	  fascin	  plays	  a	  
role	  in	  regulating	  MT	  re-­‐growth	  and	  FA	  disassembly	  following	  NOC	  washout.	  In	  this	  
chapter,	   the	  data	  additionally	   shows	   that	  S274D	   fascin	  prevents	  MT-­‐dependent	  FA	  
disassembly	  after	  NOC	  washout.	  However,	   S274D	   fascin	  expressing	   cells	   recovered	  
their	  MT	  as	   efficiently	   as	   cells	   rescued	  with	  WT	   fascin.	  All	   the	  other	   three	  mutant	  
cells	   were	   delayed	   in	   MT	   reassembly	   following	   drug	   washout.	   Furthermore,	   only	  
S274D	  fascin	   localised	  at	  ends	  of	  MT	  at	   the	  cell	  periphery,	  suggesting	  S274D	  fascin	  
may	  control	  MT	  stability	  or	  turnover	  at	  these	  sites	  to	  regulate	  FA	  disassembly.	  S274D	  
fascin	  expression	  in	  cells	  also	  led	  to	  increased	  tubulin	  acetylation	  compared	  to	  WT.	  
Figure	  4.7	   showed	  only	   S274D	   fascin	   to	   localise	  with	   acetylated	   tubulin	   at	   the	   cell	  
periphery.	   The	   co-­‐operation	   between	   S274D	   fascin	   and	   tips	   of	   MT	   at	   the	   cell	  
periphery	   may,	   therefore,	   stabilise	   MT	   preventing	   them	   from	   inducing	   FA	  
disassembly.	  Therefore	  the	  putative	  MT-­‐associated	  S274D	  fascin	  does	  not	  promote	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FA	  disassembly,	   but	   instead	  may	   act	   to	   decrease	  MT	  dynamic	   instability	   post-­‐NOC	  
washout	  and	  enhance	  MT	  re-­‐growth.	  	  
	  
S39A	  and	  S39D	  fascin	  expressing	  cells	  did	  not	  show	  any	  significant	  difference	   in	  FA	  
disassembly	  after	  nocodazole	  washout,	  compared	  to	  fascin	  KD	  cells	  rescued	  with	  WT	  
fascin,	   or	   control/parental	   cells.	   This	   suggests	   that	   the	  N-­‐terminal,	   S39-­‐dependent	  
actin	  binding	  site	  of	  fascin	  is	  not	  directly	  involved	  in	  MT-­‐dependent	  FA	  disassembly.	  
However,	   interestingly	   the	  S39A	  cells	  had	   larger	  FA	  and	   increased	  adhesion	  vs.	   the	  
opposite	  phenotype	  in	  S39D	  cells	  under	  basal	  conditions.	  MT-­‐dependent	  FA	  turnover	  
might	  not	   require	   the	  N-­‐terminal	  actin-­‐binding	  site	  as	  FA	  after	  NOC	  treatment	  and	  
washout	   are	   particularly	   unstable	   and	   artificially	   forced	   to	   turnover	   in	   an	   MT-­‐
dependent	  manner.	  The	  delayed	  MT	  re-­‐growth	  in	  cells	  expressing	  both	  S39	  mutants	  
cells	  confirms	  this	  site	  of	   fascin	   is	  not	  principally	   involved	   in	  driving	  consequent	  FA	  
disassembly.	  Indeed,	  only	  the	  S274D	  mutant	  fascin	  fully	  restored	  MT	  re-­‐growth,	  but	  
this	   potential	   co-­‐operation	   with	   MT	   is	   not	   sufficient	   to	   promote	   FA	   disassembly.	  
Indeed,	  I	  observed	  that	  S274D	  fascin	  localisation	  at	  the	  cell	  periphery	  and	  its	  efficient	  
MT	  recovery	  did	  not	  permit	  FA	  disassembly	  following	  NOC	  washout.	  This	  leads	  to	  a	  
possible	  model	  whereby	  fascin	  has	  a	  dual	  role	  regulated	  by	  phosphorylation	  cycles	  at	  
these	  two	  sites	  on	  fascin	  to	  efficiently	  regulate	  MT	  re-­‐growth	  and	  FA	  disassembly.	  It	  
is	  not	  yet	  known	  how,	  or	  if,	  mutation	  of	  S274	  impacts	  on	  the	  phosphorylation	  status	  
of	  S39,	  but	  this	  data	  would	  strongly	  suggest	  that	  S274	  plays	  the	  key	  role	  in	  mediating	  
MT	  dynamic	   instability	   and	   targeting	   to	   FA,	   but	   another	  mechanism	   is	   required	   to	  
drive	  the	  subsequent	  FA	  disassembly.	  	  
	  
Data	   shown	   in	   this	   chapter	   also	   shows	   that	   fascin-­‐actin-­‐binding	   is	   not	   directly	  
involved	  in	  the	  mechanism	  by	  which	  fascin	  controls	  FA	  disassembly	  in	  the	  NOC	  assay,	  
but	   both	   S39	  mutant	   forms	   of	   fascin	   are	   able	   to	   drive	   FA	   assembly.	   It	   is	   possible	  
therefore	   that	   S274	   controls	   MT	   and	   the	   consequent	   S39	   site	   dependent	   FA	  
disassembly	  in	  this	  context.	  We	  have	  no	  data	  concerning	  the	  phosphorylation	  status	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of	   Ser39	   when	   Ser274	   is	   phosphorylated	   (and	   potentially	   MT-­‐associated),	   but	  
considering	  basal	  differences	  in	  FA	  size/number	  in	  S39D	  and	  S274D	  fascin	  expressing	  
cells,	  we	   speculate	   that	   S39	   is	   likely	   to	   be	  de-­‐phosphorylated	   (and	   therefore	   actin	  
bound)	  when	   fascin	   drives	  MT	   re-­‐assembly.	  Moreover,	   non-­‐phosphorylated	   fascin,	  
bound	  to	  actin	  at	  the	  cell	  periphery,	  could	  readily	  be	  switched	  by	  phosphorylation	  of	  
S274.	  Preliminary	  data	   in	   the	   lab,	   along	  with	   in	   silico	   analysis	  of	   the	  S274	   site	   and	  
mass	  spec	  phospho-­‐mapping	  strongly	  suggests	  that	  this	  site	  may	  be	  a	  substrate	  for	  
protein	  kinase	  A	  (PKA).	  PKA	  is	  known	  to	  act	  primarily	  at	  the	  membrane	  and	  has	  been	  
previously	   shown	   to	  be	   localized	   to	  new	  sites	  of	  actin	  protrusion	   in	  migrating	  cells	  
(Bachmann	  et	   al.	   2013).	   This	   phosphorylation	   switch	  might	   promote	   S274D	   fascin-­‐
MT	   co-­‐operation	   and	   reduce	   actin	   binding	   which	   subsequently	   necessary	   for	   FA	  
disassembly	   in	   S274D	   fascin	   expressing	   cells.	   Although	   all	   this	   has	   to	   be	   further	  
investigated,	  locking	  S274	  fascin	  in	  a	  constitutive	  phosphorylated	  state	  and	  S39	  in	  a	  
dephosphorylated	   state	   could	   potentially	   drive	   efficient	   MT	   re-­‐growth	   and	   FA	  
disassembly	  in	  NOC-­‐induced	  cytoskeleton	  dynamics.	  
	  
Phosphorylation	   cycles	   on	   the	   two	   serines	   of	   fascin	   studied	   in	   this	   thesis	   may	  
therefore	   be	   critical	   in	   driving	   fascin-­‐dependent	  MT	   and	   FA	   dynamics.	   Our	  model	  
proposes	   the	   phosphorylation	   on	   the	   two	   sites	   to	   be	   regulated	   by	   two	   different	  
signalling	   cascades.	   The	   potential	   involvement	   of	   both	   PKC	   and	   PKA	   in	   fascin	  
phosphorylation	  may	  explain	  the	  dual	  role	  of	   fascin	   in	  driving	  MT	  assembly	  and	  FA	  
disassembly.	   Although	   PKA	   phosphorylation	   of	   S274	   requires	   further	   analysis,	   its	  
reciprocal	  regulation	  with	  Rac	  signaling	  (Bachmann	  et	  al.	  2013)	  and	  association	  with	  
actin-­‐MT	  cross-­‐linkers	  (Lee	  et	  al.	  2012)	  suggest	  a	  key	  role	  for	  this	  kinase	  in	  regulating	  
the	  actin-­‐MT	  crosstalk.	  Other	  examples	  of	  proteins	   target	  of	  different	  kinases	  exist	  
among	   molecules	   involved	   in	   the	   actin-­‐MT	   crosstalk	   (Rodriguez	   et	   al.	   2003).	   It	   is	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In	   conclusion,	   this	   chapter	  proposes	   fascin	  phosphorylation	  at	   two	  different	   serine	  
residues	   acts	   to	   regulate	   MT	   stability	   and	   FA	   assembly/disassembly	   cycles	   under	  
both	  basal	  conditions	  and	  those	  where	  FA	  dynamics	  are	   induced	  by	  NOC.	  The	  next	  
chapter	  will	   focus	  on	  determining	  whether	   fascin	   can	   control	   this	   process	   through	  
direct	   interaction	   with	   tubulin/MT	   and/or	   other	   known	   molecular	   players	   in	   the	  















5 The	  mechanism	  of	  fascin-­‐dependent	  
control	  of	  actin-­‐MT	  crosstalk.	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INTRODUCTION	  
	  
The	  crosstalk	  between	  actin	  and	  MT	  is	  known	  to	  be	  central	  in	  a	  number	  of	  processes	  
such	  as	  neuronal	  cone	  development	  (Zhou	  et	  al.	  2002)	  and	  metastasis	  dissemination	  
in	  cancer	  progression	  (Hall	  2009).	  A	  handful	  of	  molecules	  have	  been	  demonstrated	  
to	  directly	  interact	  with	  actin	  and	  MT	  in	  these	  processes	  (Efimov	  &	  Kaverina	  2009);	  
however,	   the	   way	   in	   which	   these	   pathways	   integrate	   is	   still	   poorly	   understood	  
(Morrison	   2007).	   This	   chapter	   will	   analyse	   a	   potential	   role	   for	   fascin	   as	   a	   linking	  
molecule	  between	  actin	  and	  MT.	  
	  
Data	  shown	  in	  Chapter	  4	  showed	  a	  role	  for	  S274D	  fascin	  in	  promoting	  MT	  stability.	  
Moreover,	   a	   dual	   role	   for	   fascin	   in	   regulating	   FA	   assembly	   and	  MT-­‐dependent	   FA	  
disassembly	  was	  proposed	  based	  on	   the	   lack	  of	   FA	  disassembly	   in	   the	   S274D	   cells	  
following	   NOC	   washout.	   This	   chapter	   will	   analyse	   whether	   fascin	   can	   associate	  
directly	  with	  tubulin	  to	  try	  and	  explain	  this	  role	  in	  regulating	  MT	  stability.	  	  
It	   is	   well	   established	   that	   FAK	   mediates	   FA	   formation	   through	   tyrosine	  
phosphorylation	  during	  cell	  adhesion	  (Hamadi	  et	  al.	  2005)	  and	  FAK	  phosphorylation	  
on	   Tyrosine	   397	   (p-­‐FAK)	   is	   widely	   known	   to	   promote	   the	   formation	   of	   a	   FAK-­‐Src	  
complex	  and	  increase	  FA	  turnover	  (Tomar	  &	  Schlaepfer	  2009).	  The	  way	  in	  which	  MT	  
co-­‐operate	   with	   FAK	   to	   promote	   the	   full	   assembly/disassembly	   cycle	   remains	  
unclear.	  Moreover,	   the	   role	   of	   actin	   binding	   proteins	   in	   this	   phenomenon	  has	   not	  
been	  explored	  previously.	  
	  
Experiments	  in	  this	  chapter	  aim	  to	  analyse	  whether	  fascin	  can	  bind	  directly	  to	  MT	  as	  
a	  mechanism	  driving	  MT	  stability.	  Moreover,	  experiments	  will	  aim	  to	  further	  test	  the	  
hypothesis	  that	  fascin	  acts	  as	  a	  novel	  switch	  mechanism	  regulating	  F-­‐actin	  and	  MT	  in	  
the	  context	  of	  FAK-­‐regulated	  FA	  dynamics.	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5.1.	  In	  vitro	  analysis	  of	  F-­‐actin	  bundling	  by	  fascin	  mutants	  
	  
Fascin-­‐actin	  binding	  and	  bundling	  activity	  is	  crucial	  in	  the	  formation	  of	  parallel	  actin	  
bundles.	   Published	   data	   showed	   that	  WT	   and	   S39A	   fascin	   can	   efficiently	   bind	   and	  
bundle	  actin,	  while	  S39D	  fascin	  can	  not	  bind	  or	  bundle	  actin	  (Anilkumar	  et	  al.	  2003;	  
Hashimoto	   et	   al.	   2007).	  Moreover,	   it	   has	   been	   shown	   that	   S274A	   fascin	   is	   able	   to	  
bundle	  actin	  without	  showing	  binding	  activity,	  while	  S274D	  fascin	  does	  not	  bind	  or	  
bundle	   actin	   (Zanet	   et	   al.	   2012).	   To	   confirm	   this	   data,	   fluorescence	   in	   vitro	   actin-­‐
binding	   assays	   were	   performed	   using	   purified	   His6-­‐tagged	   fascin	   mutant	   proteins.	  
This	   assay	  was	  performed	  as	   in	   (Zanet	  et	   al.	   2012)	  with	  an	  additional	   step;	   F-­‐actin	  
was	  stabilised	  with	  488-­‐phalloidin	  before	  incubation	  with	  purified	  fascin	  mutants	  in	  
order	   to	   analyse	   bundle	   formation	   by	   confocal	   microscopy	   (see	   Material	   and	  
Methods	  and	  also	  (Miller	  2004).	  
	  
Figure	  5.1	  shows	  example	  images	  of	  the	  formation	  of	  F-­‐actin	  bundles	  in	  the	  presence	  
of	  F-­‐actin	  alone	  stabilized	  with	  488-­‐phalloidin	  (left	  panel,	  top	  row)	  or	  incubated	  with	  
WT	   (centre	   panel,	   top	   row),	   S39A	   (right	   panel,	   top	   row),	   S39D	   (left	   panel,	   bottom	  
row),	  S274A	  (centre	  panel,	  top	  row)	  and	  S274D	  (right	  panel,	  bottom	  row)	  fascin.	  As	  
expected,	  F-­‐actin	  did	  not	  bundle	  on	  its	  own	  (left	  panel,	  top	  row),	  but	  was	  efficiently	  
bundled	  in	  the	  presence	  of	  WT	  fascin	  binding	  (centre	  panel,	  top	  row).	  Incubation	  of	  
F-­‐actin	  with	  S39A	  fascin	  showed	  a	  striking	  effect	  on	  actin	  bundling	  (right	  panel,	  top	  
row),	  while	   S39D	   fascin	   incubation	   showed	  no	   visible	   bundled	   F-­‐actin	   (right	   panel,	  
bottom	   row).	   Interestingly,	   the	   incubation	   of	   F-­‐actin	  with	   S274A	   fascin	   resulted	   in	  
shorter	  F-­‐actin	  filaments	  than	  in	  presence	  of	  WT	  fascin	  (centre	  panel,	  bottom	  row).	  
S274A	   fascin	   is	   known	   to	   not	   bind	   to	   actin;	   therefore,	   this	   data	   supports	   previous	  
evidence	   of	   S274A	   actin	   binding	   activity	   (Zanet	   et	   al,	   2012).	   Furthermore,	   S274D	  
fascin,	  which	   is	   also	   known	   to	   not	   bind	   to	   actin,	   did	   not	   show	   any	   F-­‐actin	   bundle	  
formation	  as	  seen	  for	  F-­‐actin	  alone	  or	  S39D	  fascin	  (right	  panel,	  bottom	  row).	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This	  data	  confirmed	  the	  role	  of	  S39	  and	  S274	  fascin	   in	  bundling	  actin	  and	  validates	  










Figure	  5.1.	  In	  vitro	  analysis	  of	  F-­‐actin	  bundling	  by	  fascin	  mutants	  
Confocal	  microscope	   images	   of	  WT	   and	  mutant	   fascin	   co-­‐incubated	  with	   F-­‐actin.	  
Actin	  was	   polymerised	   in	   vitro	   and	   stabilised	  with	   488-­‐phallodin	   (first	   panel)	   and	  
then	   incubated	   with	   WT	   fascin	   (second	   panel),	   S39A	   fascin	   (third	   panel),	   S39D	  
fascin	  (fourth	  panel),	  S274A	  fascin	  (fifth	  panel)	  or	  S274D	  fascin	  (sixth	  panel).	  Scale	  
bar=	  3	  um. 
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5.2.	  Establishing	  and	  characterising	  in	  vitro	  microtubule	  binding	  assay	  
	  
Chapter	  2	  showed	  a	  preferential	  role	  of	  S274D	  fascin	  in	  promoting	  MT	  stability	  and	  
in	  MT-­‐dependent	   FA	   disassembly.	   This	   raised	   an	   interesting	   possibility	   that	   fascin	  
could	  directly	  bind	  to	  MT.	  	  
	  
To	   test	   the	  direct	  binding	  of	   fascin	   to	  MT,	   an	   in	   vitro	   tubulin	  polymerisation	  assay	  
was	  established	  and	  characterised	  in	  the	  lab	  (Figure	  5.2).	  This	  assay	  was	  taken	  form	  
(Béraud-­‐Dufour	  et	  al.	  2007)	  and	  steps	  were	  carefully	  explained	   in	  the	  Material	  and	  
Methods	  Chapter.	  Briefly,	  bovine	  brain	  purified	  tubulin	  was	  polymerised	  at	  37	  °C	  in	  
the	   presence	   of	   salts,	   GTP	   and	   glycerol,	   followed	   by	   stabilisation	   with	   increasing	  
concentration	  of	  taxol	  (to	  stabilize	  the	  MT).	  At	  this	  step,	  the	  turbidity	  of	  the	  reaction	  
was	  measured	  as	  index	  of	  the	  tubulin	  polymerisation.	  Figure	  5.2a	  shows	  the	  turbidity	  
measurement	  before	  polymerisation	   reaction	   (t0)	   and	  after	   stabilisation	  with	   taxol	  
(tf)	  and	  is	  representative	  of	  at	  least	  three	  different	  polymerisation	  reactions.	  Figure	  
5.2a	   shows	   almost	   100%	   tubulin	   polymerisation.	   Before	   using	   the	   in	   vitro	  
polymerised	  tubulin	  in	  the	  co-­‐sedimentation	  assay,	  the	  structure	  of	  the	  polymerised	  
MT	  was	  analysed	  using	  electron	  microscopy.	  Figure	  5.2b	  shows	  an	  example	  image	  of	  
an	   in	  vitro	  polymerised	  MT.	  MT	  are	  polymerised	  with	  a	  reported	  outer	  diameter	  of	  
25	   nm	   and	   lateral	   side	   of	   6-­‐7	   protofilaments,	   formed	   by	   the	   αβ	   tubulin	   dimer	  
polymerisation.	  MT	   are	   typically	   formed	   by	   13-­‐14	   protofilaments,	   which	   gives	   the	  
striated	  feature	  shown	   in	  Figure	  5.2b.	  This	  data	  confirms	  that	  establishment	  of	  the	  




























Figure	  5.2.	  Establishing	  and	  characterising	  in	  vitro	  microtubule	  binding	  assays	  
(a)	   Turbidity	  measurement	  before	   (t0)	   and	  after	   (tf)	  bovine	  brain	  purified	   tubulin	  
polymerisation	   and	   stabilisation	  with	   taxol.	   (b)	   Electron	  microscopy	   image	   of	   the	  
microtubules	  polymerised	  in	  vitro.	  Scale	  bar=	  12	  nm. 
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5.3.	  Fascin	  associates	  with	  microtubules	  in	  vitro	  
	  
Having	   characterised	   the	   tubulin	   polymerisation	   assay,	   the	   next	   aim	   was	   to	  
investigate	   whether	   fascin	   directly	   binds	   to	   MT.	   To	   test	   this,	   a	   co-­‐sedimentation	  
assay	  was	  performed	   in	  vitro	  to	   incubate	  the	  polymerised	  MT	  with	  WT	  and	  mutant	  
forms	  of	  purified	  fascin.	  
	  
Polymerised	  MT	   corresponding	   to	   approximately	   1	  µmol	   of	   tubulin	  was	   incubated	  
with	  WT	  or	  mutant	  fascin	  as	  described	  in	  Material	  and	  Methods.	  A	  1:1	  ratio	  was	  kept	  
between	   MT	   and	   fascin	   throughout	   the	   experiments.	   The	   reaction	   mixture	   was	  
centrifuged	  and	   the	  percentage	  of	   fascin	   co-­‐sedimented	  with	  polymerised	  MT	  was	  
determined	   by	   analysing	   samples	   by	   SDSPAGE,	   silver	   staining	   and	   densitometry	  
analysis	  (Figure	  5.3).	  Examples	  of	  silver-­‐stained	  gels	  showing	  levels	  of	  fascin	  and/or	  
MT	   in	   the	   respective	   fractions	   are	   shown	   in	   Figure	   5.3a-­‐d.	   Firstly,	   control	  
experiments	   were	   performed	   with	   fascin	   alone	   to	   ensure	   the	   protein	   was	   not	  
sedimented	   in	   the	   absence	   of	   MT.	   As	   shown	   in	   Figure	   5.3a,	   none	   of	   the	   fascin	  
proteins	  showed	  sedimentation	  on	  their	  own	  as	  no	  fascin	  was	  present	  in	  the	  pellet.	  
The	   next	   step	   was	   to	   study	   ratio	   of	   MT	   alone	   and	   taxol-­‐stabilised	   MT	   in	   the	  
supernatant	   vs.	   pellet	   (s/p	   ratio).	   Figure	   5.3b	   shows	   around	   50%	   of	   the	   MT	   co-­‐
sedimented	   in	   the	   pellet	   fraction	  without	   taxol.	   Taxol	   addition	   resulted	   in	   a	   large	  
increase	   in	  MT	   co-­‐sedimentation,	  with	   almost	   100%	  of	   the	  MT	   found	   in	   the	  pellet	  
confirming	  in	  vitro	  MT	  stability	  to	  be	  dependent	  on	  taxol.	  Fascin	  and	  MT	  were	  then	  
co-­‐incubated	   and	   the	   experiment	   was	   repeated.	   Figure	   5.3c	   shows	   a	   very	   small	  
amount	  of	  WT	   fascin	  was	   co-­‐sedimented	  with	  MT	   in	   vitro	   in	   the	   absence	  of	   taxol,	  
suggesting	  WT	  fascin	  can	  directly	  bind	  to	  MT.	  Taxol	  was	  then	  added	  to	  the	  reaction	  
mixture	   to	   promote	  maximal	  MT	   polymerisation.	   Figure	   5.3d	   shows	   levels	   of	  WT,	  
S39A,	  S39D,	  S274A	  and	  S274D	   fascin	   in	   the	  supernatant	  and	  pellet	   fractions	   in	   the	  
presence	  of	  MT	  and	  taxol.	  WT	  fascin	  pellet	  increased	  by	  adding	  taxol	  (Figures	  5.3c,d),	  
suggesting	   the	   levels	   of	   fascin	   in	   the	   pellet	   was	   also	   dependent	   on	   MT	   stability.	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Surprisingly,	   all	   fascin	   mutant	   proteins	   were	   found	   to	   varying	   degrees	   within	   the	  
pellets	  containing	  taxol-­‐stabilised	  MT.	  
	  
Figure	  5.3e	   shows	   statistical	   analysis	  of	   the	  percentage	  of	   the	   fascin	   in	  pellet	  with	  
MTs	  performed	  by	  densitometry	  analysis	  of	  >4	  silver-­‐stained	  gels.	  Statistical	  analysis	  
confirmed	  WT	  and	  mutant	  fascin	  co-­‐sediment	  with	  MT	  but	  with	  differing	  efficiencies.	  
WT	  fascin,	  S39A,	  S39D	  and	  S274A	  fascin	  all	  showed	  ~10%	  of	  the	  protein	  associating	  
with	  MT.	  Interestingly,	  however,	  S274D	  fascin	  showed	  25%	  of	  pelleted	  protein	  with	  
MT	  -­‐	  almost	  3-­‐times	  higher	  than	  WT	  and	  the	  other	  three	  mutants	  (P-­‐value	  of	  S274D	  
fascin	   co-­‐sedimented	  with	  MT	   compared	   to	  WT:	  p-­‐value	  =<	  0.05).	   Taken	   together,	  
this	  data	  shows	  that	  fascin	  associates	  with	  MT	  in	  vitro	  with	  a	  preferential	  association	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Figure	  5.3.	  Fascin	  associates	  with	  microtubules	  in	  vitro	  
(a)	  Silver-­‐stained	  gel	  of	  supernatant-­‐pellet	  partitioning	  for	  WT	  and	  mutant	  fascin	  incubated	  
on	  their	  own.	  Supernatant	  (s)	  and	  pellet	   (p)	  show	  the	  soluble	  and	  the	   insoluble	  fraction	  of	  
the	   protein,	   respectively.	   (b)	   Silver-­‐stained	   gel	   of	   supernatant-­‐pellet	   partitioning	   for	  
microtubules	   (MTs)	   on	   their	   own,	  with	   and	  without	   taxol	   (TAX).	  MTs	  were	  polymerised	   in	  
vitro	   from	   bovine	   brain	   purified	   tubulin	   and	   stabilised	   with	   taxol.	   (c)	   Silver-­‐stained	   gel	   of	  
supernatant-­‐pellet	   partitioning	   for	  WT	   fascin	   incubated	  with	  MTs	   in	   absence	   of	   taxol.	   (d)	  
Silver-­‐stained	  gel	  of	  supernatant-­‐pellet	  partitioning	  for	  WT	  and	  mutant	  fascin	  incubated	  with	  
MTs	  in	  presence	  of	  taxol.	  (e)	  Statistical	  analysis	  of	  the	  percentage	  of	  fascin	  in	  pellet	  with	  MTs	  
was	  performed	  by	  densitometry	  analysis	  of	  at	  least	  three	  silver-­‐stained	  gels.	  P-­‐value	  =<	  0.05	  
(*)	   was	   considered	   as	   significant.	   Data	   are	   expressed	   as	   mean±	   sem	   and	   corrected	   with	  
fascin	  alone	  supernatant-­‐pellet	  ratio. 
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5.4.	  Fascin	  S274D	  preferentially	  associates	  with	  microtubules	  in	  vitro	  
	  
Data	  in	  Figure	  5.3	  showed	  WT	  and	  mutant	  fascin	  can	  associate	  with	  MT	  in	  vitro.	  The	  
next	   step	   was	   to	   determine	   whether	  WT	   and	  mutant	   fascin	   binding	   to	  MT	   could	  
occur	  in	  the	  presence	  of	  co-­‐incubated	  actin.	  The	  assay	  was	  therefore	  repeated	  in	  the	  
presence	  of	   F-­‐actin	   to	   test	   relative	   sedimentation	  efficiencies	  of	   all	   fascin	  proteins	  
under	  these	  conditions.	  	  
	   	  
F-­‐actin	   was	   polymerised	   in	   vitro	   as	   described	   in	   Material	   and	  Methods	   and	   in	   (J.	  
Zanet	  et	  al.	  2012)	  the	  MT-­‐fascin	  co-­‐sedimentation	  assay	  was	  repeated	  as	  previously	  
described	   for	   Figure	   5.3.	   F-­‐actin	   was	   then	   added	   to	   the	   reaction	   following	   MT	  
polymerisation.	  The	  reaction	  mixture	  was	  centrifuged	  and	  the	  percentage	  of	   fascin	  
co-­‐sedimented	  with	  MT	  and	  F-­‐actin	  was	  determined	  by	  SDS-­‐PAGE	  gels,	  silver	  staining	  
and	  densitometry	  analysis	  (Figure	  5.4).	  Example	  silver-­‐stained	  gel	  analysis	  showed	  in	  
Figure	  5.4	  shows	  supernatant/pellet	   (s/p)	  ratio	   in	  control	  gels	   (a)	  and	  experimental	  
gels	  (b).	  Figure	  5.4a	  shows	  a	  control	  gel	  of	  F-­‐actin	  incubated	  with	  MT	  alone,	  with	  and	  
without	   taxol.	   F-­‐actin	   s/p	   ratio	   did	   not	   change	   in	   the	   presence	   of	   MT	   or	   taxol-­‐
stabilised	  MT.	   This	   suggests	   no	   interaction	   occurs	   between	   actin	   and	  MT	   alone	   in	  
vitro.	   Figure	  5.4b	   shows	  a	   silver-­‐stained	  gel	  of	   s/p	   ratio	  of	  WT,	  S39A,	  S39D,	  S274A	  
and	   S274D	   fascin	   incubated	   and	   co-­‐sedimented	   together	   with	   MT	   and	   F-­‐actin.	   F-­‐
actin	  was	  added	  to	  the	  reaction	  following	  fascin	  incubation	  with	  MT.	  F-­‐actin	  addition	  
lead	  to	  changes	  in	  the	  levels	  of	  fascin	  in	  the	  pellet	  in	  all	  cases.	  The	  presence	  of	  both	  
MT	   and	   F-­‐actin	   led	   to	   higher	   levels	   of	   fascin	   in	   the	   pellet	   in	   all	   cases	   except	   the	  
reaction	  containing	  the	  S274D	  mutant	  compared	  to	  MT	  alone	  (Figure	  5.3d).	  Addition	  
of	  F-­‐actin	  did	  not	  have	  any	  effect	  on	  S274D	  fascin	  co-­‐sedimentation	  with	  MT.	  	  
	  
Figure	  5.4c	  shows	  densitometry	  analysis	  of	  the	  percentage	  of	  fascin	  co-­‐sedimented	  
with	  MTs	  (red	  bars)	  and	  with	  MT	  and	  F-­‐actin	  (green	  bars)	  from	  >4	  silver	  stained	  gels	  
over	  independent	  experiments.	  Statistical	  analysis	  shown	  in	  Figure	  5.4c	  confirmed	  a	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2-­‐fold	   increase	   of	   the	   percentage	   of	   WT,	   S39A,	   S39D	   and	   S274A	   fascin	   co-­‐
sedimented	  together	  with	  MT	  and	  F-­‐actin	  (green	  bars)	  compared	  to	  that	  seen	  with	  
MT	   alone	   (red	   bars).	   This	   data	   also	   confirmed	   that	   the	   addition	   of	   F-­‐actin	   did	   not	  
result	   in	  changes	  to	  the	  amount	  of	  S274D	  fascin	  co-­‐sedimented	  with	  MT.	  This	  data	  
demonstrates	  that	  the	  S274D	  mutant	  shows	  significantly	  higher	  association	  with	  MT	  
compared	  to	  other	  fascin	  proteins	  also	  in	  presence	  of	  F-­‐actin.	  
	  
	  
Figure	  5.4.	  Fascin	  S274D	  preferentially	  associates	  with	  microtubules	  in	  vitro	  
(a)	  Silver-­‐stained	  gel	  of	  supernatant-­‐pellet	  partitioning	  for	  F-­‐actin,	   incubated	  on	  its	  
own	   with	   and	   without	   taxol	   (TAX).	   (b)	   Silver-­‐stained	   gel	   of	   supernatant-­‐pellet	  
partitioning	  for	  WT	  and	  mutant	  fascin	  incubated	  with	  MTs	  and	  F-­‐actin	   in	  presence	  
of	  taxol.	  (e)	  Statistical	  analysis	  of	  the	  percentage	  of	  fascin	  in	  pellet	  with	  MTs	  and	  F-­‐
actin	   compared	   to	   the	   percentage	   of	   fascin	   in	   pellet	   with	  MTs	   (Figure	   5.20)	   was	  
performed	  by	  densitometry	  analysis	  of	  at	  least	  three	  silver-­‐stained	  gels.	  P-­‐value	  =<	  
0.05	   (*)	   was	   considered	   as	   significant.	   Data	   are	   expressed	   as	   mean±	   sem	   and	  
corrected	  on	  fascin	  alone	  supernatant-­‐pellet	  ratio. 
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5.5.	   S274D	   fascin	   preferentially	   associates	   with	   MT	   in	   a	   fluorescence	   assay	   for	  
analysis	  of	  F-­‐actin	  and	  MT	  	  
	  
After	   identifying	  a	  preferential	  association	  of	  S274D	  fascin	  with	  MT	  by	  biochemical	  
analysis,	  the	  next	  step	  was	  to	  use	  microscopy	  analysis	  to	  study	  formation	  of	  tubulin	  
and/or	  actin	  bundles	  in	  presence	  of	  WT	  and	  mutant	  fascin.	  Therefore,	  a	  fluorescent	  
tubulin	  and	  F-­‐actin	  polymerisation	  assay	  was	  performed	  in	  vitro	  as	  shown	  in	  5.1	  and	  
5.2.	  Rhodamine	   labeled	   tubulin	   from	  porcine	  brain	  was	  used	   in	  place	  of	  unlabeled	  
tubulin,	   and	   488-­‐phallodin	   was	   used	   to	   stabilized	   F-­‐actin	   and	   enable	   bundle	  
formation	  to	  be	  observed	  by	  confocal	  microscopy.	  The	  combined	  binding	  assay	  was	  
performed	  as	  described	  in	  5.4	  and	  in	  (Miller	  2004).	  Polymerised	  rhodamine	  tubulin	  
was	   first	   incubated	   with	  WT	   or	  mutant	   fascin	   followed	   by	   incubation	   with	   488-­‐F-­‐
actin.	  	  
	  
Figure	  5.5	  shows	  example	  confocal	   images	  of	  MT	  and/or	  actin	  bundle	   formation	   in	  
presence	  of	   tubulin	  alone	   (first	  panel,	   top	   row),	   tubulin	  and	  F-­‐actin	   (second	  panel,	  
top	  row),	  tubulin,	  F-­‐actin	  and	  WT	  fascin	  (third	  panel,	  top	  row),	  and	  then	  tubulin,	  F-­‐
actin	  and	  S39A	  fascin	   (first	  panel,	  bottom	  row),	  S39D	  fascin	   (second	  panel,	  bottom	  
row),	  S274A	  fascin	  (third	  panel,	  bottom	  row)	  or	  S274D	  fascin	  (fourth	  panel,	  bottom	  
row).	  Tubulin	  alone	  did	  not	  show	  MT	  bundle	  formation	  in	  vitro	  at	  this	  magnification	  
(first	  panel,	  top	  row).	  Addition	  of	  F-­‐actin	  alone	  did	  not	  show	  any	  visible	  effect	  on	  MT	  
bundling	  in	  vitro	  (second	  panel,	  top	  row).	  WT	  fascin	  incubation	  resulted	  in	  increased	  
F-­‐actin	   bundle	   formation	   and	   polymerised	  MT	   and	   interestingly,	   these	   bundles	   of	  
actin	  and	  MT	  co-­‐localised	  (third	  panel,	  top	  row).	  As	  shown	  in	  Chapter	  3,	  fascin	  is	  not	  
involved	  in	  basal	  tubulin	  polymerisation	  in	  cells	  but	  instead	  appears	  to	  regulate	  MT	  
stability.	  Therefore,	  the	  observed	  co-­‐localisation	  suggests	  that	  WT	  fascin	  may	  play	  a	  
role	  in	  crosslinking	  bundled	  F-­‐actin	  and	  stabilised	  MT.	  MT	  stability	  and	  co-­‐localisation	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with	  F-­‐actin	  increased	  dramatically	  when	  S39A	  fascin	  was	  added	  (first	  panel,	  bottom	  
row)	   and	   this	  was	   not	   seen	   in	   the	  presence	  of	   S39D	   fascin	   (second	  panel,	   bottom	  
row).	  This	  data	  supports	  a	  potential	  feedback	  control	  of	  S39A	  fascin-­‐actin	  binding	  on	  
MT	   stability.	   Interestingly,	   S274A	   fascin	   incubation	   together	   with	   MT	   and	   F-­‐actin	  
showed	   no	   effect	   on	   tubulin	   polymerisation	   and/or	   stability,	   but	   confirmed	   its	   F-­‐
actin	  binding	  activity,	  as	  observed	  in	  Figure	  5.1	  and	  published	  previously	  in	  (J.	  Zanet	  
et	   al.	   2012).	   Conversely,	   S274D	   fascin	   incubation	   together	   with	   MT	   and	   F-­‐actin	  
showed	   increased	  MT	   bundling,	   without	   any	   effect	   on	   F-­‐actin	   bundling.	   This	   data	  
confirms	   the	   biochemical	   analysis	   of	   fascin,	  MT	   and	   F-­‐actin	   co-­‐sedimentation	   and	  
further	  suggests	  that	   fascin	  can	  potentially	  crosslink	  MT	  and	  F-­‐actin	  to	  form	  higher	  
ordered	  cytoskeleton	  bundles.	  
	  
Figure	  5.5.	  S274D	  fascin	  preferentially	  associates	  with	  MT	  in	  fluorescent	  binding	  
assay	  
Confocal	   microscope	   images	   of	   WT	   and	   mutant	   fascin	   co-­‐incubation	   with	  
microtubules	   and	   F-­‐actin.	   Rhodamine-­‐labelled	   bovine	   brain	   purified	   tubulin	   was	  
polymerised	  in	  vitro	  and	  stabilised	  with	  taxol	  (first	  panel)	  and	  then	  incubated	  with	  F-­‐
actin,	   previously	   stabilised	   with	   488-­‐labelled	   phalloidin	   (second	   panel).	   WT	   fascin	  
(third	  panel),	  S39A	  fascin	  (fourth	  panel),	  S39D	  fascin	  (fifth	  panel),	  S274A	  fascin	  (sixth	  
panel)	  or	  S274D	  fascin	  (seventh	  panel)	  was	  added	  together	  with	  tubulin	  and	  F-­‐actin.	  
Scale	  bar=	  3	  um. 
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5.6.	  Fascin	  knockdown	  disrupts	  the	  balance	  of	  actin-­‐MT	  crosstalk	  	  
	  
In	   vitro	   data	  and	   results	  discussed	   in	  Chapter	  4	  and	  Figure	  5.5	  propose	   fascin	  as	  a	  
possible	  molecular	  bridge	  between	  actin	  and	  MT	  cytoskeletons.	  To	   further	  analyse	  
this	   hypothesis	   in	   intact	   cells,	   F-­‐actin	   formation	   during	   nocodazole	   treatment	   and	  
after	  60	  minute	  nocodazole	  washout	  was	  studied	  by	  confocal	  microscopy	  in	  control	  
and	   fasKD	  cells.	   I	   also	  analysed	  F-­‐actin	   formation	   in	   response	   to	   the	  MT-­‐stabilising	  
drug	  taxol	  in	  fasKD	  cells	  and	  in	  fasKD	  cells	  re-­‐expressing	  GFP-­‐WT	  fascin.	  
	  
Figure	  5.6	  a,b	  show	  example	  images	  of	  control	  and	  fascin	  knockdown	  MDA-­‐MB-­‐231	  
(fasKD)	   cells	   stained	   for	   total	   tubulin	   and	   phalloidin	   (to	   visualise	   F-­‐actin)	   during	  
nocodazole	  assays.	  Top	  rows	  in	  Figure	  5.6	  a,b	  show	  untreated	  cells	  (UT),	  centre	  rows	  
show	  nocodazole	  treated	  cells	   (NOC)	  and	  bottom	  rows	  show	  cells	  60	  minutes	  after	  
nocodazole	  was	  washed	  out	  (60’NOC	  wash).	  The	  first	  column	  shows	  merged	  staining	  
of	  total	  tubulin	  and	  F-­‐actin	  staining,	  while	  the	  second	  and	  third	  columns	  show	  total	  
tubulin	  and	  F-­‐actin	  alone,	  respectively.	  Control	  cells	  showed	  normal	  MT	  network	  and	  
F-­‐actin	   fibre	   formation	   (top	   row	   in	   Figure	   5.6a).	  MT	   depolymerisation	   induced	   by	  
nocodazole	   treatment	   is	   known	   to	   increase	   F-­‐actin	   fibre	   stability	   (Rooney	   et	   al.	  
2010).	   Consistently,	   NOC	   treated	  MDA-­‐MB-­‐231	   control	   cells	   became	   rounded	   and	  
increased	   stress	   fibres	   (centre	   row	   in	   Figure	   5.6a).	   After	   60	  minute	  NOC	  washout,	  
control	   cells	   spread	   again	   showing	   re-­‐polymerised	   MT	   and	   decreased	   stress	   fibre	  
formation	  compared	  to	  treated	  cells	  (bottom	  row	  in	  Figure	  5.6a).	  Figure	  5.6b	  shows	  
the	  same	  experiment	  performed	   in	  MDA-­‐MB-­‐231	   fasKD	  cells.	  As	  previously	  shown,	  
fascin	   depletion	   did	   not	   affect	   total	   tubulin	   polymerisation,	   but	   did	   alter	   F-­‐actin	  
structural	   organisation.	   Indeed,	   fasKD	   cells	   showed	   loss	   of	   filopodial	   organisation	  
and	  stress	  fibre	  formation	  (third	  panel,	  top	  row	  in	  Figure	  5.6b).	  Fascin	  depleted	  cells	  
rounded	   up	   after	   NOC	   treatment,	   but	   these	   cells	   showed	   fewer	   F-­‐actin	   bundles	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compared	   to	   control	   cells	   in	   the	   same	   condition	   (centre	   row	   in	   Figure	   5.6b).	  
Moreover,	  fasKD	  cells	  after	  60	  minute	  NOC	  washout	  did	  not	  show	  MT	  recovery,	  but	  
a	   dramatic	   increase	   in	   cortical	   F-­‐actin	   fibre	   formation	   was	   induced	   (third	   panel,	  
bottom	  row	  in	  Figure	  5.6b).	  Data	  shown	  in	  Figure	  5.6	  a,b	  suggests	  a	  role	  for	  fascin	  in	  
regulating	  F-­‐actin	  fibre	  formation	  in	  response	  to	  changes	  in	  MT	  integrity.	  	  
Finally,	   to	   investigate	   further	   the	   role	   of	   fascin	   in	   linking	   the	   actin	   and	   MT	  
cytoskeletons,	   I	   studied	   F-­‐actin	   formation	   in	   response	   to	   the	   MT-­‐stabilising	   drug	  
taxol.	  Figure	  5.6c	  shows	  example	  images	  of	  MDA-­‐MB-­‐231	  fasKD	  cells	  and	  fasKD	  cells	  
re-­‐expressing	  GFP-­‐WT	  fascin	  stained	  for	  total	  tubulin	  and	  F-­‐actin.	  The	  top	  row	  shows	  
untreated	   cells	   (UT)	   and	   the	  bottom	   row	   shows	   taxol	   treated	   cells	   (TAX).	   The	   first	  
column	   shows	   a	   merged	   image	   of	   total	   tubulin	   and	   F-­‐actin	   staining,	   whereas	   the	  
second	  and	  third	  columns	  show	  total	  tubulin	  and	  F-­‐actin	  staining,	  respectively.	  FasKD	  
cells	  (expressing	  low	  GFP	  levels)	  and	  fasKD	  resGFP-­‐WT	  fascin	  (green	  cells)	  are	  shown	  
in	   the	   same	   image	   to	   compare	   protein	   staining	   in	   the	   presence	   and	   absence	   of	  
fascin.	  Data	   shown	   in	   Chapter	   3	   demonstrated	   that	   resWT	   cells	   behave	   as	   control	  
cells.	  Data	  shown	  in	  Figure	  5.6c	  confirmed	  that	  fascin	  depletion	  did	  not	  result	  in	  an	  
obvious	  change	  in	  total	  tubulin	  organization	  (second	  panel,	  top	  row),	  but	  did	  affect	  
F-­‐actin	   structure	   organisation	   (third	   panel,	   top	   row).	   Moreover,	   taxol	   treatment	  
resulted	  in	  a	  clear	  increase	  in	  stable	  bundled	  MT	  and	  also	  increased	  F-­‐actin	  in	  GFP-­‐
WT	  fascin	  expressing	  cells	  (green	  cell	   in	  bottom	  row)	  but	  no	  increase	  was	  observed	  
in	  fasKD	  cells	  (GFP-­‐negative	  cell	  in	  bottom	  row).	  	  
	  
Taken	   together,	   this	  data	   suggests	   that	   fascin	  plays	   a	   role	   in	   regulating	   F-­‐actin-­‐MT	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FasKD	  cells	  rescued	  for	  GFP-­‐WT	  fascin 
Figure	  5.6.	  Fascin	  knockdown	  disrupts	  the	  balance	  of	  actin-­‐MT	  crosstalk	  	  
(a)	  Confocal	  microscope	  images	  of	  MDA-­‐MB-­‐231	  control	  cells	  stained	  for	  total	  tubulin	  
and	   phallodin	   (to	   stain	   F-­‐actin)	   during	   nocodazole	   treatment	   and	   after	   60	   minute	  
washout.	  (b)	  Confocal	  microscope	  images	  of	  MDA-­‐MB-­‐231	  fasKD	  cells	  stained	  for	  total	  
tubulin	   and	   phallodin	   (F-­‐actin)	   during	   nocodazole	   treatment	   and	   after	   60	   minute	  
washout.	  First	   rows	   in	  a,	  b	   show	  untreated	  cells	   (UT),	   second	   rows	  show	  nocodazole	  
treated	  cells	  (NOC)	  and	  third	  rows	  show	  60	  minute	  washed	  cells	  (NOC	  60’Wash).	  First	  
column	   in	   a,	   b	   shows	   control	   cells	   stained	   for	   total	   tubulin	   and	   phallodin	   (F-­‐actin)	  
together,	  whereas	  second	  and	  third	  rows	  show	  total	  tubulin	  or	  phallodin,	  respectively.	  
(c)	  Confocal	  microscope	   images	  of	   tubulin	  and	  F-­‐actin	   in	   fascin	  knockdown	  MDA-­‐MB-­‐
231	  cells	  re-­‐expressing	  WT	  fascin-­‐GFP.	  First	  row	  shows	  untreated	  cells	  (UT)	  and	  second	  
row	  shows	  taxol	  treated	  cells	  (Tax).	  First	  column	  shows	  fasKD	  cells	  together	  with	  fasKD	  
cells	   re-­‐expressing	  WT	   fascin-­‐GFP	   stained	   with	   total	   tubulin	   and	   phalloidin	   (used	   to	  
stain	  F-­‐actin),	  second	  column	  shows	  tubulin	  staining	  alone	  and	  the	  third	  column	  shows	  
phalloidin	  staining	  alone.	  Scale	  bar=	  10	  um. 
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5.7.	  Fascin	  is	  required	  for	  cytoskeletal	  network	  remodeling	  
	  
Data	  shown	  in	  Figure	  5.6	  showed	  fascin	  regulates	  F-­‐actin	  changes	  in	  response	  to	  MT-­‐
targeting	  drugs.	  The	  next	  step	  was	  to	   investigate	  whether	  fascin	  also	  regulated	  the	  
converse:	   ie:	   MT	   cytoskeleton	   changes	   in	   response	   to	   perturbation	   of	   the	   F-­‐actin	  
network.	  Therefore,	  control	  and	  fascin	  depleted	  cells	  were	  treated	  with	  the	  F-­‐actin	  
depolymerising	  drug	  cytochalasin	  D	  followed	  by	  fixation	  and	  staining	  for	  F-­‐actin	  and	  
MT	   by	   confocal	   microscopy.	   Cells	   were	   also	   analysed	   following	   drug	   washout	   to	  
confirm	  specificity	  and	  reversibility	  of	  the	  response.	  
	  
Figure	  5.7	  shows	  example	  images	  of	  MDA-­‐MB-­‐231	  control	  (a)	  and	  fascin	  knockdown	  
(b)	  cells	  stained	  for	  phalloidin	  (to	  visualize	  F-­‐actin)	  and	  total	  tubulin.	  The	  top	  rows	  in	  
5.7a,b	   show	   untreated	   cells	   (UT),	   centre	   rows	   show	   cytochalasin	   D	   treated	   cells	  
(cytoc	   D)	   and	   bottom	   rows	   show	   cytochalasin	   D	   60	   minute	   washout	   (cytoc	   D	  
60’wash).	   The	   first	   columns	   in	   5.7a,	   b	   show	   merged	   staining	   of	   F-­‐actin	   and	   total	  
tubulin,	   while	   second	   and	   third	   columns	   show	   F-­‐actin	   and	   total	   tubulin	   alone,	  
respectively.	   Figure	   5.7a	   top	   row	   shows	   normal	   F-­‐actin	   assembly	   and	   polymerised	  
MT	   in	   control	   cells.	   Cytochalasin	   D	   treatment	   completely	   depolymerised	   F-­‐actin	  
(second	  panel,	  centre	  row	  in	  Figure	  5.7a)	  but	  cortical	  actin	  ruffles	  remained	  in	  these	  
cells,	   and	   a	   striking	   increase	   in	   MT	   bundle	   formation	   was	   seen	   in	   the	   same	   cells	  
(third	   panel,	   centre	   row,	   Figure	   5.7a).	   Conversely,	   60	  minutes	   after	   cytochalasin	  D	  
was	   washed	   out,	   F-­‐actin	   appeared	   normal	   as	   in	   untreated	   cells	   (second	   panel,	   in	  
Figure	   5.7a)	   and	   subsequently	   MT	   network	   assembly	   was	   restored	   to	   normal	  
organization	  as	   seen	   in	  UT	   cells	   	   (bottom	   row	   in	   Figure	  5.7a).	   This	  data	   shows	   the	  
balance	   between	   actin	   and	   MT	   cytoskeletons	   is	   tightly	   controlled	   in	   these	   cells.	  
Figure	  5.7b	  shows	  the	  same	  experiment	  performed	  in	  fasKD	  cells.	  Top	  row	  in	  Figure	  
5.7b	   confirms	   that	   fascin	   depleted	   cells	   to	   have	   increased	   stress	   fibres	   compared	  
with	   control	   cells,	   but	   no	   differences	   in	   basal	   MT	   network	   assembly.	   FasKD	   cells	  
showed	   a	   dramatic	   response	   to	   cytochalasin	   D,	   becoming	   rounded	   with	   strong	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depolymerisation	  of	  both	  actin	  and	  MT	  (centre	  row	  in	  Figure	  5.7).	  This	  is	  in	  contrast	  
to	   control	   cells	   that	   showed	   a	   clear	   increase	   in	   MT	   bundles	   under	   the	   same	  
conditions	  (middle	  panels,	  Figure	  5.7a).	  Additionally,	  fasKD	  cells	  showed	  no	  recovery	  
in	   F-­‐actin	   structure	   and/or	   MT	   cytoskeleton	   following	   cytochalasin	   D	   washout,	   as	  
observed	  in	  control	  cells.	  Indeed,	  fasKD	  cells	  showed	  complete	  disruption	  of	  both	  F-­‐
actin	  and	  MT	  networks	  after	  drug	  washout.	  This	  data	  supports	  a	  role	  for	  fascin	  in	  the	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Figure	   5.7.	   Fascin	   is	   required	   for	   cytoskeletal	   network	   remodelling	  	  
(a)	  Confocal	  microscope	   images	  of	  MDA-­‐MB-­‐231	  control	   cells	   stained	   for	  phallodin	  
(to	  stain	  F-­‐actin)	  and	  total	   tubulin	  during	  cytochalasin	  D	  treatment	  and	  60	  minutes	  
washout.	   (b)	   Confocal	   microscope	   images	   of	  MDA-­‐MB-­‐231	   fasKD	   cells	   stained	   for	  
phallodin	  (F-­‐actin)	  and	  total	  tubulin	  during	  cytochalasin	  D	  treatment	  and	  60	  minutes	  
washout.	   	   First	   rows	   in	  both	   (a)	  and	   (b)	   show	  untreated	  cells	   (UT),	   second	   rows	   in	  
both	  (a)	  and	  (b)	  show	  cytochalasin	  D	  treated	  cells	  (cytochD)	  and	  third	  rows	  in	  both	  
(a)	  and	  (b)	  show	  60	  minute	  washed	  cells	  (cytochD	  60’Wash).	  First	  column	  in	  both	  (a)	  
and	  (b)	  shows	  control	  cells	  stained	  for	  phallodin	  (F-­‐actin)	  and	  total	  tubulin	  together,	  
whereas	   second	  and	   third	   rows	  show	  phallodin	  or	   total	   tubulin,	   respectively.	  Scale	  
bar=	  20	  um.	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5.8.	   Fascin	   knockdown	   cells	   show	   reduced	   levels	   of	   Focal	   adhesion	   kinase	  
phosphorylation	  (p-­‐FAK)	  
	  
Data	   shown	   in	  Chapter	  3	   showed	   that	   fascin	  depletion	  did	  not	  alter	   total	   levels	  of	  
Focal	   Adhesion	   Kinase	   (FAK)	   or	   vinculin	   protein	   but	   did	   lead	   to	   changes	   in	   FA	   size	  
under	   basal	   conditions.	   Therefore	   the	   way	   in	   which	   fascin	   regulates	   FA	  
assembly/disassembly	   remains	   unclear.	   Auto-­‐phosphorylation	   of	   FAK	   on	   Tyrosine	  
397	  is	  required	  for	  efficient	  FA	  dynamics	  (Hamadi	  et	  al.	  2005)	  and	  active	  FAK	  has	  also	  
been	   shown	   to	  be	   required	   for	  dynamin-­‐dependent	   FA	  disassembly	   following	  NOC	  
washout	   (Ezratty	   et	   al.	   2005).	   FAK	   therefore	   presented	   an	   interesting	   potential	  
protein	  as	  a	  molecular	  effector	  of	  fascin	  in	  regulating	  FA	  assembly/disassembly.	  	  
	  
To	   test	   this,	   FAK	   phosphorylation	   on	   Tyrosine	   397	   (p-­‐FAK)	   was	   analysed	   in	   cells	  
expressing	   fascin	   and	   or	   silenced	   for	   fascin	   (fasKD)	   by	   confocal	   microscopy	   and	  
western	  blotting	  (Figure	  5.8).	  Figure	  5.8a	  shows	  example	  images	  of	  p-­‐FAK	  staining	  in	  
MDA-­‐MB-­‐231	   control	   (left	   panel),	   fascin	   knockdown	   (centre	  panel)	   and	   fasKD	   cells	  
re-­‐expressing	  WT	   fascin-­‐GFP	   (right	  panel).	   Control	   cells	   showed	   clear	  peripheral	   p-­‐
FAK	   localisation	   in	   FA	   (left	   panel).	   Interestingly,	   fasKD	   cells	   showed	   smaller	   p-­‐FAK-­‐
positive	  FA	  compared	  with	  the	  control	  cells,	  despite	   the	   fact	   that	  previous	  analysis	  
has	  demonstrated	   larger	  FA	  assembly	   in	   these	  cells	  based	  on	  P-­‐tyr	   staining	   (Figure	  
3.9).	  Similar	  localization	  of	  p-­‐FAK	  was	  seen	  in	  fasKD	  re-­‐expressing	  WT	  fascin	  as	  seen	  
in	  control	  cells.	  This	  suggests	  that	  fascin	  depletion	  reduces	  levels	  of	  p-­‐FAK	  at	  FA.	  	  
	  
To	   further	   determine	  whether	   p-­‐FAK	   levels	  were	   altered	   in	   the	   absence	   of	   fascin,	  
FAK	   397-­‐phosphorlyation	   levels	   were	   analysed	   by	   western	   blotting.	   Figure	   5.8b	  
shows	   example	   western	   blots	   of	   total	   and	   p-­‐FAK	   in	   control	   (ctrl)	   and	   fascin	  
knockdown	  (fasKD)	  MDA-­‐MB-­‐231	  or	  HeLa	  cell	  lysates.	  Endogenous	  fascin	  levels	  were	  
also	  assessed	  in	  the	  same	  samples.	  GAPDH	  was	  used	  as	  a	  loading	  control.	  Total	  and	  
p-­‐FAK	   levels	   were	   quantified	   by	   densitometry	   analysis	   of	   multiple	   western	   blots	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(Figure	   5.8c)	   together	   with	   endogenous	   fascin	   levels.	   Data	   confirmed	   that	   fascin	  
depletion	  resulted	  in	  a	  dramatic	  decrease	  of	  p-­‐FAK	  without	  any	  change	  in	  total	  FAK	  
levels	   (Figure	   5.8b,	   c).	   To	   confirm	   that	   decreased	   p-­‐FAK	   levels	   were	   specifically	  
dependent	   on	   fascin	   depletion,	   western	   blotting	   and	   densitometry	   analysis	   was	  
performed	   in	   MDA-­‐MB-­‐231	   control	   (ctrl),	   fascin	   knockdown	   (fasKD)	   and	   fasKD	  
rescued	  for	  WT	  fascin	  expression	  (resWT).	  Figure	  5.8d	  shows	  total	  and	  p-­‐FAK	  levels	  
in	  a	  representative	  western	  blot.	  Endogenous	  and	  rescue	  WT	  fascin	  levels	  were	  also	  
assessed	  in	  the	  same	  samples.	  Total	  FAK	  was	  used	  as	  a	  loading	  control.	  P-­‐FAK	  levels	  
were	   quantified	   by	   densitometry	   analysis	   of	   multiple	   western	   blots	   (Figure	   5.8e),	  
together	  with	  endogenous	  and	  rescue	  WT	  fascin	  levels	  in	  control,	  fasKD	  and	  resWT	  
cells.	  Data	  confirmed	  that	  fascin	  depletion	  results	   in	  reduced	  p-­‐FAK	   levels,	  and	  this	  
was	  efficiently	  restored	  in	  cells	  re-­‐expressing	  WT	  fascin	  (Figure	  5.8d).	  The	  difference	  
in	  FAK	  phosphorylation	  between	  control	  and	  fasKD	  cells	  in	  figure	  5.8c	  and	  e	  may	  be	  
due	  to	  the	  normalization	  done	  on	  total	  levels	  of	  different	  proteins	  (GAPDH	  in	  c	  and	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Figure	  5.8.	  Fascin	  knockdown	  cells	  show	  reduced	  levels	  of	  Focal	  adhesion	  kinase	  
phosphorylation	  (p-­‐FAK)	  
(a)	  Confocal	  microscope	   images	  of	  cells	  stained	  for	  phospho-­‐FAK	  (p-­‐FAK)	   in	  MDA-­‐
MB-­‐231	   control	   cells,	   fascin	   knockdown	   cells	   and	   fascin	   knockdown	   cells	   re-­‐
expressing	   WT	   fascin-­‐GFP.	   Scale	   bar=	   10	   um.	   (b)	   Western	   blots	   of	   lysates	   from	  
MDA-­‐MB-­‐231	  and	  Hela	  control	  and	  fasKD	  cells.	  (c)	  Statistical	  analysis	  of	  fascin,	  total	  
and	  p-­‐FAK	  levels	  was	  performed	  by	  densitometry	  analysis	  of	  at	  least	  three	  western	  
blots.	  P-­‐value	  =<	  0.005	  (**)	  and	  =<	  0.05	  (*)	  was	  considered	  as	  significant.	  Data	  are	  
expressed	  as	  mean±	  sem	  and	  corrected	  on	  GAPDH	  loading	  as	  control.	  (d)	  Western	  
blots	  of	  lysates	  from	  MDA-­‐MB-­‐231	  control,	  fasKD	  cells	  and	  fasKD	  cells	  re-­‐expressing	  
WT	  fascin-­‐GFP.	  (e)	  Statistical	  analysis	  of	  fascin	  and	  p-­‐FAK	  levels	  was	  performed	  by	  
densitometry	  analysis	  of	  at	   least	   three	  western	  blots.	  P-­‐value	  =<	  0.001	   (***)	  was	  
considered	  as	  significant.	  Data	  are	  expressed	  as	  mean±	  sem	  and	  corrected	  on	  total	  
FAK	  loading	  as	  control.	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5.9.	   Fascin	   knockdown	   leads	   to	   lower	   p-­‐397	   FAK	   levels	   following	   nocodazole	  
washout	  
	  
Data	   presented	   in	   Figure	   5.8	   showed	   fascin	   dependent	   regulation	   of	   phospho-­‐FAK	  
under	  basal	  growing	  conditions.	  Given	  that	  previous	  data	  in	  this	  Chapter	  and	  Chapter	  
4	   showed	  a	   role	   for	   fascin	   in	  driving	  MT-­‐dependent	  FA	  disassembly	   following	  NOC	  
washout,	   the	   next	   step	  was	   to	   investigate	  whether	   FAK	   phosphorylation	  was	   also	  
differentially	  regulated	  by	  fascin	  under	  these	  conditions.	  
	  
To	  test	  this,	  nocodazole	  treatment	  and	  washout	  assays	  were	  performed	  in	  MDA-­‐MB-­‐
231	   fascin	   knockdown	   (fasKD)	   cells	   and	   in	   fasKD	   cells	   rescued	   for	   GFP-­‐WT	   fascin	  
expression	  (resWT)	  and	  stained	  for	  p-­‐FAK.	  Figure	  5.9a	  shows	  example	   images	  of	  p-­‐
FAK	   staining	   before	   (UT,	   top	   row)	   and	   after	   NOC	   treatment	   and	   washout	   (60’W,	  
bottom	  row).	  FasKD	  cells	  (expressing	  low	  levels	  of	  GFP)	  and	  fasKD	  resGFP-­‐WT	  fascin	  
(green	   cells)	   are	   shown	   in	   the	   same	   image	   to	   compare	   pFAK	   staining	   between	  
conditions.	  The	  first	  and	  third	  columns	  show	  fascin,	  total	  tubulin	  and	  p-­‐FAK	  staining	  
alone,	   respectively.	   Additionally,	   the	   first	   panel	   in	   each	   row	   shows	   highlighted	  
peripheral	  area	  of	  the	  cell	   to	  demonstrate	  co-­‐localisation	  of	  proteins	  at	  FA.	   Images	  
confirmed	   WT	   fascin	   peripheral	   co-­‐localisation	   with	   MT	   ends,	   as	   also	   previously	  
observed	   in	   Chapter	   3.	   Moreover,	   partial	   co-­‐localisation	   was	   seen	   between	   WT	  
fascin	  with	  p-­‐FAK	  in	  mature	  FA	  in	  cells	  rescued	  with	  GFP-­‐WT	  fascin	  expression	  (left	  
panel,	  top	  row).	  As	  also	  shown	  previously	  in	  Figure	  5.8,	  fasKD	  cells	  showed	  reduced	  
p-­‐FAK	  localisation	  at	  the	  cell	  periphery	  than	  resWT	  cells.	  As	  expected	  no	  difference	  in	  
MT	  polymerisation	  was	  observed	  between	  fasKD	  cells	  and	  fasKD/resWT	  fascin	  cells	  
(centre	   panel,	   top	   row).	   The	   bottom	   row	   in	   Figure	   5.9	   shows	   WT	   fascin	   re-­‐
localisation	  at	   the	  cell	  periphery	  after	  NOC	  washout	   (left	  panel),	   re-­‐assembling	  MT	  
(centre	   panel)	   and	   p-­‐FAK	   co-­‐localisation	   with	  WT	   fascin	   at	   the	   ends	   of	   MT	   (right	  
panel).	  On	   the	  other	  hand,	   the	   fasKD	   cell	   in	   the	   same	   image	   showed	  a	   lack	   in	  MT	  
recovery	  and	  p-­‐FAK	  localisation	  at	  the	  cell	  periphery.	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To	  further	  analyse	  p-­‐FAK	  involvement	  in	  fascin-­‐dependent	  NOC	  washout	  responses,	  
FAK	   p397-­‐phosphorlyation	   levels	   were	   analysed	   during	   the	   NOC	   assay	   by	  western	  
blotting.	   Figure	   5.9b	   shows	   total	   and	   p-­‐FAK	   in	   control	   (ctrl)	   and	   fascin	   knockdown	  
(fasKD)	   MDA-­‐MB-­‐231	   untreated,	   NOC	   treated	   and	   after	   30	   and	   60	   minute	   drug	  
washout.	  Total	  FAK	  was	  used	  as	  a	   loading	  control.	  P-­‐FAK	   levels	  were	  quantified	  by	  
densitometry	   analysis	   of	  multiple	  western	   blots	   (Figure	   5.9c)	   in	   control	   and	   fasKD	  
cells.	   Figure	  5.9b,c	   shows	   that	  pFAK	   levels	   in	  control	   cells	   increased	   following	  NOC	  
washout	   as	   has	   been	   previously	   suggested	   (Ezratty	   et	   al,	   2005).	   Conversely,	   fasKD	  
cells	   did	   not	   show	   increased	   FAK	   phosphorylation	   after	   60	   minute	   NOC	   washout	  
compared	   to	  control	   cells.	   	   This	  data	   suggests	   that	   fascin	  may	  co-­‐operate	  with	  MT	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  Figure	  5.9.	  Fascin	  knockdown	  leads	  to	  lower	  p-­‐397	  FAK	  levels	  following	  nocodazole	  
washout	  
(a)	   Confocal	   microscope	   images	   of	   MDA-­‐MB-­‐231	   cells	   expressing	   WT	   fascin-­‐GFP	  
stained	  for	  total	  tubulin	  and	  f-­‐FAK	  before	  (UT)	  and	  after	  (60’W)	  nocodazole	  treatment	  
and	  washout.	  Top	  row	  shows	  untreated	  cells	  (UT)	  and	  bottom	  row	  shows	  60’	  minute	  
washed	  cells	   (60’W).	   First	   column	  shows	  WT	   fascin-­‐GFP,	   second	  column	  shows	   total	  
tubulin	   staining	   and	   third	   column	   shows	   p-­‐FAK	   staining.	   Scale	   bar=	   20	   um.	  Merged	  
zoom	  of	  the	  highlighted	  area	  is	  shown	  to	  show	  fascin	  co-­‐localisation	  with	  f-­‐FAK.	  Scale	  
bar=	   3	   um.	   (b)	  Western	   blots	   of	   lysates	   from	  MDA-­‐MB-­‐231	   control	   and	   fasKD	   cells	  
during	  nocodazole	  treatment	  and	  washout	  assay.	  (c)	  Statistical	  analysis	  of	  p-­‐FAK	  levels	  
was	   performed	  by	   densitometry	   analysis	   of	   at	   least	   three	  western	   blots.	   P-­‐value	   =<	  
0.001	   (***)	   was	   considered	   as	   significant.	   Data	   are	   expressed	   as	   mean±	   sem	   and	  
corrected	  on	  total	  FAK	  loading	  as	  control.	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5.10.	   S274D	   fascin	   shows	   increased	   colocalisation	   with	   p-­‐397	   FAK	   at	   the	   cell	  
periphery	  
	  
After	  observing	  changes	   in	  p-­‐397	  FAK	   levels	  and	   localisation	   in	  cells	  expressing	  WT	  
fascin	   and	   in	   fascin	   depleted	   cells,	   the	   next	   step	   was	   to	   investigate	   whether	  
expression	  of	  fascin	  mutants	  had	  any	  effect	  on	  p-­‐FAK	  and	  whether	  this	  may	  correlate	  
with	  the	  FA	  assembly/disassembly	  defects	  seen	  in	  these	  cells	  (Chapter	  4).	  
	  
To	   study	   this,	   fascin	   knockdown	  MDA-­‐MB-­‐231	   cells	   (fasKD)	   were	   transfected	   wth	  
GFP	   tagged	   sh-­‐resistant	   fascin	   constructs.	  Cells	   re-­‐expressing	  GFP-­‐WT,	   S39A,	   S39D,	  
S274A	  and	  S274D	  fascin	  were	  stained	  for	  p-­‐FAK	  and	  levels	  and	  localisation	  with	  GFP-­‐	  
WT	   and	  mutant	   fascin	  were	   analysed	   by	   confocal	  microscopy	   (Figure	   5.10a).	   Each	  
panel	  in	  Figure	  5.10a	  shows	  the	  highlighted	  peripheral	  area	  of	  the	  cell	  used	  to	  study	  
co-­‐localisation	  of	   fascin	  with	  p-­‐FAK	  at	  FA.	  Western	  blotting	  was	  also	  performed	  on	  
lysates	   from	   these	   cells	   to	   quantify	   basal	   p-­‐FAK	   levels	   by	   densitometry	   analysis	  
(Figure	   5.10b,c).	   Figure	   5.10a	   shows	   example	   images	   of	   GFP-­‐WT	   and	   mutant	  
expressing	   cells	   stained	   for	   p-­‐397	   FAK.	   As	   previously	   observed	   in	   Figure	   5.9a,	  WT	  
fascin	   localised	   at	   the	   cell	   periphery,	   co-­‐localising	   with	   p-­‐FAK	   in	   distinct	   FA	   (first	  
panel	  in	  Figure	  5.10a).	  The	  first	  panel	  top	  row	  shows	  larger	  FA	  containing	  high	  levels	  
of	   p-­‐FAK	   in	   cells	   expressing	   S39A	   fascin.	   However,	   S39A	   fascin	   was	   not	   found	   to	  
clearly	   co-­‐localise	   with	   p-­‐FAK	   at	   the	   periphery.	   The	   second	   panel	   top	   row	   shows	  
small	   immature	  FA	  with	   lower	  FAK-­‐phosphorylation	   levels	   in	  S39D	  expressing	  cells,	  
and	   no	   peripheral	   fascin	   localization,	   further	   suggesting	   fascin-­‐actin	   binding	   is	  
required	   to	  promote	  FA	  assembly/stability.	  The	   first	  panel	   in	  bottom	  row	   in	  Figure	  
5.10a	   shows	   large	   FA	   but	   no	   peripheral	   fascin	   localisation	   in	   cells	   expressing	   the	  
S274A	  mutant.	  Finally,	  the	  second	  panel	  bottom	  row	  shows	  distinct	  co-­‐localisation	  of	  
p-­‐FAK	   in	   S274D	   fascin	   within	   peripheral	   FA	   (Chapter	   2)	   in	   cells	   re-­‐expressing	   this	  
mutant,	  as	  observed	  in	  WT	  fascin	  rescued	  cells.	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FAK	   397-­‐phosphorlyation	   levels	   were	   analysed	   in	  mutant	   rescue	   cells	   under	   basal	  
growing	  conditions	  by	  western	  blotting.	  Figure	  5.10b	  shows	  total	  and	  p-­‐FAK	  in	  MDA-­‐
MB-­‐231	   fasKD	   cells	   expressing	   GFP-­‐WT,	   S39A,	   S39D,	   S274A	   and	   S274D	   fascin	  
constructs.	  Total	  FAK	  was	  used	  as	  a	  loading	  control.	  P-­‐FAK	  levels	  were	  quantified	  by	  
densitometry	  analysis	  of	  at	  least	  three	  western	  blots	  (Figure	  5.10c)	  in	  all	  cells.	  Figure	  
5.10c	  shows	  increased	  p-­‐FAK	  levels	  in	  S39A	  fascin	  expressing	  cells	  compared	  to	  WT	  
expressing	  cells.	  S39D	  fascin	  expressing	  cells	  showed	  lower	  p-­‐FAK	  levels	  than	  in	  S39A	  
or	  WT	  fascin	  expressing	  cells.	  S274A	  fascin	  expressing	  cells	  showed	  higher	   levels	  of	  
p-­‐FAK	   compared	   to	   any	   other	   fascin	   construct.	   S274D	   fascin	   rescue	   cells	   however	  
showed	   a	   small	   but	   significant	   increase	   in	   p-­‐FAK	   levels	   compared	   to	   WT	   fascin	  
expressing	  cells,	  suggesting	  p-­‐FAK	  was	  also	  involved	  in	  regulating	  basal	  FA	  in	  cells	  re-­‐
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Figure	  5.10.	  S274D	  fascin	  shows	  increased	  colocalisation	  with	  p-­‐397	  FAK	  at	  the	  cell	  
periphery	  
(a)	  Confocal	  microscope	  images	  of	  cells	  stained	  for	  phospho-­‐FAK	  (p-­‐FAK)	  in	  MDA-­‐MB-­‐231	  
fascin	  knockdown	  cells	  re-­‐expressing	  WT	  or	  mutant	  fascin-­‐GFP.	  Scale	  bar=	  10	  um.	  Zoom	  
of	  the	  highlighted	  area	  is	  shown	  to	  show	  fascin	  co-­‐localisation	  with	  p-­‐FAK.	  Scale	  bar=	  3	  
um.	   (b)	  Western	   blots	   of	   lysates	   from	  MDA-­‐MB-­‐231	   fasKD	   cells	   re-­‐expressing	  WT	   and	  
mutant	   fascin.	   (c)	   Statistical	   analysis	   of	   fascin	   and	   p-­‐FAK	   levels	   was	   performed	   by	  
densitometry	  analysis	  of	  at	   least	   three	  western	  blots.	  P-­‐value	  =<	  0.001	   (***),	  =<	  0.005	  
(**)	  and	  =<	  0.05	  (*)	  was	  considered	  as	  significant.	  Data	  are	  expressed	  as	  mean±	  sem	  and	  
corrected	  on	  total	  FAK	  loading	  as	  control.	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5.11.	  Fascin	  forms	  a	  complex	  with	  FAK	  
	  
Data	  presented	  in	  Figures	  5.8	  and	  5.9	  supports	  a	  possible	  role	  for	  fascin	  in	  controlling	  
levels	   of	   p-­‐397	   FAK	   in	   both	   basal	   and	   MT-­‐induced	   FA	   disassembly	   conditions.	  
Moreover,	   both	   WT	   and	   S274D	   fascin,	   but	   not	   other	   fascin	   mutants	   showed	   co-­‐
localisation	  with	  p-­‐FAK	  at	  peripheral	  FA.	  	  The	  next	  step	  was	  therefore	  to	  investigate	  
whether	  fascin	  may	  be	  able	  to	  form	  a	  complex	  with	  FAK	  in	  cells.	  
	  
To	   test	   this,	   immuno-­‐precipitations	   (IP)	   were	   performed	   using	   anti-­‐total	   FAK	  
antibody-­‐coated	   beads	   incubated	   with	   lysates	   from	   control	   MDA-­‐MB-­‐231	   cells	  
(Figure	   5.11a,b).	   GFP-­‐WT	   fascin	  was	   overexpressed	   to	   permit	   analysis	   of	   potential	  
fascin	  binding	  as	  opposed	   to	  endogenous	   fascin,	   as	  endogenous	   fascin	   runs	  at	   the	  
same	  molecular	  weight	  as	  the	  IgG,	  whereas	  the	  GFP-­‐tag	  allowed	  us	  to	  separate	  the	  
GFP-­‐fascin	  band	  (~80	  kDa)	   from	  the	  control	   IgG	  band	  (~50	  kDa).	  Experiments	  were	  
performed	  under	  basal,	   untreated	   (UT)	  or	   in	   the	  presence	  of	  nocodazole	   (NOC)	  or	  
taxol	  (TAX)	  treated	  cells	  to	  evaluate	  whether	  MT	  targeting	  drugs	  altered	  the	  putative	  
fascin-­‐FAK	  complex.	   Figure	  5.11a	   shows	  example	  western	  blots	  of	   FAK	   IP	  assays	   in	  
untreated,	  NOC	  and	  Tax	   treated	  cells.	  Non-­‐specific	   IgG-­‐coated	  beads	  were	  used	  as	  
control	  for	  the	  non-­‐specific	  binding	  in	  untreated	  cells	  (first	  lane	  in	  the	  IP	  blot	  shown	  
in	   Figure	   5.11a).	   Surprisingly,	   GFP-­‐WT	   fascin	   was	   immuno-­‐precipitated	   by	   FAK	   in	  
untreated	   cells	   (second	   lane	   in	   the	   IP	   blot	   in	   Figure	   5.11a).	   No	   fascin	   band	   was	  
detected	   in	   the	   IgG	   negative	   control	   lane.	   Interestingly,	   GFP-­‐fascin	   was	   readily	  
detected	   in	   the	  UT	   cells	   in	   a	   complex	  with	   FAK,	   and	   this	  was	   significantly	   lower	   in	  
cells	  treated	  with	  either	  NOC	  or	  taxol.	  Figure	  5.11b	  shows	  densitometry	  analysis	  of	  
multiple	   IP	   experiments.	   Data	   shows	  WT	   fascin	   forms	   a	   complex	  with	   FAK	   and	   its	  
formation	   is	   dependent	   on	  MT	   integrity	   (p-­‐value	   of	  WT	   fascin-­‐GFP	   IPed	   by	   FAK	   in	  
NOC	  or	  taxol	  cells	  compared	  to	  UT	  cells:	  p-­‐value	  =<	  0.005).	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Figure	  5.10	  demonstrates	  that	  different	  fascin	  mutant	  expression	  results	  in	  different	  
p-­‐FAK	  levels	  and	  localisation.	  After	  observing	  WT	  fascin	  complex	  formation	  with	  FAK,	  
the	   next	   step	   was	   to	   test	   the	   ability	   of	   the	   different	   fascin	   mutants	   to	   form	   a	  
complex	   with	   FAK.	   FAK	   IP’s	   were	   therefore	   performed	   as	   before	   in	   lysates	   from	  
MDA-­‐MB-­‐231	   fascin	   knockdown	   cells	   re-­‐expressing	  GFP-­‐WT,	   S39A,	   S39D,	   S274A	  or	  
S274D	  fascin	  constructs	  (Figure	  5.11c,d).	  IgG-­‐coated	  beads	  were	  used	  as	  a	  control	  for	  
non-­‐specific	  binding	  as	  in	  Figure	  5.11a.	  Figure	  5.11c	  shows	  example	  western	  blots	  of	  
these	  experiments.	  All	  fascin	  mutants	  were	  detected	  in	  a	  complex	  with	  FAK,	  but	  with	  
differences	   in	  the	   level	  of	  co-­‐association.	  Figure	  5.11d	  shows	  densitometry	  analysis	  
of	  multiple	  IP	  experiments.	  S39A	  fascin	  showed	  a	  modest	  but	  significant	  increase	  in	  
binding	  to	  FAK	  compared	  to	  WT	  fascin.	  S39D	  fascin	  was	  also	  found	  in	  complex	  with	  
FAK,	  at	  much	  higher	  levels	  than	  any	  of	  the	  other	  fascin	  constructs	  analysed.	  Similar	  
levels	   of	   S274A	   fascin	   were	   immuno-­‐precipitated	   with	   FAK	   to	   that	   seen	   for	   WT	  
fascin.	   S274D	   fascin	   however	   formed	   similar	   levels	   in	   complex	   with	   FAK	   as	   S39D	  
fascin.	  Data	  confirms	  that	  S39D	  fascin	  shows	  the	  highest	  association	  with	  total	  FAK	  in	  
a	  complex,	  followed	  by	  S274D,	  S39A	  and	  WT/S274A	  fascin	  respectively.	  
	  
Finally,	   to	   investigate	   whether	   fascin	   was	   able	   to	   directly	   bind	   to	   FAK,	   pull-­‐down	  
assays	  were	  performed	  using	  purified	  GST	   tagged	  domains	  of	   FAK.	   The	  diagram	   in	  
Figure	  5.11e	  shows	  the	  three	  main	  domains	  of	  the	  FAK	  protein:	  the	  N-­‐terminal	  FERM	  
domain,	   a	   central	   kinase	   domain	   and	   a	   C-­‐terminal	   focal	   adhesion-­‐targeting	   (FAT)	  
region.	  The	  FERM	  domain	  at	  the	  N	  terminus	  of	  FAK	  is	  known	  to	  binding	  scaffolding	  
proteins	   such	   as	   ezrin	   that	   indirectly	   link	   to	   the	   actin	   cytoskeleton	   (Frame	   et	   al.	  
2010).	  The	  kinase	  domain,	  which	  contains	  Y397,	  is	  essential	  for	  FAK	  phosphorylation	  
activity	   (M.	   Schober	   et	   al.	   2007)	   and	   the	   C	   terminus	   contains	   the	   Focal	   Adhesion	  
Targeting	   (FAT)	  domain,	  which	   is	   critical	   to	   recruit	   FAK	  and	  other	  proteins	   such	  as	  
Talin	  and	  Paxillin	  at	  FA	  (Hamadi	  et	  al.	  2005).	  Figure	  5.11e	  shows	  a	  Coomassie	  stained	  
gel	   to	   show	   the	   presence	   of	   purified	   GST-­‐FAK	   domains.	   Importantly,	   despite	  
numerous	   attempts	   under	   different	   optimization	   conditions	   it	   emerged	   that	   the	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Kinase	   domain	   of	   FAK	   was	   not	   suitable	   for	   protein	   production	   as	   it	   was	   toxic	   to	  
bacteria	  (see	  Material	  and	  Methods).	  Thus	  only	  FERM	  and	  C-­‐terminal	  domains	  could	  
be	  considered	  in	  these	  assays.	  GST	  tagged	  FAK	  proteins	  or	  GST	  alone	  were	  incubated	  
with	   lysates	   from	  MDA	   MB	   231	   cells	   expressing	   GFP-­‐WT	   fascin	   and	   subjected	   to	  
analysis	  of	  complexes	  by	  SDSPAGE	  gel	  and	  western	  blotting.	  Figure	  5.11f	  shows	  an	  
example	   of	   a	   western	   blot	   performed	   to	   detect	   WT	   fascin	   pulled	   down	   by	   FAK	  
domains.	   Fascin	   was	   not	   pulled	   down	   by	   any	   of	   the	   FAK	   domains	   (Figure	   5.11f),	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Figure	  5.11.	  Fascin	  forms	  a	  complex	  with	  FAK	  
(a)	   Immunoprecipitation	  of	  WT	  fascin	  with	  total	  FAK	  (and	  IgG	  as	  control)	   in	  MDA-­‐
MB-­‐231	   rescue	   cells	   untreated	   (UT),	   nocodazole	   treated	   (NOC)	   and	   taxol	   treated	  
(TAX).	   (b)	   Statistical	   analysis	   of	   immunoprecipitated	   fascin	   was	   performed	   by	  
densitometry	  analysis	  of	  three	  experiments.	  P-­‐value	  =<	  0.005	  (**)	  was	  considered	  
as	  significant.	  Data	  are	  expressed	  as	  mean±	  sem	  and	  corrected	  on	  total	  FAK	  loading	  
as	   control.	   (c)	   Immunoprecipitation	   of	   WT	   and	   mutant	   fascin	   with	   total	   FAK	   in	  
MDA-­‐MB-­‐231	   control	   cells	   rescued	   for	   WT	   and	   mutant	   fascin	   expression.	   (d)	  
Statistical	  analysis	  of	  immunoprecipitated	  WT	  and	  mutant	  fascin	  was	  performed	  by	  
densitometry	  analysis	  of	  three	  experiments.	  P-­‐value	  =<	  0.05	  (*)	  was	  considered	  as	  
significant.	  Data	  are	  expressed	  as	  mean±	  sem	  and	  corrected	  on	  total	  FAK	  loading	  as	  
control.	   (e)	   Graphic	   panel	   and	   coomassie	   staining	   of	   GST-­‐tagged	   FAK	   domain	  
purification.	  (f)	  Pull-­‐down	  assay	  between	  GST-­‐tagged	  FAK	  domains	  and	  His6-­‐tagged	  
WT	  fascin.	  GST-­‐Kinase	  domain	  of	  FAK	  is	  missing	  in	  (f)	  as	  the	  domain	  is	  not	  suitable	  
for	  protein	  production. 
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DISCUSSION	  	  
	  
Data	  presented	  in	  this	  chapter	  proposes	  fascin	  as	  a	  molecular	  mediator	  of	  the	  actin-­‐
MT	   crosstalk	   in	   human	   cancer	   cells.	  MT	   are	   known	   to	   play	   a	   role	   in	   regulating	   FA	  
stability	  and	  turnover	  (Ezratty	  et	  al.	  2005;	  Wehrle-­‐Haller	  &	  Imhof	  2003).	  Moreover,	  
MT	  regulation	  on	  FA	  also	  involves	  a	  feedback	  control	  of	  MT	  dynamics	  by	  actin-­‐based	  
structures.	  For	  instance,	  stress	  fibers	  emanating	  from	  FA	  can	  act	  to	  stabilise	  the	  MT	  
network	   (Kaverina	   et	   al.	   1998).	   How	   this	   crosstalk	   is	   maintained	   remains	   poorly	  
understood,	  although	  some	  molecules	  have	  been	  proposed	  as	  key	  regulators	  of	  this	  
process.	   For	   example,	   +TIP	   MT	   binding	   protein	   family	   members	   have	   been	  
demonstrated	   to	   co-­‐operate	   with	   actin-­‐dependent	   structures	   in	   different	   cellular	  
contexts	  (Geraldo	  et	  al.	  2008;	  Byron	  et	  al.	  2012).	  For	  instance,	  the	  +	  TIP	  MT	  binding	  
protein	  EB3	  has	  been	  shown	  to	  localise	  to	  filopodia	  protrusions	  by	  direct	  binding	  to	  
drebrin,	   a	   F-­‐actin	   associated	   protein	   (Geraldo	   et	   al.	   2008).	   Large	   scaffold	   proteins	  
such	  as	  ACF7	  have	  also	  been	  shown	  to	  act	  as	   linking	  molecules	  between	  actin	  and	  
MT	   (Jefferson	  et	   al.	   2004;	  Wu	  et	   al.,	   2011).	  However	   common	   signalling	  pathways	  
involved	   in	   the	   regulation	   of	   both	   actin	   and	   MT-­‐based	   structures	   are	   still	   poorly	  
defined,	   particularly	   in	   the	   context	   of	   cancer	   cell	   invasion.	   Data	   presented	   in	   this	  
Chapter	  showed	  that	  fascin	  plays	  a	  role	  in	  regulating	  both	  actin	  and	  MT	  in	  response	  
to	  either	  MT	  or	  actin	  depolymerizing	  drugs.	  Thus,	  fascin	  may	  be	  a	  novel	  addition	  to	  
the	  family	  of	  proteins	  that	  act	  at	  the	  interface	  between	  actin	  and	  MT	  cytoskeletons.	  	  
	  
Data	  presented	  here	  showed	  that	  WT	  fascin	  is	  able	  to	  directly	  associate	  with	  MT	   in	  
vitro.	  However,	  details	  of	  how	  fascin	  may	  bind	  to	  MT	  from	  a	  structural	  perspective	  
remain	   untested.	   Indeed,	   fascin	   is	   not	   comprised	   of	   α-­‐helices,	   which	   are	  
characteristic	  of	  many	  of	  MT+	  TIP	  protein	  structures	  (Akhmanova	  &	  Steinmetz	  2008).	  
Moreover,	   in	   silico	   or	   alignment	   analysis	   to	   identify	   putative	  MT	   binding	   domains	  
within	   fascin	   have	   not	   revealed	   any	   sequence	   homology	   between	   fascin	   and	  MT-­‐
related	  proteins.	  However,	  MT	  binding	  domains	  are	  notoriously	  difficult	   to	   identify	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using	   such	  means,	  meaning	   that	   a	  MT	  binding	  domain	  may	   exist	  within	   fascin	   but	  
that	   extensive	   domain	   deletion	   or	  mutagenesis	   experiments	  would	   be	   required	   to	  
identify	   this	   site.	   Potential	   MT-­‐binding	   domains	   on	  MT	   associate	   proteins	   (MAPs)	  
have	   been	   identified	   from	   the	   alignment	   of	   selected	   peptides	   to	   MAPs	   sequence	  
(Cao	  &	  Mao	  2009).	   Some	  of	   these	  MT-­‐binding	  domains	  were	   found	   in	  Proline-­‐rich	  
regions	  or	   basic	   stretches	   and	  others	   in	   Ser/Thr/Val/Lys	   (S/T/V/K)-­‐rich	   regions	   and	  
repeats.	   Alignment	   analysis	   revealed	   two	   putative	   S/T/V/K	   rich	   regions	  within	   the	  
second	   and	   the	   fourth	   β-­‐trefoil	   domain	   of	   fascin.	   Although	   we	   could	   not	   find	   a	  
potential	  MT-­‐binding	  region	  in	  the	  third	  β-­‐trefoil	  domain	  (containing	  the	  Ser274),	  the	  
second	  β-­‐trefoil	  domain	  of	  fascin	  resides	   in	  the	  same	  cleft	  of	  the	  protein	  structure.	  
Indeed,	   the	   fascin	   polypeptide	   is	   known	   to	   fold	   into	   four	   β-­‐trefoil	   domains	   with	  
domain	   1-­‐2	   and	  3-­‐4	   forming	   two	   semi-­‐independent	   units	   related	  by	  pseudo-­‐2-­‐fold	  
symmetry	  (Jansen	  et	  al.,	  2011)	  Consequently,	  domains	  2	  and	  3	  (as	  domains	  1	  and	  4)	  
are	  parts	  of	  two	  independent	  units	  and	  they	  face	  each	  other	  forming	  a	  cleft	  in	  fascin	  
structure.	   The	   cleft	   formed	   by	   domains	   1	   and	   4	   is	   critical	   in	   actin	   binding.	  On	   the	  
other	  hand,	  a	  MT-­‐binding	  cleft	  may	  be	   formed	  between	  domains	  2	  and	  3.	   Indeed,	  
the	  potential	  MT-­‐binding	  regions	  within	  the	  second	  β-­‐trefoil	  domain	  may	  co-­‐operate	  
with	  the	  Ser274	  within	  the	  third	  β-­‐trefoil	  domain	  in	  the	  MT-­‐binding.	  Ongoing	  work	  in	  
the	  lab	  aims	  to	  further	  investigate	  this	  hypothesis	  by	  studying	  different	  affinities	  to	  
F-­‐actin	   and/or	   MT	   of	   fascin	   mutants	   differentially	   mutated	   within	   the	   second	   β-­‐
trefoil	  domain.	  
	  
It	   is	  not	  yet	  clear	  how	  the	  proposed	  phosphorylation	  cycles	  on	  the	  two	  major	  actin	  
binding	   sites	   as	   discussed	   in	   the	   previous	   chapter	  might	   contribute	   to	   changes	   in	  
fascin	   structure.	   In	   Chapter	   4,	   a	   dual	   role	   of	   fascin	   in	   regulating	   actin	   and	   MT	  
dynamics	  depending	  on	  both	  serines	  phosphorylation	  state	  was	  proposed.	  A	  recent	  
study	  shows	  that	  both	  major	  actin	  binding	  sites	  on	  fascin	  are	  critical	   in	  bundling	  F-­‐
actin	   and	   that	   any	   impairment	   in	   one	   actin	   binding	   site	   leads	   to	   a	   concerted	  
conformational	  change,	  which	  disables	  the	  other	  actin	  binding	  site	  (Yang	  et	  al.	  2013).	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In	  particular,	  their	  structural	  analysis	  showed	  fascin	  mutants	  in	  all	  actin-­‐binding	  sites	  
to	  display	  the	  same	  inactive	  configuration.	  They	  therefore	  concluded	  that	  the	  actin-­‐
binding	   sites	   are	   conformationally	   interconnected.	   Moreover,	   they	   proposed	   that	  
individual	   fascin	   proteins	   are	   in	   constant	   motion,	   sampling	   active,	   inactive	   and	  
possibly	  other	  conformations.	   It	   is	  therefore	  reasonable	  to	  propose	  a	  dynamic	  dual	  
role	  of	  fascin	  in	  regulating	  actin	  and	  MT	  cytoskeletons.	  The	  in	  vitro	  co-­‐sedimentation	  
assay	   shown	   in	   this	   Chapter	   demonstrate	   that	   S274D	   fascin	   is	   the	   only	  mutant	   to	  
preferentially	  bind	  to	  MT,	  and	  this	  binding	   level	   is	  unchanged	  in	  the	  presence	  of	  F-­‐
actin.	  Our	  model	  proposes	  a	  dual	  role	  for	  fascin	  that	  controls	  switching	  between	  F-­‐
actin	  and	  MT,	  depending	  on	  the	  serine	  phosphorylation	  state.	  	  
	  
S274D	  fascin-­‐MT	  binding	  may	  also	  promote	  a	  negative	  feedback	  control	  on	  assembly	  
of	   fascin-­‐dependent	   F-­‐actin-­‐based	   structures.	   Conversely,	   S39A-­‐actin	   binding	   may	  
promote	  MT	   stability.	   Data	   presented	   in	   Chapter	   4	   showed	   that	   S39A	   and	   S274D	  
fascin	  expressing	  cells	  have	  similar	   increases	   in	   large	  bundles	  of	  acetylated	  tubulin,	  
which	   further	   suggests	   that	   both	   mutants	   can	   contribute	   to	   MT	   dynamics	   under	  
basal	   conditions,	   but	   that	   S39A	   fascin	   may	   be	   additionally	   preferentially	  
phosphorylated	   at	   S274	   in	   order	   to	   fulfill	   this	   task.	   Further	   experiments	  would	   be	  
required	   to	   analyse	   this	   using	   either	   double	   S39A/S274D	   mutants,	   or	   antibodies	  
specifically	  recognizing	  the	  phosphorylation	  at	  each	  Serine	  site	  individually.	  	  
	  
Data	   presented	   here	   demonstrates	   that	   active	   p-­‐Y397FAK	   may	   play	   a	   role	   in	  
combination	   with	   fascin	   in	   regulating	   both	   basal	   FA	   turnover	   and	   FA	   disassembly	  
following	  NOC	  washout.	   FAK	  phosphorylation	  on	  Tyrosine	  397	   (p-­‐FAK)	   is	   known	   to	  
promote	  the	  formation	  of	  a	  FAK-­‐Src	  complex	  and	  increase	  basal	  FA	  turnover	  (Tomar	  
&	   Schlaepfer	   2009).	   Moreover,	   p-­‐FAK	   has	   been	   shown	   to	   be	   involved	   in	   the	   co-­‐
ordination	   of	   dynamin-­‐dependent	   endocytosis	   at	   FA	   and	   thus	   acts	   to	   promote	   FA	  
disassembly	  after	  NOC	  washout	  (Ezratty	  et	  al.	  2005).	  Data	  presented	  in	  this	  Chapter	  
shows	   that	   levels	   of	   fascin	   can	   regulate	   levels	   of	   p-­‐FAK	   and	   this	   potentially	   can	   in	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turn	  explain	  differences	  in	  basal	  FA	  size	  and	  number	  seen	  in	  cells	  depleted	  of	  fascin	  
or	   re-­‐expressing	   fascin	  mutants.	   Low	   levels	   of	   p-­‐FAK	   in	   fasKD	   cells	   correlated	  with	  
increased	  numbers	  of	  FA	  observed	  in	  these	  cells	  in	  Chapter	  3.	  Moreover,	  fasKD	  cells	  
do	  not	  increase	  p-­‐FAK	  levels	  after	  NOC	  washout	  as	  was	  seen	  in	  WT	  fascin	  expressing	  
cells,	  suggesting	  fascin	  also	  plays	  a	  role	  in	  regulating	  activation	  of	  FAK	  to	  promote	  FA	  
disassembly	  following	  MT	  re-­‐growth.	  Further	  experiments	  demonstrated	  evidence	  of	  
a	  fascin-­‐FAK	  complex	  and	  that	  this	  was	  dependent	  on	  MT	  integrity.	  The	  formation	  of	  
a	  fascin	  complex	  with	  FAK	  may	  explain	  the	  mechanisms	  driving	  both	  fascin	  roles	   in	  
both	  basal	  and	  MT-­‐dependent	  FA	  dynamics.	  Evidence	  presented	  here	  suggests	  fascin	  
is	   not	  directly	  bound	   to	   FAK	  but	   instead	  may	   form	  part	  of	   a	   larger	  multimolecular	  
complex	  with	  FAK	  bridged	  by	  another	  protein	  or	  proteins.	  Indeed,	  fascin	  localises	  at	  
the	  cell	  periphery	  in	  basal	  conditions,	  where	  it	  is	  possible	  that	  fascin	  may	  act	  to	  form	  
the	  complex	  with	  FAK	  and	  promoting	  FA	  turnover	  through	  its	  phosphorylation.	  NOC	  
treatment	   leads	   to	  FA	  growth,	  but	  without	  a	  change	   in	   total	  p-­‐FAK	   levels,	  which	   is	  
indicative	   of	   FA	   stabilization.	   It	   is	   possible	   that	   under	   these	   conditions,	   fascin-­‐FAK	  
complexes	  are	  reduced	  or	  lost,	  and	  fascin	  is	  no	  longer	  present	  at	  the	  cell	  periphery,	  
or	   in	   proximity	   to	   FA	   complexes	   or	   active	   FAK.	   Several	   FA	   components,	   such	   as	  
Paxillin	  and/or	  Talin	  have	  already	  been	  shown	  to	  be	  associated	  with	  FAK	  (Schober	  et	  
al.	  2007),	  but	  their	  role	  in	  increasing	  FA	  assembly	  during	  MT	  de-­‐polymerisation	  has	  
not	   been	   investigated.	   Therefore,	   data	   presented	   here	   demonstrated	   fascin-­‐FAK	  
complex	   formation	   is	   involved	   in	   regulating	   basal	   and	  MT-­‐dependent	   FA	   turnover	  
but	  the	  accessory	  or	  scaffold	  molecules	  that	  form	  part	  of	  this	  complex	  have	  yet	  to	  be	  
defined.	  
	  
Fascin-­‐complex	   formation	   with	   FAK	   provides	   a	   possible	   mechanism	   by	   which	   WT	  
fascin	   is	   translocated	   to	   the	   cell	   periphery	   and	   then	   drives	   basal	   FA	   turnover.	  
Experiments	   shown	   in	   this	   thesis	  did	  not	   investigate	   the	  phosphorylation	   status	  of	  
FAK	   when	   in	   a	   complex	   with	   fascin.	   However,	   images	   showed	   WT	   fascin	   co-­‐
localisation	  with	  p-­‐397	  FAK	  at	  FA	  suggesting	  that	  the	  kinase	  may	  be	  phosphorylated	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when	  in	  complex	  with	  fascin.	  Moreover,	  biochemical	  data	  presented	  in	  this	  chapter	  
showed	  differences	  in	  fascin	  ability	  to	  form	  the	  complex	  with	  FAK	  depending	  on	  its	  
actin	   binding	   ability.	   This	   also	   correlates	   with	   differences	   in	   basal	   FA	   numbers	  
observed	  in	  the	  fascin	  mutant	  rescue	  cells	  (Chapter	  4).	  S39A	  fascin,	  which	  is	  bound	  
to	  actin	  at	  the	  periphery,	   is	  able	  to	  form	  a	  complex	  with	  FAK,	  albeit	  at	   lower	  levels	  
than	  seen	  with	  S39D	  or	  S274D	  fascin.	  However,	  S39A	  fascin	  does	  not	  show	  clear	  co-­‐
localisation	   with	   p-­‐397	   FAK	   as	   was	   observed	   for	   WT	   or	   S274D	   fascin.	   This	   may	  
explain	  why	  FA	  do	  not	  disassemble	  properly	   in	   the	  S39A	   fascin	   rescue	  cells,	  as	   the	  
fascin-­‐FAK	   complex	   is	   potentially	   less	   strong	   and	   thus	   fascin	   is	   unable	   to	   exert	   its	  
effects	  over	  p-­‐FAK	  dependent	  FA	  disassembly.	  This	  combined	  with	  the	  higher	  levels	  
of	  acetylated,	   stable	  MT	  seen	  under	  basal	  conditions	   in	   the	  S39A	   fascin	  expressing	  
cells	  would	  also	  slow	  down	  FA	  disassembly	  and	   lead	  to	  the	   larger	  FA	  seen	   in	  these	  
cells,	   as	  well	   as	   the	   increased	   cell	   adhesion	   (Chapter	   4).	   Interestingly,	   S39D	   fascin	  
was	  seen	  at	   the	  highest	   levels	   in	  complex	  with	  FAK	  by	  co-­‐IP,	  suggesting	  that	   fascin	  
forms	  a	  tighter	  complex	  when	  it	  is	  not	  bound	  to	  actin.	  However,	  S39D	  fascin	  complex	  
formation	   with	   FAK	   does	   not	   promote	   the	   FAK	   activation	   and/or	   S39D	   fascin	  
localisation	  at	  the	  cell	  periphery.	  This	  may	  suggest	  that	  the	  complex	  is	  too	  stable	  to	  
promote	  normal	  FA	  turnover.	  S274A	  fascin	  did	  not	  show	  a	  notable	  ability	  to	  form	  a	  
complex	   with	   FAK	   and	   did	   not	   co-­‐localise	   with	   p-­‐FAK.	   However,	   S274A	   fascin	   can	  
bundle	   F-­‐actin	   in	   an	   actin-­‐binding	   independent	   manner,	   and	   previous	   data	   has	  
suggested	  a	  distinct	  filopodial	  tip	  localization	  of	  this	  mutant	  that	  suggests	  additional	  
alternative	  binding	  partners	  (Zanet	  et	  al.	  2012).	  Thus	  it	  is	  plausible	  that	  this	  mutant	  
acts	  through	  an	  as	  yet	  unidentified	  alternative	  pathway	  that	   is	   largely	   independent	  
of	  actin	  or	  MT	  binding	  capabilities.	  This	  will	  require	  more	  detailed	  analysis	  in	  future.	  
274D	  fascin	  showed	  higher	  binding	  in	  complex	  with	  FAK	  compared	  to	  WT,	  but	  lower	  
than	   S39D	  mutant.	   However,	   S274D	   fascin	   co-­‐localised	   with	   p-­‐397	   FAK	   at	   FA	   and	  
S274D	   expressing	   cells	   showed	   higher	   levels	   of	   active	   FAK.	   It	   is	   therefore	   possible	  
that	   S274D	   fascin,	   which	   shows	   preferential	   association	   with	   MT	   in	   vitro	   and	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promotes	  MT	  stability	  is	  able	  to	  more	  readily	  form	  a	  complex	  with	  FAK	  and	  thereby	  
co-­‐ordinate	  MT	  and	  FAK	  within	  FA	  at	  the	  cell	  membrane.	  
	  
Data	   presented	   in	   this	   chapter	   shows	   neither	   S39A	   nor	   S39D	   fascin	   expression	  
promotes	  basal	  FA	  turnover.	  Indeed,	  S39A	  fascin	  expressing	  cells	  showed	  very	  large	  
and	   stable	  FA	  and,	   conversely,	   S39D	   fascin	  expressing	   cells	   showed	  very	   small	   and	  
immature	   FA.	   The	   S39A	   fascin	   complex	   formation	   with	   FAK	   and	   the	   protein	  
localisation	   at	   the	   cell	   periphery	   (bound	   to	   actin)	   may	   promote	   the	   increased	   FA	  
assembly	   in	   these	   cells,	   but	   another	   mechanism	   is	   involved	   in	   inducing	   FA	  
disassembly	  and	  thus	  turnover.	  On	  the	  other	  hand,	  the	  increased	  level	  of	  S39D	  fascin	  
in	  complex	  with	  FAK	  may	  disrupt	  FA	  growth.	  Indeed	  this	  complex	  does	  not	  correlate	  
with	  fascin	  translocation	  to	  the	  cell	  periphery	  or	  the	  high	  levels	  of	  peripheral	  active	  
FAK.	  The	  S274D	  fascin	  expressing	  cells	  showed	  the	  same	  size	  and	  number	  of	  FA	  as	  
the	   S39A	   fascin	   cells.	   As	   previously	   discussed,	   despite	   not	   being	   able	   to	   efficiently	  
bundle	  actin,	  274D	  fascin	  was	  also	  found	  to	  localise	  at	  the	  cell	  periphery	  as	  seen	  for	  
WT	  fascin.	  	  This	  localisation	  and	  co-­‐localisation	  with	  the	  ends	  of	  MT	  and	  active	  FAK	  
may	  contribute	  to	  the	  decreased	  FA	  disassembly	  seen	  in	  cells	  expressing	  this	  mutant.	  
In	   addition,	   S274D	   expressing	   cells	   showed	   lower	   adhesion	   and	   smaller	   cell	   area	  
compared	  to	  S39A	  expressing	  cells	  (Chapter	  4).	  These	  observations	  suggest	  that	  the	  
large	   FA	   in	   S274D	   fascin	   expressing	   cells	  may	   potentially	   support	   faster	   spreading	  
through	   the	   control	  of	   cell	  membrane	   contact	   area	  with	   the	   substrate.	   I	   therefore	  
concluded	   that	   peripherally	   localized	   S274D	   fascin	   has	   a	   role	   in	   regulating	   FA	  
disassembly,	   in	   an	   actin-­‐binding	   independent	  manner.	   Accordingly,	   the	  WT	   fascin-­‐
FAK	   complex	   was	   also	   shown	   to	   be	   dependent	   on	  MT	   integrity	   as	   decreased	  MT	  
instability	   promoted	   fascin-­‐FAK	   complex	   formation.	   MT	   instability	   decreases	  
drastically	  after	  NOC	  washout	  and	  S274D	  fascin	  appears	  to	  play	  a	  primary	  role	  in	  this	  
context.	   Therefore,	   S274D	   fascin-­‐MT	   binding	   may	   control	   fascin-­‐FAK	   complex	  
formation	   and	   regulate	   FA	   turnover	   in	   both	   basal	   and	   NOC-­‐induced	   conditions.	  
However,	   data	   shown	   in	   Chapter	   4	   demonstrates	   that	   S274D	   cells	   do	   not	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disassemble	   FA	   following	  NOC	  washout,	   but	   show	  an	   opposite	   FA	   response	   in	   the	  
NOC	  assay	  compared	  with	  WT	  and	  S274A	  mutant.	  This	  suggests	  that	  the	  fascin-­‐FAK	  
complex	   seen	   in	   the	   case	   of	   this	   mutant	   is	   not	   active	   or	   viable	   in	   terms	   of	   the	  
promoting	   FAK-­‐dependent	   MT-­‐induced	   FA	   disassembly.	   Chapter	   4	   showed	   fascin	  
actin-­‐binding	  at	  S39	   is	  not	   required	   for	  MT-­‐induced	  FA	  disassembly;	   therefore,	   the	  
mechanism	  controlling	  S274-­‐dependent	  FA	  crosstalk	  requires	  further	  investigation.	  It	  
is	  possible	   that	  S274	  needs	   to	  be	  de-­‐phosphorylated	   to	  enable	  p-­‐FAK	   to	   induce	  FA	  
disassembly,	  and	  that	  the	  S274D	  fascin,	  locked	  in	  a	  phospho-­‐mimetic	  state,	  is	  unable	  
to	  undergo	  this	  transition.	  	  
	  
In	  conclusion,	  data	  presented	  in	  this	  chapter	  proposes	  fascin	  phosphorylation	  status	  
as	  a	  critical	  event	  to	  controlling	  fascin	  binding	  to	  MT	  and/or	  FAK	  and	  thereby	  basal	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6.1.	  Fascin	  regulates	  focal	  adhesion	  assembly	  and	  disassembly	  potentially	  through	  
direct	  interactions	  with	  microtubules	  	  
	  
A	   role	   for	   fascin	   in	   regulating	   Focal	   Adhesion	   (FA)	   turnover	   has	   previously	   been	  
suggested,	   as	   colon	   carcinoma	   cells	   depleted	   of	   fascin	   showed	   more	   stable	   FA	  
(Hashimoto	  et	  al.	  2007).	  However,	  fascin	  has	  not	  been	  previously	  shown	  to	  localise	  
in	   FA	   and	   therefore	   the	   mechanism(s)	   by	   which	   it	   regulates	   adhesion	   structure	  
dynamics	   is	   still	  poorly	  understood.	  Microtubules	   (MT)	  have	  been	  widely	  shown	  to	  
target	   FA	   components	   promoting	   their	   turnover	   (Ganguly	   et	   al.	   2012;	   Stehbens	  &	  
Wittmann	  2012).	  The	  nocodazole	  (NOC)	  treatment	  and	  washout	  assay	  employed	  in	  
this	  thesis	  is	  widely	  used	  to	  control	  FA	  assembly/disassembly	  and	  permit	  the	  role	  of	  
MT	  and	  associated	  proteins	  in	  FA	  turnover	  to	  be	  dissected.	  MT	  re-­‐growth	  following	  
NOC	  washout	  has	  been	  shown	  to	  induce	  FA	  disassembly	  in	  fibroblasts	  (Ezratty	  et	  al.	  
2005)	   and	  data	   in	   this	   thesis	   demonstrates	   that	   this	   is	   also	   the	   case	   in	  breast	   and	  
cervical	  cancer	  cells.	  Moreover,	  data	  presented	  in	  Chapter	  3	  (Results	  1)	  showed	  that	  
fascin	   is	   important	   in	  the	  control	  of	  both	  MT	  re-­‐growth	  and	  FA	  disassembly	   in	  cells	  
post-­‐NOC	  washout.	  	  
	  
The	   localization	  of	  WT	  fascin	  with	  MT	  at	   the	  cell	  periphery	  prompted	  us	  to	   further	  
analyse	   the	   fascin-­‐dependent	   mechanisms	   controlling	   both	   MT	   recovery	   and	   the	  
subsequent	  FA	  turnover.	  Data	  demonstrated	  that	  fascin	  was	  able	  to	  directly	  interact	  
with	  polymerised	  MT	   in	  vitro,	  and	  was	  also	  required	  to	  promote	  MT-­‐dependent	  FA	  
disassembly	   in	   cells.	   Furthermore,	   the	   S274	   phospho-­‐mimic	   mutant	   of	   fascin	  
(S274D),	   which	   we	   have	   previously	   shown	   is	   unable	   to	   bind	   to	   actin	   or	   support	  
filopodia	   formation	   (Zanet	   et	   al.	   2012),	   demonstrated	   a	   higher	   affinity	   for	   MT	  
compared	  to	  WT	  fascin	  and	  the	  other	  mutant	  fascin	  proteins	  tested.	  Moreover,	  the	  
association	  between	  S274D	  fascin	  and	  MT	   in	  vitro	  was	  unchanged	  in	  presence	  of	  F-­‐
actin,	  suggesting	  phosphorylation	  at	  this	  residue	  may	  act	  to	  preferentially	  promote	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mediator	  of	  the	  actin-­‐MT	  crosstalk	  and	  potentially	  an	  important	  molecular	  linker	  in	  
the	  control	  of	  FA	  dynamics	  and	  cancer	  cell	  invasion.	  Table	  6.1	  provides	  an	  overview	  
of	  data	   from	  this	   thesis	   to	  summarise	  WT	  and	  mutant	   fascin	  actin	  and	  MT	  binding	  
activity.	  
	  
	   Actin	  binding	   Actin	  bundling	   	  	  	  	  	  MT	  binding	  
Fascin	  WT	   +	   +	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  +	  
Fascin	  S39A	   ++	   ++	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  +	  
Fascin	  S39D	   -­‐	   -­‐	   +	  
Fascin	  S274A	   -­‐	   +	   +	  
Fascin	  S274D	   -­‐	   -­‐	   ++	  
	  
Table	  6.1.	  WT	  and	  mutant	  fascin	  actin	  and	  MT	  binding	  activity	  	  
In	  the	  table	  above,	  +	  stands	  for	  ‘involved’,	  ++	  stands	  for	  ‘essential’	  and	  –	  stands	  for	  
‘not	  involved’.	  	  
	  
	  
The	  role	  of	  fascin	   in	  binding/bundling	  F-­‐actin	  structures	  has	  been	  well	  documented	  
by	   our	   lab	   and	   others	   (Anilkumar	   et	   al.	   2003;	   Hashimoto	   et	   al.	   2007;	   Parsons	   &	  
Adams	  2008;	  Vignjevic	  et	  al.	  2006).	  However,	  data	  presented	  in	  this	  thesis	  proposes	  
a	   dual	   role	   for	   fascin	   in	   regulating	   both	   actin	   and	   MT	   networks.	   Moreover,	   data	  
presented	  in	  Chapter	  4	  (Results	  2)	  showed	  fascin	  regulation	  to	  be	  dependent	  on	  the	  
phosphorylation	   state	   of	   the	   two	   characterised	   actin-­‐binding	   sites	   of	   the	   protein.	  
Serine	  39	  (S39),	  which	  is	  phosphorylated	  by	  classical	  Protein	  Kinase	  C	  (PKC)	  isoforms,	  
partly	   controls	   the	   actin-­‐binding	   and	   filopodia	   formation,	   and	   data	   shown	   in	   this	  
thesis	   demonstrates	   S39	   can	   also	   promote	   larger,	   more	   stable	   FA	   under	   basal	  
conditions,	  but	  does	  not	  appear	  to	  play	  a	  role	   in	  dynamic	  FA	  turnover.	  Conversely,	  
the	   expression	   of	   the	   MT-­‐associated	   S274D	   fascin	   regulated	   FA	   stability	   and	   also	  
showed	   clear	   localisation	   within	   peripheral	   adhesion	   structures.	   Actin-­‐MT	   binding	  
proteins	  captured	  by	  MT	  at	   the	  plasma	  membrane	  have	  been	  previously	   shown	  to	  
regulate	   cell	   spreading	   and	  migration	   (Zaoui	   et	   al.	   2010).	   Therefore,	   S274D	   fascin	  
may	   be	   delivered	   to	   the	   plasma	  membrane	   through	   its	   contact	  with	  MT	   and	   thus	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poorly	  characterised	  but	  our	  unpublished	  in	  silico	  analysis	  has	  suggested	  this	  site	  is	  a	  
consensus	   target	   sequence	   for	   Protein	   Kinase	   A	   (PKA).	   Interestingly,	   PKA	  
phosphorylation	  has	  already	  been	  shown	  to	  regulate	  the	  MT	  binding	  affinity	  of	  other	  
F-­‐actin	   binding	   proteins	   (Lee	   et	   al.	   2012).	   It	   therefore	   seems	   feasible	   that	   a	  
phosphorylation-­‐dependent	  switch	  in	  fascin	  may	  act	  to	  regulate	  its	  association	  with	  
actin	  or	  MT	  and	  therefore	  control	  FA	  assembly/disassembly.	  
	  
6.2.	  Phosphorylation	  cycling	  determine	  fascin	  association	  with	  actin	  and/or	  MT	  	  
	  
FA	  assembly	  and	  disassembly	  have	  recently	  been	  proposed	  to	  be	  controlled	  through	  
two	   distinct	   pathways.	   Several	   studies	   have	   shown	   adhesion	   disassembly	   is	   under	  
the	  control	  of	  RhoA	  and	  MT	  in	  signaling	  pathways,	  which	  are	  not	  directly	  involved	  in	  
FA	  assembly	  and	  stability	  (Chang	  et	  al.	  2008;	  Goldyn	  et	  al.	  2009;	  Rooney	  et	  al.	  2010).	  
Data	  presented	  in	  this	  thesis	  showed	  WT	  and	  S274D	  fascin	  associate	  with	  MT	  at	  the	  
cell	   periphery	   following	   NOC	   washout	   and	   this	   may	   be	   one	   way	   to	   direct	  MT	   re-­‐
growth	  and	  FA	  targeting.	  Indeed,	  MT-­‐S274D	  fascin	  expression	  restored	  MT	  network	  
assembly	   following	   NOC	  washout	   as	   efficiently	   as	  WT	   fascin.	   However,	   the	   S274D	  
mutant	  did	  not	  promote	  FA	  disassembly	  following	  NOC	  washout.	  This	  could	  be	  due	  
to	   the	   known	   inability	   of	   the	   S274D	   fascin	   to	   bind	   F-­‐actin	   and/or	   change	   its	  
association	  with	  MT	  in	  presence	  of	  F-­‐actin.	  An	  F-­‐actin-­‐MT	  cross-­‐linking	  protein	  relies	  
on	   its	   ability	   to	   re-­‐organise	   and	   dynamically	   integrate	   both	   actin	   and	   MT	  
cytoskeletons	   (Lee	   et	   al.	   2012;	   Geraldo	   et	   al.	   2008).	   Therefore,	   phosphorylation	  
cycles	   regulating	   WT	   fascin	   ability	   to	   bind	   F-­‐actin	   and	   MT	   may	   be	   crucial	   to	  
coordinate	   their	   roles	   in	   FA	   assembly/disassembly.	   The	   phosphorylation	   status	   of	  
S39	   when	   fascin	   is	   bound	   to	   MT	   remains	   unknown,	   but	   our	   in	   vitro	   and	   in	   vivo	  
analysis	   supports	   a	   potential	   role	   for	   a	   phosphorylation	   switch	   event	   at	   S39	   that	  
subsequently	   promotes	   FA	   disassembly,	   following	   274D	   fascin-­‐dependent	   MT	  
targeting.	  The	  peripheral	  localisation	  of	  both	  S39A	  and	  S274D	  fascin	  mutants,	  albeit	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phosphorylation	   status	   of	   each	   residue	   to	   control	   an	   on-­‐off	   switch	   in	   MT/actin	  
binding.	   Ongoing	   studies	   in	   the	   lab	   are	   evaluating	   this	   hypothesis	   by	   studying	   FA	  
dynamics	  in	  cells	  expressing	  fascin	  mutated	  at	  both	  S39	  and	  S274.	  	  
	  
Several	   recent	   studies	   have	   identified	  molecules	   and	   signals	   that	   control	   crosstalk	  
between	   actin	   and	  MT	   cytoskeletons.	   ACF7	   is	   one	   example	   of	   a	   large	   scaffolding	  
protein	   that	   has	   been	   shown	   to	   act	   as	   linking	   molecules	   between	   actin	   and	   MT	  
(Jefferson	   et	   al.	   2004;	  Wu	   et	   al.	   2011).	   Data	   presented	   in	   this	   thesis	   showed	   that	  
fascin	  plays	  a	  role	  in	  regulating	  both	  actin	  and	  MT	  in	  response	  to	  either	  MT	  or	  actin	  
depolymerizing	   drugs.	   Common	   signalling	   pathways	   involved	   in	   the	   regulation	   of	  
both	   actin	   and	   MT-­‐based	   structures	   are	   still	   poorly	   defined,	   particularly	   in	   the	  
context	  of	  cancer	  cell	  invasion.	  
	  
6.3.	  Fascin	  control	  of	  MT	  stability	  
	  
Fascin-­‐dependent	   regulation	   of	   MT	   dynamics	   was	   not	   directly	   measured	   in	   this	  
thesis.	  However,	  data	  demonstrated	  that	  fascin	  depletion	  did	  not	  alter	  MT	  network	  
assembly	  on	  a	  gross	  scale	  under	  basal	  conditions,	  but	  did	  lead	  to	  increased	  levels	  of	  
tubulin	   acetylation.	   Moreover,	   data	   demonstrated	   that	   S274D	   fascin	   co-­‐localised	  
with	   acetylated	   tubulin	   and	   thus	   contributing	   to	   their	   association	   at	   the	   cell	  
membrane.	   MT	   +TIP	   proteins	   such	   as	   EB1	   are	   known	   to	   promote	   MT	   assembly.	  
Therefore,	   it	   is	   possible	   that	   peripherally	   localised	   fascin	   may	   regulate	   MT	   +TIP	  
protein	   association	   with	   the	   MT	   network.	   Competition	   between	   fascin	   and	   +TIP	  
proteins	  may	   provide	   a	  way	   in	  which	   fascin	   could	   capture	   and	   stabilize	  MT	   at	   the	  
periphery	  in	  order	  to	  co-­‐ordinate	  FA	  targeting.	  Similarly,	  enzymes	  involved	  in	  tubulin	  
acetylation	  and	  stabilisation,	  such	  as	  HDAC6,	  have	  also	  been	  shown	  to	  alter	  adhesion	  
dynamics	  (Tran	  et	  al.	  2007;	  Gierke	  &	  Wittmann	  2012).	   	   It	   is	  possible	  therefore	  that	  
fascin	  may	  act	  to	  directly	  or	  indirectly	  control	  enzymes	  regulating	  tubulin	  acetylation	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As	   discussed	   in	   Chapter	   5	   (Results	   Chapter	   3),	   the	   structural	   details	   of	   the	   MT-­‐
binding	  domain	  of	  fascin	  are	  still	  unknown.	  However,	  analysis	  of	  putative	  consensus	  
MT	   binding	   domains	   within	   the	   fascin	   sequence	   revealed	   a	   possible	   MT-­‐binding	  
region	  within	   the	   second	  β-­‐trefoil	   domain.	   The	   second	  β-­‐trefoil	   domain	   lies	  within	  
the	   tertiary	   pseudo-­‐2-­‐fold	   symmetric	   structure	   of	   the	   fascin	   protein	   and	   acts	   in	  
concert	  with	  domain	  one	  to	  regulate	  the	  N-­‐terminal	  actin-­‐binding	  site.	  However,	  the	  
fold	  between	  domains	  2	  and	  3	  is	  also	  tightly	  controlled,	  potentially	  to	  allow	  fascin	  to	  
form	  the	  correct	  tertiary	  structure	  required	  to	  stabilize	  the	  correct	  conformation	  for	  
F-­‐actin	   bundling.	   Therefore,	   it	   is	   possible	   that	   the	   identified	   putative	   MT	   binding	  
sequence	   within	   the	   second	   β-­‐domain	   may	   undergo	   a	   conformational	   change	  
following	   post-­‐translational	   modification	   of	   S274	   on	   the	   third	   β-­‐trefoil	   domain	   to	  
promote	  MT	  binding.	   There	   is	   currently	  no	  data	   in	   the	   literature	   that	  explores	   the	  
potential	  for	  fascin	  to	  undergo	  conformational	  changes	  in	  response	  to	  actin	  binding	  
or	   post-­‐translational	  modification.	   However,	   ongoing	  work	   in	   the	   lab	   is	   evaluating	  
MT	  binding	  affinity	  and	  functions	   in	  cells	  of	   fascin	  mutated	   in	  residues	   lying	  within	  
the	   putative	  MT	   binding	   site	   in	   the	   second	   β-­‐trefoil	   domain	   of	   fascin.	   Identifying	  
mutant	  forms	  of	  fascin	  that	  bind	  specifically	  to	  MT	  or	  actin	  would	  permit	  important	  
future	   dissection	   of	   the	   relative	   contributions	   of	   fascin	   to	   regulating	   each	  
cytoskeletal	  network	  during	  cell	  migration	  and	  invasion.	  	  
	  
6.4.	  Fascin	  complexes	  with	  adhesion	  signaling	  molecules	  
	  
Focal	   Adhesion	   Kinase	   (FAK)	   has	   been	   shown	   to	   co-­‐operate	   with	   dynamin	   and	  
promote	  MT-­‐induced	  FA	  dynamics	  following	  NOC	  washout	   in	  fibroblasts	   (Ezratty	  et	  
al.	   2005;	   Wang	   et	   al.	   2011).	   Data	   shown	   in	   this	   thesis	   confirms	   that	   levels	   of	  
autophosphorylation	  of	  397-­‐Tyrosine	  on	  FAK	   is	  also	   tightly	   regulated	  during	  cancer	  
cell	   FA	   disassembly	   post-­‐NOC	   washout	   and	   this	   is	   dependent	   on	   the	   presence	   of	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complex	   that	   is	   indirect,	   and	   may	   act	   as	   a	   regulatory	   mechanism	   for	   fascin-­‐MT	  
translocation	   to	   the	  cell	  membrane.	  The	   fascin-­‐FAK	  complex	  was	   further	   shown	   to	  
depend	  upon	  fascin	  association	  with	  actin	  or	  MT.	  Both	  S39D	  and	  S274D	  fascin	  were	  
found	  at	  higher	   levels	   in	  complex	  with	  FAK,	  but	  only	  S274D	   fascin	  was	  seen	   to	  co-­‐
localise	  with	   p-­‐FAK	   at	   the	   plasma	  membrane.	   This	  may	   suggest	   that	   the	   observed	  
high	  levels	  of	  S274D	  fascin-­‐MT	  association	  may	  activate	  FAK	  and	  thus	  indirectly	  co-­‐
ordinate	  FA	  turnover.	  Conversely,	  the	  S39D	  fascin	  may	  favour	  binding	  to	  inactive	  FAK	  
and	   in	   doing	   so	   restrict	   delivery	   or	   localization	   of	   active	   FAK	   to	   FA.	   S39A	   fascin	   is	  
known	  to	  be	  stably	  bound	  to	  F-­‐actin	  and	  is	   located	  in	  peripheral	  filopodia,	  and	  this	  
may	  explain	  the	  lower	  levels	  of	  FAK	  found	  in	  complex	  with	  this	  mutant.	  An	  overview	  
of	   the	   proposed	  model	   for	   fascin-­‐dependent	   regulation	   of	  MT	   and	   FA	   dynamics	   is	  













	   208	  
Figure	  6.1.	  Proposed	  model	  of	  mutant	  fascin	  regulation	  of	  FA	  turnover	  through	  
direct	  binding	  to	  MT	  
	  (a)	   Fascin	   phosphorylation	   on	   S274	   (potentially	   PKA-­‐dependent)	   results	   in	   more	  
stable	   association	   between	   fascin	   and	   MT.	   (b)	   Fascin-­‐MT	   binding	   occurs	  
preferentially	   at	   the	   cell	   periphery.	   Phospho-­‐S274	   fascin	   forms	   a	   complex	   with	  
phospho-­‐FAK	  at	  the	  membrane	  and	  thus	  brings	  MT	  and	  FAK	  into	  close	  proximity	  and	  
promotes	  FA	  turnover.	  (c)	  Fascin	  that	  is	  de-­‐phosphorylated	  at	  S39	  bundles	  F-­‐actin	  at	  
the	  cell	  periphery,	  promoting	  FA	  assembly.	  (d)	  S39	  fascin	  also	  promotes	  MT	  stability	  
contributing	  to	  MT-­‐dependent	  FA	  turnover.	  (e)	  PKCα-­‐dependent	  phosphorylation	  of	  
the	   S39	   results	   in	   loss	   of	   actin	   bundling	   by	   fascin.	   (f)	   The	   cytosolic	   phospho-­‐S39	  
fascin	   forms	  a	  complex	  with	   inactive	  FAK.	  The	  potential	   function	  of	   this	  complex	   is	  
still	  unknown.	  (g)	  Fascin	  that	  is	  de-­‐phosphorylated	  at	  Ser274	  does	  not	  bundle	  F-­‐actin	  
and	  therefore	  does	  not	  promote	  FA	  assembly	  or	  contribute	   to	  FA	   turnover.	  Yellow	  
arrows	  show	  phosphorylation	  cycles	  on	  fascin	  and	  black	  arrows	  show	  the	  novel	  roles	  





6.5.	   Fascin	   as	   a	   F-­‐actin-­‐MT	   crosslinker:	   involvement	   in	   cancer	   cell	   adhesion	   and	  
invasion	  
	  
PKCα-­‐dependent	   fascin	   phosphorylation	   is	   known	   to	   promote	   filopodia	   and	  
invadopodia	   formation	   in	   invasive	   cancer	   cells.	   Indeed,	   high	   levels	   of	   fascin	  
expression	   have	   been	   proposed	   to	   act	   as	   a	  marker	   for	   poor	   prognosis	   in	   disease.	  
However,	  the	  precise	  changes	  in	  cytoskeletal	  network	  reorganisation	  associated	  with	  
fascin	   up-­‐regulation	   at	   the	   invasive	   tumour	   front	   have	   not	   been	   defined.	   Several	  
studies	  have	  speculated	  about	  an	  unknown	  role	  for	  fascin	  role	  beyond	  the	  ability	  to	  
control	   actin	   bundling	   (Machesky	   &	   Li	   2010;	   Zanet	   et	   al.	   2012).	   Data	   shown	   here	  
provides	   novel	   evidence	   to	   suggest	   that	   fascin	   may	   also	   regulate	   cytoskeletal	  
changes	  through	  direct	  associations	  with	  MT.	  Therefore,	  this	  thesis	  contributes	  to	  a	  
better	  understanding	  of	  the	  role	  of	  fascin	  in	  driving	  cancer	  cell	  adhesion	  and	  invasion	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switch	  that	   is	  controlled	  through	  action	  of	  PKC	  and	  potentially	  PKA.	  Such	  a	  cycle	  of	  
phosphorylation	  would	   thereby	   control	   fascin-­‐dependent	   filopodia	   stability	   as	  well	  
as	   invadopodia	   or	   FA	   dynamics,	   and	   thus	   locally	   and	   dynamically	   regulate	   the	  
cytoskeleton	   and	   cell	   invasion.	   It	   has	   been	   shown	   that	   altering	   or	   locking	   one	   or	  
more	  phosphorylation	  sites	  on	  fascin	  alters	  cytoskeletal	  structure	  assembly/stability	  
(Yang	   et	   al.	   2013).	   Additionally,	   the	   concept	   that	   different	   forms	   of	   fascin,	   both	  
active	  and	  inactive,	  exist	   in	  the	  cytosol	  has	  been	  proposed.	  It	   is	  therefore	  tempting	  
to	  speculate	  that	  fascin	  can	  also	  act	  as	  a	  dynamic	  modulator	  of	  cell	  sensing	  of	  the	  EC	  
environment	  and	  potentially	   respond	  to	   local	  changes	   in	  extracellular	  environment	  
during	  tumour	  cell	  invasion.	  An	  important	  future	  direction	  of	  this	  study	  would	  be	  to	  
study	   and	   correlate	   fascin	   association	   with	   MT	   and	   its	   regulation	   of	   FA	   with	   cell	  
invasion	  in	  a	  more	  physiological	  3D	  extracellular	  matrix	  environment.	  	  
	  
In	  conclusion,	  work	  arising	  from	  this	  thesis	  has	  led	  us	  to	  propose	  a	  novel	  function	  for	  
fascin	   in	  controlling	  MT-­‐dependent	  FA	  turnover	  and	  thereby	  potentially	  offering	  an	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FUTURE	  DIRECTIONS	  
• Analyse	  fascin	  phosphorylation-­‐dependent	  roles	  in	  regulating	  MT-­‐induced	  FA	  
assembly	  and	  disassembly	  by	  performing	  fixed	  and	  live	  imaging	  experiments	  
in	  cells	  expressing	  fascin	  mutated	  at	  both	  S39	  and	  S274	  (eg.	  S39A/S274D	  or	  
S39D/S274D).	  
	  
• Analyse	   the	   role	   of	   PKA	   in	   S274	   phosphorylation	   in	   vitro	   and	   biochemical	  
analysis	   and	   study	   PKA	   inhibition	   effects	   on	   fascin	   peripheral	   localisation	  
and/or	  pFAK	  activation.	  
	  
• Inhibiting	   FAK	   phosphorylation	   to	   determine	   whether	   this	   alters	   co-­‐
association	  with	  fascin	  and	  analyse	  the	  potential	  role	  of	  a	  fascin-­‐inactive	  FAK	  
complex.	  
	  
• Characterise	  the	  MT-­‐binding	  domain	  of	  fascin	  by	  performing	   in	  vitro	  MT	  co-­‐
sedimentation	  assay	  using	   fascin	  mutated	  within	   the	  putative	   identified	  MT	  
binding	  region	  within	  the	  second	  β-­‐trefoil	  domain	  of	  fascin.	  
	  
• Elucidate	   the	   role	   of	   fascin	   in	   MT	   growth	   and	   stability	   by	   analysing	   MT	  
dynamics	  in	  live	  imaging	  experiments	  in	  fascin	  knockdown	  and	  cells	  rescued	  
for	  different	  fascin	  mutants.	  
	  
• Inhibit	   enzymes	   involved	   in	   tubulin	   post-­‐translational	   modification	   such	   as	  
HDAC6	   to	   identify	   signaling	   pathways	   involved	   in	   fascin-­‐dependent	   MT	  
stability.	  	  
	  
• Analyse	   fascin-­‐dependent	   regulation	   of	   MT	   growth	   and	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